TITLE 1. ADMINISTRATION
OFFICE OF THE STATE INSPECTOR GENERAL
Final Regulation
Title of Regulation: 1VAC42-30. Fraud and Abuse
Whistle Blower Reward Fund (adding 1VAC42-30-10 through 1VAC42-30-100).
Statutory Authority: § 2.2-3014 of the Code of Virginia.
Effective Date: June 27, 2019.
Agency Contact: Mark Courtney, Regulatory Coordinator,
Office of the State Inspector General, P.O. Box 1151, Richmond, VA 23218,
telephone (804) 625-3255, FAX (804) 371-0165, or email
mark.courtney@osig.virginia.gov.
Summary:
The regulation defines the Fraud and Abuse Whistle Blower
Reward Fund and its administration by the Office of the State Inspector
General, including (i) eligibility requirements, (ii) amount and distribution,
(iii) process for leftover moneys at the end of the fiscal year, and (iv) the
fund's establishment on the books of the Comptroller.
Summary of Public Comments and Agency's Response: No
public comments were received by the promulgating agency.
CHAPTER 30
FRAUD AND ABUSE WHISTLE BLOWER REWARD FUND
1VAC42-30-10. Definitions.
The following words and terms when used in this chapter
shall have the following meanings unless the context clearly indicates
otherwise:
"Abuse" means an employer's or employee's
conduct or omissions that result in substantial misuse, destruction, waste, or
loss of funds or resources belonging to or derived from federal, state, or
local government sources.
"Commonwealth" means the Commonwealth of
Virginia.
"Disclosure" means a voluntary formal or
informal communication or transmission of (i) any violation of any law, rule,
or regulation; (ii) gross mismanagement; (iii) a gross waste of funds; (iv) an
abuse of authority; or (v) a substantial and specific danger to public health
or safety.
"Employee" means any individual who is employed
on either a salaried or wage basis, whose tenure is not restricted as to
temporary or provisional appointment, in the service of and whose compensation
is payable no more often than biweekly in whole or in part by a Virginia
governmental agency.
"Employer" means a person supervising one or
more employees, including the employee filing a good faith report, a superior
of that supervisor, or an agent of the governmental agency.
"Executive branch agency" or "agency"
means any agency, institution, board, bureau, commission, council, public
institution of higher education, or instrumentality of state government in the
executive department listed in the appropriation act.
"Fraud" means the intentional deception
perpetrated by an individual or an organization, either internal or external to
state government, that could result in a tangible or intangible benefit to
themselves, others, or the Commonwealth, including local government, or could
cause detriment to others or the Commonwealth. Fraud includes a false
representation of the facts, whether by words or by conduct. Fraud also
includes false or misleading statements, the concealment of essential
information, or information or actions that deceive or are intended to deceive.
"Fraud and Abuse Whistle Blower Protection Act
Program" or "WBPA Program" means the policy of the Commonwealth
that Commonwealth citizens and employees of state government are freely able to
report instances of wrongdoing or abuse committed by their employing agency,
other state agencies, or independent contractors of state agencies.
"Fraud and Abuse Whistle Blower Reward Fund" or
"fund" means the fund used solely to provide monetary rewards to
Commonwealth citizens who have disclosed information of wrongdoing or abuse
under the WBPA Program that results in a recovery of at least $5,000.
"Good faith report" means a reported incident of
possible wrongdoing or abuse made without malice, for which the person
reporting has reasonable cause to believe wrongdoing or abuse occurred.
"Governmental agency" means (i) any agency,
institution, board, bureau, commission, council, or instrumentality of state
government in the executive branch listed in the appropriation act and any
independent agency; (ii) any county, city, town, or local or regional
governmental authority; and (iii) any local school division as defined in § 22.1-280.2:2
of the Code of Virginia.
"Hotline coordinator" means a qualified
employee, designated by a governmental agency director or chief administrator,
responsible for conducting State Fraud, Waste and Abuse Hotline investigations
referred to the agency by OSIG.
"Internal audit director" means a director of a
governmental agency internal audit program.
"Misconduct" means conduct or behavior by an
employee that is inconsistent with state, local, or agency standards for which
specific corrective or disciplinary action is warranted.
"Nonstate agency" means any public or private
foundation, authority, institute, museum, corporation, or similar organization
that is (i) not a unit of state government or a political subdivision of the
Commonwealth as established by general law or special act and (ii) wholly or
principally supported by state funds. "Nonstate agency" shall not
include any such entity that receives state funds (a) as a subgrantee of a
state agency; (b) through a state grant-in-aid program authorized by law; (c)
as a result of an award of a competitive grant or a public contract for the
procurement of goods, services, or construction; or (d) pursuant to a lease of
real property as described in subdivision 5 of § 2.2-1149 of the Code of
Virginia.
"Office of the State Inspector General" or
"OSIG" means the governmental agency that conducts independent
investigations, performance audits, and other services designed to provide
objective and useful information to the Commonwealth and those charged with its
governance and promotes efficiency and effectiveness in state government
executive branch agencies in accordance with Article 1 (§ 2.2-307 et seq.)
of Chapter 13.2 of the Code of Virginia.
"Public body" means any legislative body; any
authority, board, bureau, commission, district, agency, or political
subdivision of the Commonwealth, including counties, cities, towns, city
councils, boards of supervisors, school boards, planning commissions, and
boards of visitors of institutions of higher education; and other
organizations, corporations, or agencies in the Commonwealth supported wholly
or principally by public funds. "Public body" includes any committee,
subcommittee, or other entity however designated of the public body or formed
to advise the public body, including those with private sector or citizen
members and corporations organized by the Virginia Retirement System. For the
purposes of this chapter, the term "public body" does not include the
courts of the Commonwealth.
"Reward" means a monetary benefit payable from
the fund by OSIG to an eligible whistle blower.
"Screening process" means OSIG's internal review
to ensure reports of information or disclosures of wrongdoing fall within the
authority of the WBPA Program.
"State Fraud, Waste and Abuse Hotline" or
"hotline" means the program (i) that provides Commonwealth citizens
with a confidential and anonymous method to report suspected occurrences of
fraud, waste, and abuse in state agencies and institutions and (ii) that
provides the Commonwealth a way to investigate such occurrences to determine
their validity and make appropriate recommendations to address deficiencies.
"Whistle blower" means a Commonwealth employee
or citizen who witnesses or has evidence of wrongdoing or abuse and who makes a
good faith, open, and public report of the wrongdoing or abuse to one of the
employee's superiors, an agent of the employer, or an appropriate authority.
"Wrongdoing" means a violation, which is not of
a merely technical or minimal nature, of a federal or state law or regulation
or a formally adopted code of conduct or ethics of a professional organization
designed to protect the interests of the public or an employee.
"Wrongdoing" includes (i) any violation of any law, rule, or
regulation; (ii) gross mismanagement; (iii) a gross waste of funds; (iv) an
abuse of authority; or (v) a substantial and specific danger to public health
or safety.
1VAC42-30-20. Office of the State Inspector General
responsibilities.
A. OSIG is responsible for administering the WBPA Program
and fund and the following tasks:
1. Notifying annually Commonwealth employees, citizens, and
governmental bodies, including state agencies, of the WBPA Program and fund
regulations and procedures for submitting information regarding wrongdoing or
abuse.
2. Protecting the identity of Commonwealth employees and
citizens who make allegations of wrongdoing or abuse through the WBPA Program.
OSIG will keep this information confidential to the extent allowed by law.
3. Conducting appropriate investigations and preparing
official reports.
4. Receiving and evaluating fund claims.
5. Ensuring payment of approved fund moneys to whistle
blowers.
6. Submitting an annual report on WBPA Program activities
to the Governor and General Assembly.
7. Notifying individuals making allegations of the possible
incentives as a result of moneys recovered and available through the fund.
B. OSIG is responsible for assigning, coordinating, and
investigating alleged wrongdoing or abuse reported to OSIG under the WBPA
Program. OSIG may work with executive branch agency internal audit directors,
executive branch agency hotline coordinators, or representatives of public
bodies when performing WBPA Program investigations.
1VAC42-30-30. Fraud and Abuse Whistle Blower Protection Act
Program and Reward Fund notification.
A. Annually, the State Inspector General will communicate
with all state agency heads. The communication will:
1. Publicize the WBPA Program and fund.
2. Explain the protections afforded to individuals who
report instances of wrongdoing or abuse committed within executive branch
agencies and nonstate agencies.
3. Notify state agency heads of relevant statutory
amendments or program changes.
4. Contain the requirements for reporting allegations to
OSIG and the incentives under the WBPA Program.
5. Clarify pertinent differences between the WBPA Program
and the hotline regarding the rules governing anonymity and confidentiality.
6. Provide available materials to assist agency heads in
promoting the WBPA Program and fund, as well as available training for Commonwealth
employees regarding the WBPA Program and fund.
B. Annually, OSIG will publicize the WBPA Program and fund
on the OSIG website and to Commonwealth citizens through the distribution of a
news release to Virginia media, as well as to state employees through an
electronic communication in partnership with the Department of Human Resource
Management. The communication will:
1. Contain the requirements for reporting allegations to
OSIG and the incentives under the WBPA Program.
2. Clarify pertinent differences between the WBPA Program
and the hotline regarding the rules governing anonymity and confidentiality.
1VAC42-30-40. Reporting alleged fraud, abuse, or wrongdoing.
A. A Commonwealth employee or citizen with an allegation
of wrongdoing or abuse under the WBPA Program may contact OSIG by phone, email,
online complaint form, United States Postal Service, or FAX.
B. OSIG staff is available to advise citizens on what to
report that meets the definition of wrongdoing or abuse.
C. If an investigation results in recoverable funds, and
the whistle blower seeks to file a fund claim under the WBPA Program, the
whistle blower will be required to provide his name and lawful residence.
While not anonymous, OSIG will keep this information
confidential to the extent allowed by law.
1VAC42-30-50. Office of the State Inspector General receipt
of an allegation.
A. Allegations of wrongdoing or abuse received by OSIG
undergo the hotline screening process.
B. Allegations submitted by an individual who is not a
Commonwealth employee or citizen will be referred to the appropriate
governmental agency or organization.
C. If the agency or organization reported is not an
executive branch or independent state agency or entity or a local governmental
agency or entity or school division, the information will be forwarded to that
entity where possible for informational purposes only.
1VAC42-30-60. Allegation investigative process.
A. OSIG will prepare a detailed written summary that
describes the allegation of wrongdoing or abuse submitted through the WBPA
Program.
B. The hotline manager or designee will create a
confidential tracking number for each case and assign it for formal
investigation.
C. OSIG will monitor the progress of each investigation
and provide the State Inspector General with regular status updates of the
assignment.
D. Upon completion of an investigation, the investigator
will prepare and submit a case report for management review and approval. When
appropriate, recommendations for corrective action to address procedural
deficiencies disclosed during the investigation will be included in the case
report.
E. Formal case reports will describe all financial
recovery realized on behalf of the Commonwealth as a result of the information
received from the whistle blower and the subsequent investigation.
F. Case reports will be forwarded to the State Inspector
General for review. Upon authorization by the State Inspector General, the
investigator will prepare an executive summary that recaps the findings of the
investigation, the recommendations, the recovery of funds, and the status of
applicable fund claims. Upon signature approval of the State Inspector General,
the executive summary will be forwarded to the subject state executive branch
agency head, respective secretariat, and the Chief of Staff of the Governor.
1VAC42-30-70. Nonreverting fund.
A. OSIG will coordinate with the State Comptroller to
establish a special nonreverting fund.
B. The fund will be established on the books of the State
Comptroller and administered by the State Inspector General.
C. All moneys recovered by an OSIG investigation as a
result of whistle blower activity shall be deposited in the fund.
D. Except for the moneys described in subsection F of this
section, moneys remaining in the fund at the end of each fiscal year, including
interest, shall not revert to the general fund, but shall remain in the fund.
E. Moneys in the fund shall solely be used to:
1. Provide monetary rewards to Commonwealth employees and
citizens who have disclosed information of wrongdoing or abuse under the WBPA
Program (§ 2.2-3009 et seq. of the Code of Virginia), and the disclosure
resulted in a recovery of at least $5,000.
2. Support the administration of the fund, defray fund
advertising costs, or subsidize the operation of the hotline.
F. Per the State Inspector General's authorization by the
end of each calendar quarter, 85% of all sums recovered by an OSIG
investigation will be remitted to the institutions or agencies concerned,
unless otherwise directed by a court of law.
1VAC42-30-80. Fund payments to whistle blowers.
A. Within 10 working days, excluding state holidays and
weekends, of the closing of a WBPA Program investigation that verifies a final
recovery and deposit in the fund of $5,000 or more, the State Inspector General
will review and certify the fund claim. Within five working days after the
State Inspector General's verification, the whistle blower will be notified of
the award amount he is eligible to receive. Upon approval of the fund claim,
the State Inspector General will submit a written request to the State
Comptroller to make a reward payment from the fund to the whistle blower.
B. The State Treasurer will make reward payments from the
fund based on a warrant issued by the State Comptroller and a written request
signed by the State Inspector General.
C. Award amounts.
1. The amount of the fund reward shall be up to 10% of the
actual sums recovered by the Commonwealth as a result of the disclosure of the
wrongdoing or abuse.
2. OSIG will consider many factors in determining the
amount of an award based on the unique facts and circumstances of each case.
OSIG may increase the award percentage up to the maximum allowed based on the
following factors: (i) the significance of the information provided to OSIG to
the success of any proceeding brought against wrongdoers; (ii) the extent of
the assistance provided to OSIG in its investigation and any resulting
findings; (iii) OSIG's law-enforcement interest in deterring violations of the
applicable laws by making awards to whistle blowers who provide information
that leads to the successful enforcement of these laws; and (iv) whether and
the extent to which the whistle blower participated in his agency's internal
compliance systems, such as, for example, reporting the possible violations
through internal whistle blower, legal, or compliance procedures, before or at
the same time the possible violations were reported to OSIG.
3. OSIG may reduce the amount of an award based on the
following: (i) if the whistle blower was a participant in or culpable for the
violations reported; (ii) if the whistle blower unreasonably delayed reporting
the violations to OSIG; and (iii) if the whistle blower interfered with his
agency's internal compliance and reporting systems, such as, for example,
making false statements to the compliance department that hindered its efforts
to investigate possible wrongdoing or abuse.
4. The amount of the reward will not exceed the balance of
the fund, regardless of the sums recovered.
5. In the event that multiple whistle blowers have
simultaneously reported the same fund-eligible occurrence of wrongdoing or
abuse, the fund moneys may be split up to 10% among the whistle blowers at the
State Inspector General's discretion. The State Inspector General's decision
regarding the allocation of fund moneys is final and binding upon all parties
and cannot be appealed.
6. The request for payment will include the name and
address of the whistle blower and the payment amount. OSIG will provide
documentation supporting the amount of the payment to the State Comptroller.
7. Once approved, the State Comptroller shall forward the
request to Finance and Administration of the Department of Accounts (DOA) with
a request that Finance and Administration process the payment to the whistle
blower.
8. DOA will ensure the amount of the fund reward is
properly included in the whistle blower's federal and state tax records (i.e.,
W-2 for employees; 1099 for Commonwealth citizens).
9. OSIG will confirm that DOA processes the fund request
and that the reward payment is made to the whistle blower for the amount
approved by the State Inspector General.
D. Five percent of all sums recovered on behalf of the
Commonwealth will be retained in the fund to support the administration of the
fund, defray advertising costs, and subsidize the operation of the hotline.
Expenditures for administrative costs for management of the fund will be
approved by the State Inspector General.
1VAC42-30-90. Whistle blower protections.
A. Employee protections.
1. No employer may discharge,
threaten, or otherwise discriminate or retaliate against a whistle blower,
whether acting individually or under the direction of another individual.
2. No employer may discharge, threaten, or otherwise
discriminate or retaliate against a whistle blower who is requested or
subpoenaed by an appropriate authority to participate in an investigation,
hearing, or inquiry.
3. Nothing in this chapter shall prohibit an employer from
disciplining or discharging a whistle blower for misconduct or violation of
criminal law.
4. If an employee has, in
good faith, exhausted existing internal procedures for reporting and seeking
recovery of falsely claimed sums through official channels, and if the
Commonwealth failed to act on the information provided in a reasonable period
of time, no court shall have jurisdiction over an action brought under § 8.01-216.5 of the Code of Virginia based on information
discovered by a present or former employee of the Commonwealth during the
course of his employment.
5. Any whistle blower covered
by the state grievance procedure may initiate a grievance alleging retaliation
for reporting wrongdoing or abuse through the WBPA Program and may request
relief throughout that procedure.
B. Commonwealth citizen protections.
1. No governmental agency may
threaten or otherwise discriminate or retaliate against a citizen whistle
blower because the whistle blower is requested or subpoenaed by an appropriate
authority to participate in an investigation, hearing, or inquiry.
2. Except for the provisions
of § 2.2-3011 E of the Code of Virginia, the WBPA Program does not limit the
remedies provided by the Virginia Fraud Against Taxpayers Act (§ 8.01-216.1
et seq. of the Code of Virginia).
C. Protection against
discrimination and retaliation - good faith required.
1. To be protected by the
provisions of this chapter, an employee or Commonwealth citizen who discloses
information about suspected wrongdoing or abuse shall do so in good faith and
upon a reasonable belief information provided is accurate.
2. Reckless disclosures or
disclosures the employee or citizen knows or should have known were false,
confidential by law, or malicious are not deemed good faith reports and are not
protected.
1VAC42-30-100. Whistle Blower Protection Act Program and
Reward Fund annual report.
A. OSIG shall submit an annual report to the Governor and
the General Assembly of Virginia summarizing the activities of the fund.
B. OSIG will provide a copy of the WBPA Program annual
report to the Chief of Staff to the Governor, the Secretary of Finance, and the
State Comptroller.
VA.R. Doc. No. R16-4186; Filed May 7, 2019, 10:34 a.m.
TITLE 2. AGRICULTURE
BOARD OF AGRICULTURE AND CONSUMER SERVICES
Final Regulation
REGISTRAR'S NOTICE: The
Board of Agriculture and Consumer Services is claiming an exemption from the
Administrative Process Act in accordance with § 2.2-4002 A 13 of the Code
of Virginia, which excludes the board when promulgating regulations pursuant to
§ 3.2-5206 of the Code of Virginia.
Title of Regulation: 2VAC5-490. Regulations Governing
Grade "A" Milk (amending 2VAC5-490-50).
Statutory Authority: § 3.2-5206 of the Code of Virginia.
Effective Date: May 27, 2019.
Agency Contact: Ryan Davis, Program Manager, Office of
Dairy and Foods, Department of Agriculture and Consumer Services, P.O. Box
1163, Richmond, VA 23218, telephone (804) 786-8899, FAX (804) 371-7792, TTY
(800) 828-1120, or email ryan.davis@vdacs.virginia.gov.
Summary:
In response to a petition for rulemaking, the amendments
reduce maximum bacteria count to 50,000 bacteria per milliliter of milk and
reduce maximum somatic cell count to 500,000 per milliliter of milk as
standards that must be met for milk to be considered grade A in Virginia.
Additional amendments since publication of the proposed regulation clarify that
these reductions only apply to cow's milk.
Part VI
Standards for Milk and Milk Products
2VAC5-490-50. Quality standards for milk and milk products.
A. No person may produce, provide, manufacture, sell, offer
for sale, or store in the Commonwealth, or bring, send, or receive into the
Commonwealth, any milk, milk product, condensed milk product, or dry milk
product for use in the commercial preparation of grade A pasteurized,
ultra-pasteurized, or aseptically processed milk or milk products that do not
comply with the following:
1. Grade A raw milk for pasteurization or
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging and all grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall be produced, processed, manufactured and pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaged to conform with the following chemical, physical,
bacteriological, somatic cell, and temperature standards, and with the
requirements of this chapter;
2. No process or manipulation other than (i) pasteurization;
(ii) ultra-pasteurization; (iii) aseptic processing and packaging; (iv) retort
processed after packaging; or (v) processing methods integral with
pasteurization, ultra-pasteurization, aseptic processing and packaging, or
retort processed after packaging; and refrigeration may be applied to milk or
milk products for the purpose of removing or deactivating microorganisms
provided that filtration, bactofugation, or filtration and bactofugation may be
performed in the plant in which the milk or milk product is pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaged. Nothing in this chapter is deemed to prohibit any grade A
permit holder who operates a milk plant from preparing bulk shipments of cream,
skim milk, reduced fat or lowfat milk labeled as "heat treated"; if
the raw milk, raw cream, skim milk, reduced fat or lowfat milk is heated, one
time, to a temperature warmer than 125°F but cooler than 161°F for separation
purposes. In the case of heat treated cream, the cream may be further heated to
less than 166°F in a continuing heating process and immediately cooled to 45°F
or less when necessary for enzyme deactivation (such as lipase reduction) for a
functional reason;
3. Grade A raw milk and milk products for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall comply with the following standards:
a. The temperature of the raw milk shall be cooled to 40°F or
cooler, but not frozen, within two hours after milking and the temperature
after the first or any subsequent milking shall not be warmer than 50°F;
b. The bacteria count of [ the ] raw [ cow's ]
milk shall not exceed 100,000 50,000 bacteria per milliliter
prior to commingling with any other milk; and the bacteria count of [ the ]
raw [ cow's ] milk that is commingled shall not exceed 300,000
bacteria per milliliter prior to pasteurization;
c. [ The bacteria count of raw sheep's milk, raw
goat's milk, raw water buffalo's milk, or raw milk from any other hooved mammal
shall not exceed 100,000 bacteria per milliliter prior to commingling with any
other milk; and the bacteria count of raw sheep's milk, raw goat's milk, raw
water buffalo's milk, or raw milk from any other hooved mammal that is
commingled shall not exceed 300,000 bacteria per milliliter prior to
pasteurization;
d. ] Raw milk shall freeze at or below -0.530°
Hortvet;
[ d. e. ] Raw milk shall have no
positive results of tests for drug residues by detection methods reported to
the State Regulatory Authority by official laboratories, officially designated
laboratories, milk plants, receiving stations, or transfer stations;
[ e. f. ] The somatic cell count of
raw cow's milk [ , raw water buffalo's milk, or raw sheep's milk ]
shall not exceed 750,000 500,000 somatic cells per milliliter.
[ The somatic cell count of raw water buffalo's milk, raw sheep's milk,
or raw milk from any other hooved mammal shall not exceed 750,000 somatic cells
per milliliter. ] The somatic cell count of raw goat's milk shall not
exceed 1,500,000 somatic cells per milliliter;
[ f. g. ] Raw milk shall not exceed
the actionable level, tolerance level, or safe level for any chemical residue
or pesticide residue specified in 40 CFR Part 180 and 21 CFR Parts 70, 71,
73, 74, 80, 82, 130, 131, 133, 170, 172, 173, 174, 175, 176, 177, 178, 189,
556, 570, 573, and 589. In the event that no actionable level, tolerance
level, or safe level for a chemical residue or pesticides residue has been
established in 40 CFR Part 180 and 21 CFR Parts 70, 71, 73, 74, 80, 82,
130, 131, 133, 170, 172, 173, 174, 175, 176, 177, 178, 189, 556, 570, 573, and
589, the tolerance level shall be deemed to be zero; and
[ g. h. ] Raw milk shall not contain
aflatoxin residues equal to or greater than 0.50 parts per billion as
determined by the Charm II aflatoxin test or other equivalent method;
4. Grade A pasteurized or ultra-pasteurized milk and milk
products shall comply with the following standards:
a. The temperature of milk products shall be cooled to 45°F or
cooler (but not frozen) and maintained at that temperature;
b. The bacteria count for any milk or milk products (except
acidified or cultured milk or milk products, eggnog, cottage cheese, and other
milk or milk products as identified in FDA M-a-98) shall not exceed 20,000
bacteria per milliliter;
c. Except for commingled milk shipped in a transport tank the
coliform count for any milk or milk products shall not exceed 10 coliform
organisms per milliliter. Commingled milk shipped in a transport tank shall not
exceed 100 coliform organisms per milliliter;
d. The phenol value of test samples of pasteurized finished
product shall be no greater than the maximum specified for the particular
product as determined and specified by (i) any phosphatase test method
prescribed in the Official Methods of Analysis, 19th Edition, 2012, published
by the Association of Official Analytical Chemists; (ii) the Fluorometer test
method; (iii) the Charm ALP test method; or (iv) other equivalent method as
determined by the Virginia Department of Agriculture and Consumer Services. A
phenol value greater than the maximum specified for the particular product
shall mean that the product was not properly pasteurized. A phenol value less
than the maximum specified for the particular product shall not be deemed to
mean that the product was properly pasteurized, unless there is evidence of
proper pasteurization equipment in conformance with this chapter and records to
determine an adequate pasteurization process has been completed for each
separate batch or lot of milk, milk product, condensed milk, condensed milk
product, dry milk, or dry milk product;
e. Milk or milk products shall have no positive results of
tests for drug residues by detection methods reported to the State Regulatory
Authority by official laboratories, officially designated laboratories, milk
plants, receiving stations, or transfer stations;
f. Milk or milk products shall not exceed the actionable
level, tolerance level, or safe level for any chemical residue or pesticide
residue specified in 40 CFR Part 180 and 21 CFR Parts 70, 71, 73, 74, 80, 82,
130, 131, 133, 170, 172, 173, 174, 175, 176, 177, 178, 189, 556, 570, 573, and
589. In the event that no actionable level, tolerance level, or safe level for
a chemical residue or pesticides residue has been established in 40 CFR Part
180 and 21 CFR Parts 70, 71, 73, 74, 80, 82, 130, 131, 133, 170, 172, 173, 174,
175, 176, 177, 178, 189, 556, 570, 573, and 589, the tolerance level
shall be deemed to be zero; and
g. Milk or milk products shall not contain aflatoxin residues
equal to or greater than 0.50 parts per billion as determined by the Charm II
aflatoxin test or other equivalent method;
5. Grade A pasteurized concentrated (condensed) milk or milk
product shall comply with the following standards:
a. The temperature of milk products shall be cooled to 45°F or
cooler (but not frozen) and maintained thereat unless drying is commenced
immediately after condensing;
b. Except for commingled milk shipped in a transport tank, the
coliform count for any milk or milk product shall not exceed 10 coliform
organisms per gram. Commingled milk shipped in a transport tank shall not
exceed 100 coliform organisms per gram;
6. Grade A aseptically processed and packaged milk and milk
products shall comply with the following standards:
a. Aseptically processed and packaged milk and milk products
shall be commercially sterile;
b. Aseptically processed and packaged milk and milk products
shall have no positive results of tests for drug residues by detection methods
reported to the State Regulatory Authority by official laboratories, officially
designated laboratories, milk plants, receiving stations, or transfer stations;
c. Aseptically processed and packaged milk and milk products
shall not exceed the actionable level, tolerance level, or safe level for any
chemical residue or pesticide residue specified in 40 CFR Part 180 and 21 CFR
Parts 70, 71, 73, 74, 80, 82, 130, 131, 133, 170, 172, 173, 174, 175, 176, 177,
178, 189, 556, 570, 573, and 589. In the event that no actionable level,
tolerance level, or safe level for a chemical residue or pesticides residue has
been established in 40 CFR Part 180 and 21 CFR Parts 70, 71, 73, 74, 80, 82,
130, 131, 133, 170, 172, 173, 174, 175, 176, 177, 178, 189, 556, 570, 573, and
589, the tolerance level shall be deemed to be zero; and
d. Aseptically processed and packaged milk and milk products
milk shall not contain aflatoxin residues equal to or greater than 0.05 parts
per billion;
7. Grade A nonfat dry milk and dry milk or milk products shall
comply with the following standards:
a. The bacteria count shall not exceed 10,000 bacteria per
gram, and
b. The coliform count shall not exceed 10 coliform organisms
per gram;
8. Grade A whey for condensing or drying shall be maintained
at a temperature of 45°F (7°C) or less, or 135°F (57°C) or greater; provided that,
acid-type whey with a titratable acidity of 0.40% or above or a pH of 4.6 or
below shall be exempt for the requirements of this subdivision;
9. Grade A pasteurized condensed whey and whey products shall
be cooled to 50°F (10°C) or less during crystallization and within 72 hours of
condensing. The coliform count of grade A pasteurized condensed whey and whey
products shall not exceed 10 coliform organisms per gram; and
10. The coliform count of grade A dry whey, grade A dry whey
products, grade A dry buttermilk, and grade A dry buttermilk products shall not
exceed 10 coliform organisms per gram.
B. Sanitation requirements for grade A raw milk.
1. Each person who holds a grade A permit to produce raw milk
for pasteurization, ultra-pasteurization, aseptic processing and packaging, or
retort processed after packaging shall comply with:
a. The following administrative procedures contained in the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision":
Section 4; Section 7, Items 1r, 2r, 3r, 4r, 5r, 6r, 7r, 8r, 9r, 10r(1), 10r(2),
11r, 12r, 13r, 14r, 15r, 16r, 17r, 18r(2), 18r(3), and 19r; Section 8;
Section 10; and Section 13;
b. The following appendices contained in the "Grade
"A" Pasteurized Milk Ordinance, 2013 Revision": Appendices A, B,
C, D, F, G, H, N, Q, and R;
c. Item 1r. Abnormal milk. Each person who holds a grade A
permit to produce raw milk for pasteurization, ultra-pasteurization, aseptic
processing and packaging, or retort processed after packaging shall:
(1) Milk last or with separate equipment cows, sheep, goats,
water buffalo, or other mammals that show evidence of the secretion of abnormal
milk in one or more quarters (based upon bacteriological, chemical, or physical
examination) and discard the milk obtained from cows, sheep, goats, water
buffalo, or other mammals that show evidence of the secretion of abnormal milk
in one or more quarters based upon bacteriological, chemical, or physical
examination; and
(2) Milk last or with separate equipment cows, sheep, goats,
water buffalo, or other mammals treated with, or that have consumed, chemical,
medicinal, or radioactive agents that are capable of being secreted in the milk
and that may be deleterious to human health; and dispose of in a manner that
will not pollute the environment or any human food the milk obtained from cows,
sheep, goats, water buffalo, or other mammals treated with, or that have
consumed, chemical, medicinal, or radioactive agents that are capable of being
secreted in the milk and that may be deleterious to human health;
d. Item 2r. Milking barn, stable, or parlor; construction.
Each person who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Provide on the person's dairy farm a milking barn, stable,
or parlor in which the milking herd shall be housed during milking time;
(2) Provide on the grade A permit holder's dairy farm a
milking barn, stable, or parlor, which milking barn, stable, or parlor shall:
(a) Have floors constructed of concrete or equally impervious
material;
(b) Have walls and ceiling that are smooth, painted, or
finished in an approved manner, and in good repair and have a ceiling which is
dust tight;
(c) Have separate stalls or pens for horses, calves, and
bulls;
(d) Have natural or artificial light, well distributed for day
or night milking;
(e) Have sufficient air space and air circulation to prevent
condensation and excessive odors;
(f) Have dust-tight covered boxes or bins, or separate storage
facilities for ground, chopped, or concentrated feed; and
(g) Not be overcrowded; and
(3) Provide and use only an "automatic milking
installation" that complies with the requirements of Appendix Q of the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision" if
the person milks any cows, goats, sheep, water buffalo, or other mammals
(except humans) using robots or other automated means in the absence of any
human;
e. Item 3r. Milking barn, stable, or parlor; cleanliness. Each
person who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Keep the interior of the milking barn, stable, or parlor
clean;
(2) Keep the floors, walls, ceilings, windows, pipelines, and
equipment in the milking barn, stable, or parlor free of filth or litter and
clean;
(3) Keep swine and fowl out of the milking barn, stable, and
parlor;
(4) Keep surcingles, belly straps, milk stools, and
antikickers clean and stored above the floor; and
(5) Store feed in a manner that will not increase the dust
content of the air or interfere with the cleaning of the floor;
f. Item 4r. Cow yard, sheep yard, goat yard, water buffalo
yard, or other milking mammal yard. Each person who holds a grade A permit to
produce raw milk for pasteurization, ultra-pasteurization, aseptic processing
and packaging, or retort processed after packaging shall:
(1) Provide and maintain the cow yard, sheep yard, goat yard,
water buffalo yard or other milking mammal yard, to be graded and drained, and
to have no standing pools of water or accumulations of organic wastes;
(2) In the cow loafing, goat loafing, sheep loafing, water
buffalo loafing, or other milking mammal loafing, cattle-housing, sheep-housing,
goat-housing, water buffalo-housing, or other milking mammal-housing areas
remove cow droppings, sheep droppings, goat droppings, water buffalo droppings,
and other milking mammal droppings and remove soiled bedding or add clean
bedding at sufficiently frequent intervals to prevent the soiling of the cow's,
sheep's, goat's, water buffalo's, or other milking mammal's udder and flanks;
(3) Assure that waste feed does not accumulate in the goat
yard, cow yard, sheep yard, water buffalo yard, other milking mammal yard, cow
loafing, sheep loafing, goat loafing, water buffalo loafing, other milking
mammal loafing, cattle-housing, sheep-housing, goat-housing, water
buffalo-housing, or other milking mammal-housing area;
(4) Maintain any manure packs so as to be properly drained and
so as to provide a reasonably firm footing; and
(5) Keep swine and fowl out of the cow yard, sheep yard, goat
yard, water buffalo yard, other milking mammal yard, cow loafing, sheep
loafing, goat loafing, water buffalo loafing, other milking mammal loafing,
cattle-housing, sheep-housing, goat-housing, water buffalo-housing, or other
milking mammal-housing area;
g. Item 5r. Milkhouse or room; construction and facilities.
Each who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Provide a milkhouse or milkroom of sufficient size in
which the cooling, handling, and storing of milk and the washing, sanitizing,
and storing of milk containers and utensils shall be conducted except as
provided under subdivision 1 n of this subsection;
(2) Provide a milkhouse with a smooth floor, constructed of
concrete or equally impervious material graded to drain, and maintained in good
repair;
(3) Dispose of in a sanitary manner all liquid waste generated
in the milkhouse;
(4) Provide one or more floor drains in the milkhouse, which
floor drains shall be accessible, and if connected to a sanitary sewer system
trapped;
(5) Provide in the milkhouse walls and ceilings constructed of
a smooth material, in good repair, well painted, or finished in an equally
suitable manner;
(6) Provide adequate natural or artificial light and
ventilation in the milkhouse;
(7) Use the milkhouse for no other purpose than milkhouse
operations;
(8) Provide no direct opening from the milkhouse into any
barn, stable, or into any room used for domestic purposes, other than a direct
opening between the milkhouse and milking barn, stable, or parlor provided with
a tight-fitting, self-closing, solid door, which door has been hinged to be
single or double acting. Screened vents in the wall between the milkhouse and a
breezeway, which separates the milkhouse from the milking parlor, are
permitted, provided animals are not housed within the milking facility;
(9) Provide in the milkhouse water under pressure which has
been piped into the milkhouse;
(10) Provide in the milkhouse a two-compartment wash vat and
adequate hot water heating facilities;
(11) Except as provided for under subdivision 1 g (12) of this
subsection provide a suitable shelter for the receipt of milk when the grade A
permit holder uses a transportation tank for the cooling or storage of milk on
the grade A permit holder's dairy farm, which shelter adjacent to, but not a
part of, the milkroom; and with the requirements of the milkroom shall comply
with respect to construction, light, drainage, insect and rodent control, and
general maintenance. In addition to providing a suitable shelter as required by
this subsection, the grade A permit holder shall:
(a) Install an accurate, accessible temperature-recording
device in the milk line used to fill the transportation tank downstream from an
effective cooling device capable of cooling the milk to 40°F or less before the
milk enters the transportation tank. Electronic records that comply with the
applicable provisions as referred to in Sections IV and V of Appendix H of the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision," with
or without hard copy, may be used in place of temperature-recording records;
(b) Install an indicating thermometer as close as possible to
the temperature-recording device in the milk line used to fill the
transportation tank to be used for verification of recording temperatures,
which indicating thermometer shall:
(i) Have a temperature span of not less than 50°F including
normal storage temperatures plus or minus 5°F, with an extension of the scale
on either side permitted and graduated in not more than 2°F divisions;
(ii) Have temperature scale divisions spaced not less than
0.0625 inches apart between 35°F and 55°F;
(iii) Have an accuracy within plus or minus 2°F throughout the
scale range; and
(iv) Have the stem fitting installed in a pressure-tight seat
or other sanitary fitting with no threads exposed;
(c) Provide an effective means to agitate the transport tank
or an approved in-line sampling device in order to collect a representative
milk sample;
(12) If the State Regulatory Authority determines conditions
exist whereby the milk transport tank may be adequately protected and sampled
without contamination, a shelter need not be provided if the grade A permit
holder:
(a) Provides a means to make all milk hose connections to the
transport tank accessible from within the milkhouse;
(b) Provides a means to completely protect the milk hose
connection to the transport tank from the outside environment. With approval of
the State Regulatory Authority, the direct loading of milk from the milkhouse
to the milk tank truck may be conducted through a properly designed hose port
that adequately protects the milkhouse opening or by stubbing the milk transfer
and associated CIP cleaned lines outside the milkhouse wall in accordance with
Item 5r, Administrative Procedure #15, of the "Grade "A"
Pasteurized Milk Ordinance, 2013 Revision";
(c) Ensures only milk transport tanks the manholes of which
have been sealed after cleaning and sanitizing are utilized;
(d) Ensures only milk transport tanks that have been washed
and sanitized at permitted dairy plants or a permitted milk tank truck cleaning
facilities acceptable to the State Regulatory Agency are utilized;
(e) Installs an accurate, accessible temperature-recording
device in the milk line used to fill the transportation tank downstream from an
effective cooling device capable of cooling the milk to 40°F or less before the
milk enters the transportation tank. Electronic records that comply with the
applicable provisions as referred to in Sections IV and V of Appendix H of the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision," with
or without hard copy, may be used in place of temperature-recording records;
(f) Installs an indicating thermometer as close as possible to
the temperature-recording device in the milk line used to fill the transportation
tank to be used for verification of recording temperatures, which indicating
thermometer shall:
(i) Have a temperature span of not less than 50°F including
normal storage temperatures plus or minus 5°F, with an extension of the scale
on either side permitted and graduated in not more than 2°F divisions;
(ii) Have temperature scale divisions spaced not less than
0.0625 inches apart between 35°F and 55°F;
(iii) Have an accuracy within plus or minus 2°F throughout the
scale range; and
(iv) Have the stem fitting installed in a pressure-tight seat
or other sanitary fitting with no threads exposed;
(g) Provides an effective means to agitate the transport tank
or an approved in-line sampling device in order to collect a representative
milk sample; and
(h) Provides a self-draining concrete or equally impervious
surface on which the transport tank can be parked during filling and storage;
h. Item 6r. Milkhouse or milkroom; cleanliness. Each person
who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Keep clean the floors, walls, ceilings, windows, tables,
shelves, cabinets, wash vats, nonproduct contact surfaces of milk containers,
utensils, equipment, and other milkroom equipment in the milkroom;
(2) Place in the milkroom only those articles directly related
to milkroom activities; and
(3) Keep the milkroom free of trash, animals, and fowl;
i. Item 7r. Toilets. Each person who holds a grade A permit to
produce raw milk for pasteurization, ultra-pasteurization, aseptic processing
and packaging, or retort processed after packaging shall:
(1) Provide on the person's grade A dairy farm one or more
toilets, which shall be conveniently located and properly constructed, and
operated, and maintained in a sanitary manner;
(2) Prevent the access of flies to the waste contained in or
from the toilet;
(3) Prevent the waste contained in or from the toilet from
polluting the soil surface or contaminating any water supply; and
(4) Assure that there is no direct opening from the toilet
into any milkroom;
j. Item 8r. Water supply. Each person who holds a grade A
permit to produce raw milk for pasteurization, ultra-pasteurization, aseptic
processing and packaging, or retort processed after packaging shall:
(1) Provide water for milkhouse and milking operations from a
water supply properly located, protected, and operated. The water supply shall
be easily accessible, adequate, of a safe, sanitary quality, and meet the
construction standards of Appendix D of the "Grade "A"
Pasteurized Milk Ordinance, 2013 Revision";
(2) Construct the water supply so that no cross connections
between a safe water supply and any unsafe or questionable water supply or
other source of pollution exists; and
(3) Construct the water supply so that no submerged inlets
exist through which a safe water supply may be contaminated;
k. Item 9r. Utensils and equipment-construction. Each person
who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Provide multiuse containers, equipment, and utensils for
use in the handling, storage, or transportation of any milk, which multiuse containers,
equipment, and utensils, shall be made of smooth, nonabsorbent,
corrosion-resistant, and nontoxic materials; constructed as to be easily
cleaned; and maintained in good repair;
(2) Provide milk pails that are constructed to be seamless and
of the hooded type if the grade A permit holder does hand milking and
stripping;
(3) Abstain from using multiple-use woven material for
straining any milk;
(4) Use only single-service articles that have been
manufactured, packaged, transported, stored, and handled in a sanitary manner
and that comply with the requirements of subdivision C 1 of this section;
(5) Abstain from reusing any article intended for
single-service use; and
(6) Provide farm holding or cooling tanks, welded sanitary
piping, and transportation tanks that comply with the requirements of
subdivisions C 1 l and C 1 m of this section on any grade A dairy farm;
l. Item 10r. Utensils and equipment; cleaning. Each person who
holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Clean after each use, or once every 24 hours in the case
of continuous operations, the product-contact surfaces of all multiuse
containers, multiuse equipment, and multiuse utensils used in the handling,
storage, or transportation of any milk;
(2) Offer for sale or sell no milk that has passed through any
equipment if the milk-contact surfaces of the equipment are no longer visible
or are covered or partially covered by an accumulation of milk solids, milk
fat, cleaning compounds, or other soils. Any milk that passes through
equipment, the milk-contact surfaces of which are no longer visible, or are
covered or partially covered by an accumulation of milk solids, milk fat,
cleaning compounds, or other soils shall be deemed adulterated; and
(3) Construct a separate wash manifold for all CIP cleaned
milk pipelines in all new or extensively remodeled facilities;
m. Item 11r. Utensils and equipment; sanitization. Each person
who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall sanitize before each use the product-contact surfaces of
all multiuse containers, equipment, and utensils used in the handling, storage,
or transportation of any milk;
n. Item 12r. Utensils and equipment; storage. Each person who
holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall store containers, utensils, and equipment used in the
handling, storage, or transportation of any milk in a sanitizing solution or
store the containers, utensils, and equipment used in the handling, storage, or
transportation of any milk to assure complete drainage, and protected from
contamination prior to use. Nothing in this requirement shall be deemed to
prohibit a grade A permit holder from storing in a milking barn or milking
parlor a milk pipeline, or the following pipeline milking equipment: milker
claw, inflation, weigh jar, meter, milk hose, milk receiver, tubular cooler,
plate cooler, or milk pump; if the milk pipeline or pipeline milking equipment
specified in this subdivision is designed for mechanical cleaning; and
designed, installed, and operated to protect the milk product and
solution-contact surfaces from contamination at all times;
o. Item 13r. Milking; flanks, udders, and teats. Each person
who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Milk all cows, sheep, goats, water buffalo, and other
mammals in a milking barn, stable, or parlor;
(2) Trim the hair from the udder and tail of all milking cows,
sheep, goats, water buffalo, and other mammals to facilitate cleaning of the
udder and tail;
(3) Keep the flanks, udders, bellies, and tails of all milking
cows, sheep, goats, water buffalo, and other mammals free of visible dirt;
(4) Keep the hair on the udders of all milking cows, sheep,
goats, water buffalo, and other mammals to a length that the hair on the udder
of any cow, sheep, goat, water buffalo, or other mammal cannot be incorporated
with the teat in the inflation during milking;
(5) Abstain from milking any cow, sheep, goat, water buffalo,
or other mammal whose udder or teats is not clean and dry;
(6) Treat with a sanitizing solution, just prior to milking,
the teats of each milking cow, sheep, goat, water buffalo, and other mammal and
dry the teats of each milking cow, sheep, goat, water buffalo, and other mammal
before milking; and
(7) Milk all cows, sheep, goats, water buffalo, and other
mammal with dry hands;
p. Item 14r. Protection from contamination. Each person who
holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall:
(1) Locate and operate the milking and milk house operations,
equipment, and facilities to prevent any contamination of the milk, equipment,
containers, or utensils;
(2) Transfer immediately from the milking barn, stable, or
parlor to the milkhouse each pail or container of milk;
(3) Strain, pour, transfer, or store any milk unless it is
protected from contamination;
(4) Handle all containers, utensils and equipment that have
been sanitized in such a manner as to prevent contamination of any
product-contact surfaces;
(5) Transport from the grade A permit holder's dairy farm to a
milk plant or receiving station all milk in cans, using vehicles that are
constructed and operated to protect the milk from sun, freezing, and
contamination;
(6) Keep clean the inside and outside of each vehicle used to
transport from the grade A permit holder's dairy farm to a milk plant or
receiving station any milk in cans; and
(7) Transport no substance capable of contaminating the milk
when transporting milk;
q. Item 15r. Drug and chemical control. Each person who holds
a grade A permit to produce raw milk for pasteurization, ultra-pasteurization,
aseptic processing and packaging, or retort processed after packaging shall:
(1) Store all drugs and medicinals in such a manner that
neither the drugs nor the medicinals can contaminate any milk or the milk
product-contact surface of any equipment, containers, or utensils;
(2) Abstain from using unapproved or improperly labeled
medicinals or drugs to treat any dairy animals or store unapproved or
improperly labeled medicinals or drugs in the milkhouse, milking barn, stable
or parlor. Except for topical antiseptics, wound dressings (unless intended for
direct injection into the teat), vaccines and other biologics, and dosage form
vitamins and mineral products, a drug or medicinal is properly labeled only if
the drug or medicinal is labeled with the following:
(a) For over-the-counter medicinals or drugs, the name and
address of the manufacturer or distributor, or for prescription and extra-label
use medicinals or drugs, the name of the veterinary practitioner dispensing the
product;
(b) Directions for use of the drug or medicinal and the
prescribed holding time;
(c) Any cautionary statement for the drug or medicinal, if
needed; and
(d) The active ingredient or ingredients in the drug or
medicinal;
(3) Except for topical antiseptics, wound dressings (unless
intended for direct injection into the teat), vaccines and other biologics, and
dosage form vitamins and mineral products, segregate all medicinals and drugs
used for lactating dairy animals from any medicinals and drugs used for
nonlactating dairy animals to include dairy calves, dairy heifers, and dairy
bulls;
(4) Except for topical antiseptics, wound dressings (unless
intended for direct injection into the teat), vaccines and other biologics, and
dosage form vitamins and mineral products, provide separate shelves in a
cabinet, refrigerator, or other storage facility for the storage of all
medicinals and drugs for treatment of nonlactating dairy animals, to include
dairy calves, dairy heifers, and dairy bulls, separate from those medicinals or
drugs used for lactating dairy animals; and
(5) Store topical antiseptics, wound dressings (unless
intended for direct injection into the teat), vaccines and other biologics, and
dosage-form vitamins and mineral products in a manner that does not contaminate
any milk or the milk-product surfaces of any containers or utensils;
r. Item 16r. Personnel; hand-washing facilities. Each person
who holds a grade A permit to produce raw milk for pasteurization,
ultra-pasteurization, aseptic processing and packaging, or retort processed
after packaging shall provide hand-washing facilities that are convenient to
the milkhouse, milking barn, stable, or parlor, and flush toilet and that
include separate hot and cold running water; soap or detergent; and individual
sanitary towels or other approved hand-drying devices. When individual sanitary
towels are used, covered trash containers shall be provided;
s. Item 17r. Personnel; cleanliness. Each person who holds a
grade A permit to produce raw milk for pasteurization, ultra-pasteurization,
aseptic processing and packaging, or retort processed after packaging shall:
(1) Wash clean and dry with an individual sanitary towel or other
approved hand drying device the person's hands immediately before milking,
before performing any milkhouse function, and immediately after the
interruption of milking or performing any milkhouse function; and
(2) Wear clean outer garments while milking or handling any
milk, milk containers, utensils, or equipment. Bulk milk haulers shall wear
clean outer garments while handling any milk, milk containers, utensils, or
equipment;
t. Item 18r. Cooling. Each person who holds a grade A permit
to produce raw milk for pasteurization, ultra-pasteurization, aseptic
processing and packaging, or retort processed after packaging shall:
(1) Cool to 40°F or cooler (but not freeze) all raw milk for
pasteurization, ultra-pasteurization, aseptic processing and packaging, or
retort processed after packaging within two hours after the grade A permit
holder completes milking and assure that the temperature of the grade A permit
holder's raw milk is not warmer than 50°F after the first milking or any
subsequent milking. Raw milk for pasteurization that is warmer than a
temperature of 50°F after the first milking or any subsequent milking shall be
deemed a public health hazard and shall not be offered for sale or sold;
(2) Assure that circular recording charts are operated
continuously and maintained in a properly functioning manner. Circular charts
shall not overlap; and
(3) Agitate all raw milk for pasteurization for not less than
five minutes at least once every hour; assure that the milk in the farm's bulk
milk cooling or holding tank covers the agitator paddle sufficiently to
facilitate proper cooling and sampling after the completion of the first
milking; and abstain from selling or offering for sale milk that does not cover
the agitator paddle sufficiently to facilitate proper cooling and sampling
after the completion of the first milking;
u. Item 19r. Insect and rodent control. Each person who holds
a grade A permit to produce raw milk for pasteurization, ultra-pasteurization,
aseptic processing and packaging, or retort processed after packaging shall:
(1) Take effective measures to prevent the contamination of
any milk, containers, equipment, and utensils by insects, rodents, and other
animals, and by chemicals used to control insects, rodents, and other animals;
(2) Maintain the milkroom free of insects, rodents and other
animals;
(3) Keep the areas surrounding the milkhouse; milking barn;
milking stable; milking parlor; cattle, sheep, water buffalo, other mammal, or
goat housing; cattle, sheep, water buffalo, other mammal, or goat loafing area;
water supply; or other facilities on the grade A permit holder's dairy farm
neat, clean, and free of conditions that might harbor or be conducive to the
breeding of insects and rodents; and
(4) Store all feed in such a manner that the feed will not
attract birds, rodents, or insects.
C. Sanitation requirements for grade A pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaged milk or milk products.
1. Each person who holds a grade A permit to produce grade A
pasteurized, ultra-pasteurized, aseptically processed and packaged, or retort
processed after packaged milk or milk products shall comply with:
a. The following administrative procedures contained in the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision":
Section 7, Items 1p, 2p, 3p, 4p, 5p, 6p, 7p, 8p, 9p, 10p, 11p, 12p, 13p, 14p,
15p, 16p, 17p, 18p, 19p, 20p, 21p, and 22p (provided in the case of milk plants
or portions of milk plants that are IMS Listed to produce aseptically processed
and packaged milk or milk products, the APPS or RPPS, respectively, as defined
in the "Grade "A" Pasteurized Milk Ordinance, 2013
Revision," shall be exempt from Items 7p, 10p, 11p, 12p, 13p, 15p, 16p,
17p, 18p, and 19p of the "Grade "A" Pasteurized Milk Ordinance,
2013 Revision" and shall comply with the applicable portions of 21 CFR
Parts 108, 110, and 113); Section 13; and Section 14;
b. The following appendices contained in the "Grade
"A" Pasteurized Milk Ordinance, 2013 Revision": Appendices D, F,
G, H, I, J, K, L, N, O, R, and S;
c. Item 1p. Floors; construction. Each person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall:
(1) Except as specified in subdivision C 1 c (2) of this
section, provide floors for all rooms in which milk or milk products are
processed, handled, packaged, or stored, or in which milk containers,
equipment, or utensils are washed, constructed of concrete or other equally
impervious and easily cleaned material and that are smooth, properly sloped,
provided with trapped drains, and kept in good repair;
(2) The floor in any cold-storage room used for storing milk
and milk products need not be provided with floor drains if the floors are
sloped to drain to one or more exits from the cold-storage room. The floor in
any storage room used for storing dry ingredients or packaging materials need
not be provided with drains, and the floor in any storage room used for storing
dry ingredients or packaging materials may be constructed of tightly joined
wood;
d. Item 2p. Walls and ceilings; construction. Each person who
holds a grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall provide walls and ceilings of rooms in which milk or milk
products are handled, processed, packaged, or stored, or in which milk
containers, utensils, or equipment are washed, that have a smooth, washable,
light-colored surface, and that are in good repair;
e. Item 3p. Doors and windows. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall
provide:
(1) Effective means to prevent the access of insects and
rodents to any part of a milk plant, receiving station, or transfer station;
and
(2) Solid doors or glazed windows for all openings to the
outside of any milk plant, receiving station, or transfer station and keep the
doors and windows closed during dusty weather;
f. Item 4p. Lighting and ventilation. Each person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall provide rooms in which any milk or milk products are handled,
processed, packaged, or stored, or in which any milk containers, equipment, or
utensils are washed, that are well lighted and well ventilated;
g. Item 5p. Separate rooms. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall:
(1) Provide separate rooms for: (i) pasteurizing, processing,
cooling, reconstituting, condensing, drying, and packaging of milk, dry milk,
and milk products; (ii) cleaning milk cans, containers, bottles, cases, and dry
milk or dry milk product containers; (iii) the fabrication of containers and
closures for milk and milk products, except for aseptically processed and packaged
milk and milk products, or retort processed after packaging milk and milk
products in which the containers and closures are fabricated within the APPS or
RPPS, respectively; (iv) cleaning and sanitizing facilities for bulk milk
transport tanks if the grade A permit holder receives any milk or milk product
in bulk milk transport tanks; and (v) receiving cans of milk and milk products
separate from clauses (i), (ii) and (iii) of this subdivision, unless all of
the grade A permit holder's milk or milk products are received in bulk milk
transport tanks;
(2) Not use any room with a direct opening into any stable or
room used for domestic purposes to handle, process, or store any milk or milk
products or to wash or store any milk containers, utensils, or equipment;
(3) Use rooms of sufficient size so as not to be crowded to
handle, process, or store any milk or milk products or to wash or store any
milk containers, utensils, or equipment; and
(4) Provide designated areas or rooms for the receiving,
handling, and storage of returned packaged milk and milk products if the permit
holder receives any returned packaged milk or milk products;
h. Item 6p. Toilet-sewage disposal facilities. Each person who
holds a grade A permit to produce grade A pasteurized, ultra-pasteurized,
aseptically processed and packaged, or retort processed after packaged milk or
milk products shall provide each milk plant with toilet facilities conforming
with the regulations of the Commonwealth and the following requirements: no
toilet room may open directly into any room in which milk or milk products are
processed; the toilet room shall be completely enclosed and shall have
tight-fitting, self-closing doors; the dressing room, toilet room, and fixtures
shall be kept in a clean condition, in good repair, and shall be well
ventilated and well lighted; and sewage and other liquid wastes from the toilet
room shall be disposed of in a sanitary manner;
i. Item 7p. Water supply. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall:
(1) Provide water for each milk plant from a supply that is
properly located, protected, and operated; and
(2) Provide water from a supply that is easily accessible for
inspection by the State Regulatory Authority, adequate, and of a safe, sanitary
quality;
j. Item 8p. Hand-washing facilities. Each person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall:
(1) Provide hand-washing facilities, including separate hot
and cold running water, mix valve, soap, and individual sanitary towels or
other approved hand-drying devices, convenient in any area where milk or milk
products are handled, processed, or stored, and any area where containers,
utensils, or equipment, are washed or stored; and
(2) Keep the hand-washing facilities clean and in good repair;
k. Item 9p. Milk plant cleanliness. Each person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall:
(1) Keep clean, neat, and free of any evidence of animals,
insects, or rodents all rooms in which milk or milk products are handled,
processed, or stored or in which containers, utensils, or equipment are washed
or stored; and
(2) Permit only equipment directly related to processing
operations or to the handling of containers, utensils, and equipment, in
pasteurizing, processing, cooling, condensing, drying, packaging, bulk milk, or
milk product storage rooms;
l. Item 10p. Sanitary piping. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall:
(1) Use only sanitary piping, fittings, and connections
consisting of smooth, impervious corrosion-resistant, nontoxic, easily
cleanable materials that are exposed to any milk or milk products, or from
which liquids may drip, drain, or be drawn into any milk or milk products;
(2) Keep all piping in good repair;
(3) Except as specified in subdivision 1 l of this subsection,
use only sanitary piping to transfer any pasteurized or ultra-pasteurized milk
or milk products from one piece of equipment to another piece of equipment; and
(4) Transport cottage cheese, cheese dressings, or cheese
ingredients by methods that protect the product from contamination;
m. Item 11p. Construction and repair of containers and
equipment. Each person who holds a grade A permit to produce grade A
pasteurized, ultra-pasteurized, aseptically processed and packaged, or retort
processed after packaged milk or milk products shall:
(1) Use only multiuse containers and equipment, that may come
in contact with any milk or milk products constructed of smooth, impervious,
corrosion-resistant, and nontoxic materials; constructed for ease of cleaning; and
kept in good repair;
(2) Use only single-service containers, closures, gaskets, and
other articles that may come in contact with any milk or milk products that are
nontoxic and have been manufactured, packaged, transported, and handled in a
sanitary manner;
(3) Abstain from using more than once any articles intended
for single-service use; and
(4) Use only single-service containers, closures, caps,
gaskets, and similar articles manufactured, packed, transported, and handled in
a manner that complies with the requirements of Appendix J, "Standards for
the Fabrication of Single-Service Containers and Closures for Milk and Milk
Products" contained in the "Grade "A" Pasteurized Milk
Ordinance, 2013 Revision";
n. Item 12p. Cleaning and sanitizing of containers and
equipment. Each person who holds a grade A permit to produce grade A
pasteurized, ultra-pasteurized, aseptically processed and packaged, or retort
processed after packaged milk or milk products shall:
(1) Effectively clean and sanitize before each use the
product-contact surfaces of all multiuse containers and equipment, utensils,
and equipment used in the transportation, processing, handling, and storage of
any milk or milk products;
(2) Use only multiuse containers for packaging pasteurized milk
and milk products that comply with the following: (i) the residual bacteria
count on multiuse containers may not exceed one per milliliter of capacity when
the rinse test is used, or the residual bacteria count on multiuse containers
shall not exceed 50 colonies per eight square inches (one per square
centimeter) of product-contact surface when the swab test is used; in
three-out-of-four samples taken at random on a given day; and (ii) all multiuse
containers shall be free of coliform organisms; and
(3) Use only single-service containers for packaging
pasteurized milk and milk products that comply with the following: (i) the
residual bacteria count of single-service containers shall not exceed 50 per
container when the rinse test is used, except that in containers less than 100
milliliters, the count shall not exceed 10, or the residual bacteria count of
single-service containers shall not exceed 50 colonies per eight square inches
(one per square centimeter) of product contact surface when the swab test is
used; in three-out-of-four samples taken at random on a given day; and (ii) all
single-service containers shall be free of coliform organisms;
o. Item 13p. Storage of cleaned containers and equipment. Each
person who holds a grade A permit to produce grade A pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaged milk or milk products, shall after cleaning any multiuse milk or
milk product containers, utensils, or equipment, transport or store the multiuse
milk or milk product containers, utensils, or equipment in a manner that
assures complete drainage and in a manner that protects the multiuse milk or
milk product containers, utensils, or equipment from contamination before use;
p. Item 14p. Storage of single-service containers, utensils,
and materials. Each person who holds a grade A permit to produce grade A
pasteurized, ultra-pasteurized, aseptically processed and packaged, or retort
processed after packaged milk or milk products shall:
(1) Purchase all single-service caps, cap stock, parchment
paper, containers, gaskets, and other single-service articles for use in
contact with milk or milk products in sanitary tubes, wrappings, or cartons;
(2) Store in a clean dry place until used, single-service caps,
cap stock, parchment paper, containers, gaskets, and other single-service
articles for use in contact with milk or milk products;
(3) Store single-service caps, cap stock, parchment paper,
containers, gaskets, and other single-service articles for use in contact with
milk or milk products in sanitary tubes, wrappings, or cartons; and
(4) Handle single-service caps, cap stock, parchment paper,
containers, gaskets, and other single-service articles for use in contact with
milk or milk products in a sanitary manner;
q. Item 15p. Protection from contamination. Each person who
holds a grade A permit to produce grade A pasteurized, ultra-pasteurized,
aseptically processed and packaged, or retort processed after packaged milk or
milk products shall:
(1) Locate the person's equipment and facilities and conduct
milk plant operations to prevent any contamination of any milk or milk
products, ingredients, equipment, containers, or utensils;
(2) Discard all milk, milk products, or ingredients that have
been spilled, overflowed, or leaked;
(3) Perform the processing and handling of products other than
grade A milk and milk products in the person's milk plant to preclude the
contamination of any grade A milk or milk products;
(4) Store, handle, or use any poisonous or toxic material to
preclude the contamination of any milk, milk product, or ingredient and the
milk product contact surfaces of all equipment, containers, or utensils; and
(5) Clean, prior to use, all multiuse cases used to encase
packaged milk or milk product containers;
r. Item 16p. Pasteurization and ultra-pasteurization. Each
person who holds a grade A permit to produce grade A pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaged milk or milk products shall:
(1) Perform pasteurization or ultra-pasteurization as defined
in 2VAC5-490-10, and Item 16p of the "Grade "A" Pasteurized Milk
Ordinance, 2013 Revision"; and
(2) Perform aseptic processing and packaging and retort
processed after packaging in accordance with the applicable requirements of 21
CFR Parts 108, 110, and 113;
s. Item 17p. Cooling of milk. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall:
(1) Maintain all raw milk and milk products at a temperature
of 45°F or cooler, but not frozen, until processed;
(2) Maintain all whey and whey products for condensing,
drying, or condensing and drying at a temperature of 45°F (7°C) or cooler; or
135°F (57°C) or greater until processed, except that acid-type whey with a
titratable acidity of 0.40% or above, or a pH of 4.6 or below, is exempted from
these temperature requirements;
(3) Completely empty and clean the tanks and vessels used to
blend and hold all milk or milk product flavoring slurries that contain milk
and milk products after each four hours of operation or less if such tanks are
not intended to be injected within a HTST pasteurization system as part of a
liquid ingredient injection system as outlined in Appendix H of the "Grade
"A" Pasteurized Milk Ordinance, 2013 Revision" or unless the
slurry is stored at a temperature of 45°F (7°C) or cooler, or at a temperature
of 150°F (66°C) or greater and maintained thereat;
(4) Immediately cool, except for the following milk or milk
products, all pasteurized or ultra-pasteurized milk or milk products prior to
filling or packaging in approved cooling equipment to a temperature of 45°F or
cooler, but not frozen, unless drying is commenced immediately after
condensing:
(a) Those milk or milk products to be cultured;
(b) Cultured sour cream at all milkfat levels with a pH of
4.70 or below;
(c) Acidified sour cream at all milkfat levels with a pH of
4.60 or below;
(d) All yogurt products at all milkfat levels with an initial
pH of 4.80 or below at filling;
(e) Cultured buttermilk at all milkfat levels with a pH of
4.60 or below;
(f) All condensed whey and whey products shall be cooled
during the crystallization process to 50°F (10°C) or less within 72 hours of
condensing, including the filling and emptying time, unless filling occurs
above 135°F (57°C), in which case, the 72-hour time period begins when cooling
started; and
(g) All cultured cottage cheese at all milkfat levels with a
pH of 5.2 or below shall be cooled as per specifications of Item 17p (6a-6e) of
the "Grade "A" Pasteurized Milk Ordinance, 2013 Revision";
(5) Store, transport, and deliver at a temperature of 45°F or
cooler, but not frozen, all pasteurized or ultra-pasteurized milk or milk
products with the following exceptions:
(a) Cultured sour cream at all milkfat levels with a pH of
4.70 or below shall be cooled to 45°F (7°C) or cooler within 168 hours of
filling;
(b) Acidified sour cream at all milkfat levels with a pH of
4.60 or below shall be cooled to 45°F (7°C) or cooler within 168 hours of
filling;
(c) All yogurt products at all milkfat levels with an initial
pH of 4.80 or below at filling and with a subsequent pH of 4.60 or below within
24 hours after filling shall be cooled to 45°F (7°C) or cooler within 96 hours
after filling;
(d) Cultured buttermilk at all milkfat levels with a pH of
4.60 or below shall be cooled to 45°F (7°C) or cooler within 24 hours after
filling; and
(e) Cultured cottage cheese at all milkfat levels with a pH of
5.2 or below shall be stored as per specifications of item 17p (5a-5d) of the
"Grade "A" Pasteurized Milk Ordinance, 2013 Revision";
(6) Store all pasteurized milk and milk products to be
condensed, dried, or condensed and dried at a temperature of 50°F (10°C) or
cooler until further processed;
(7) Equip with an accurate indicating thermometer each of the
rooms or tanks in which any milk, milk products, whey, or whey products are
stored;
(8) Maintain the temperature on delivery vehicles of milk and
milk products at 45°F (7°C) or cooler. Aseptically processed and packaged milk
and milk products and retort processed after packaged milk and milk products to
be packaged in hermetically sealed containers shall be exempt from the cooling
requirements of this item; and
(9) Provide ready access at the plant to cleaning records and
product storage temperature records stored electronically for review by the
State Regulatory Authority. Electronic records of cleaning shall comply with
the applicable provisions of Appendix H, Sections IV and V of the "Grade
"A" Pasteurized Milk Ordinance, 2013 Revision";
t. Item 18p. Bottling and packaging. Each person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall:
(1) Bottle or package all milk or milk products at the place
of pasteurization in the grade A permit holder's milk plant and in approved
mechanical equipment;
(2) Package and store in a sanitary manner all dry milk
products in new containers, which protect the contents from contamination; and
(3) Transport and store in a sanitary manner all condensed and
dry milk products in sealed containers from one milk plant to another milk
plant for further processing or packaging;
u. Item 19p. Capping. Each person who holds a grade A permit
to produce grade A pasteurized, ultra-pasteurized, aseptically processed and
packaged, or retort processed after packaged milk or milk products shall:
(1) Cap or close all milk or milk product containers in a
sanitary manner by use of approved mechanical capping or closing and sealing
equipment; and
(2) Use only caps or closures for all milk or milk products
that protect the pouring lip of a milk or milk product container to at least
its largest diameter and, use with respect to fluid product containers, only
caps or closures that the removal of the cap or closure cannot be made without
detection;
v. Item 20p. Personnel; cleanliness. No person who holds a
grade A permit to produce grade A pasteurized, ultra-pasteurized, aseptically
processed and packaged, or retort processed after packaged milk or milk
products shall:
(1) Permit any person in a milk plant to commence any plant
function before the person has thoroughly washed the person's hands to remove
soil and contamination or to permit any person in a milk plant to continue any
plant function if the person's hands are not clean;
(2) Permit any person in a milk plant to resume work after the
person has visited the toilet room before the person has thoroughly washed the
person's hands;
(3) Permit any person in a milk plant to engage in the
processing, pasteurization, handling, storage, or transportation of any milk,
milk products, containers, equipment or utensils, unless the person is wearing
clean outer garments;
(4) Permit any person in a milk plant to engage in the
processing of any milk or milk products unless the person wears adequate hair
covering; or
(5) Permit any person in a milk plant to engage in the
processing of any milk or milk products if the person is using tobacco;
w. Item 21p. Vehicles. Each person who holds a grade A permit
to produce grade A pasteurized, ultra-pasteurized, aseptically processed and
packaged, or retort processed after packaged milk or milk products shall use
vehicles to transport pasteurized and ultra-pasteurized milk and milk products
that are constructed and operated so that the milk or milk products are
maintained at a temperature of 45°F or cooler, but not frozen, and protected
from sunlight, from freezing, and from contamination;
x. Item 22p. Surroundings. Each person who holds a grade A
permit to produce grade A pasteurized, ultra-pasteurized, aseptically processed
and packaged, or retort processed after packaged milk or milk products shall
keep neat, clean, and free from conditions that might attract or harbor flies,
other insects, rodents, or other pests that otherwise constitute a nuisance,
the area surrounding any milk plant;
y. Each grade A permit holder's receiving station shall comply
with subdivisions C 1 a through q of this section, inclusive, and subdivisions
C 1 s, v, and x of this section, except that the partitioning requirement of
subdivision C 1 g of this section shall not be deemed to apply;
z. Each grade A permit holder's transfer station shall comply
with subdivisions C 1 c, f, h through n, p, q, s, v, and x of this section, and
as climatic and operating conditions require, the provisions of subdivisions C
1 d and e of this section; except that each person shall provide overhead
protection for a transfer station; and
a1. Each grade A permit holder's facilities for the cleaning
and sanitizing of bulk tanks that transport milk and milk products shall comply
with subdivisions C 1 a, f, h through n, p, q, v, and x of this section, and as
climatic and operating conditions require, the provisions of subdivisions C 1 d
and e of this section except that each grade A permit holder shall provide
overhead protection for facilities for the cleaning and sanitizing of bulk
tanks which transport milk and milk products in the grade A permit holder's
milk plant, receiving station, or transfer station.
D. Minimum facilities requirements for milk processing plant.
Each person who holds a grade A permit to produce grade A pasteurized,
ultra-pasteurized, aseptically processed and packaged, or retort processed
after packaging milk or milk products shall:
1. Provide a separate receiving room meeting the requirements
of subdivision C 1 y of this section from any other area of the plant for the
receipt of milk or milk products in bulk if the plant receives any milk or milk
products in bulk;
2. Provide cleaning and sanitizing facilities for milk tank
trucks as part of the plant's receiving room facilities if the plant receives
any milk or milk products in bulk;
3. Provide a separate receiving room from any other area of
the plant for the receipt of milk or milk product in cans or other containers
if the plant receives any milk or milk product in cans or other containers;
4. Provide a separate room from any other area of the plant
for the cleaning of milk cans or containers, bottles, milk cases, and dry milk
or milk product containers if the plant receives any milk in cans or containers
or washes any bottles, milk cases, or dry milk or milk product containers;
5. Provide a separate room for the fabrication of containers
and closures for milk and milk products if the plant fabricates any containers
or closures;
6. Provide a separate room for the packaging of dry milk or
milk products if the plant packages any dry milk or milk product; and
7. Provide separate rooms from any other area of the plant for
each of the following operations performed on any milk, milk product, or
condensed and dry milk product: (i) pasteurization; (ii) processing; (iii)
cooling; (iv) reconstitution; (v) condensing; (vi) drying; and (vii) packaging,
if the operation is performed in the plant.
VA.R. Doc. No. R18-34; Filed May 6, 2019, 4:35 p.m.
TITLE 3. ALCOHOLIC BEVERAGES
ALCOHOLIC BEVERAGE CONTROL AUTHORITY
Final Regulation
REGISTRAR'S NOTICE: The
Alcoholic Beverage Control Authority is claiming an exemption from Article 2 of
the Administrative Process Act in accordance with § 2.2-4006 A 4 a of the
Code of Virginia, which excludes regulations that are necessary to conform to
changes in Virginia statutory law or the appropriation act where no agency
discretion is involved. The Alcoholic Beverage Control Authority will receive,
consider, and respond to petitions by any interested person at any time with
respect to reconsideration or revision.
Title of Regulation: 3VAC5-50. Retail Operations (amending 3VAC5-50-60).
Statutory Authority: § 4.1-103 and 4.1-111 Code of
Virginia.
Effective Date: July 1, 2019.
Agency Contact: LaTonya D. Hucks-Watkins, Legal Liaison,
Virginia Alcoholic Beverage Control Authority, 2901 Hermitage Road, Richmond,
VA 23220, telephone (804) 213-4698, FAX (804) 213-4574, or email
latonya.hucks-watkins@abc.virginia.gov.
Summary:
Pursuant to Chapter 706 of the 2019 Acts of Assembly, the
amendments provide that the Board of Directors of the Alcoholic Beverage
Control Authority may suspend the privilege of a mixed beverage licensee to
purchase spirits from the board if the licensee fails to submit records or
other documents necessary to verify the licensee's compliance with applicable
minimum food sale requirements within 30 days of the date such records or
documents are due.
3VAC5-50-60. Procedures for mixed Mixed beverage
licensees generally; mixed beverage restaurant licensees; sales of
spirits in closed containers; suspension of purchase privileges.
A. No mixed beverage restaurant or carrier licensee shall:
1. Serve as one drink the entire contents of a container of
spirits in its original container for on-premises consumption except as
provided by subsections C, D, and E of this section.
2. Sell any mixed beverage to which alcohol has been added.
B. No mixed beverage restaurant licensee shall:
1. Allow to be kept upon the licensed premises any container
of alcoholic beverages of a type authorized to be purchased under his license
that does not bear the required mixed beverage stamp imprinted with his license
number and purchase report number.
2. Use in the preparation of a mixed beverage any alcoholic
beverage not purchased from the board or a wholesale wine licensee.
3. Fail to obliterate the mixed beverage stamp immediately
when any container of spirits is emptied.
4. Allow any patron to possess more than two drinks of mixed
beverages at any one time, except that a mixed beverage licensee may sell to a
patron who may lawfully purchase mixed beverages a flight of distilled spirits
products consisting of samples of not more than five different spirits
products. Each distilled spirits product shall contain no more than one-half
ounce of distilled spirits.
C. If a restaurant for which a mixed beverage restaurant
license has been issued under § 4.1-210 of the Code of Virginia is located
on the premises of a hotel or motel, whether the hotel or motel be under the
same or different ownership, sales of mixed beverages, including sales of
spirits packaged in original closed containers purchased from the board, as
well as other alcoholic beverages, for consumption in bedrooms and private
rooms of such hotel or motel, may be made by the licensee subject to the
following conditions in addition to other applicable laws:
1. Spirits sold by the drink as mixed beverages or in original
closed containers must have been purchased under the mixed beverage restaurant
license upon purchase forms provided by the board;
2. Delivery of sales of mixed beverages and spirits in
original closed containers shall be made only in the bedroom of the registered
guest or to the sponsoring group in the private room of a scheduled function.
This section shall not be construed to prohibit a licensee catering a scheduled
private function from delivering mixed beverage drinks to guests in attendance
at such function;
3. Receipts from the sale of mixed beverages and spirits sold
in original closed containers, as well as other alcoholic beverages, shall be
included in the gross receipts from sales of all such merchandise made by the
licensee; and
4. Complete and accurate records of sales of mixed beverages
and sales of spirits in original closed containers to registered guests in
bedrooms and to sponsors of scheduled private functions in private rooms shall
be kept separate and apart from records of all mixed beverage sales.
D. Carrier licensees may serve miniatures not in excess of
two fluid ounces or 50 milliliters, in their original containers, for
on-premises consumption.
E. A mixed beverage restaurant may serve as one drink the
entire contents of a container of soju in its original container for
on-premises consumption under the following conditions:
1. The container may be no larger than 375 milliliters.
2. Each container of soju served must be served for
consumption by at least two patrons legally eligible to consume alcoholic
beverages.
F. A mixed beverage restaurant licensee may infuse, store,
and sell flavored distilled spirits under the following circumstances:
1. If infused in the original spirits container, the mixed
beverage stamp must remain affixed to the bottle.
2. If infused in a container other than the original spirits
container, the substitute container, which shall not exceed 20 liters in
volume, will be labeled with the following information:
a. Date of infusion;
b. Brand of spirits; and
c. Amount of spirits used.
3. Accurate records must be kept by the mixed beverage
licensee as to the spirits used in any spirits infusion process.
4. Licensees infusing distilled spirits shall comply with all
applicable state and federal food safety regulations.
G. Mixed beverage licensees may premix containers of sangria
and other mixed beverages and serve such alcoholic beverages in pitchers
subject to the following limitations:
1. Pitchers of mixed beverages may only be sold in containers
with a maximum capacity of 32 fluid ounces or one liter if the container is in
metric size containing a spirits product mixed with nonalcoholic beverages.
2. A pitcher of mixed beverages may only be served to two or
more patrons. A licensee shall not allow any two patrons to possess more than
one pitcher at any one time.
3. Containers of premixed sangria and other mixed beverages
must be labeled as to the type of mixed beverage and the quantities of the
products used to produce the mixed beverage.
H. The board may suspend the privilege of a mixed beverage
licensee to purchase spirits from the board upon such licensee's failure to
submit any records or other documents necessary to verify the licensee's
compliance with applicable minimum food sale requirements within 30 days of the
date such records or documents are due.
VA.R. Doc. No. R19-5972; Filed May 1, 2019, 9:43 a.m.
TITLE 9. ENVIRONMENT
STATE AIR POLLUTION CONTROL BOARD
Final Regulation
Title of Regulation: 9VAC5-140. Regulation for Emissions
Trading Programs (adding 9VAC5-140-6010 through 9VAC5-140-6440).
Statutory Authority: §§ 10.1-1308 and 10.1-1322.3
of the Code of Virginia; §§ 108, 109, 110, and 302 of the Clean Air Act;
40 CFR Part 51.
Effective Date: June 26, 2019.
Agency Contact: Karen G. Sabasteanski, Department of
Environmental Quality, 1111 East Main Street, Suite 1400, P.O. Box 1105,
Richmond, VA 23218, telephone (804) 698-4426, FAX (804) 698-4510, or email
karen.sabasteanski@deq.virginia.gov.
Summary:
This action establishes the Virginia CO2 Budget
Trading Program. The regulation includes provisions to (i) implement a
declining cap on carbon emissions and establish an allowance that will be issued
for each ton of carbon emitted by an electricity generating facility, which can
then decide whether to reduce carbon emissions and sell the resulting
additional allowances or not reduce carbon emissions and make up the difference
with purchased allowances; (ii) establish a consignment auction as the
mechanism for determining the cost of allowances; (iii) provide cost
containment reserve allowances and emission containment reserve allowances to
ensure market stability; (iv) implement monitoring, recording, and
recordkeeping requirements; and (v) allocate conditional allowances to the
Department of Mines, Minerals and Energy.
Amendments since publication of the revised proposed
regulation in 35:12 VA.R. 1404-1438 February 4, 2019,
include (i) modifying several definitions, (ii) adding a section to address
program implementation, (iii) modifying 9VAC5-140-6040 and 9VAC5-140-6050
regarding applicability, (iv) removing 2031–2040 budget reductions from
9VAC5-140-6190, and (v) providing that post-2031 base budgets may be modified
as a result of program review and regulatory action.
Summary of Public Comments and Agency's Response: A
summary of comments made by the public and the agency's response may be
obtained from the promulgating agency or viewed at the office of the Registrar
of Regulations.
Part VII
CO2 Budget Trading Program
Article 1
CO2 Budget Trading Program General Provisions
9VAC5-140-6010. Purpose.
This part establishes the Virginia component of the CO2
Budget Trading Program, which is designed to reduce anthropogenic emissions of
CO2, a greenhouse gas, from CO2 budget sources in an
economically efficient manner a manner that is protective of human health
and the environment and is economically efficient.
9VAC5-140-6020. Definitions.
A. As used in this part, all words or terms not defined
here shall have the meanings given them in 9VAC5-10 (General Definitions),
unless otherwise required by the context.
B. For the purpose of this part and any related use, the
words or terms shall have the meanings given them in this section.
C. Terms defined.
"Account number" means the identification number
given by the department or its agent to each COATS account.
"Acid rain emission limitation" means, as defined
in 40 CFR 72.2, a limitation on emissions of sulfur dioxide (SO2)
or nitrogen oxides (NOX) under the Acid Rain Program under Title IV
of the CAA.
"Acid Rain Program" means a multistate SO2
and NOX air pollution control and emission reduction program
established by the administrator under Title IV of the CAA and 40 CFR Parts 72
through 78.
"Adjustment for banked allowances" means an
adjustment applied to the Virginia CO2 Budget Trading Program base
budget for allocation years 2021 through 2025 to address allowances held in
general and compliance accounts, including compliance accounts established
pursuant to the CO2 Budget Trading Program, but not including
accounts opened by participating states, that are in addition to the aggregate quantity
of emissions from all CO2 budget sources in all of the participating
states at the end of the [ initial ] control period in
2020 and as reflected in the CO2 Allowance Tracking System on March
[ 17 15 ], 2021.
"Administrator" means the administrator of the
U.S. Environmental Protection Agency or the administrator's authorized
representative.
"Allocate" or "allocation" means the
determination by the department of the number of [ CO2 ]
conditional allowances [ allocated to a CO2 budget
unit recorded in the conditional allowance account of a CO2
budget unit ] or to the Department of Mines, Minerals and Energy
(DMME) pursuant to 9VAC5-140-6211.
"Allocation year" means a calendar year for which
the department allocates [ CO2 ] conditional
allowances pursuant to Article 5 (9VAC5-140-6190 et seq.) of this part. The
allocation year of each [ CO2 ] conditional
allowance is reflected in the unique identification number given to the
allowance pursuant to 9VAC5-140-6250 C.
"Allowance" means an allowance up to one ton
of CO2 purchased from the consignment auction in accordance with
Article 9 (9VAC5-140-6410 et seq.) of this part and that may be deposited in
the compliance account of a CO2 budget source.
"Allowance auction" or "auction" means
an auction in which the department or its agent offers [ CO2
conditional ] allowances for sale.
"Alternate CO2 authorized account
representative" means, for a CO2 budget source and each CO2
budget unit at the source, the alternate natural person who is authorized by the
owners and operators of the source and all CO2 budget units at the
source, in accordance with Article 2 (9VAC5-140-6080 et seq.) of this part, to
represent and legally bind each owner and operator in matters pertaining to the
CO2 Budget Trading Program or, for a general account, the alternate
natural person who is authorized, under Article 6 (9VAC5-140-6220 et seq.) of
this part, to transfer or otherwise dispose of CO2 allowances held
in the general account. If the CO2 budget source is also subject to
the Acid Rain Program, CSAPR NOX Annual Trading Program, CSAPR NOX
Ozone Season Trading Program, CSAPR SO2 Group 1 Trading Program, or
CSAPR SO2 Group 2 Trading Program then, for a CO2 Budget
Trading Program compliance account, this alternate natural person shall be the
same person as the alternate designated representative as defined in the
respective program.
"Attribute" means a characteristic associated
with electricity generated using a particular renewable fuel, such as its
generation date, facility geographic location, unit vintage, emissions output,
fuel, state program eligibility, or other characteristic that can be
identified, accounted for, and tracked.
"Attribute credit" means a credit that represents
the attributes related to one megawatt-hour of electricity generation.
"Automated Data Acquisition and Handling System"
or "DAHS" means that component of the Continuous Emissions Monitoring
System (CEMS), or other emissions monitoring system approved for use under
Article 8 (9VAC5-140-6330 et seq.) of this part, designed to interpret and
convert individual output signals from pollutant concentration monitors, flow
monitors, diluent gas monitors, and other component parts of the monitoring
system to produce a continuous record of the measured parameters in the
measurement units required by Article 8 (9VAC5-140-6330 et seq.) of this part.
"Billing meter" means a measurement device used
to measure electric or thermal output for commercial billing under a contract.
The facility selling the electric or thermal output shall have different owners
from the owners of the party purchasing the electric or thermal output.
"Boiler" means an enclosed fossil or other
fuel-fired combustion device used to produce heat and to transfer heat to
recirculating water, steam, or other medium.
"CO2 allowance" means a limited
authorization by the department or another participating state under the CO2
Budget Trading Program to emit up to one ton of CO2, subject to all
applicable limitations contained in this part. CO2 offset allowances
generated by other participating states will be recognized by the department.
"CO2 allowance deduction" or
"deduct CO2 allowances" means the permanent withdrawal of
CO2 allowances by the department or its agent from a COATS
compliance account to account for the number of tons of CO2 emitted
from a CO2 budget source for the [ initial control
period, ] a control period [ , ] or an
interim control period [ , ] determined in accordance
with Article 8 (9VAC5-140-6330 et seq.) of this part, or for the forfeit or
retirement of CO2 allowances as provided by this part.
"CO2 Allowance Tracking System" or
"COATS" means the system by which the department or its agent records
allocations, deductions, and transfers of CO2 allowances under the
CO2 Budget Trading Program. The tracking system may also be used to
track CO2 allowance prices and emissions from affected sources.
"CO2 Allowance Tracking System
account" means an account in COATS established by the department or its
agent for purposes of recording the allocation, holding, transferring, or
deducting of CO2 allowances.
"CO2 allowance transfer deadline"
means midnight of March 1 occurring after the end of the [ relevant
initial control period, the ] control period [ , ]
and each [ relevant ] interim control period
[ , ] or [ , ] if that March
1 is not a business day, midnight of the first business day thereafter and is
the deadline by which CO2 allowances shall be submitted for recordation
in a CO2 budget source's compliance account for the source to meet
the CO2 requirements of 9VAC5-140-6050 C for the [ initial
control period, a ] control period [ , ] and
each interim control period immediately preceding such deadline.
"CO2 allowances held" or "hold CO2
allowances" means the CO2 allowances recorded by the department
or its agent, or submitted to the department or its agent for recordation, in
accordance with Article 6 (9VAC5-140-6220 et seq.) and Article 7
(9VAC5-140-6300 et seq.) of this part, in a COATS account.
"CO2 authorized account
representative" means, for a CO2 budget source and each CO2
budget unit at the source, the natural person who is authorized by the owners
and operators of the source and all CO2 budget units at the source,
in accordance with Article 2 (9VAC5-140-6080 et seq.) of this part, to
represent and legally bind each owner and operator in matters pertaining to the
CO2 Budget Trading Program or, for a general account, the natural
person who is authorized, under Article 6 (9VAC5-140-6220 et seq.) of this
part, to transfer or otherwise dispose of CO2 allowances held in the
general account. If the CO2 budget source is also subject to the
Acid Rain Program, CSAPR NOX Annual Trading Program, CSAPR NOX
Ozone Season Trading Program, CSAPR SO2 Group 1 Trading Program, or
CSAPR SO2 Group 2 Trading Program, then for a CO2 Budget
Trading Program compliance account, this natural person shall be the same
person as the designated representative as defined in the respective program.
"CO2 authorized alternate account
representative" means, for a CO2 budget source and each CO2
budget unit at the source, the alternate natural person who is authorized by
the owners and operators of the source and all CO2 budget units at
the source, in accordance with Article 2 (9VAC5-140-6080 et seq.) of this part,
to represent and legally bind each owner and operator in matters pertaining to
the CO2 Budget Trading Program or, for a general account, the
alternate natural person who is authorized, under Article 6 (9VAC5-140-6220 et
seq.) of this part, to transfer or otherwise dispose of CO2
allowances held in the general account. If the CO2 budget source is
also subject to the Acid Rain Program, CSAPR NOX Annual Trading
Program, CSAPR NOX Ozone Season Trading Program, CSAPR SO2
Group 1 Trading Program, or CSAPR SO2 Group 2 Trading Program then,
for a CO2 Budget Trading Program compliance account, this alternate
natural person shall be the same person as the alternate designated representative
as defined in the respective program.
"CO2 budget emissions limitation"
means, for a CO2 budget source, the tonnage equivalent, in CO2
emissions in [ the initial control period, ] a control
period [ , ] or an interim control period [ , ]
of the CO2 allowances available for compliance deduction for the
source for a control period or an interim control period.
"CO2 budget permit" means the portion
of the legally binding permit issued by the department pursuant to 9VAC5-85
(Permits for Stationary Sources of Pollutants Subject to Regulation) to a CO2
budget source or CO2 budget unit that specifies the CO2
Budget Trading Program requirements applicable to the CO2 budget
source, to each CO2 budget unit at the CO2 budget source,
and to the owners and operators and the CO2 authorized account
representative of the CO2 budget source and each CO2
budget unit.
"CO2 budget source" means a source
that includes one or more CO2 budget units.
"CO2 Budget Trading Program" means the
Regional Greenhouse Gas Initiative (RGGI), a multistate CO2 air
pollution control and emissions reduction program established according to this
part and corresponding regulations in other states as a means of reducing
emissions of CO2 from CO2 budget sources.
"CO2 budget unit" means a unit that is
subject to the CO2 Budget Trading Program requirements under
9VAC5-140-6040.
"CO2 cost containment reserve
allowance" or "CO2 CCR allowance" means [ a
conditional CO2 allowance that is offered for sale an
allowance that has been sold ] at an auction for the purpose of
containing the cost of CO2 allowances. CO2 CCR allowances
offered for sale at an auction are separate from and additional to CO2
allowances allocated from the Virginia CO2 Budget Trading Program
base and adjusted budgets. CO2 CCR allowances are subject to all
applicable limitations contained in this part.
"CO2 cost containment reserve trigger
price" or "CCR trigger price" means the minimum price at which
CO2 CCR allowances are offered for sale at an auction. Beginning
in 2020 and each calendar year thereafter, the CCR trigger price shall be 1.025
multiplied by the CCR trigger price from the previous calendar year, rounded to
the nearest whole cent. The CCR trigger price in calendar year 2020 shall
be $10.77. The CCR trigger price in calendar year 2021 shall be $13. Each
calendar year thereafter, the CCR trigger price shall be 1.07 multiplied by the
CCR trigger price from the previous calendar year, rounded to the nearest whole
cent, as shown in Table 140-1A.
Table 140-1A
CO2 CCR Trigger Price
|
2020
|
$10.77
|
2021
|
$13.00
|
2022
|
$13.91
|
2023
|
$14.88
|
2024
|
$15.93 $15.92
|
2025
|
$17.04 $17.03
|
2026
|
$18.23 $18.22
|
2027
|
$19.51 $19.50
|
2028
|
$20.88 $20.87
|
2029
|
$22.34 $22.33
|
2030
|
$23.90 $23.89
|
"CO2 [ emission
emissions ] containment reserve allowance" or "CO2
ECR allowance" means a [ CO2
conditional ] allowance that is withheld from sale at an auction by
the department for the purpose of additional emission reduction in the event of
lower than anticipated emission reduction costs.
"CO2 [ emission
emissions ] containment reserve trigger price" or "ECR
trigger price" means the price below which [ CO2
conditional ] allowances will be withheld from sale by the
department or its agent at an auction. The ECR trigger price in calendar year
2021 shall be $6.00. Each calendar year thereafter, the ECR trigger price shall
be 1.07 multiplied by the ECR trigger price from the previous calendar year,
rounded to the nearest whole cent, as shown in Table 140-1B.
Table 140-1B
CO2 ECR Trigger Price
|
2021
|
$ 6.00
|
2022
|
$ 6.42
|
2023
|
$ 6.87
|
2024
|
$ 7.35
|
2025
|
$ 7.86
|
2026
|
$ 8.42 $8.41
|
2027
|
$ 9.00
|
2028
|
$ 9.63
|
2029
|
$10.31 $10.30
|
2030
|
$11.03 $11.02
|
"CO2 offset allowance" means a CO2
allowance that is awarded to the sponsor of a CO2 emissions offset
project by a participating state and is subject to the relevant compliance
deduction limitations of the participating state's corresponding offset
regulations as a means of reducing CO2 from CO2 budget
sources.
"Combined cycle system" means a system comprised
of one or more combustion turbines, heat recovery steam generators, and steam
turbines configured to improve overall efficiency of electricity generation or
steam production.
"Combustion turbine" means an enclosed fossil or
other fuel-fired device that is comprised of a compressor (if applicable), a
combustor, and a turbine, and in which the flue gas resulting from the
combustion of fuel in the combustor passes through the turbine, rotating the
turbine.
"Commence commercial operation" means, with
regard to a unit that serves a generator, to have begun to produce steam, gas,
or other heated medium used to generate electricity for sale or use, including
test generation. For a unit that is a CO2 budget unit under
9VAC5-140-6040 on the date the unit commences commercial operation, such date
shall remain the unit's date of commencement of commercial operation even if
the unit is subsequently modified, reconstructed, or repowered. For a unit that
is not a CO2 budget unit under 9VAC5-140-6040 on the date the unit
commences commercial operation, the date the unit becomes a CO2
budget unit under 9VAC5-140-6040 shall be the unit's date of commencement of
commercial operation.
"Commence operation" means to begin any
mechanical, chemical, or electronic process, including, with regard to a unit,
start-up of a unit's combustion chamber. For a unit that is a CO2
budget unit under 9VAC5-140-6040 on the date of commencement of operation, such
date shall remain the unit's date of commencement of operation even if the unit
is subsequently modified, reconstructed, or repowered. For a unit that is not a
CO2 budget unit under 9VAC5-140-6040 on the date of commencement of
operation, the date the unit becomes a CO2 budget unit under
9VAC5-140-6040 shall be the unit's date of commencement of operation.
"Compliance account" means a COATS account,
established by the department or its agent for a CO2 budget source
under Article 6 (9VAC5-140-6220 et seq.) of this part, in which [ are
held ] CO2 allowances available for use by the
source for [ the initial control period, ] a control
period [ , ] and each interim control period
[ are held ] for the purpose of meeting the CO2
requirements of 9VAC5-140-6050 C.
"Conditional allowance" means an allowance
allocated by the department to [ a ] CO2
budget [ sources and source or ] to DMME.
Such conditional allowance shall be consigned by the entity to whom it is
allocated to the consignment auction as specified under Article 9
(9VAC5-140-6410 et seq.) of this part, after which the conditional allowance
becomes an allowance to be used for compliance purposes. a CO2
allowance once it is sold to an auction participant. [ A
conditional allowance may also be contained in the CCR and may be auctioned. ]
"Conditional [ allowance
account" means a general COATS account established by the department for
CO2 budget sources and DMME or its contractor where conditional
allowances allocated to CO2 budget sources and DMME are held until
auction.
"Conditional cost containment reserve allowance"
or "conditional ] CCR allowance" means [ a
CCR an ] allowance that may be offered for sale when the
CCR is triggered. If any [ conditional ] CCR allowances
are unsold, they [ shall be returned to the CCR account and ]
may be offered for sale in future auctions during the same year. [ Conditional
CCR allowances offered for sale at an auction are separate from and additional
to conditional allowances allocated from the Virginia CO2 Budget
Trading Program base and adjusted budgets. Conditional CCR allowances are
subject to all applicable limitations contained in this part. ]
"Consignment auction" or "auction"
means the CO2 auction conducted on a quarterly basis by RGGI,
Inc. the CO2 Budget Trading Program, in which CO2
budget sources and DMME are allocated a share of allowances by the department
that CO2 budget sources and the holder of a public contract with
DMME consign into the auction, and auction revenue is returned to CO2
budget sources and the holder of a public contract with DMME in accordance with
procedures established by the department.
"Continuous Emissions Monitoring System" or
"CEMS" means the equipment required under Article 8 (9VAC5-140-6330
et seq.) of this part to sample, analyze, measure, and provide, by means of
readings recorded at least once every 15 minutes (using an automated DAHS), a
permanent record of stack gas volumetric flow rate, stack gas moisture content,
and oxygen or carbon dioxide concentration (as applicable), in a manner
consistent with 40 CFR Part 75 and Article 8 (9VAC5-140-6330 et seq.) of
this part. The following systems are types of CEMS required under Article 8
(9VAC5-140-6330 et seq.) of this part:
a. A flow monitoring system, consisting of a stack flow
rate monitor and an automated DAHS and providing a permanent, continuous record
of stack gas volumetric flow rate, in standard cubic feet per hour (scf);
b. A NOX emissions rate (or NOX-diluent)
monitoring system, consisting of a NOX pollutant concentration
monitor, a diluent gas (CO2 or O2) monitor, and an
automated DAHS and providing a permanent, continuous record of NOX
concentration, in parts per million (ppm), diluent gas concentration, in
percent CO2 or O2, and NOX emissions rate, in
pounds per million British thermal units (lb/MMBtu);
c. A moisture monitoring system, as defined in 40 CFR
75.11(b)(2) and providing a permanent, continuous record of the stack gas
moisture content, in percent H2O;
d. A CO2 monitoring system, consisting of a CO2
pollutant concentration monitor (or an O2 monitor plus suitable
mathematical equations from which the CO2 concentration is derived)
and an automated DAHS and providing a permanent, continuous record of CO2
emissions, in percent CO2; and
e. An O2 monitoring system, consisting of an O2
concentration monitor and an automated DAHS and providing a permanent,
continuous record of O2, in percent O2.
"Control period" means a three-calendar-year time
period. The [ first fifth ] control
period is from January 1, 2021, to December 31, 2023, inclusive [ .
Each subsequent compliance control period shall be a sequential
three-calendar-year period. , which is the first control period of
Virginia's participation in the CO2 Budget Trading Program. ]
The first two [ compliance calendar ] years
of each control period are each defined as an interim control period, beginning
on January 1, [ 2022 2021 ].
"Cross State Air Pollution Rule (CSAPR) NOX
Annual Trading Program" means a multistate NOX air pollution
control and emission reduction program established in accordance with Subpart AAAAA
of 40 CFR Part 97 and 40 CFR 52.38(a), including such a program that is
revised in a SIP revision approved by the administrator under 40 CFR
52.38(a)(3) or (4) or that is established in a SIP revision approved by the
administrator under 40 CFR 52.38(a)(5), as a means of mitigating interstate
transport of fine particulates and NOX.
"Cross State Air Pollution Rule (CSAPR) NOX
Ozone Season Trading Program" means a multistate NOX air
pollution control and emission reduction program established in accordance with
Subpart BBBBB of 40 CFR Part 97 and 40 CFR 52.38(b), including such a
program that is revised in a SIP revision approved by the administrator under
40 CFR 52.38(b)(3) or (4) or that is established in a SIP revision approved by
the administrator under 40 CFR 52.38(b)(5), as a means of mitigating
interstate transport of ozone and NOX.
"Cross State Air Pollution Rule (CSAPR) SO2
Group 1 Trading Program" means a multistate SO2 air pollution
control and emission reduction program established in accordance with Subpart
CCCCC of 40 CFR Part 97 and 40 CFR 52.39(a), (b), (d) through (f), (j),
and (k), including such a program that is revised in a SIP revision approved by
the administrator under 40 CFR 52.39(d) or (e) or that is established in a SIP
revision approved by the administrator under 40 CFR 52.39(f), as a means of
mitigating interstate transport of fine particulates and SO2.
"Cross State Air Pollution Rule (CSAPR) SO2
Group 2 Trading Program" means a multistate SO2 air pollution
control and emission reduction program established in accordance with Subpart
DDDDD of 40 CFR Part 97 and 40 CFR 52.39(a), (c), and (g) through (k),
including such a program that is revised in a SIP revision approved by the
administrator under 40 CFR 52.39(g) or (h) or that is established in a SIP
revision approved by the administrator under 40 CFR 52.39(i), as a means of
mitigating interstate transport of fine particulates and SO2.
"Department" means the Virginia Department of
Environmental Quality.
"DMME" means the Virginia Department of Mines,
Minerals and Energy.
"Excess emissions" means any tonnage of CO2
emitted by a CO2 budget source during [ the initial
control period or ] a control period that exceeds the CO2
budget emissions limitation for the source.
"Excess interim emissions" means any tonnage of
CO2 emitted by a CO2 budget source during an interim
control period multiplied by 0.50 that exceeds the CO2 budget
emissions limitation for the source.
"Fossil fuel" means natural gas, petroleum, coal,
or any form of solid, liquid, or gaseous fuel derived from such material.
"Fossil fuel-fired" means the combustion of
fossil fuel, alone or in combination with any other fuel, where the fossil fuel
combusted comprises, or is projected to comprise, more than 10% 5.0% of
the annual heat input on a Btu basis during any year.
"General account" means a COATS account
[ , ] established under Article 6 (9VAC5-140-6220 et
seq.) of this part that is not a compliance account.
"Gross generation" means the electrical output in
MWe at the terminals of the generator.
"Initial control period" means the period
beginning January 1, 2020, and ending December 31, 2020.
"Interim control period" means a
one-calendar-year time period [ , ] during each
of the first and second calendar years of each three-year control period. The
first interim control period starts January 1, 2021, and ends December 31,
2021, inclusive. The second interim control period starts January 1, 2022, and
ends December 31, 2022, inclusive. Each successive three-year control period
will have two interim control periods, comprised of each of the first two
calendar years of that control period.
"Life-of-the-unit contractual arrangement" means
a unit participation power sales agreement under which a customer reserves, or
is entitled to receive, a specified amount or percentage of nameplate capacity
or associated energy from any specified unit pursuant to a contract:
a. For the life of the unit;
b. For a cumulative term of no less than 30 years,
including contracts that permit an election for early termination; or
c. For a period equal to or greater than 25 years or 70% of
the economic useful life of the unit determined as of the time the unit is
built, with option rights to purchase or release some portion of the nameplate
capacity and associated energy generated by the unit at the end of the period.
"Maximum design heat input" means the ability
of a unit to combust a stated maximum amount of fuel per hour on a steady state
basis, as determined by the physical design and physical characteristics of the
unit.
"Maximum potential hourly heat input" means an
hourly heat input used for reporting purposes when a unit lacks certified
monitors to report heat input. If the unit intends to use Appendix D of 40 CFR
Part 75 to report heat input, this value shall be calculated, in accordance
with 40 CFR Part 75, using the maximum fuel flow rate and the maximum
gross calorific value. If the unit intends to use a flow monitor and a diluent
gas monitor, this value shall be reported, in accordance with 40 CFR Part 75,
using the maximum potential flow rate and either the maximum CO2
concentration in percent CO2 or the minimum O2
concentration in percent O2.
"Minimum reserve price" means, in calendar year
2020, $2.00 $2.32. Each calendar year thereafter, the minimum reserve
price shall be 1.025 multiplied by the minimum reserve price from the previous
calendar year, rounded to the nearest whole cent.
"Monitoring system" means any monitoring system
that meets the requirements of Article 8 (9VAC5-140-6330 et seq.) of this part,
including a CEMS, an excepted monitoring system, or an alternative monitoring
system.
"Nameplate capacity" means the maximum electrical
output in MWe that a generator can sustain over a specified period of time when
not restricted by seasonal or other deratings as measured in accordance with
the U.S. Department of Energy standards.
"Net-electric output" means the amount of gross
generation in MWh the generators produce, including output from steam turbines,
combustion turbines, and gas expanders, as measured at the generator terminals,
less the electricity used to operate the plant (i.e., auxiliary loads); such
uses include fuel handling equipment, pumps, fans, pollution control equipment,
other electricity needs, and transformer losses as measured at the transmission
side of the step up transformer (e.g., the point of sale).
"Non-CO2 budget unit" means a unit
that does not meet the applicability criteria of 9VAC5-140-6040.
"Operator" means any person who operates,
controls, or supervises a CO2 budget unit or a CO2 budget
source and shall include any holding company, utility system, or plant manager
of such a unit or source.
"Owner" means any of the following persons:
a. Any holder of any portion of the legal or equitable
title in a CO2 budget unit;
b. Any holder of a leasehold interest in a CO2
budget unit, other than a passive lessor, or a person who has an equitable
interest through such lessor, whose rental payments are not based, either
directly or indirectly, upon the revenues or income from the CO2
budget unit;
c. Any purchaser of power from a CO2 budget unit
under a life-of-the-unit contractual arrangement in which the purchaser
controls the dispatch of the unit; or
d. With respect to any general account, any person who has
an ownership interest with respect to the CO2 allowances held in the
general account and who is subject to the binding agreement for the CO2
authorized account representative to represent that person's ownership interest
with respect to the CO2 allowances.
"Participating state" means a state that has
established a corresponding regulation as part of participates in
the CO2 Budget Trading Program.
"Receive" or "receipt of" means, with
regard to CO2 allowances, the movement of CO2 allowances
by the department or its agent from one COATS account to another, for purposes
of allocation, transfer, or deduction when referring to the department or
its agent, to come into possession of a document, information, or
correspondence (whether sent in writing or by authorized electronic
transmission) as indicated in an official correspondence log, or by a notation
made on the document, information, or correspondence by the department or its
agent in the regular course of business.
"Recordation," "record," or
"recorded" means, with regard to CO2 allowances, the
movement of CO2 allowances by the department or its agent from one
COATS account to another, for purposes of allocation, transfer, or deduction.
"RGGI, Inc." means the 501(c)(3) nonprofit
corporation created to support development and implementation of the Regional
Greenhouse Gas Initiative (RGGI). Participating RGGI states use RGGI, Inc., as
their agent to conduct the consignment auction and to operate and manage COATS.
"Reserve price" means the minimum acceptable
price for each [ CO2 conditional ]
allowance in a specific auction. The reserve price at an auction is either
the minimum reserve price or the CCR trigger price, as specified in Article 9 (9VAC5-140-6410
et seq.) of this part.
"Serial number" means, when referring to CO2
allowances, the unique identification number assigned to each CO2
allowance by the department or its agent under 9VAC5-140-6250 C.
"Source" means any governmental, institutional,
commercial, or industrial structure, installation, plant, building, or facility
that emits or has the potential to emit any air pollutant. A source, including
a source with multiple units, shall be considered a single facility.
"State" means the Commonwealth of Virginia.
The term "state" shall have its conventional meaning where such
meaning is clear from the context.
"Submit" or "serve" means to send or
transmit a document, information, or correspondence to the person specified in
accordance with the applicable regulation:
a. In person;
b. By U.S. United States Postal Service; or
c. By other means of dispatch or transmission and delivery.
Compliance with any "submission,"
"service," or "mailing" deadline shall be determined by the
date of dispatch, transmission, or mailing and not the date of receipt.
"Ton" or "tonnage" means any short ton,
or 2,000 pounds. For the purpose of determining compliance with the CO2
requirements of 9VAC5-140-6050 C, total tons for [ the initial
control period, an interim control period, or ] a control period
shall be calculated as the sum of all recorded hourly emissions, or the tonnage
equivalent of the recorded hourly emissions rates, in accordance with Article 8
(9VAC5-140-6330 et seq.) of this part, with any remaining fraction of a ton
equal to or greater than 0.50 ton deemed to equal one ton and any fraction of a
ton less than 0.50 ton deemed to equal zero tons. A short ton is equal to
0.9072 metric tons.
"Total useful energy" means the sum of gross
electrical generation and useful net thermal energy.
"Undistributed [ CO2
conditional ] allowances" means [ CO2
conditional ] allowances originally allocated to a set aside
account as pursuant to 9VAC5-140-6210 that were not distributed.
"Unit" means a fossil fuel-fired stationary
boiler, combustion turbine, or combined cycle system.
"Unit operating day" means a calendar day in
which a unit combusts any fuel.
"Unsold [ CO2
conditional ] allowances" means [ CO2
conditional ] allowances that have been made available for sale in
an auction conducted by the department or its agent, but not sold.
"Useful net thermal energy" means energy:
1. In the form of direct heat, steam, hot water, or other
thermal form that is used in the production and beneficial measures for
heating, cooling, humidity control, process use, or other thermal end use
energy requirements, excluding thermal energy used in the power production
process (e.g., house loads and parasitic loads); and
2. For which fuel or electricity would otherwise be
consumed.
"Virginia CO2 Budget Trading Program
adjusted budget" means an adjusted budget determined in accordance with
9VAC5-140-6210 and is the annual amount of CO2 tons available in
Virginia for allocation in a given allocation year, in accordance with the CO2
Budget Trading Program. [ CO2 Conditional ]
CCR allowances offered for sale at an auction are separate from and
additional to [ CO2 conditional ]
allowances allocated from the Virginia CO2 Budget Trading Program
adjusted budget.
"Virginia CO2 Budget Trading Program base
budget" means the budget specified in 9VAC5-140-6190. [ CO2
Conditional ] CCR allowances offered for sale at an auction are
separate from and additional to [ CO2
conditional ] allowances allocated from the Virginia CO2
Budget Trading Program base budget.
9VAC5-140-6030. Measurements, abbreviations, and
acronyms.
Measurements, abbreviations, and acronyms used in this part
are defined as follows:
Btu - British thermal unit.
CAA - federal Clean Air Act.
CCR - cost containment reserve.
CEMS - Continuous Emissions Monitoring System.
COATS - CO2 Allowance Tracking System.
CO2 - carbon dioxide.
DAHS - Data Acquisition and Handling System.
EEM - efficiency measure.
H2O - water.
lb - pound.
LME - low mass emissions.
MMBtu - million British thermal units.
MW - megawatt.
MWe - megawatt electrical.
MWh - megawatt hour.
NOX - nitrogen oxides.
O2 - oxygen.
ORIS - Office of Regulatory Information Systems.
QA/QC - quality assurance/quality control.
ppm - parts per million.
scf - standard cubic feet per hour.
SO2 - sulfur dioxide.
9VAC5-140-6040. Applicability.
A. Any fossil fuel-fired unit that serves an electricity
generator with a nameplate capacity equal to or greater than 25 MWe shall be a
CO2 budget unit, and any source that includes one or more such units
shall be a CO2 budget source, subject to the requirements of this
part.
B. Exempt from the requirements of this part is any
[ fossil fuel ] power generating unit owned by an
individual facility and located at that individual facility that generates
electricity and heat from fossil fuel for the primary use of operation of the
facility CO2 budget source located at or adjacent to and
physically interconnected with a manufacturing facility that, prior to January
1, 2019, and in every subsequent calendar year, met either of the following
requirements:
1. Supplies less than or equal to 10% of its annual net
electrical generation to the electric grid; or
2. Supplies less than or equal to 15% of its annual total
useful energy to any entity other than the manufacturing facility to which the
CO2 budget source is interconnected.
For the purpose of subdivision 1 of this subsection,
annual net electrical generation shall be determined as follows:
(ES – EP) / EG x 100
Where:
ES = electricity sales to the grid from the CO2
budget source
EP = electricity purchases from the grid by the CO2
budget source and the manufacturing facility to which the CO2 budget
source is interconnected
EG = electricity generation
Such CO2 budget source shall have an operating
permit containing the applicable restrictions under this subsection.
[ 9VAC5-140-6045. CO2 Budget Trading Program
implementation.
In the event the allocation of conditional allowances by
the department as required by 9VAC5-140-6190 B has not occurred by January 1,
2020, the program will be considered to be operating and effective as of the
calendar year following the date on which the department allocates the
conditional allowances as it corresponds to the schedule of 9VAC5-140-6190 A.
Permitting and compliance dates, including the due date for a permit as
required by 9VAC5-140-6150, shall be adjusted to be in force six months after
the date the department allocates the conditional allowances. Any excess emissions
tonnage identified by the new program implementation date may be addressed
through program review and regulatory action as necessary to ensure compliance
with the final compliance date. The department will notify the board and each
affected CO2 budget source accordingly. ]
9VAC5-140-6050. Standard requirements.
A. Permit requirements shall be as follows.
1. The CO2 authorized account representative of
each CO2 budget source required to have an operating permit pursuant
to 9VAC5-85 (Permits for Stationary Sources of Pollutants Subject to
Regulation) and each CO2 budget unit required to have an operating
permit pursuant to 9VAC5-85 shall:
a. Submit to the department a complete CO2
budget permit application under 9VAC5-140-6160 in accordance with the deadlines
specified in 9VAC5-140-6150; and
b. Submit in a timely manner any supplemental information
that the department determines is necessary in order to review the CO2
budget permit application and issue or deny a CO2 budget permit.
2. The owners and operators of each CO2 budget
source required to have an operating permit pursuant to 9VAC5-85 (Permits for
Stationary Sources of Pollutants Subject to Regulation) and each CO2
budget unit required to have an operating permit pursuant to 9VAC5-85 for the
source shall have a CO2 budget permit and operate the CO2
budget source and the CO2 budget unit at the source in compliance
with such CO2 budget permit.
B. Monitoring requirements shall be as follows.
1. The owners and operators and, to the extent applicable,
the CO2 authorized account representative of each CO2
budget source and each CO2 budget unit at the source shall comply
with the monitoring requirements of Article 8 (9VAC5-140-6330 et seq.) of this
part.
2. The emissions measurements recorded and reported in
accordance with Article 8 (9VAC5-140-6330 et seq.) of this part shall be used
to determine compliance by the unit with the CO2 requirements under
subsection C of this section.
C. CO2 requirements shall be as follows.
1. The owners and operators of each CO2 budget
source and each CO2 budget unit at the source shall hold CO2
allowances available for compliance deductions under 9VAC5-140-6260, as of the
CO2 allowance transfer deadline, in the source's compliance account
in an amount not less than the total CO2 emissions [ that
have been generated as a result of combusting fossil fuel ] for the
[ initial control period, an interim control period, or ] control
period from all CO2 budget units at the source, less the CO2
allowances deducted to meet the requirements of subdivision 2 of this
subsection, with respect to the previous two interim control periods as
determined in accordance with Article 6 (9VAC5-140-6220 et seq.) and Article 8
(9VAC5-140-6330 et seq.) of this part.
2. The owners and operators of each CO2 budget
source and each CO2 budget unit at the source shall hold CO2
allowances available for compliance deductions under 9VAC5-140-6260, as of the
CO2 allowance transfer deadline, in the source's compliance account
in an amount not less than the total CO2 emissions [ that
have been generated as a result of combusting fossil fuel ] for the
[ initial control period, an interim control period, or ] for
the interim control period from all CO2 budget units at the source
multiplied by 0.50, as determined in accordance with Article 6 (9VAC5-140-6220
et seq.) and Article 8 (9VAC5-140-6330 et seq.) of this part.
3. Each ton of CO2 emitted in excess of the CO2
budget emissions limitation for [ the initial control period or ]
a control period shall constitute a separate violation of this part and
applicable state law.
4. Each ton of excess interim emissions shall constitute a
separate violation of this part and applicable state law.
5. A CO2 budget unit shall be subject to the
requirements under subdivision 1 of this subsection starting on the later of
January 1, 2020, or the date on which the unit commences operation.
6. CO2 allowances shall be held in, deducted
from, or transferred among COATS accounts in accordance with Article 5
(9VAC5-140-6190 et seq.), Article 6 (9VAC5-140-6220 et seq.), and Article 7
(9VAC5-140-6300 et seq.) of this part.
7. A CO2 allowance shall not be deducted, to
comply with the requirements under subdivision 1 or 2 of this subsection, for a
control period that ends prior to the year for which the CO2
allowance was allocated.
8. A CO2 allowance under the CO2
Budget Trading Program is a limited authorization by the department to emit one
ton of CO2 in accordance with the CO2 Budget Trading
Program. No provision of the CO2 Budget Trading Program, the CO2
budget permit application, or the CO2 budget permit or any provision
of law shall be construed to limit the authority of the department or a
participating state to terminate or limit such authorization.
9. A CO2 allowance under the CO2
Budget Trading Program does not constitute a property right.
D. The owners and operators of a CO2 budget
source that has excess emissions in [ any an initial
control period or a ] control period shall:
1. Forfeit the CO2 allowances required for
deduction under 9VAC5-140-6260 D 1; and
2. Pay any fine, penalty, or assessment or comply with any
other remedy imposed under 9VAC5-140-6260 D 2.
E. Recordkeeping and reporting requirements shall be as
follows:
1. Unless otherwise provided, the owners and operators of
the CO2 budget source and each CO2 budget unit at the source
shall keep on site at the source each of the following documents for a period
of 10 years from the date the document is created. This period may be extended
for cause, at any time prior to the end of 10 years, in writing by the
department.
a. The account certificate of representation for the CO2
authorized account representative for the source and each CO2 budget
unit at the source and all documents that demonstrate the truth of the
statements in the account certificate of representation, in accordance with
9VAC5-140-6110, provided that the certificate and documents shall be retained
on site at the source beyond such 10-year period until such documents are
superseded because of the submission of a new account certificate of
representation changing the CO2 authorized account representative.
b. All emissions monitoring information, in accordance with
Article 8 (9VAC5-140-6330 et seq.) of this part and 40 CFR 75.57.
c. Copies of all reports, compliance certifications, and
other submissions and all records made or required under the CO2
Budget Trading Program.
d. Copies of all documents used to complete a CO2
budget permit application and any other submission under the CO2
Budget Trading Program or to demonstrate compliance with the requirements of
the CO2 Budget Trading Program.
2. The CO2 authorized account representative of
a CO2 budget source and each CO2 budget unit at the
source shall submit the reports and compliance certifications required under
the CO2 Budget Trading Program, including those under Article 4
(9VAC5-140-6170 et seq.) of this part.
F. Liability requirements shall be as follows.
1. No permit revision shall excuse any violation of the
requirements of the CO2 Budget Trading Program that occurs prior to
the date that the revision takes effect.
2. Any provision of the CO2 Budget Trading
Program that applies to a CO2 budget source, including a provision
applicable to the CO2 authorized account representative of a CO2
budget source, shall also apply to the owners and operators of such source and
of the CO2 budget units at the source.
3. Any provision of the CO2 Budget Trading
Program that applies to a CO2 budget unit, including a provision
applicable to the CO2 authorized account representative of a CO2
budget unit, shall also apply to the owners and operators of such unit.
G. No provision of the CO2 Budget Trading
Program, a CO2 budget permit application, or a CO2 budget
permit shall be construed as exempting or excluding the owners and operators
and, to the extent applicable, the CO2 authorized account
representative of the CO2 budget source or CO2 budget
unit from compliance with any other provisions of applicable state and federal
law or regulations.
9VAC5-140-6060. Computation of time.
A. Unless otherwise stated, any time period scheduled,
under the CO2 Budget Trading Program, to begin on the occurrence of
an act or event shall begin on the day the act or event occurs.
B. Unless otherwise stated, any time period scheduled,
under the CO2 Budget Trading Program, to begin before the occurrence
of an act or event shall be computed so that the period ends the day before the
act or event occurs.
C. Unless otherwise stated, if the final day of any time
period, under the CO2 Budget Trading Program, falls on a weekend or
a state or federal holiday, the time period shall be extended to the next
business day.
9VAC5-140-6070. Severability.
If any provision of this part, or its application to any
particular person or circumstances, is held invalid, the remainder of this
part, and the application thereof to other persons or circumstances, shall not
be affected thereby.
Article 2
CO2 Authorized Account Representative for CO2 Budget
Sources
9VAC5-140-6080. Authorization and responsibilities of the CO2
authorized account representative.
A. Except as provided under 9VAC5-140-6090, each CO2
budget source, including all CO2 budget units at the source, shall
have one and only one CO2 authorized account representative, with
regard to all matters under the CO2 Budget Trading Program
concerning the source or any CO2 budget unit at the source.
B. The CO2 authorized account representative of
the CO2 budget source shall be selected by an agreement binding on
the owners and operators of the source and all CO2 budget units at
the source and must act in accordance with the [ account ]
certificate of representation under 9VAC5-140-6110.
C. Upon receipt by the department or its agent of a
complete account certificate of representation under 9VAC5-140-6110, the CO2
authorized account representative of the source shall represent and, by his
representations, actions, inactions, or submissions, legally bind each owner
and operator of the CO2 budget source represented and each CO2
budget unit at the source in all matters pertaining to the CO2
Budget Trading Program, notwithstanding any agreement between the CO2
authorized account representative and such owners and operators. The owners and
operators shall be bound by any decision or order issued to the CO2
authorized account representative by the department or a court regarding the
source or unit.
D. No CO2 budget permit shall be issued, and no
COATS account shall be established for a CO2 budget source, until
the department or its agent has received a complete account certificate of
representation under 9VAC5-140-6110 for a CO2 authorized account
representative of the source and the CO2 budget units at the source.
E. Each submission under the CO2 Budget Trading
Program shall be submitted, signed, and certified by the CO2
authorized account representative for each CO2 budget source on
behalf of which the submission is made. Each such submission shall include the
following certification statement by the CO2 authorized account
representative: "I am authorized to make this submission on behalf of the
owners and operators of the CO2 budget sources or CO2
budget units for which the submission is made. I certify under penalty of law
that I have personally examined, and am familiar with, the statements and
information submitted in this document and all its attachments. Based on my
inquiry of those individuals with primary responsibility for obtaining the
information, I certify that the statements and information are to the best of
my knowledge and belief true, accurate, and complete. I am aware that there are
significant penalties for submitting false statements and information or
omitting required statements and information, including the possibility of fine
or imprisonment."
F. The department or its agent will accept or act on a
submission made on behalf of owners or operators of a CO2 budget
source or a CO2 budget unit only if the submission has been made,
signed, and certified in accordance with subsection E of this section.
9VAC5-140-6090. Alternate CO2 authorized
alternate account representative.
A. An account certificate of representation may designate
one and only one alternate CO2 authorized alternate account
representative who may act on behalf of the CO2 authorized account
representative. The agreement by which the alternate CO2
authorized alternate account representative is selected shall include a
procedure for authorizing the alternate CO2 authorized
alternate account representative to act in lieu of the CO2
authorized account representative.
B. Upon receipt by the department or its agent of a
complete account certificate of representation under 9VAC5-140-6110, any
representation, action, inaction, or submission by the alternate CO2
authorized alternate account representative shall be deemed to be a
representation, action, inaction, or submission by the CO2
authorized account representative.
C. Except in this section and 9VAC5-140-6080 A,
9VAC5-140-6100, 9VAC5-140-6110, and 9VAC5-140-6230, whenever the term "CO2
authorized account representative" is used in this part, the term shall be
construed to include the alternate CO2 authorized alternate
account representative.
9VAC5-140-6100. Changing the CO2 authorized
account representatives and the alternate CO2 authorized
alternate account representative; changes in the owners and operators.
A. The CO2 authorized account representative
may be changed at any time upon receipt by the department or its agent of a
superseding complete account certificate of representation under
9VAC5-140-6110. Notwithstanding any such change, all representations, actions,
inactions, and submissions by the previous CO2 authorized account
representative or alternate CO2 authorized alternate account
representative prior to the time and date when the department or its agent
receives the superseding account certificate of representation shall be binding
on the new CO2 authorized account representative and the owners and
operators of the CO2 budget source and the CO2 budget
units at the source.
B. The alternate CO2 authorized
alternate account representative may be changed at any time upon receipt by the
department or its agent of a superseding complete account certificate of
representation under 9VAC5-140-6110. Notwithstanding any such change, all
representations, actions, inactions, and submissions by the previous or
alternate CO2 authorized alternate account representative or alternate
CO2 authorized alternate account representative prior to the time
and date when the department or its agent receives the superseding account
certificate of representation shall be binding on the new alternate CO2
authorized alternate account representative and the owners and operators of the
CO2 budget source and the CO2 budget units at the source.
C. Changes in the owners and operators shall be addressed
as follows.
1. In the event a new owner or operator of a CO2
budget source or a CO2 budget unit is not included in the list of
owners and operators submitted in the account certificate of representation,
such new owner or operator shall be deemed to be subject to and bound by the
account certificate of representation, the representations, actions, inactions,
and submissions of the CO2 authorized account representative and any
alternate CO2 authorized alternate account representative of
the source or unit, and the decisions, orders, actions, and inactions of the
department, as if the new owner or operator were included in such list.
2. Within 30 days following any change in the owners and
operators of a CO2 budget source or a CO2 budget unit,
including the addition of a new owner or operator, the CO2
authorized account representative or alternate CO2
authorized alternate account representative shall submit a revision to the
account certificate of representation amending the list of owners and operators
to include the change.
9VAC5-140-6110. Account certificate of representation.
A. A complete account certificate of representation for a
CO2 authorized account representative or an alternate a
CO2 authorized alternate account representative shall include the
following elements in a format prescribed by the department or its agent:
1. Identification of the CO2 budget source and
each CO2 budget unit at the source for which the account certificate
of representation is submitted;
2. The name, address, email address, telephone number, and
facsimile transmission number of the CO2 authorized account
representative and any alternate CO2 authorized alternate
account representative;
3. A list of the owners and operators of the CO2
budget source and of each CO2 budget unit at the source;
4. The following certification statement by the CO2
authorized account representative and any alternate CO2
authorized alternate account representative: "I certify that I was
selected as the CO2 authorized account representative or alternate
CO2 authorized alternate account representative, as applicable, by
an agreement binding on the owners and operators of the CO2 budget
source and each CO2 budget unit at the source. I certify that I have
all the necessary authority to carry out my duties and responsibilities under
the CO2 Budget Trading Program on behalf of the owners and operators
of the CO2 budget source and of each CO2 budget unit at
the source and that each such owner and operator shall be fully bound by my
representations, actions, inactions, or submissions and by any decision or
order issued to me by the department or a court regarding the source or
unit."; and
5. The signature of the CO2 authorized account
representative and any alternate CO2 authorized alternate
account representative and the dates signed.
B. Unless otherwise required by the department or its
agent, documents of agreement referred to in the account certificate of
representation shall not be submitted to the department or its agent. Neither
the department nor its agent shall be under any obligation to review or
evaluate the sufficiency of such documents, if submitted.
9VAC5-140-6120. Objections concerning the CO2
authorized account representative.
A. Once a complete account certificate of representation
under 9VAC5-140-6110 has been submitted and received, the department and its
agent will rely on the account certificate of representation unless and until
the department or its agent receives a superseding complete account certificate
of representation under 9VAC5-140-6110.
B. Except as provided in 9VAC5-140-6100 A or B, no
objection or other communication submitted to the department or its agent
concerning the authorization, or any representation, action, inaction, or
submission of the CO2 authorized account representative shall affect
any representation, action, inaction, or submission of the CO2
authorized account representative or the finality of any decision or order by
the department or its agent under the CO2 Budget Trading Program.
C. Neither the department nor its agent will adjudicate
any private legal dispute concerning the authorization or any representation,
action, inaction, or submission of any CO2 authorized account
representative, including private legal disputes concerning the proceeds of CO2
allowance transfers.
9VAC5-140-6130. Delegation by CO2 authorized
account representative and alternate CO2 authorized alternate
account representative.
A. A CO2 authorized account representative may
delegate, to one or more natural persons, his authority to make an electronic
submission to the department or its agent under this part.
B. An alternate A CO2 authorized
alternate account representative may delegate, to one or more natural persons,
his authority to make an electronic submission to the department or its agent
under this part.
C. To delegate authority to make an electronic submission
to the department or its agent in accordance with subsections A and B of this
section, the CO2 authorized account representative or alternate
CO2 authorized alternate account representative, as appropriate,
shall submit to the department or its agent a notice of delegation, in a format
prescribed by the department that includes the following elements:
1. The name, address, email address, telephone number, and
facsimile transmission number of such CO2 authorized account
representative or alternate CO2 authorized alternate account
representative;
2. The name, address, email address, telephone number, and
facsimile transmission number of each such natural person, referred to as the
"electronic submission agent";
3. For each such natural person, a list of the type of
electronic submissions under subsection A or B of this section for which
authority is delegated to him; and
4. The following certification statement by such CO2
authorized account representative or alternate CO2 authorized
alternate account representative: "I agree that any electronic submission
to the department or its agent that is by a natural person identified in this
notice of delegation and of a type listed for such electronic submission agent
in this notice of delegation and that is made when I am a CO2
authorized account representative or alternate CO2 authorized
alternate account representative, as appropriate, and before this notice of
delegation is superseded by another notice of delegation under 9VAC5-140-6130 D
shall be deemed to be an electronic submission by me. Until this notice of
delegation is superseded by another notice of delegation under 9VAC5-140-6130
D, I agree to maintain an email account and to notify the department or its agent
immediately of any change in my email address unless all delegation authority
by me under 9VAC5-140-6130 is terminated."
D. A notice of delegation submitted under subsection C of
this section shall be effective, with regard to the CO2 authorized
account representative or alternate CO2 authorized alternate
account representative identified in such notice, upon receipt of such notice
by the department or its agent and until receipt by the department or its agent
of a superseding notice of delegation by such CO2 authorized account
representative or alternate CO2 authorized alternate account
representative as appropriate. The superseding notice of delegation may replace
any previously identified electronic submission agent, add a new electronic
submission agent, or eliminate entirely any delegation of authority.
E. Any electronic submission covered by the certification
in subdivision C 4 of this section and made in accordance with a notice of
delegation effective under subsection D of this section shall be deemed to be
an electronic submission by the CO2 authorized account
representative or alternate CO2 authorized alternate account
representative submitting such notice of delegation.
F. A CO2 authorized account representative may
delegate, to one or more natural persons, his authority to review information
in the CO2 allowance tracking system under this part.
G. An alternate A CO2 authorized
alternate account representative may delegate, to one or more natural persons,
his authority to review information in the CO2 allowance tracking
system under this part.
H. To delegate authority to review information in the CO2
allowance tracking system in accordance with subsections F and G of this
section, the CO2 authorized account representative or alternate
CO2 authorized alternate account representative, as appropriate, must
shall submit to the department or its agent a notice of delegation, in a format
prescribed by the department that includes the following elements:
1. The name, address, email address, telephone number, and
facsimile transmission number of such CO2 authorized account
representative or alternate CO2 authorized alternate account
representative;
2. The name, address, email address, telephone number, and
facsimile transmission number of each such natural person, referred to as the
"reviewer";
3. For each such natural person, a list of the type of
information under subsection F or G of this section for which authority is
delegated to him; and
4. The following certification statement by such CO2
authorized account representative or alternate CO2 authorized
alternate account representative: "I agree that any information that is
reviewed by a natural person identified in this notice of delegation and of a
type listed for such information accessible by the reviewer in this notice of
delegation and that is made when I am a CO2 authorized account
representative or alternate CO2 authorized alternate account
representative, as appropriate, and before this notice of delegation is
superseded by another notice of delegation under subsection I of this section
shall be deemed to be a reviewer by me. Until this notice of delegation is
superseded by another notice of delegation under subsection I of this section,
I agree to maintain an email account and to notify the department or its agent
immediately of any change in my email address unless all delegation authority
by me under this section is terminated."
I. A notice of delegation submitted under subsection H of
this section shall be effective, with regard to the CO2 authorized
account representative or alternate CO2 authorized alternate
account representative identified in such notice, upon receipt of such notice
by the department or its agent and until receipt by the department or its agent
of a superseding notice of delegation by such CO2 authorized account
representative or alternate CO2 authorized alternate account
representative as appropriate. The superseding notice of delegation may replace
any previously identified reviewer, add a new reviewer, or eliminate entirely
any delegation of authority.
Article 3
Permits
9VAC5-140-6140. CO2 budget permit requirements.
A. Each CO2 budget source shall have a permit
issued by the department pursuant to 9VAC5-85 (Permits for Stationary Sources
of Pollutants Subject to Regulation).
B. Each CO2 budget permit shall contain all
applicable CO2 Budget Trading Program requirements and shall be a
complete and distinguishable portion of the permit under subsection A of this
section.
9VAC5-140-6150. Submission of CO2 budget permit
applications.
For any CO2 budget source, the CO2
authorized account representative shall submit a complete CO2 budget
permit application under 9VAC5-140-6160 covering such CO2 budget
source to the department by the later of January 1, 2020, or 12 months before
the date on which the CO2 budget source, or a new unit at the
source, commences operation.
9VAC5-140-6160. Information requirements for CO2
budget permit applications.
A complete CO2 budget permit application shall
include the following elements concerning the CO2 budget source for
which the application is submitted, in a format prescribed by the department:
1. Identification of the CO2 budget source,
including plant name and the ORIS (Office of Regulatory Information Systems) or
facility code assigned to the source by the Energy Information Administration
of the U.S. Department of Energy if applicable;
2. Identification of each CO2 budget unit at the
CO2 budget source; and
3. The standard requirements under 9VAC5-140-6050.
Article 4
Compliance Certification
9VAC5-140-6170. Compliance certification report.
A. For [ the initial control period and ]
each control period in which a CO2 budget source is subject to
the CO2 requirements of 9VAC5-140-6050 C, the CO2
authorized account representative of the source shall submit to the department
by March 1 following the relevant control period, a compliance certification
report. A compliance certification report is not required as part of the
compliance obligation during an interim control period.
B. The CO2 authorized account representative
shall include in the compliance certification report under subsection A of this
section the following elements, in a format prescribed by the department:
1. Identification of the source and each CO2
budget unit at the source;
2. At the CO2 authorized account representative's
option, the serial numbers of the CO2 allowances that are to be
deducted from the source's compliance account under 9VAC5-140-6260 for the
control period; and
3. The compliance certification under subsection C of this
section.
C. In the compliance certification report under subsection
A of this section, the CO2 authorized account representative shall
certify, based on reasonable inquiry of those persons with primary
responsibility for operating the source and the CO2 budget units at
the source in compliance with the CO2 Budget Trading Program,
whether the source and each CO2 budget unit at the source for which
the compliance certification is submitted was operated during the calendar
years covered by the report in compliance with the requirements of the CO2
Budget Trading Program, including:
1. Whether the source was operated in compliance with the
CO2 requirements of 9VAC5-140-6050 C;
2. Whether the monitoring plan applicable to each unit at
the source has been maintained to reflect the actual operation and monitoring
of the unit, and contains all information necessary to attribute CO2
emissions to the unit, in accordance with Article 8 (9VAC5-140-6330 et seq.) of
this part;
3. Whether all the CO2 emissions from the units
at the source were monitored or accounted for through the missing data
procedures and reported in the quarterly monitoring reports, including whether
conditional data were reported in the quarterly reports in accordance with
Article 8 (9VAC5-140-6330 et seq.) of this part. If conditional data were
reported, the owner or operator shall indicate whether the status of all
conditional data has been resolved and all necessary quarterly report
resubmissions have been made;
4. Whether the facts that form the basis for certification
under Article 8 (9VAC5-140-6330 et seq.) of this part of each monitor at each
unit at the source, or for using an excepted monitoring method or alternative
monitoring method approved under Article 8 (9VAC5-140-6330 et seq.) of this
part, if any, have changed; and
5. If a change is required to be reported under subdivision
4 of this subsection, specify the nature of the change, the reason for the
change, when the change occurred, and how the unit's compliance status was
determined subsequent to the change, including what method was used to
determine emissions when a change mandated the need for monitor
recertification.
9VAC5-140-6180. Action on compliance certifications.
A. The department or its agent may review and conduct
independent audits concerning any compliance certification or any other
submission under the CO2 Budget Trading Program and make appropriate
adjustments of the information in the compliance certifications or other
submissions.
B. The department or its agent may deduct CO2
allowances from or transfer CO2 allowances to a source's compliance
account based on the information in the compliance certifications or other
submissions, as adjusted under subsection A of this section.
Article 5
CO2 Allowance Allocations
Editor's Note: Two versions of 9VAC5-140-6190 are
provided for comment. The board seeks comment on whether the base budget should
be 33 million tons or 34 million tons, with corresponding 3.0% per year
reductions. The first version (Version 1) represents a 33 million ton base
budget, and the second version (Version 2) represents a 34 million ton base
budget.
9VAC5-140-6190. Base budgets.
Version
1, 33 million ton base budget:
A. The Virginia CO2 Budget Trading Program base
budget shall be as follows:
1. For 2020, the Virginia CO2 Budget Trading Program
base budget is 33 28 million tons.
2. For 2021, the Virginia CO2 Budget Trading
Program base budget is 32.01 27.16 million tons.
3. For 2022, the Virginia CO2 Budget Trading
Program base budget is 31.02 26.32 million tons.
4. For 2023, the Virginia CO2 Budget Trading
Program base budget is 30.03 25.48 million tons.
5. For 2024, the Virginia CO2 Budget Trading
Program base budget is 29.04 24.64 million tons.
6. For 2025, the Virginia CO2 Budget Trading
Program base budget is 28.05 23.80 million tons.
7. For 2026, the Virginia CO2 Budget Trading
Program base budget is 27.06 22.96 million tons.
8. For 2027, the Virginia CO2 Budget Trading
Program base budget is 26.07 22.12 million tons.
9. For 2028, the Virginia CO2 Budget Trading
Program base budget is 25.08 21.28 million tons.
10. For 2029, the Virginia CO2 Budget Trading
Program base budget is 24.09 20.44 million tons.
11. For 2030, the Virginia CO2 Budget Trading
Program base budget is 23.10 19.60 million tons.
B. The department will allocate conditional allowances to
CO2 budget units and to DMME. After a conditional allowance has been
consigned in an auction by a CO2 budget unit [ and
or ] the holder of a public contract with DMME as specified under
Article 9 (9VAC5-140-6410 et seq.) of this part, the conditional allowance
becomes [ an allowance to be used for compliance purposes
a CO2 allowance once it is sold to an auction participant ].
C. For 2031 and each succeeding calendar year, the
Virginia CO2 Budget Trading Program base budget is 23.10 million
tons [ the department will review the Virginia CO2
Budget Trading Program base budget and recommend to the board appropriate
adjustments in the base budget for such succeeding years. The department will
consider the best available science and all relevant information and policies
available from any CO2 multistate trading program in which Virginia
is participating when considering further reductions. Absent any adjustment,
the Virginia CO2 Budget Trading Program base budget for each year of
the decade 2031-2040 shall be reduced by 840,000 tons from the preceding year
the Virginia CO2 Budget Trading Program base budget is 19.60 million
tons unless modified as a result of a program review and future regulatory
action ].
Version
2, 34 million ton base budget:
A. The Virginia CO2 Budget Trading Program
base budget shall be as follows:
1. For 2020, the Virginia CO2 Budget Trading
Program base budget is 34 million tons.
2. For 2021, the Virginia CO2 Budget Trading
Program base budget is 32.98 million tons.
3. For 2022, the Virginia CO2 Budget Trading
Program base budget is 31.96 million tons.
4. For 2023, the Virginia CO2 Budget Trading
Program base budget is 30.94 million tons.
5. For 2024, the Virginia CO2 Budget Trading
Program base budget is 29.92 million tons.
6. For 2025, the Virginia CO2 Budget Trading
Program base budget is 28.90 million tons.
7. For 2026, the Virginia CO2 Budget Trading
Program base budget is 27.88 million tons.
8. For 2027, the Virginia CO2 Budget Trading
Program base budget is 26.86 million tons.
9. For 2028, the Virginia CO2 Budget Trading
Program base budget is 25.84 million tons.
10. For 2029, the Virginia CO2 Budget Trading
Program base budget is 24.82 million tons.
11. For 2030, the Virginia CO2 Budget Trading
Program base budget is 23.80 million tons.
B. The department will allocate conditional allowances
to CO2 budget units and to DMME. After a conditional allowance has
been consigned in an auction by a CO2 budget unit and the holder of
a public contract with DMME as specified under Article 9 (9VAC5-140-6410 et
seq.) of this part, the conditional allowance becomes an allowance to be used
for compliance purposes.
C. For 2031 and each succeeding calendar year, the
Virginia CO2 Budget Trading Program base budget is 23.80 million
tons.
9VAC5-140-6200. Undistributed and unsold [ CO2
conditional ] allowances.
A. The department may will retire undistributed CO2
conditional allowances at the end of [ the initial control period
and ] each [ subsequent ] control period.
B. The department may will retire unsold CO2
conditional allowances at the end of [ the initial control period
and ] each [ subsequent ] control period.
Editor's
Note:
Two versions of 9VAC5-140-6210 are provided for comment. The board seeks
comment on whether the base budget should be 33 million tons or 34 million
tons, with corresponding 3.0% per year reductions. The first version (Version
1) represents a 33 million ton base budget, and the second version (Version 2)
represents a 34 million ton base budget.
9VAC5-140-6210. [ CO2
Conditional ] allowance allocations.
Version
1, 33 million ton base budget:
A. The department will allocate 95% of the Virginia
CO2 Budget Trading Program base budget [ conditional ]
allowances to CO2 budget sources to be consigned to auction to
the Virginia Consignment Auction Account.
B. The department will allocate 5.0% of the Virginia CO2
Budget Trading Program base budget to DMME to be consigned to auction by DMME
to assist the department for the abatement and control of air pollution,
specifically, CO2.
C. B. For allocation years 2020 through
2031, the Virginia CO2 Budget Trading Program adjusted budget shall
be the maximum number of allowances available for allocation in a given
allocation year, except for [ CO2
conditional ] CCR allowances.
D. C. [ Conditional allowances
allocated for a calendar year will be automatically transferred to the Virginia
Consignment Auction Account to be consigned to auction. Following each auction,
all conditional allowances sold at the auction will be transferred from the
Virginia Consignment Auction Account to winning bidders' accounts as CO2
allowances.
D. ] The cost containment reserve (CCR)
allocation shall be managed as follows. The department will allocate
[ CO2 conditional ] CCR
allowances, separate from and additional to the Virginia CO2 Budget
Trading Program base budget set forth in 9VAC5-140-6190 [ , ]
to the Virginia [ Consignment ] Auction Account. The
CCR allocation is for the purpose of containing the cost of CO2
allowances. The department will allocate [ CO2
conditional ] CCR allowances as follows [ .: ]
1. The Beginning in
calendar year 2020, the department will initially allocate 3.3 million [ CO2, ] on
a pro rata basis to CO2 budget sources, 2.8 million [ conditional ]
CO2 CCR allowances for calendar year 2020.
2. On or before January 1,
2021, and each year thereafter, the department will allocate, on a pro rata
basis to CO2 budget sources, current vintage year [ conditional ] CCR allowances
equal to the quantity in Table 140-5A [ , and withdraw the
number of CO2 CCR allowances that remain in the Virginia Auction
Account at the end of the prior calendar year ].
Table 140-5A
[ Conditional ] CCR Allowances from 2021 Forward
|
2021
|
3.201 2.716 million tons
|
2022
|
3.102 2.632 million tons
|
2023
|
3.003 2.548 million tons
|
2024
|
2.904 2.464 million tons
|
2025
|
2.805 2.380 million tons
|
2026
|
2.706 2.296 million tons
|
2027
|
2.607 2.212 million tons
|
2028
|
2.508 2.128 million tons
|
2029
|
2.409 2.044 million tons
|
2030 and each year thereafter
|
2.310 1.960 million tons
|
3. The pro rata calculation to be used for the distribution
of [ CO2 conditional ] CCR
allowances is as follows:
SAA/TAA * CCR = SCCR
Where:
SAA = source adjusted allocation
TAA = total adjusted allocation
SCCR = source CCR
[ 4. Conditional CCR allowances allocated for a
calendar year will be automatically transferred to the Virginia Consignment
Auction Account to be consigned to auction. Following each auction, all
conditional CCR allowances sold at auction will be transferred to winning
bidders' accounts as CO2 CCR allowances.
5. Unsold conditional CCR allowances will remain in the
Virginia Consignment Auction Account to be re-offered for sale at auction
within the same calendar year. Conditional CCR allowances remaining unsold at
the end of the calendar year in which they were originated will be made
unavailable for sale at future auctions. ]
[ E. ] Annual
base budgets as described in subsections A and B of this section may be
decreased in any year as necessary to account for transfers to the Virginia
Emission Containment Reserve (ECR) account and adjustments for banked
allowances [ D. ] In the event that the ECR
is triggered during an auction, the department will authorize its agent to
withhold conditional allowances as needed. The department will further
authorize its agent to convert and transfer any CO2
conditional allowances that have been withheld from any auction in the prior
year into the Virginia ECR account. The ECR withholding is for the purpose
of additional emission reduction in the event of lower than anticipated
emission reduction costs. The department department's agent will
withhold CO2 ECR allowances as follows:
1. If the condition in 9VAC5-140-6420 D 1 is met at an
auction, then the maximum number of CO2 ECR allowances that will be
withheld from that auction will be equal to the quantity shown in Table 140-5B
minus the total quantity of CO2 ECR allowances that have been
withheld from any prior auction in that calendar year. Any CO2 ECR
allowances withheld from an auction will be transferred into the Virginia ECR
account.
Table 140-5B
ECR Allowances from 2021 Forward
|
2021
|
3.201 2.716 million tons
|
2022
|
3.102 2.632 million tons
|
2023
|
3.003 2.548 million tons
|
2024
|
2.904 2.464 million tons
|
2025
|
2.805 2.380 million tons
|
2026
|
2.706 2.296 million tons
|
2027
|
2.607 2.212 million tons
|
2028
|
2.508 2.128 million tons
|
2029
|
2.409 2.044 million tons
|
2030 and each year thereafter
|
2.310 1.960 million tons
|
2. Allowances that have been transferred into the Virginia
ECR account shall not be withdrawn.
F. E. The adjustment for banked allowances shall
will be as follows. On March [ 15 17 ], 2021,
the department will may determine the third adjustment for banked
allowances quantity for allocation years 2021 through 2025 through the
application of the following formula:
TABA = ((TA – TAE)/5) x RS%
Where:
TABA is the adjustment for banked allowances quantity in
tons.
TA, adjustment, is the total quantity of allowances of
vintage years prior to 2021 held in general and compliance accounts, including
compliance accounts established pursuant to the CO2 Budget Trading
Program but not including accounts opened by participating states, as reflected
in the CO2 Allowance Tracking System on March 15, 2021.
TAE, adjustment emissions, is the total quantity of 2018,
2019, and 2020 emissions from all CO2 budget sources in all
participating states, reported pursuant to CO2 Budget Trading
Program as reflected in the CO2 Allowance Tracking System on March
[ 15 17 ], 2021.
RS% is Virginia budget divided by the regional budget.
G. F. CO2 Budget Trading Program
adjusted budgets for 2021 through 2025 shall be determined as follows
[ . On: on April 15, 2021, the department will determine
the Virginia CO2 Budget Trading Program adjusted budgets for the
2021 through 2025 allocation years by the following formula:
AB = BB – TABA
Where:
AB is the Virginia CO2 Budget Trading Program
adjusted budget.
BB is the Virginia CO2 Budget Trading Program
base budget.
TABA is the adjustment for banked allowances quantity in
tons.
H. G. The department or its agent will publish the
CO2 trading program adjusted budgets for the 2021 through 2025
allocation years.
I. H. Timing requirements for [ CO2
conditional ] allowance allocations shall be as follows.:
1. By [ May 1 August 25 ],
2019, the department will submit to RGGI, Inc., its agent the CO2
conditional allowance allocations, in a format prescribed by RGGI, Inc., and
in accordance with 9VAC5-140-6215 A and B, for the initial control period,
2020.
2. By [ May 1 the month and day
established by subdivision 1 of this subsection ], 2020, the
department will submit to its agent 50% of the conditional allowance
allocations in accordance with 9VAC5-140-6215 A and B, for the 2021 control
period. By [ April 1 the month and day one month
before the date established by subdivision 1 of this subsection ],
2021, the department will submit to its agent the remainder of the conditional
allowance allocations in accordance with 9VAC5-140-6215 A and B, for 2021.
3. By [ May 1, ] 2020
[ the month and day established by subdivision 1 of this subsection, ]
2021, and [ May 1 the month and day established by
subdivision 1 of this subsection ] of every third
subsequent year thereafter, the department will submit to RGGI, Inc.,
its agent the [ CO2 conditional ]
allowance allocations, in a format prescribed by RGGI, Inc., for the
applicable control period, and in accordance with 9VAC5-140-6215 A and
B.
I. J. Implementation of the CCR (subsection
C of this section), the ECR (subsection D of this section) and the banking
adjustment (subsection E of this section) shall be determined based on the
extent of the CO2 trading program.
[ K. Conditional allowances and conditional CCR
allowances allocated for a calendar year will be automatically transferred to
the Virginia Consignment Auction Account to be consigned to auction. Following
each auction, all conditional allowances sold at the auction will be transferred
from the Virginia Consignment Auction Account to winning bidders' accounts as
CO2 allowances. Conditional CCR allowances sold at auction will be
transferred to winning bidders' accounts as CO2 CCR allowances.
Unsold conditional CCR allowances will remain in the Virginia Consignment
Auction Account to be re-offered for sale at auction within the same calendar
year. Conditional CCR allowances remaining unsold at the end of the calendar
year in which they were originated will be made unavailable for sale at future
auctions. ]
Version
2, 34 million ton base budget:
A. The department will allocate 95% of the Virginia CO2
Budget Trading Program base budget to CO2 budget sources to be
consigned to auction to the Virginia Consignment Auction Account.
B. The department will allocate 5.0% of the Virginia CO2
Budget Trading Program base budget to DMME to be consigned to auction by the
holder of a public contract with DMME to assist the department for the
abatement and control of air pollution, specifically CO2.
C. For allocation years 2020 through 2031, the Virginia
CO2 Budget Trading Program adjusted budget shall be the maximum
number of allowances available for allocation in a given allocation year,
except for CO2 CCR allowances.
D. The cost containment reserve (CCR) allocation shall
be managed as follows. The department will allocate CO2 CCR
allowances, separate from and additional to the Virginia CO2 Budget
Trading Program base budget set forth in 9VAC5-140-6190, to the Virginia
Auction Account. The CCR allocation is for the purpose of containing the cost
of CO2 allowances. The department will allocate CO2 CCR
allowances as follows.
1. The department will initially allocate 3.4 million CO2
CCR allowances for calendar year 2020.
2. On or before January 1, 2021, and each year
thereafter, the department will allocate current vintage year CCR allowances
equal to the quantity in Table 140-5A, and withdraw the number of CO2
CCR allowances that remain in the Virginia Auction Account at the end of the
prior calendar year.
Table 140-5A
CCR Allowances from 2021 Forward
|
2021
|
3.298 million tons
|
2022
|
3.196 million tons
|
2023
|
3.094 million tons
|
2024
|
2.992 million tons
|
2025
|
2.890 million tons
|
2026
|
2.788 million tons
|
2027
|
2.686 million tons
|
2028
|
2.584 million tons
|
2029
|
2.482 million tons
|
2030 and each year thereafter
|
2.390 million tons
|
E. Annual base budgets as described in subsections A
and B of this section may be decreased in any year as necessary to account for
transfers to the Virginia Emission Containment Reserve (ECR) account and
adjustments for banked allowances. The department will convert and transfer any
CO2 allowances that have been withheld from any auction in the prior
year into the Virginia ECR account. The ECR withholding is for the purpose of
additional emission reduction in the event of lower than anticipated emission
reduction costs. The department will withhold CO2 ECR allowances as
follows:
1. If the condition in 9VAC5-140-6420 D 1 is met at an
auction, then the maximum number of CO2 ECR allowances that will be
withheld from that auction will be equal to the quantity shown in Table 140-5B
minus the total quantity of CO2 ECR allowances that have been
withheld from any prior auction in that calendar year. Any CO2 ECR
allowances withheld from an auction will be transferred into the Virginia ECR
account.
Table 140-5B
ECR Allowances from 2021 Forward
|
2021
|
3.298 million tons
|
2022
|
3.196 million tons
|
2023
|
3.094 million tons
|
2024
|
2.992 million tons
|
2025
|
2.890 million tons
|
2026
|
2.788 million tons
|
2027
|
2.686 million tons
|
2028
|
2.584 million tons
|
2029
|
2.482 million tons
|
2030 and each year thereafter
|
2.390 million tons
|
2. Allowances that have been transferred into the
Virginia ECR account shall not be withdrawn.
F. The adjustment for banked allowances shall be as
follows. On March 15, 2021, the department will determine the third adjustment
for banked allowances quantity for allocation years 2021 through 2025 through
the application of the following formula:
TABA = ((TA – TAE)/5) x RS%
Where:
TABA is the adjustment for banked allowances quantity in
tons.
TA, adjustment, is the total quantity of allowances of
vintage years prior to 2021 held in general and compliance accounts, including
compliance accounts established pursuant to the CO2 Budget Trading
Program but not including accounts opened by participating states, as reflected
in the CO2 Allowance Tracking System on March 15, 2021.
TAE, adjustment emissions, is the total quantity of
2018, 2019, and 2020 emissions from all CO2 budget sources in all
participating states, reported pursuant to CO2 Budget Trading
Program as reflected in the CO2 Allowance Tracking System on March
15, 2021.
RS% is Virginia budget divided by the regional budget.
G. CO2 Budget Trading Program adjusted
budgets for 2021 through 2025 shall be determined as follows. On April 15,
2021, the department will determine the Virginia CO2 Budget Trading
Program adjusted budgets for the 2021 through 2025 allocation years by the
following formula:
AB = BB – TABA
Where:
AB is the Virginia CO2 Budget Trading Program
adjusted budget.
BB is the Virginia CO2 Budget Trading Program
base budget.
TABA is the adjustment for banked allowances quantity in
tons.
H. The department or its agent will publish the CO2
trading program adjusted budgets for the 2021 through 2025 allocation years.
I. Timing requirements for CO2 allowance
allocations shall be as follows:
1. By May 1, 2019, the department will submit to RGGI,
Inc., the CO2 conditional allowance allocations, in a format
prescribed by RGGI, Inc., and in accordance with 9VAC5-140-6215 A and B, for
the initial control period, 2020.
2. By May 1, 2020, and May 1 of every third year
thereafter, the department will submit to RGGI, Inc., the CO2
allowance allocations, in a format prescribed by RGGI, Inc., for the applicable
control period, and in accordance with 9VAC5-140-6215 A and B.
9VAC5-140-6211. [ CO2
Conditional ] allowance allocations, DMME allowances.
Notwithstanding 9VAC5-140-6210, the department will
allocate 5.0% of the Virginia CO2 Budget Trading Program base or
adjusted budget allowances, as applicable, to DMME to be consigned to auction
by the holder of a public contract with DMME to assist the department for the
abatement and control of air pollution, specifically CO2, by the
implementation of programs that lower base and peak electricity demand and
reduce the cost of the program to consumers and budget sources.
9VAC5-140-6215. [ CO2
Conditional ] allocation methodology.
A. The net-electric output in MWh used with respect to
[ CO2 conditional ] allowance
allocations under subsection B of this section for each CO2 budget
unit shall be:
1. For units operating on or before January 1, 2020, the
average of the three amounts of the unit's net-electric output during 2016,
2017, and 2018 to determine allocations for the initial control period.
2. For all units operating in each control period after
2020, the average of the three amounts of the unit's total net-electric output
during the three most recent years for which data are available prior to the
start of the control period.
B. 1. For each control period beginning in 2020 and
thereafter, the department will allocate to all CO2 budget units
that have a net-electric output, as determined under subsection A of this
section, a total amount of [ CO2 ] conditional
allowances equal to the CO2 base budget.
2. The department will allocate [ CO2 ]
conditional allowances to each [ CO2
conditional ] budget unit under subdivision 1 of this subsection in
an amount determined by multiplying the total amount of CO2
allowances allocated under subdivision 1 of this subsection by the ratio of the
baseline electrical output of such CO2 budget unit to the total
amount of baseline electrical output of all such CO2 budget units
and rounding to the nearest whole allowance as appropriate.
3. New CO2 budget units will be allocated
[ CO2 ] conditional allowances once they
have established electrical output data to be used in the conditional allowance
allocation process.
C. For the purpose of the allocation process as described
in subsections A and B of this section, CO2 budget units shall
report the unit's net-electric output to the department on a yearly basis as
follows:
1. By [ March 1 August 25 ],
2019, each CO2 budget unit shall report yearly net-electric output data
during 2016, 2017, and 2018.
2. By [ March 1, the month and
day established by subdivision 1 of this subsection, ] 2020, and
each year thereafter, each CO2 budget unit shall report yearly
net-electric output data for the previous year.
Article 6
CO2 Allowance Tracking System
9VAC5-140-6220. CO2 Allowance Tracking System
accounts.
A. Consistent with 9VAC5-140-6230 A, the department or its
agent will establish one compliance account for each CO2 budget
source. Allocations of [ CO2 ] conditional
allowances pursuant to Article 5 (9VAC5-140-6190 et seq.) of this part and
deductions or transfers of [ CO2 ] conditional
allowances pursuant to 9VAC5-140-6180, 9VAC5-140-6260, 9VAC5-140-6280, or
Article 7 (9VAC5-140-6300 et seq.) of this part will be recorded in the
compliance accounts in accordance with this section.
B. Consistent with 9VAC5-140-6230 B, the department or its
agent will establish, upon request, a general account for any person. Transfers
of CO2 allowances pursuant to Article 7 (9VAC5-140-6300 et seq.) of
this part will be recorded in the general account in accordance with this
article.
9VAC5-140-6230. Establishment of accounts.
A. Upon receipt of a complete account certificate of
representation under 9VAC5-140-6110, the department or its agent will establish
a conditional allowance account and a compliance account for each CO2
budget source [ for which an account certificate of representation
was submitted ] and a conditional [ compliance
allowance ] account for DMME [ for which the account
certificate of representation was submitted ].
B. General accounts shall operate as follows.
1. Any person may apply to open a general account for the
purpose of holding and transferring CO2 allowances. An application
for a general account may designate one and only one CO2 authorized
account representative and one and only one alternate CO2
authorized alternate account representative who may act on behalf of the CO2
authorized account representative. The agreement by which the alternate
CO2 authorized alternate account representative is selected shall
include a procedure for authorizing the alternate CO2
authorized alternate account representative to act in lieu of the CO2
authorized account representative. A complete application for a general account
shall be submitted to the department or its agent and shall include the
following elements in a format prescribed by the department or its agent:
a. Name, address, email address, telephone number, and
facsimile transmission number of the CO2 authorized account
representative and any alternate CO2 authorized
alternate account representative;
b. At the option of the CO2 authorized account
representative, organization name and type of organization;
c. A list of all persons subject to a binding agreement for
the CO2 authorized account representative or any alternate CO2
authorized alternate account representative to represent their ownership
interest with respect to the CO2 allowances held in the general
account;
d. The following certification statement by the CO2
authorized account representative and any alternate CO2
authorized alternate account representative: "I certify that I was
selected as the CO2 authorized account representative or the CO2
alternate authorized alternate account representative, as applicable, by
an agreement that is binding on all persons who have an ownership interest with
respect to CO2 allowances held in the general account. I certify
that I have all the necessary authority to carry out my duties and
responsibilities under the CO2 Budget Trading Program on behalf of
such persons and that each such person shall be fully bound by my
representations, actions, inactions, or submissions and by any order or
decision issued to me by the department or its agent or a court regarding the
general account.";
e. The signature of the CO2 authorized account
representative and any alternate CO2 authorized alternate
account representative and the dates signed; and
f. Unless otherwise required by the department or its
agent, documents of agreement referred to in the application for a general
account shall not be submitted to the department or its agent. Neither the
department nor its agent shall be under any obligation to review or evaluate
the sufficiency of such documents, if submitted.
2. Authorization of the CO2 authorized account
representative shall be as follows:
a. Upon receipt by the department or its agent of a
complete application for a general account under subdivision 1 of this
subsection:
(1) The department or its agent will establish a general
account for the person for whom the application is submitted.
(2) The CO2 authorized account representative
and any alternate CO2 authorized alternate account
representative for the general account shall represent and, by his
representations, actions, inactions, or submissions, legally bind each person
who has an ownership interest with respect to CO2 allowances held in
the general account in all matters pertaining to the CO2 Budget
Trading Program, notwithstanding any agreement between the CO2
authorized account representative or any alternate CO2
authorized alternate account representative and such person. Any such person
shall be bound by any order or decision issued to the CO2 authorized
account representative or any alternate CO2 authorized
alternate account representative by the department or its agent or a court
regarding the general account.
(3) Any representation, action, inaction, or submission by
any alternate CO2 authorized alternate account representative
shall be deemed to be a representation, action, inaction, or submission by the
CO2 authorized account representative.
b. Each submission concerning the general account shall be
submitted, signed, and certified by the CO2 authorized account
representative or any alternate CO2 authorized alternate
account representative for the persons having an ownership interest with
respect to CO2 allowances held in the general account. Each such
submission shall include the following certification statement by the CO2
authorized account representative or any alternate CO2
authorized alternate account representative: "I am authorized to make this
submission on behalf of the persons having an ownership interest with respect
to the CO2 allowances held in the general account. I certify under
penalty of law that I have personally examined, and am familiar with, the
statements and information submitted in this document and all its attachments.
Based on my inquiry of those individuals with primary responsibility for
obtaining the information, I certify that the statements and information are to
the best of my knowledge and belief true, accurate, and complete. I am aware
that there are significant penalties for submitting false statements and
information or omitting required statements and information, including the
possibility of fine or imprisonment."
c. The department or its agent will accept or act on a
submission concerning the general account only if the submission has been made,
signed, and certified in accordance with subdivision 2 b of this subsection.
3. Changing CO2 authorized account
representative and alternate CO2 authorized alternate account
representative, and changes in persons with ownership interest, shall be
accomplished as follows:
a. The CO2 authorized account representative for
a general account may be changed at any time upon receipt by the department or
its agent of a superseding complete application for a general account under
subdivision 1 of this subsection. Notwithstanding any such change, all
representations, actions, inactions, and submissions by the previous CO2
authorized account representative, or the previous alternate CO2
authorized alternate account representative, prior to the time and date when
the department or its agent receives the superseding application for a general
account shall be binding on the new CO2 authorized account
representative and the persons with an ownership interest with respect to the
CO2 allowances in the general account.
b. The alternate CO2 authorized
alternate account representative for a general account may be changed at
any time upon receipt by the department or its agent of a superseding complete
application for a general account under subdivision 1 of this subsection.
Notwithstanding any such change, all representations, actions, inactions, and
submissions by the previous CO2 authorized account representative,
or the previous alternate CO2 authorized alternate account
representative, prior to the time and date when the department or its agent
receives the superseding application for a general account shall be binding on
the new alternate CO2 authorized account representative and the
persons with an ownership interest with respect to the CO2
allowances in the general account.
c. In the event a new person having an ownership interest
with respect to CO2 allowances in the general account is not
included in the list of such persons in the application for a general account,
such new person shall be deemed to be subject to and bound by the application
for a general account, the representations, actions, inactions, and submissions
of the CO2 authorized account representative and any alternate
CO2 authorized alternate account representative, and the decisions,
orders, actions, and inactions of the department or its agent, as if the new
person were included in such list.
d. Within 30 days following any change in the persons
having an ownership interest with respect to CO2 allowances in the
general account, including the addition or deletion of persons, the CO2
authorized account representative or any alternate CO2
authorized alternate account representative shall submit a revision to the
application for a general account amending the list of persons having an
ownership interest with respect to the CO2 allowances in the general
account to include the change.
4. Objections concerning CO2 authorized account
representative shall be governed as follows:
a. Once a complete application for a general account under
subdivision 1 of this subsection has been submitted and received, the
department or its agent will rely on the application unless and until a
superseding complete application for a general account under subdivision 1 of
this subsection is received by the department or its agent.
b. Except as provided in subdivisions 3 a and 3 b of this
subsection, no objection or other communication submitted to the department or
its agent concerning the authorization, or any representation, action,
inaction, or submission of the CO2 authorized account representative
or any alternate CO2 authorized alternate account
representative for a general account shall affect any representation, action,
inaction, or submission of the CO2 authorized account representative
or any alternate CO2 authorized alternate account
representative or the finality of any decision or order by the department or
its agent under the CO2 Budget Trading Program.
c. Neither the department nor its agent will adjudicate any
private legal dispute concerning the authorization or any representation,
action, inaction, or submission of the CO2 authorized account
representative or any alternate CO2 authorized alternate
account representative for a general account, including private legal disputes
concerning the proceeds of CO2 allowance transfers.
5. Delegation by CO2 authorized account
representative and alternate CO2 authorized alternate account
representative shall be accomplished as follows:
a. A CO2 authorized account representative may
delegate, to one or more natural persons, his authority to make an electronic
submission to the department or its agent provided for under this article and
Article 7 (9VAC5-140-6300 et seq.) of this part.
b. An alternate A CO2 authorized
alternate account representative may delegate, to one or more natural persons,
his authority to make an electronic submission to the department or its agent
provided for under this article and Article 7 (9VAC5-140-6300 et seq.) of this
part.
c. To delegate authority to make an electronic submission
to the department or its agent in accordance with subdivisions 5 a and 5 b of
this subsection, the CO2 authorized account representative or alternate
CO2 authorized alternate account representative, as appropriate,
shall submit to the department or its agent a notice of delegation, in a format
prescribed by the department that includes the following elements:
(1) The name, address, email address, telephone number, and
facsimile transmission number of such CO2 authorized account
representative or alternate CO2 authorized alternate account
representative;
(2) The name, address, email address, telephone number, and
facsimile transmission number of each such natural person, referred to as
"electronic submission agent";
(3) For each such natural person, a list of the type of
electronic submissions under subdivision 5 c (1) or 5 c (2) of this subsection
for which authority is delegated to him; and
(4) The following certification statement by such CO2
authorized account representative or alternate CO2 authorized
alternate account representative: "I agree that any electronic submission
to the department or its agent that is by a natural person identified in this
notice of delegation and of a type listed for such electronic submission agent
in this notice of delegation and that is made when I am a CO2
authorized account representative or alternate CO2 authorized
alternate account representative, as appropriate, and before this notice of
delegation is superseded by another notice of delegation under 9VAC5-140-6230 B
5 d shall be deemed to be an electronic submission by me. Until this notice of
delegation is superseded by another notice of delegation under 9VAC5-140-6230 B
5 d, I agree to maintain an email account and to notify the department or its
agent immediately of any change in my email address unless all delegation
authority by me under 9VAC5-140-6230 B 5 is terminated."
d. A notice of delegation submitted under subdivision 5 c
of this subsection shall be effective, with regard to the CO2
authorized account representative or alternate CO2 authorized
alternate account representative identified in such notice, upon receipt of
such notice by the department or its agent and until receipt by the department
or its agent of a superseding notice of delegation by such CO2
authorized account representative or alternate CO2 authorized
alternate account representative as appropriate. The superseding notice of
delegation may replace any previously identified electronic submission agent,
add a new electronic submission agent, or eliminate entirely any delegation of
authority.
e. Any electronic submission covered by the certification
in subdivision 5 c (4) of this subsection and made in accordance with a notice
of delegation effective under subdivision 5 d of this subsection shall be
deemed to be an electronic submission by the CO2 authorized account
representative or alternate CO2 authorized alternate account
representative submitting such notice of delegation.
C. The department or its agent will assign a unique
identifying number to each account established under subsection A or B of this
section.
9VAC5-140-6240. CO2 Allowance Tracking System
responsibilities of CO2 authorized account representative.
Following the establishment of a COATS account, all
submissions to the department or its agent pertaining to the account, including
submissions concerning the deduction or transfer of CO2 allowances
in the account, shall be made only by the CO2 authorized account
representative for the account.
9VAC5-140-6250. Recordation of [ CO2
conditional ] allowance allocations.
A. By January 1 of each calendar year, the department or
its agent will record in the following accounts:
1. In each CO2 budget source's and DMME's
conditional allowance account, the [ CO2 ]
conditional allowances allocated to those sources and DMME by the department
prior to being consigned to auction; and
2. In each CO2 budget source's compliance
account, the CO2 allowances purchased at auction by CO2
budget units at the source under 9VAC5-140-6210 A.
B. Each year the department or its agent will record
[ CO2 conditional ] allowances, as
allocated to the unit under Article 5 (9VAC5-140-6190 et seq.) of this part, in
the compliance account for the year after the last year for which [ CO2
conditional ] allowances were previously allocated to the
compliance account. Each year, the department or its agent will also record
[ CO2 conditional ] allowances, as
allocated under Article 5 (9VAC5-140-6190 et seq.) of this part, in an
allocation set-aside for the year after the last year for which [ CO2
conditional ] allowances were previously allocated to an allocation
set-aside.
C. Serial numbers for allocated [ CO2
conditional ] allowances shall be managed as follows. When
allocating [ CO2 conditional ] allowances
to and recording them in an account, the department or its agent will assign
each [ CO2 conditional ] allowance
a unique identification number that will include digits identifying the year
for which the [ CO2 conditional ]
allowance is allocated.
9VAC5-140-6260. Compliance.
A. CO2 allowances that meet the following
criteria are available to be deducted for a CO2 budget source to
comply with the CO2 requirements of 9VAC5-140-6050 C for [ the
initial control period, ] a control period [ , ]
or an interim control period.
1. The CO2 allowances are of allocation years
that fall within [ an initial control period, ] a prior
control period, the same control period, or the same interim control period for
which the allowances will be deducted.
2. The CO2 allowances are held in the CO2
budget source's compliance account as of the CO2 allowance transfer
deadline for that [ initial control period, ] control
period [ , ] or interim control period or are
transferred into the compliance account by a CO2 allowance transfer
correctly submitted for recordation under 9VAC5-140-6300 by the CO2
allowance transfer deadline for that [ initial control period, ]
control period [ , ] or interim control period.
3. For CO2 offset allowances generated by other
participating states, the number of CO2 offset allowances that are
available to be deducted in order for a CO2 budget source to comply
with the CO2 requirements of 9VAC5-140-6050 C for a control period
[ or an ] initial control period [ , or an
interim control period ] shall not exceed 3.3% of the CO2
budget source's CO2 emissions for that control period, or may not
exceed 3.3% of 0.50 times the CO2 budget source's CO2
emissions for an interim control period, as determined in accordance with this
article and Article 8 (9VAC5-140-6330 et seq.) of this part.
3. 4. The CO2 allowances are not
necessary for deductions for excess emissions for a prior [ initial
control period or a ] control period under subsection D of this
section.
B. Following the recordation, in accordance with
9VAC5-140-6310, of CO2 allowance transfers submitted for recordation
in the CO2 budget source's compliance account by the CO2
allowance transfer deadline for [ the initial control period, ]
a control period [ , ] or [ an ]
interim control period, the department or its agent will deduct CO2
allowances available under subsection A of this section to cover the source's
CO2 emissions, as determined in accordance with Article 8
(9VAC5-140-6330 et seq.) of this part, for the [ initial control
period, ] control period [ , ] or interim
control period, as follows:
1. Until the amount of CO2 allowances deducted
equals the number of tons of total CO2 emissions, or 0.50 times the
number of tons of total CO2 emissions for an interim control period,
determined in accordance with Article 8 (9VAC5-140-6330 et seq.) of this part,
from all CO2 budget units at the CO2 budget source for
the [ initial control period, ] control period
[ , ] or interim control period; or
2. If there are insufficient CO2 allowances to
complete the deductions in subdivision 1 of this subsection, until no more CO2
allowances available under subsection A of this section remain in the
compliance account.
C. Identification of available CO2 allowances
by serial number and default compliance deductions shall be managed as follows:
1. The CO2 authorized account representative for
a source's compliance account may request that specific CO2
allowances, identified by serial number, in the compliance account be deducted
for emissions or excess emissions for [ the initial control period, ]
a control period [ , ] or interim control period in
accordance with subsection B or D of this section. Such identification shall be
made in the compliance certification report submitted in accordance with
9VAC5-140-6170.
2. The department or its agent will deduct CO2
allowances for [ the initial control period, an interim control
period, or ] a control period from the CO2 budget
source's compliance account, in the absence of an identification or in the case
of a partial identification of available CO2 allowances by serial
number under subdivision 1 of this subsection, as follows: Any CO2
allowances that are available for deduction under subdivision 1 of this
subsection. CO2 allowances shall be deducted in chronological order
(i.e., CO2 allowances from earlier allocation years shall be
deducted before CO2 allowances from later allocation years). In the
event that some, but not all, CO2 allowances from a particular
allocation year are to be deducted, CO2 allowances shall be deducted
by serial number, with lower serial number allowances deducted before higher
serial number allowances.
D. Deductions for excess emissions shall be managed as
follows.
1. After making the deductions for compliance under
subsection B of this section, the department or its agent will deduct from the
CO2 budget source's compliance account a number of CO2
allowances equal to three times the number of the source's excess emissions. In
the event that a source has insufficient CO2 allowances to cover
three times the number of the source's excess emissions, the source shall be
required to immediately transfer sufficient allowances into its compliance
account.
2. Any CO2 allowance deduction required under
subdivision 1 of this subsection shall not affect the liability of the owners
and operators of the CO2 budget source or the CO2 budget
units at the source for any fine, penalty, or assessment, or their obligation
to comply with any other remedy, for the same violation, as ordered under
applicable state law. The following guidelines will be followed in assessing
fines, penalties, or other obligations:
a. For purposes of determining the number of days of
violation, if a CO2 budget source has excess emissions for a control
period, each day in the control period constitutes a day in violation unless
the owners and operators of the unit demonstrate that a lesser number of days
should be considered.
b. Each ton of excess emissions is a separate violation.
c. For purposes of determining the number of days of
violation, if a CO2 budget source has excess interim emissions for
an interim control period, each day in the interim control period constitutes a
day in violation unless the owners and operators of the unit demonstrate that a
lesser number of days should be considered.
d. Each ton of excess interim emissions is a separate
violation.
3. The propriety of the department's determination that a
CO2 budget source had excess emissions and the concomitant deduction
of CO2 allowances from that CO2 budget source's account
may be later challenged in the context of the initial administrative
enforcement, or any civil or criminal judicial action arising from or
encompassing that excess emissions violation. The commencement or pendency of
any administrative enforcement, or civil or criminal judicial action arising
from or encompassing that excess emissions violation will not act to prevent
the department or its agent from initially deducting the CO2
allowances resulting from the department's original determination that the
relevant CO2 budget source has had excess emissions. Should the
department's determination of the existence or extent of the CO2
budget source's excess emissions be revised either by a settlement or final
conclusion of any administrative or judicial action, the department will act as
follows:
a. In any instance where the department's determination of
the extent of excess emissions was too low, the department will take further
action under subdivisions 1 and 2 of this subsection to address the expanded
violation.
b. In any instance where the department's determination of
the extent of excess emissions was too high, the department will distribute to
the relevant CO2 budget source a number of CO2 allowances
equaling the number of CO2 allowances deducted which are
attributable to the difference between the original and final quantity of
excess emissions. Should such CO2 budget source's compliance account
no longer exist, the CO2 allowances will be provided to a general
account selected by the owner or operator of the CO2 budget source
from which they were originally deducted.
E. The department or its agent will record in the
appropriate compliance account all deductions from such an account pursuant to
subsections B and D of this section.
F. Action by the department on submissions shall be as
follows:
1. The department may review and conduct independent audits
concerning any submission under the CO2 Budget Trading Program and
make appropriate adjustments of the information in the submissions.
2. The department may deduct CO2 allowances from
or transfer CO2 allowances to a source's compliance account based on
information in the submissions, as adjusted under subdivision 1 of this
subsection.
9VAC5-140-6270. Banking.
Each CO2 allowance that is held in a compliance
account or a general account will remain in such account unless and until the
CO2 allowance is deducted or transferred under 9VAC5-140-6180,
9VAC5-140-6260, 9VAC5-140-6280, or Article 7 (9VAC5-140-6300 et seq.) of this
part.
9VAC5-140-6280. Account error.
The department or its agent may, at its sole discretion
and on its own motion, correct any error in any COATS account. Within 10
business days of making such correction, the department or its agent will
notify the CO2 authorized account representative for the account.
9VAC5-140-6290. Closing of general accounts.
A. A CO2 authorized account representative of a
general account may instruct the department or its agent to close the account
by submitting a statement requesting deletion of the account from the COATS and
by correctly submitting for recordation under 9VAC5-140-6300 a CO2
allowance transfer of all CO2 allowances in the account to one or
more other COATS accounts.
B. If a general account shows no activity for a period of
one year or more and does not contain any CO2 allowances, the
department or its agent may notify the CO2 authorized account
representative for the account that the account will be closed in the COATS 30
business days after the notice is sent. The account will be closed after the
30-day period unless before the end of the 30-day period the department or its
agent receives a correctly submitted transfer of CO2 allowances into
the account under 9VAC5-140-6300 or a statement submitted by the CO2
authorized account representative demonstrating to the satisfaction of the
department or its agent good cause as to why the account should not be closed.
The department or its agent will have sole discretion to determine if the owner
or operator of the unit demonstrated that the account should not be closed.
Article 7
CO2 Allowance Transfers
9VAC5-140-6300. Submission of CO2 allowance
transfers.
The CO2 authorized account representatives
seeking recordation of a CO2 allowance transfer shall submit the
transfer to the department or its agent. To be considered correctly submitted,
the CO2 allowance transfer shall include the following elements in a
format specified by the department or its agent:
1. The numbers identifying both the transferor and
transferee accounts;
2. A specification by serial number of each CO2
allowance to be transferred;
3. The printed name and signature of the CO2
authorized account representative of the transferor account and the date
signed;
4. The date of the completion of the last sale or purchase
transaction for the allowance, if any; and
5. The purchase or sale price of the allowance that is the
subject of a sale or purchase transaction under subdivision 4 of this section.
9VAC5-140-6310. Recordation.
A. Within five business days of receiving a CO2
allowance transfer, except as provided in subsection B of this section, the
department or its agent will record a CO2 allowance transfer by
moving each CO2 allowance from the transferor account to the
transferee account as specified by the request, provided that:
1. The transfer is correctly submitted under
9VAC5-140-6300; and
2. The transferor account includes each CO2
allowance identified by serial number in the transfer.
B. A CO2 allowance transfer into or out of a
compliance account that is submitted for recordation following the CO2
allowance transfer deadline and that includes any CO2 allowances
that are of allocation years that fall within a control period prior to or the
same as the control period to which the CO2 allowance transfer
deadline applies will not be recorded until after completion of the process
pursuant to 9VAC5-140-6260 B.
C. Where a CO2 allowance transfer submitted for
recordation fails to meet the requirements of subsection A of this section, the
department or its agent will not record such transfer.
9VAC5-140-6320. Notification.
A. Within five business days of recordation of a CO2
allowance transfer under 9VAC5-140-6310, the department or its agent will
notify each party to the transfer. Notice will be given to the CO2
authorized account representatives of both the transferor and transferee
accounts.
B. Within 10 business days of receipt of a CO2
allowance transfer that fails to meet the requirements of 9VAC5-140-6310 A, the
department or its agent will notify the CO2 authorized account
representatives of both accounts subject to the transfer of (i) a decision not
to record the transfer and (ii) the reasons for such nonrecordation.
C. Nothing in this section shall preclude the submission
of a CO2 allowance transfer for recordation following notification
of nonrecordation.
Article 8
Monitoring, Reporting, and Recordkeeping
9VAC5-140-6330. General requirements.
A. The owners and operators, and to the extent applicable,
the CO2 authorized account representative of a CO2 budget
unit shall comply with the monitoring, recordkeeping, and reporting
requirements as provided in this section and all applicable sections of 40 CFR
Part 75. Where referenced in this article, the monitoring requirements of 40 CFR
Part 75 shall be adhered to in a manner consistent with the purpose of
monitoring and reporting CO2 mass emissions pursuant to this part.
For purposes of complying with such requirements, the definitions in
9VAC5-140-6020 and in 40 CFR 72.2 shall apply, and the terms
"affected unit," "designated representative," and
"CEMS" in 40 CFR Part 75 shall be replaced by the terms "CO2
budget unit," "CO2 authorized account
representative," and "CEMS," respectively, as defined in
9VAC5-140-6020. For units not subject to an acid rain emissions limitation, the
term "administrator" in 40 CFR Part 75 shall be replaced with
"the department or its agent." Owners or operators of a CO2
budget unit who monitor a non-CO2 budget unit pursuant to the
common, multiple, or bypass stack procedures in 40 CFR 75.72(b)(2)(ii), or 40
CFR 75.16 (b)(2)(ii)(B) pursuant to 40 CFR 75.13, for purposes of complying with
this part, shall monitor and report CO2 mass emissions from such
non-CO2 budget unit units according to the procedures for CO2
budget units established in this article.
B. The owner or operator of each CO2 budget
unit shall meet the following general requirements for installation,
certification, and data accounting.
1. Install all monitoring systems necessary to monitor CO2
mass emissions in accordance with 40 CFR Part 75, except for equation G-1.
Equation G-1 in Appendix G shall not be used to determine CO2
emissions under this part. This may require systems to monitor CO2
concentration, stack gas flow rate, O2 concentration, heat input,
and fuel flow rate.
2. Successfully complete all certification tests required
under 9VAC5-140-6340 and meet all other requirements of this section and 40 CFR
Part 75 applicable to the monitoring systems under subdivision 1 of this
subsection.
3. Record, report, and quality-assure the data from the
monitoring systems under subdivision 1 of this subsection.
C. The owner or operator shall meet the monitoring system
certification and other requirements of subsection B of this section on or
before the following dates. The owner or operator shall record, report, and
quality-assure the data from the monitoring systems under subdivision B 1 of
this section on and after the following dates:
1. The owner or operator of a CO2 budget unit,
except for a CO2 budget unit under subdivision 2 of this subsection,
shall comply with the requirements of this section by January 1, 2020.
2. The owner or operator of a CO2 budget unit
that commences commercial operation July 1, 2020, shall comply with the
requirements of this section by (i) January 1, 2021, or (ii) the earlier of 90
unit operating days after the date on which the unit commences commercial
operation, or 180 calendar days after the date on which the unit
commences commercial operation.
3. For the owner or operator of a CO2 budget
unit for which construction of a new stack or flue installation is completed
after the applicable deadline under subdivision 1 or 2 of this subsection by
the earlier of (i) 90 unit operating days after the date on which emissions
first exit to the atmosphere through the new stack or flue or (ii) 180 calendar
days after the date on which emissions first exit to the atmosphere through the
new stack or flue.
D. Data shall be reported as follows:
1. Except as provided in subdivision 2 of this subsection,
the owner or operator of a CO2 budget unit that does not meet the
applicable compliance date set forth in subsection C of this section for any
monitoring system under subdivision B 1 of this section shall, for each such
monitoring system, determine, record, and report maximum potential, or as
appropriate minimum potential, values for CO2 concentration, CO2
emissions rate, stack gas moisture content, fuel flow rate, heat input, and any
other parameter required to determine CO2 mass emissions in
accordance with 40 CFR 75.31(b)(2) or (c)(3) or Section 2.4 of Appendix D of 40
CFR Part 75 as applicable.
2. The owner or operator of a CO2 budget unit
that does not meet the applicable compliance date set forth in subdivision C 3
of this section for any monitoring system under subdivision B 1 of this section
shall, for each such monitoring system, determine, record, and report
substitute data using the applicable missing data procedures in Subpart D, or
Appendix D of 40 CFR Part 75, in lieu of the maximum potential, or as
appropriate minimum potential, values for a parameter if the owner or operator
demonstrates that there is continuity between the data streams for that
parameter before and after the construction or installation under subdivision C
3 of this section.
a. CO2 budget units subject to an acid rain
emissions limitation or CSAPR NOX Ozone Season Trading Program that
qualify for the optional SO2, NOX, and CO2
(for acid rain) or NOX (for CSAPR NOX Ozone Season
Trading Program) emissions calculations for low mass emissions (LME) units
under 40 CFR 75.19 and report emissions for such programs using the
calculations under 40 CFR 75.19, shall also use the CO2
emissions calculations for LME units under 40 CFR 75.19 for purposes of
compliance with these regulations.
b. CO2 budget units subject to an acid rain
emissions limitation that do not qualify for the optional SO2, NOX,
and CO2 (for acid rain) or NOX (for CSAPR NOX
Ozone Season Trading Program) emissions calculations for LME units under 40 CFR
75.19 shall not use the CO2 emissions calculations for LME units
under 40 CFR 75.19 for purposes of compliance with these regulations.
c. CO2 budget units not subject to an acid rain
emissions limitation shall qualify for the optional CO2 emissions
calculation for LME units under 40 CFR 75.19, provided that they emit less than
100 tons of NOX annually and no more than 25 tons of SO2
annually.
3. The owner or operator of a CO2 budget unit
shall report net-electric output data to the department as required by Article
5 (9VAC5-140-6190 et seq.) of this part.
E. Prohibitions shall be as follows.
1. No owner or operator of a CO2 budget unit
shall use any alternative monitoring system, alternative reference method, or
any other alternative for the required CEMS without having obtained prior
written approval in accordance with 9VAC5-140-6380.
2. No owner or operator of a CO2 budget unit
shall operate the unit so as to discharge, or allow to be discharged, CO2
emissions to the atmosphere without accounting for all such emissions in
accordance with the applicable provisions of this article and 40 CFR Part 75.
3. No owner or operator of a CO2 budget unit
shall disrupt the CEMS, any portion thereof, or any other approved emissions
monitoring method, and thereby avoid monitoring and recording CO2
mass emissions discharged into the atmosphere, except for periods of
recertification or periods when calibration, quality assurance testing, or
maintenance is performed in accordance with the applicable provisions of this
article and 40 CFR Part 75.
4. No owner or operator of a CO2 budget unit
shall retire or permanently discontinue use of the CEMS, any component thereof,
or any other approved emissions monitoring system under this article, except
under any one of the following circumstances:
a. The owner or operator is monitoring emissions from the
unit with another certified monitoring system approved, in accordance with the
applicable provisions of this article and 40 CFR Part 75, by the department for
use at that unit that provides emissions data for the same pollutant or
parameter as the retired or discontinued monitoring system; or
b. The CO2 authorized account representative
submits notification of the date of certification testing of a replacement
monitoring system in accordance with 9VAC5-140-6340 D 3 a.
9VAC5-140-6340. Initial certification and recertification
procedures.
A. The owner or operator of a CO2 budget unit
shall be exempt from the initial certification requirements of this section for
a monitoring system under 9VAC5-140-6330 B 1 if the following conditions are
met:
1. The monitoring system has been previously certified in
accordance with 40 CFR Part 75; and
2. The applicable quality-assurance and quality-control
requirements of 40 CFR 75.21 and Appendix B and Appendix D of 40 CFR Part 75
are fully met for the certified monitoring system described in subdivision 1 of
this subsection.
B. The recertification provisions of this section shall
apply to a monitoring system under 9VAC5-140-6330 B 1 exempt from initial
certification requirements under subsection A of this section.
C. Notwithstanding subsection A of this section, if the
administrator has previously approved a petition under 40 CFR
75.72(b)(2)(ii), or 40 CFR 75.16(b)(2)(ii)(B) as pursuant to 40 CFR 75.13 for
apportioning the CO2 emissions rate measured in a common stack or a
petition under 40 CFR 75.66 for an alternative requirement in 40 CFR Part
75, the CO2 authorized account representative shall submit the
petition to the department under 9VAC5-140-6380 A to determine whether the
approval applies under this program.
D. Except as provided in subsection A of this section, the
owner or operator of a CO2 budget unit shall comply with the
following initial certification and recertification procedures for a CEMS and
an excepted monitoring system under Appendix D of 40 CFR Part 75 and under 9VAC5-140-6330
B 1. The owner or operator of a unit that qualifies to use the low mass
emissions excepted monitoring methodology in 40 CFR 75.19 or that
qualifies to use an alternative monitoring system under Subpart E of 40 CFR
Part 75 shall comply with the procedures in subsection E or F of this section,
respectively.
1. For initial certification, the owner or operator shall
ensure that each CEMS required under 9VAC5-140-6330 B 1, which includes the
automated DAHS, successfully completes all of the initial certification testing
required under 40 CFR 75.20 by the applicable deadlines specified in
9VAC5-140-6330 C. In addition, whenever the owner or operator installs a
monitoring system to meet the requirements of this article in a location where
no such monitoring system was previously installed, initial certification in
accordance with 40 CFR 75.20 is required.
2. For recertification, the following requirements shall
apply.
a. Whenever the owner or operator makes a replacement,
modification, or change in a certified CEMS under 9VAC5-140-6330 B 1 that the
administrator or the department determines significantly affects the ability of
the system to accurately measure or record CO2 mass emissions or to
meet the quality-assurance and quality-control requirements of 40 CFR 75.21 or
Appendix B to 40 CFR Part 75, the owner or operator shall recertify the
monitoring system according to 40 CFR 75.20(b).
b. For systems using stack measurements such as stack flow,
stack moisture content, CO2 or O2 monitors, whenever the
owner or operator makes a replacement, modification, or change to the flue gas
handling system or the unit's operation that the administrator or the
department determines to significantly change the flow or concentration
profile, the owner or operator shall recertify the CEMS according to 40 CFR
75.20(b). Examples of changes that require recertification include replacement
of the analyzer, change in location or orientation of the sampling probe or
site, or change of flow rate monitor polynomial coefficients.
3. The approval process for initial certifications and
recertification shall be as follows: Subdivisions subdivisions 3 a
through 3 d of this subsection apply to both initial certification and
recertification of a monitoring system under 9VAC5-140-6330 B 1. For
recertifications, replace the words "certification" and "initial
certification" with the word "recertification," replace the word
"certified" with "recertified," and proceed in the manner
prescribed in 40 CFR 75.20(b)(5) and (g)(7) in lieu of subdivision 3 e of this
subsection.
a. The CO2 authorized account representative
shall submit to the department or its agent, the appropriate EPA Regional
Office and the administrator a written notice of the dates of certification in
accordance with 9VAC5-140-6360.
b. The CO2 authorized account representative
shall submit to the department or its agent a certification application for
each monitoring system. A complete certification application shall include the
information specified in 40 CFR 75.63.
c. The provisional certification date for a monitor shall
be determined in accordance with 40 CFR 75.20(a)(3). A provisionally certified
monitor may be used under the CO2 Budget Trading Program for a
period not to exceed 120 days after receipt by the department of the complete
certification application for the monitoring system or component thereof under
subdivision 3 b of this subsection. Data measured and recorded by the
provisionally certified monitoring system or component thereof, in accordance
with the requirements of 40 CFR Part 75, will be considered valid
quality-assured data, retroactive to the date and time of provisional
certification, provided that the department does not invalidate the provisional
certification by issuing a notice of disapproval within 120 days of receipt of
the complete certification application by the department.
d. The department will issue a written notice of approval
or disapproval of the certification application to the owner or operator within
120 days of receipt of the complete certification application under subdivision
3 b of this subsection. In the event the department does not issue such a
notice within such 120-day period, each monitoring system that meets the
applicable performance requirements of 40 CFR Part 75 and is included in the
certification application will be deemed certified for use under the CO2
Budget Trading Program.
(1) If the certification application is complete and shows
that each monitoring system meets the applicable performance requirements of 40
CFR Part 75, then the department will issue a written notice of approval of the
certification application within 120 days of receipt.
(2) If the certification application is incomplete, then
the department will issue a written notice of incompleteness that sets a
reasonable date by which the CO2 authorized account representative
shall submit the additional information required to complete the certification
application. If the CO2 authorized account representative does not
comply with the notice of incompleteness by the specified date, then the
department may issue a notice of disapproval under subdivision 3 d (3) of this
subsection. The 120-day review period shall not begin before receipt of a
complete certification application.
(3) If the certification application shows that any
monitoring system or component thereof does not meet the performance
requirements of 40 CFR Part 75, or if the certification application is
incomplete and the requirement for disapproval under subdivision 3 d (2) of
this subsection is met, then the department will issue a written notice of
disapproval of the certification application. Upon issuance of such notice of
disapproval, the provisional certification is invalidated by the department and
the data measured and recorded by each uncertified monitoring system or
component thereof shall not be considered valid quality assured data beginning
with the date and hour of provisional certification. The owner or operator
shall follow the procedures for loss of certification in subdivision 3 e of
this subsection for each monitoring system or component thereof, which is
disapproved for initial certification.
(4) The department may issue a notice of disapproval of the
certification status of a monitor in accordance with 9VAC5-140-6350 B.
e. If the department issues a notice of disapproval of a
certification application under subdivision 3 d (3) of this subsection or a
notice of disapproval of certification status under subdivision 3 d (3) of this
subsection, then:
(1) The owner or operator shall substitute the following
values for each disapproved monitoring system, for each hour of unit operation
during the period of invalid data beginning with the date and hour of
provisional certification and continuing until the time, date, and hour specified
under 40 CFR 75.20(a)(5)(i) or 40 CFR 75.20(g)(7): (i) for units using or
intending to monitor for CO2 mass emissions using heat input or for
units using the low mass emissions excepted methodology under 40 CFR
75.19, the maximum potential hourly heat input of the unit; or (ii) for units
intending to monitor for CO2 mass emissions using a CO2
pollutant concentration monitor and a flow monitor, the maximum potential
concentration of CO2 and the maximum potential flow rate of the unit
under Section 2.1 of Appendix A of 40 CFR Part 75 [ .; ]
(2) The CO2 authorized account representative
shall submit a notification of certification retest dates and a new
certification application in accordance with subdivisions 3 a and 3 b of this
subsection; and
(3) The owner or operator shall repeat all certification
tests or other requirements that were failed by the monitoring system, as
indicated in the department's notice of disapproval, no later than 30 unit
operating days after the date of issuance of the notice of disapproval.
E. The owner or operator of a unit qualified to use the
low mass emissions excepted methodology under 9VAC5-140-6330 D 3 shall meet the
applicable certification and recertification requirements of 40 CFR
75.19(a)(2), 40 CFR 75.20(h), and this section. If the owner or operator
of such a unit elects to certify a fuel flow meter system for heat input
determinations, the owner or operator shall also meet the certification and
recertification requirements in 40 CFR 75.20(g).
F. The CO2 authorized account of each unit for
which the owner or operator intends to use an alternative monitoring system
approved by the administrator and, if applicable, the department under Subpart
E of 40 CFR Part 75 shall comply with the applicable notification and
application procedures of 40 CFR 75.20(f).
9VAC5-140-6350. Out-of-control periods.
A. Whenever any monitoring system fails to meet the
quality assurance/quality control (QA/QC) requirements or data validation
requirements of 40 CFR Part 75, data shall be substituted using the applicable
procedures in Subpart D or Appendix D of 40 CFR Part 75.
B. Whenever both an audit of a monitoring system and a
review of the initial certification or recertification application reveal that
any monitoring system should not have been certified or recertified because it
did not meet a particular performance specification or other requirement under
9VAC5-140-6340 or the applicable provisions of 40 CFR Part 75, both at the
time of the initial certification or recertification application submission and
at the time of the audit, the department or administrator will issue a notice
of disapproval of the certification status of such monitoring system. For the
purposes of this subsection, an audit shall be either a field audit or an audit
of any information submitted to the department or the administrator. By issuing
the notice of disapproval, the department or administrator revokes
prospectively the certification status of the monitoring system. The data
measured and recorded by the monitoring system shall not be considered valid
quality-assured data from the date of issuance of the notification of the
revoked certification status until the date and time that the owner or operator
completes subsequently approved initial certification or recertification tests
for the monitoring system. The owner or operator shall follow the initial
certification or recertification procedures in 9VAC5-140-6340 for each
disapproved monitoring system.
9VAC5-140-6360. Notifications.
The CO2 authorized account representative for a
CO2 budget unit shall submit written notice to the department and
the administrator in accordance with 40 CFR 75.61.
9VAC5-140-6370. Recordkeeping and reporting.
A. The CO2 authorized account representative
shall comply with all recordkeeping and reporting requirements in this section,
the applicable recordkeeping and reporting requirements under 40 CFR 75.73, and
the requirements of 9VAC5-140-6080 E.
B. The owner or operator of a CO2 budget unit
shall submit a monitoring plan in the manner prescribed in 40 CFR 75.62.
C. The CO2 authorized account representative
shall submit an application to the department within 45 days after completing
all CO2 monitoring system initial certification or recertification
tests required under 9VAC5-140-6340, including the information required under
40 CFR 75.63 and 40 CFR 75.53(e) and (f).
D. The CO2 authorized account representative
shall submit quarterly reports, as follows:
1. The CO2 authorized account representative
shall report the CO2 mass emissions data for the CO2
budget unit, in an electronic format prescribed by the department unless
otherwise prescribed by the department for each calendar quarter.
2. The CO2 authorized account representative
shall submit each quarterly report to the department or its agent within 30
days following the end of the calendar quarter covered by the report. Quarterly
reports shall be submitted in the manner specified in Subpart H of 40 CFR Part
75 and 40 CFR 75.64. Quarterly reports shall be submitted for each CO2
budget unit, or group of units using a common stack, and shall include all of
the data and information required in Subpart G of 40 CFR Part 75, except for
opacity, heat input, NOX, and SO2 provisions.
3. The CO2 authorized account representative
shall submit to the department or its agent a compliance certification in
support of each quarterly report based on reasonable inquiry of those persons
with primary responsibility for ensuring that all of the unit's emissions are
correctly and fully monitored. The certification shall state that:
a. The monitoring data submitted were recorded in
accordance with the applicable requirements of this article and 40 CFR
Part 75, including the quality assurance procedures and specifications;
b. For a unit with add-on CO2 emissions controls
and for all hours where data are substituted in accordance with 40 CFR
75.34(a)(1), the add-on emissions controls were operating within the range of
parameters listed in the QA/QC program under Appendix B of 40 CFR Part 75 and
the substitute values do not systematically underestimate CO2
emissions; and
c. The CO2 concentration values substituted for
missing data under Subpart D of 40 CFR Part 75 do not systematically underestimate
CO2 emissions.
9VAC5-140-6380. Petitions.
A. Except as provided in subsection C of this section, the
CO2 authorized account representative of a CO2 budget
unit that is subject to an acid rain emissions limitation may submit a petition
to the administrator under 40 CFR 75.66 and to the department requesting
approval to apply an alternative to any requirement of 40 CFR Part 75.
Application of an alternative to any requirement of 40 CFR Part 75 is in
accordance with this article only to the extent that the petition is approved
in writing by the administrator, and subsequently approved in writing by the
department.
B. Petitions for a CO2 budget unit that is not
subject to an acid rain emissions limitation shall meet the following
requirements.
1. The CO2 authorized account representative of
a CO2 budget unit that is not subject to an acid rain emissions
limitation may submit a petition to the administrator under 40 CFR 75.66
and to the department requesting approval to apply an alternative to any
requirement of 40 CFR Part 75. Application of an alternative to any requirement
of 40 CFR Part 75 is in accordance with this article only to the extent
that the petition is approved in writing by the administrator and subsequently
approved in writing by the department.
2. In the event that the administrator declines to review a
petition under subdivision 1 of this subsection, the CO2 authorized
account representative of a CO2 budget unit that is not subject to
an acid rain emissions limitation may submit a petition to the department
requesting approval to apply an alternative to any requirement of this article.
That petition shall contain all of the relevant information specified in 40 CFR
75.66. Application of an alternative to any requirement of this article is in
accordance with this article only to the extent that the petition is approved
in writing by the department.
C. The CO2 authorized account representative of
a CO2 budget unit that is subject to an acid rain emissions
limitation may submit a petition to the administrator under 40 CFR 75.66
and to the department requesting approval to apply an alternative to a
requirement concerning any additional CEMS required under the common stack
provisions of 40 CFR 75.72 or a CO2 concentration CEMS used under 40 CFR
75.71(a)(2). Application of an alternative to any such requirement is in
accordance with this article only to the extent the petition is approved in
writing by the administrator and subsequently approved in writing by the
department.
9VAC5-140-6390. (Reserved.)
9VAC5-140-6400. (Reserved.)
Article 9
Auction of CO2 CCR and ECR Allowances
9VAC5-140-6410. Purpose.
The following requirements shall apply to each allowance
auction. The department or its agent may specify additional information in the
auction notice for each auction. Such additional information may include the
time and location of the auction, auction rules, registration deadlines, and
any additional information deemed necessary or useful.
9VAC5-140-6420. General requirements.
A. The department's agent will include the following
information in the auction notice for each auction:
1. The number of [ CO2
conditional ] allowances offered for sale at the auction, not including
any [ CO2 conditional ] CCR
allowances;
2. The number of [ CO2
conditional ] CCR allowances that will be offered for sale at the
auction if the condition of subdivision [ B ] 1 of this
[ subsection section ] is met;
3. The minimum reserve price for the auction;
4. The CCR trigger price for the auction;
5. The maximum number of [ CO2
conditional ] allowances that may be withheld from sale at the
auction if the condition of subdivision D 1 of this section is met; and
6. The ECR trigger price for the auction.
B. The department's agent will follow these rules for the
sale of [ CO2 conditional ] CCR
allowances.
1. [ CO2 Conditional ]
CCR allowances shall only be sold at an auction in which total demand for
allowances, above the CCR trigger price, exceeds the number of [ CO2
conditional ] allowances available for purchase at the auction, not
including any [ CO2 conditional ]
CCR allowances.
2. If the condition of subdivision 1 of this subsection is
met at an auction, then the number of [ CO2
conditional ] CCR allowances offered for sale by the department or
its agent at the auction shall be equal to the number of [ CO2
conditional ] CCR allowances in the Virginia [ auction
account Consignment Auction Account ] at the time of the
auction.
3. After all of the [ CO2
conditional ] CCR allowances in the Virginia [ auction
Consignment Auction Account ] account have been sold in a given
calendar year, no additional [ CO2
conditional ] CCR allowances will be sold at any auction for the
remainder of that calendar year, even if the condition of subdivision 1 of this
subsection is met at an auction.
4. At an auction in which [ CO2
conditional ] CCR allowances are sold, the reserve price for the
auction shall be the CCR trigger price.
5. If the condition of subdivision 1 of this subsection is
not satisfied, no [ CO2 conditional ]
CCR allowances shall be offered for sale at the auction, and the reserve
price for the auction shall be equal to the minimum reserve [ prices
price ].
C. The department's agent shall implement the reserve
price as follows: (i) no allowances shall be sold at any auction for a price
below the reserve price for that auction and (ii) if the total demand for
allowances at an auction is less than or equal to the total number of
allowances made available for sale in that auction, then the auction clearing
price for the auction shall be the reserve price.
D. The department's agent will meet the following rules
for the withholding of CO2 ECR allowances from an auction.
1. CO2 ECR allowances shall only be withheld
from an auction if the demand for allowances would result in an auction
clearing price that is less than the ECR trigger price prior to the withholding
from the auction of any ECR allowances.
2. If the condition in subdivision 1 of this subsection is
met at an auction, then the maximum number of CO2 ECR allowances
that may be withheld from that auction will be equal to the quantity shown in
Table 140-5B of 9VAC5-140-6210 E minus the total quantity of CO2 ECR
allowances that have been withheld from any prior auction in that calendar
year. Any CO2 ECR allowances withheld from an auction will be
transferred into the Virginia ECR Account.
9VAC5-140-6430. Consignment auction.
In accordance with Article 5 (9VAC5-140-6190 et seq.) of
this part, one quarter of the annual conditional allowances
allowance allocation shall be consigned by the CO2 budget source to
whom they are allocated or the holder of a public contract with DMME to each
auction on a quarterly pro rata basis in accordance with procedures
specified by the department. At the completion of the consignment auction, a
conditional allowance sold at auction shall become an allowance to be used
for compliance purposes a CO2 allowance.
9VAC5-140-6435. Other auction.
Notwithstanding the requirements of 9VAC5-140-6430, the
department may participate in a direct auction of allowances without
consignment in accordance with requirements established by the Virginia General
Assembly. A "direct auction" means a CO2 auction conducted
by a CO2 Budget Trading Program in which Virginia is a participating
state.
Article 10
Program Monitoring and Review
9VAC5-140-6440. Program monitoring and review.
In conjunction with the CO2 Budget Trading
Program program monitoring and review process, the department will evaluate
impacts of the program specific to Virginia, including economic, energy, and
environmental impacts and impacts on vulnerable and environmental justice and
underserved communities. The department will, in evaluating the impacts on
environmental justice communities, including low income, minority, and tribal
communities, develop and implement a plan to ensure increased participation of
environmental justice communities in the review.
VA.R. Doc. No. R17-5140; Filed May 1, 2019, 3:08 p.m.
TITLE 12. HEALTH
DEPARTMENT OF HEALTH
Forms
REGISTRAR'S NOTICE:
Forms used in administering the regulation have been filed by the agency. The
forms are not being published; however, online users of this issue of the
Virginia Register of Regulations may click on the name of a form with a
hyperlink to access it. The forms are also available from the agency contact or
may be viewed at the Office of the Registrar of Regulations, 900 East Main
Street, 11th Floor, Richmond, Virginia 23219.
Title of Regulation: 12VAC5-115. Virginia
Immunization Information System.
Contact Information: Kristin Collins, Policy Analyst,
Office of Epidemiology, Virginia Department of Health, 109 Governor Street,
Office 642, Richmond, VA 23219-3623, telephone (804) 864-7298, or email kristin.collins@vdh.virginia.gov.
FORMS (12VAC5-115)
Administrator Information, VIISADM (eff. 10/2012)
Electronic Data Exchange with VIIS (eff. 10/2012)
Information Systems Security Access Agreement
(eff. 10/2012)
Organization Information, VIISORG (eff. 10/2012)
VIIS Security Policy and User Confidentiality Agreement
Memorandum of Agreement between Virginia
Department of Health/Division of Immunization (VDH/DOI) and VIIS Organization
Interested in Data Exchange (8/2011)
Virginia Immunization Information System (VIIS)
Opt-In of VIIS (reviewed 6/2015)
Virginia Immunization Information System (VIIS)
Opt-Out of VIIS (reviewed 6/2015)
VIIS
Security Policy and User Confidentiality Agreement (rev. 5/2019)
VIIS User Acknowledgement Page
VIIS User Signature Page
VA.R. Doc. No. R19-5998; Filed May 10, 2019, 4:01 p.m.
TITLE 12. HEALTH
DEPARTMENT OF MEDICAL ASSISTANCE SERVICES
Final Regulation
Title of Regulation: 12VAC30-141. Family Access to
Medical Insurance Security Plan (amending 12VAC30-141-10 through 12VAC30-141-70,
12VAC30-141-100, 12VAC30-141-110, 12VAC30-141-150, 12VAC30-141-160,
12VAC30-141-175, 12VAC30-141-500, 12VAC30-141-660 through 12VAC30-141-760,
12VAC30-141-790, 12VAC30-141-800, 12VAC30-141-880; repealing 12VAC30-141-120).
Statutory Authority: § 32.1-351 of the Code of
Virginia; 42 USC § 1396 et seq.
Effective Date: June 26, 2019.
Agency Contact: Emily McClellan, Regulatory Supervisor,
Policy Division, Department of Medical Assistance Services, 600 East Broad
Street, Suite 1300, Richmond, VA 23219, telephone (804) 371-4300, FAX (804)
786-1680, or email emily.mcclellan@dmas.virginia.gov.
Summary:
Effective January 1, 2014, the Affordable Care Act required
eligibility for health coverage under all health insurance affordability
programs to be based on a new modified adjusted gross income (MAGI)
methodology. Calculating MAGI eligibility entails defining household
composition and executing income counting procedures based on Internal Revenue
Service rules. Federal law requires these changes to be made in the State Child
Health Plan under Title XXI of the Social Security Act.
The amendments incorporate the required changes in
eligibility determination standards and update operational processes supporting
eligibility and renewal actions, including (i) adding new definitions and
modifying existing definitions pertinent to MAGI and operational processes; (ii)
updating operational processes to reflect current practice; (iii) updating the
reference to the Children's Health Insurance Program Advisory Committee; (iv)
specifying financial and nonfinancial eligibility standards consistent with
MAGI requirements and updating operational processes pertinent to the Virginia
Department of Social Services (VDSS) and Cover Virginia, the central processing
unit (CPU); (v) clarifying that inpatient status in an institution for mental
disease is a factor for ineligibility at initial enrollment or renewal; (vi)
updating terminology regarding VDSS and CPU consistent with implementation of
MAGI standards; (vii) streamlining application, case documentation, and
maintenance processes in implementation of MAGI standards; and (viii)
specifying that a choice of managed care organization may be made at the time
of application.
Technical, nonsubstantive amendments to conform to style
guidelines were made for publication of the final regulation.
Summary of Public Comments and Agency's Response: No
public comments were received by the promulgating agency.
Part I
General Provisions
12VAC30-141-10. Definitions.
The following words and terms when used in this chapter shall
have the following meanings unless the context clearly indicates otherwise:
"Act" means the Social Security Act.
"Adult caretaker relative" or "caretaker
relative" means an individual who is age 18 or older, who is not the
parent of, but who is related to, the child by blood or marriage, and who lives
with and assumes responsibility for day-to-day care of the child in a place of
residence maintained as his or their own home.
"Adverse action," consistent with 42 CFR
457.1130, means the denial of eligibility; failure to make a timely
determination of eligibility; suspension or termination of enrollment,
including disenrollment for failure to pay cost sharing; or delay, denial,
reduction, suspension, or termination of health services, in whole or in part,
including a determination about the type or level of services; and failure to
approve, furnish, or provide payment for health services in a timely manner;
provided, however, that determination of eligibility to participate in and
termination of participation in the FAMIS Select program shall not constitute
an adverse action.
"Adverse benefit determination," consistent with
42 CFR 438.400, means the denial or limited authorization of a requested
service; the failure to take action or timely take action on a request for
service; the reduction, suspension, or termination of a previously authorized
service; denial in whole or in part of a payment for a service; failure to
provide services within the timeframes required by the state; for a resident of
a rural exception area with only one MCO, the denial of a enrollee's request to
exercise the enrollee's right under 42 CFR 438.52(b)(2)(ii) to obtain services
outside of the network; the denial of a enrollee's request to dispute a
financial liability as provided in 42 CFR [ 438(b)(7)
438.400(b)(7) ]; or the failure of an MCO to act within the
timeframes provided in 42 CFR 438.408(b).
"Agency" means a local department of social
services, the central processing unit, or other entity designated by DMAS to
make eligibility determinations for FAMIS.
"Agency error" means a person or persons
received benefits to which they were not entitled as a result of an error on
the part of an eligibility worker at a local department of social services or
the central processing unit.
"Agent" means an individual designated in writing
to act on behalf of a FAMIS Plan applicant or enrollee during the
administrative review process.
"Appeal" means an enrollee's request for review
of an adverse benefit determination by an MCO or an adverse action by the LDSS,
CPU, or DMAS.
"Applicant" means a child who has filed an
application (or who has an application filed on his behalf) for child health
insurance and is awaiting a determination of eligibility. A child is an
applicant until his eligibility has been determined.
"Application for health insurance" means the form
or forms developed and approved by the Department of Medical Assistance
Services that are used for determining eligibility for Family Access to Medical
Insurance Security Plan (FAMIS), FAMIS Plus (Children's Medicaid), for Medicaid
for pregnant women, and for FAMIS MOMS. single streamlined application
for determining eligibility in public health insurance programs operated by the
Commonwealth.
"Authorized representative" means a person, 18
years of age or older, who is authorized to conduct the personal or
financial affairs for an individual who is 18 years of age or older.
"Board" or "BMAS" means that policy
board created by § 32.1-324 of the Code of Virginia to administer the
plans established by the Social Security Act.
"CMSIP" means that original child health
insurance program that preceded FAMIS.
"Central processing unit" or "CPU" means Cover
Virginia, which is the private contractor that will determine
eligibility for and administer part of the Family Access to Medical Insurance
Security Plan or FAMIS centralized entity supported by DMAS to accept
and act on applications for health insurance.
"Child" means an individual under the age of
younger than 19 years of age.
"Competent individual" means a person who has
not been judged by a court to be legally incapacitated.
"Comprehensive health insurance coverage" means
health benefits coverage, which includes the following categories of services
at a minimum: inpatient and outpatient hospital services; physician's surgical
and medical services; and laboratory and radiological services.
"Conservator" means a person appointed by a court
of competent jurisdiction to manage the estate and financial affairs of an
incapacitated individual.
"Continuation of enrollment coverage"
means ensuring an enrollee's benefits are continued until completion of the
review process, with the condition that should the enrollee not prevail in the
review process, the enrollee shall be liable for the repayment of all benefits
received during the review process.
"Director" means the individual, or his designee,
specified in § 32.1-324 of the Code of Virginia with all of the attendant
duties and responsibilities to administer the State Plan for Medical Assistance
and the State Plan for FAMIS.
"DMAS" or "department" means the
Department of Medical Assistance Services.
[ "Eligibility worker" means an
individual who, under supervision, applies regulations, policies, and
procedures to determine eligibility for public assistance programs, including
FAMIS and FAMIS MOMS."Enrollee" means a child who has been determined
eligible to participate in FAMIS and is enrolled in the FAMIS program. ]
"Ex parte review" means the review of
administratively available information pertinent to the application or renewal
process, conducted by eligibility staff, in order to expediently process the
applicant's renewal without seeking that information from the applicant.
"External quality review organization" means the
independent contractor assigned by DMAS to handle quality reviews and to
conduct final review of MCHIP adverse actions for FAMIS.
"Family" means parents, including adoptive and
stepparents, and their children under the age of 19, who are living in the same
household. Family shall not mean grandparents, other relatives, or legal
guardians.
"Family," when used in the context of the FAMIS
Select component, means a unit or group that has access to an a
private or employer's group health plan. Thus, it includes the policyholder
or employee and any dependents who can be covered under the employer's
plan.
"Family income" means the total income of all
family members in a household. Income includes, but is not necessarily limited
to, before-tax earnings from a job, including cash, wages, salary, commissions,
tips, self-employment net profits, Social Security, Retirement Survivor
Disability Insurance (RSDI), veterans benefits, Railroad Retirement, disability
workers' compensation, unemployment benefits, child support, alimony, spousal
support, pensions, retirement benefits, settlement benefits, rental income, and
lottery/bingo winnings. Income excludes public assistance program benefits such
as SSI and TANF payments, foster care payments, general relief, loans, grants,
or scholarships for educational expenses or earned income of a child who is a
student.
"FAMIS" means the Family Access to Medical
Insurance Security Plan.
"FAMIS Select" means an optional program available
to children determined eligible for FAMIS, whereby DMAS provides premium
assistance to the family to cover the child through a private or
employer-sponsored health plan instead of directly through the FAMIS program.
"Federal poverty level" or "FPL" means
that income standard as published annually by the U.S. Department of Health and
Human Services in the Federal Register.
"Fee-for-service" means the traditional Medicaid
health care delivery and payment system in which physicians and other providers
receive a payment for each unit of service they provide.
"Fixed premium assistance amount" means a
predetermined amount of premium assistance that DMAS will pay per child to a
family who chooses to enroll its FAMIS eligible child in a private or
employer-sponsored health plan. The fixed premium assistance amount will be
determined annually by DMAS to ensure that the FAMIS Select program is
cost-effective as compared to the cost of covering a child directly through the
FAMIS program.
"Fraud" means an intentional deception or
misrepresentation made by a person with the knowledge that the deception could
result in some unauthorized benefit to himself or some other person. It
includes any act that constitutes fraud under applicable federal or state laws.
"Group health plan" or "health insurance
coverage" means that health care coverage as defined in § 2791 of the
Public Health Services Act (42 USC § 300gg-91(a) and (b)(1)).
"Guardian" means a person appointed by a court of
competent jurisdiction to be responsible for the affairs of an incapacitated
individual, including responsibility for making decisions regarding the
person's support, care, health, safety, habilitation, education, and
therapeutic treatment, and if not inconsistent with an order of commitment,
residence.
"Household" means the household composition and
follows the federal tax rules through the use of modified adjusted gross income
(MAGI) methodology. An individual's household is based upon the tax filing
relationships of applicant, persons living with the individual, and those
claimed as dependents and as outlined in 42 USC § 435.603(3)(f)(1) through
(f)(4) [ ,. ]
"Household income" means the sum of MAGI-based
income as outlined in 42 USC § 435.603(3)(d) through (3)(e) to include every
individual in the household.
"Incapacitated individual" means a person who,
pursuant to an order of a court of competent jurisdiction, has been found to be
incapable of receiving and evaluating information effectively or responding to
people, events, or environments to such an extent that the individual lacks the
capacity to (i) meet the essential requirements of his health, care, safety, or
therapeutic needs without the assistance or protection of a guardian, or (ii)
manage property or financial affairs or provide for his support or for the
support of his legal dependents without the assistance or protection of a
conservator.
"Internal appeal" means a request to the MCO by
an enrollee, an enrollee's authorized representative, or a provider, acting on
behalf of the enrollee and with the enrollee's written consent, for review of
an MCO's adverse benefit determination. The internal appeal is the only level
of appeal with the MCO and must be exhausted by an enrollee or deemed exhausted
according to 42 CFR 438.408(c)(3) before the enrollee may initiate a state fair
hearing.
"Lawfully residing" means the individual is
lawfully present in the United States.
"Legally emancipated" means that the parents and
child have gone through the court and a judge has declared that the parents
have surrendered the right to care, custody, and earnings of the child and have
renounced parental duties. A married minor is not emancipated unless a court
has declared the married minor emancipated from his parents.
"LDSS" or "local department" means the
local department of social services.
"Managed care health insurance plan" or
"MCHIP" as defined in § 32.1-137.1 of the Code of Virginia means an
arrangement for the delivery of health care in which a health carrier means
under contract with DMAS for Title XXI delivery systems, undertakes to provide,
arrange and pay for, or reimburse any of the costs of health care services for
a covered person on a prepaid or insured basis, which contains one or more
incentive arrangements, including any credential requirements intended to
influence the cost of the health care services between the health carrier and
one or more providers and requires or creates benefit payment differential
incentives for covered persons to use providers that are directly or indirectly
managed, owned, under contract with or employed by the health carrier.
"Maternal and child health insurance
application" means the form or forms developed and approved by the
Department of Medical Assistance Services that are used by local departments of
social services and the FAMIS CPU for determining eligibility for Medicaid for
poverty-level children and for the Family Access to Medical Insurance Security
Plan (FAMIS).
"Member of a family," for purposes of
determining whether the child is eligible for coverage under a state employee
health insurance plan, means a parent or parents, including stepparents with
whom the child is living if the stepparent claims the child as a dependent on
the employee's federal tax return.
"Managed care organization" or "MCO"
means an organization that offers managed care health insurance plans (MCHIPs)
as [ "MCHIP" is ] defined in [ this
section § 32.1-137.1 of the Code of Virginia ].
[ "Notice of reasonable opportunity"
means the written notice that is sent to the applicant to inform the applicant
that the applicant must provide verification of citizenship and identity within
90 calendar days. ]
"Premium assistance" means the portion of the
family's cost of participating in a private or employer's health plan
that DMAS will pay to cover the FAMIS-eligible children under the private or
employer-sponsored plan if DMAS determines it is cost effective to do so.
"Private or employer-sponsored health insurance
coverage plan" means a health insurance policy that is either
purchased by an individual directly or through an employer. This component of
FAMIS refers to the ability of DMAS to provide coverage to FAMIS-eligible
children by providing premium assistance to families who enroll the
FAMIS-eligible children in a private or employer-sponsored health plan.
"Provider" means the individual, facility or other
entity registered, licensed, or certified, as appropriate, and enrolled by an
MCHIP or in fee-for-service to render services to FAMIS enrollees eligible for
services.
"Supplemental coverage" means coverage provided
to FAMIS-eligible children covered under the FAMIS Select component so that
they can receive all childhood immunizations included in the FAMIS benefits.
"Reasonable opportunity period" means a
90-calendar-day period given to applicants to supply verification of
citizenship and identity.
"State fair hearing" means, consistent with 42
CFR 438.400, the process set forth in 42 CFR 431 Subpart E.
"Targeted low-income child" means an uninsured
child younger than age 19 years whose household income is within the FAMIS
eligibility standards established by the Commonwealth.
[ "Targeted low-income pregnant woman"
means an uninsured pregnant woman whose household income is within the Medicaid
or FAMIS MOMS eligibility standards established by the Commonwealth. ]
"Title XXI" means the federal State Children's
Health Insurance Program as established by Subtitle J of the Balanced Budget
Act of 1997.
"Virginia State Employee Health Insurance Plan"
means a health insurance plan offered by the Commonwealth of Virginia to its
employees.
12VAC30-141-20. Administration and general background.
A. The state shall use funds provided under Title XXI for
obtaining coverage that meets the requirements for a State Child Health
Insurance Plan (also known as Title XXI).
B. The DMAS director will have the authority to contract with
entities for the purpose of establishing a centralized processing site,
determining eligibility, enrolling eligible children into health plans,
performing outreach, data collection, reporting, and other services necessary
for the administration of the Family Access to Medical Insurance Security Plan and
for employing state staff to perform Medicaid eligibility determinations on
children referred by FAMIS staff.
C. Health care services under FAMIS shall be provided through
MCHIPs and through fee-for-service or through any other health care delivery
system deemed appropriate by the Department of Medical Assistance Services.
12VAC30-141-30. Outreach and public participation.
A. DMAS will work cooperatively with other state agencies and
contractors to ensure that federal law and any applicable federal regulations
are met.
B. Pursuant to § 32.1-351.2 of the Code of Virginia, DMAS
shall establish an Outreach Oversight Committee (committee) to discuss
strategies to improve outreach activities. The committee members shall be
selected by DMAS and shall be composed of representatives from community-based
organizations engaged in outreach activities, social services eligibility
workers, the provider community, health plans, and consumers. The committee
shall meet on a quarterly basis. As may be appropriate, the committee shall
make recommendations regarding state-level outreach activities, the
coordination of regional and local outreach activities, and procedures for
streamlining and simplifying the application process, brochures, other printed
materials, forms, and applicant correspondence.
C. The board, in consultation with the committee, shall
develop a comprehensive, statewide community-based outreach plan to enroll
children in the FAMIS program and, if so eligible, in Medicaid. The outreach
plan shall include specific strategies for: (i) improving outreach and
enrollment in those localities where enrollment is less than the statewide
average and (ii) enrolling uninsured children of former Temporary Assistance to
Needy Families (TANF) recipients.
D. B. DMAS shall develop a comprehensive
marketing and outreach effort. The marketing and outreach efforts will be aimed
at promoting the FAMIS and Medicaid programs and increasing enrollment,
and may include contracting with a public relations firm, nonprofit
agencies, and foundations; coordination with other state agencies,;
coordination with the business community,; and coordination with
health care associations and providers.
C. DMAS shall ensure consultation by Native American
tribes on the development and implementation of enrollment processes and
procedures to exempt cost-sharing for American Indian and Alaskan Native
children in compliance with 42 CFR 457.120 and 42 CFR 457.125.
Part II
Review Appeal of Adverse Actions
12VAC30-141-40. Review Appeal of adverse actions or
adverse benefit determinations.
A. Upon written request, all FAMIS Plan applicants and
enrollees shall have the right to a review state fair hearing of
an adverse action made by the MCHIP, local department of social
services, CPU, or DMAS and to an internal appeal of an adverse
benefit determination made by an MCO.
B. During review the appeal of a suspension or
termination of enrollment or a reduction, suspension, or termination of
services, the enrollee shall have the right to continuation of coverage if the
enrollee requests review an internal appeal with the MCO or an appeal
to DMAS prior to the effective date of the suspension or termination of
enrollment or suspension, reduction, or termination of services.
C. Review An appeal of an adverse action made
by the local department of social services, CPU, or DMAS shall be heard
and decided by an agent of DMAS who has not been directly involved in the
adverse action under review appeal.
D. Review An internal appeal of an adverse action
benefit determination made by the MCHIP MCO must be
conducted by a person or agent of the MCHIP MCO who has not been
directly involved in the adverse action benefit determination
under review appeal.
E. After final review by the MCHIP, Pursuant to 42 CFR
438.402(c)(1)(B), after exhausting the MCO's internal appeals process,
there shall also be opportunity for final independent the
enrollee to request an external medical review by the an
independent external quality review organization. [ "External
quality review organization" means the independent contractor assigned by
DMAS to handle quality reviews and to conduct final review of MCHIP adverse
actions for FAMIS. ] The review is optional and shall not be
required before proceeding to a state fair hearing. The review shall not extend
any of the timeframes for issuing a decision and shall not disrupt any
continuation of coverage granted to the enrollee.
F. There will be no opportunity for review appeal
of an adverse action to the extent that such adverse action is based on a
determination by the director that funding for FAMIS has been terminated or
exhausted. There will be no opportunity for review based on which type of
delivery system (i.e., fee-for-service, MCHIP) is assigned. There will be
no opportunity for review appeal if the sole basis for the adverse
action is a state or federal law or regulation requiring an automatic change
that affects all applicants or enrollees or a group of applicants or enrollees
without regard to their individual circumstances. decision is a
provision in the State Plan or in a state or federal law requiring an automatic
change in eligibility or enrollment or is a change in coverage under the health
benefits package that affects all applicants or enrollees or a group of applicants
or enrollees without regard to their individual circumstances.
G. The burden of proof shall be upon the applicant or
enrollee to show that an adverse action or adverse benefit determination
is incorrect.
H. At no time shall the MCHIP's, local department's
department of social services, the CPU's, or DMAS' MCO, CPU,
or DMAS failure to meet the time frames timeframes set in
this chapter or set in the MCHIP's MCO or DMAS' DMAS
written review appeal procedures constitute a basis for granting
the applicant or enrollee the relief sought.
I. Adverse actions related to health benefits covered through
the FAMIS Select program shall be resolved between the insurance company or
employer's plan and the FAMIS Select enrollee, and are not subject to
further review appeal by DMAS or its contractors. Adverse
actions made by an MCHIP, the local department of social services, the CPU, or
DMAS shall be subject to the review process set forth in Part II
(12VAC30-141-40 et seq.) of this chapter.
12VAC30-141-50. Notice of adverse action or adverse benefit
determination.
A. The local department of social services, the CPU,
or DMAS shall send written notification to enrollees at least 10 calendar days
prior to suspension or termination of enrollment.
B. DMAS or the MCHIP MCO shall send written
notification to enrollees at least 10 calendar days prior to reduction,
suspension, or termination of a previously authorized health service.
C. The local department of social services, the CPU,
DMAS, or the MCHIP MCO shall send written notification to
applicants and enrollees of all other adverse actions within 10 calendar days
of the adverse action.
D. Notice shall include the reasons for determination, an
explanation of applicable rights to a review of that determination, the standard
and expedited time frames for review, the manner in which a review can be
requested, and the circumstances under which enrollment or services may
continue pending review.:
1. The determination the LDSS, CPU, DMAS, or MCO has made
or intends to make;
2. The reasons for the determination, including the right
of the enrollee to be provided, upon request and free of charge, reasonable
access to and copies of all documents, records, and other information relevant
to the determination;
3. An explanation of applicable rights to request an appeal
of that determination. For adverse benefit determinations by an MCO, this shall
include information on the MCO's internal appeal process and, after the
internal appeal process is exhausted, a state fair hearing pursuant to 42 CFR
402(b) and 42 CFR 402(c);
4. The procedure for exercising these appeal rights;
5. The circumstances under which an appeal process can be
expedited and how to request it; and
6. The circumstances under which enrollment or services may
continue pending appeal, how to request benefits be continued, and the
circumstances, consistent with state policy, under which the enrollee may be
required to pay the costs of these services.
12VAC30-141-60. Request for review appeal.
A. Requests for review internal appeal of MCHIP
MCO adverse actions benefit determinations shall be
submitted orally or in writing to the MCHIP MCO. Unless
the enrollee requests an expedited appeal, an oral appeal request must be
followed by a written appeal request. The enrollee must exhaust the MCO's
internal appeals process before appealing to DMAS.
B. If the MCO fails to adhere to the notice or timing
requirements set forth in this part, the enrollee is deemed to have exhausted
the MCO's internal appeals process and may initiate a state fair hearing.
C. Requests for review appeal of adverse
actions made by the local department of social services, the CPU, or
DMAS or of internal appeal decisions by the MCO shall be submitted in
writing to DMAS.
C. D. Any written communication clearly
expressing a desire to have an adverse action benefit determination
by an MCO reviewed shall be treated as a request for review an
internal appeal. Any communication expressing a desire to have an
adverse action by the LDSS, CPU, or DMAS reviewed shall be treated as a request
for a state fair hearing. Any communication expressing a desire to have an
MCO's internal appeal decision reviewed shall be treated as a request for a
state fair hearing.
D. E. To be timely, requests for review internal
appeal of a MCHIP an MCO's adverse benefit determination
shall be received by the MCHIP MCO no later than 30 60
calendar days from the date of the MCHIP's MCO's notice of
adverse action benefit determination.
E. F. To be timely, a request for an appeal of an
adverse benefit determination upheld in whole or in part by the MCO's internal
appeal decision shall be received by DMAS within 120 calendar days from the
date of the internal appeal decision.
G. To be timely, requests for review appeal
of a local department of social services, DMAS, or CPU determination adverse
action shall be filed with DMAS no later than 30 calendar days from the
date of the CPU's, LDSS' or DMAS' notice of adverse action. Requests for
review appeal of a local department of social services, DMAS,
or CPU an agency determination shall be considered filed with DMAS
on the date the request is postmarked, if mailed, or on the date the
request is received, if delivered other than by mail, by DMAS.
12VAC30-141-70. Review Appeal procedures.
A. At a minimum, the MCHIP review MCO internal
appeal shall be conducted pursuant to written procedures as defined in §
32.1-137.6 of the Code of Virginia and as may be further defined by DMAS
42 CFR 438.400 et seq. Such procedures shall be subject to review and
approval by DMAS.
B. Any adverse benefit determination upheld in whole or in
part by the internal appeal decision issued by the MCO may be appealed by the
enrollee to DMAS in accordance with the DMAS client appeals regulations at
12VAC30-110-10 through 12VAC30-110-370. DMAS shall conduct an evidentiary
hearing in accordance with the 12VAC30-110-10 through 12VAC30-110-370 and shall
not base any appealed decision on the record established by any internal appeal
decision of the MCO. The MCO shall comply with the DMAS appeal decision. The
DMAS decision in these matters shall be final and shall not be subject to
appeal by the MCO.
The DMAS review C. Appeals of adverse actions by
the LDSS, CPU, or DMAS shall be conducted pursuant to written procedures
developed by DMAS 12VAC30-110.
C. The procedures in effect on the date a particular
request for review is received by the MCHIP or DMAS shall apply throughout the
review.
D. Copies of the procedures shall be promptly mailed provided
by the MCHIP MCO or DMAS to applicants and enrollees upon receipt
of timely requests for review internal appeals or state fair hearings.
Such written procedures shall include but not be limited to the
following:
1. The right to representation by an attorney or other agent
of the applicant's or enrollee's choice, but at no time shall the MCHIP MCO,
local department of social services, DSS, or DMAS be required to obtain or
compensate attorneys or other agents acting on behalf of applicants or
enrollees;
2. The right to timely review of their files and other
applicable information relevant to the review of the internal appeal
or state fair hearing decision;
3. The right to fully participate in the review internal
appeal or state fair hearing process, whether the review internal
appeal or state fair hearing is conducted in person or in writing,
including the presentation of supplemental information during the review
internal appeal or state fair hearing process;
4. The right to have personal and medical information and
records maintained as confidential; and
5. The right to a written final decision within 90 calendar
days of receipt of the request for review, unless the applicant or enrollee
requests or causes a delay.:
a. For internal appeals to the MCO, within 30 calendar days
of receipt of the request for an internal appeal; or
b. For state fair hearings, within the time limitations for
appeals imposed by federal regulations and as permitted in 12VAC30-110-30;
6. For eligibility and enrollment matters, if the applicant's
or enrollee's physician or health plan determines that the 90-calendar-day
timeframe could seriously jeopardize the applicant's or enrollee's life or
health or ability to attain, maintain, or regain maximum function, an applicant
or enrollee will have the opportunity to request an expedited review
appeal. Under these conditions, a request for review an
expedited appeal shall result in a written final decision within three
business days 72 hours after DMAS receives, the expedited
appeal request from the physician or health plan, with the
case record and information indicating that taking the time for a standard
resolution of the review appeal request could seriously
jeopardize the applicant's or enrollee's life or health or ability to attain,
maintain, or regain maximum function, unless the applicant or enrollee or
his authorized representative causes a delay. requests an extension;
7. For health services matters for FAMIS enrollees receiving
services through MCHIPs, if an MCO:
a. If the enrollee's physician or health plan
determines that the 90-calendar-day 30-calendar-day timeframe for
a standard internal appeal could seriously jeopardize the enrollee's life
or health or ability to attain, maintain, or regain maximum function, an
enrollee will have the opportunity to request an expedited review
internal appeal. Under these conditions, a request for review an
internal appeal shall result in a written decision by the external
quality review organization MCO within 72 hours from the time an
enrollee requests the expedited review internal appeal is
requested, unless the applicant, enrollee, or authorized representative
requests or causes a delay. If a delay is requested or caused by
the applicant, enrollee, or authorized representative, then the
expedited review internal appeal may be extended up to 14
calendar days.
b. If the adverse benefit determination is upheld in whole
or in part by the expedited internal appeal decision issued by the MCO, and if
the enrollee's physician or health plan determines that the timeframe for a
standard appeal to DMAS could seriously jeopardize the enrollee's life or
health or ability to attain, maintain, or regain maximum function, and enrollee
will have the opportunity to request an expedited appeal to DMAS. Under these
conditions, a request for a state fair hearing shall result in a written
decision within 72 hours from the time an enrollee requests the expedited
appeal, unless the applicant, enrollee, or authorized representative requests a
delay. If a delay is requested by the applicant, enrollee, or authorized
representative, then the expedited appeal may be extended up to 14 calendar
days; and
8. For health services matters for FAMIS enrollees receiving
services through fee-for-service, if the enrollee's physician or health plan
determines that the 90-calendar-day timeframe for a standard appeal
could seriously jeopardize the enrollee's life, health, or ability to
attain, maintain, or regain maximum function, an enrollee will have the
opportunity to request an expedited review. Under these conditions, a
request for review an expedited appeal shall result in a written
decision within 72 hours from the time an enrollee requests the
expedited review appeal is requested, unless the applicant,
enrollee, or authorized representative requests or causes a delay. If a
delay is requested or caused by the applicant, enrollee, or authorized
representative, then expedited review appeal may be extended up
to 14 calendar days.
Part III
Eligibility Determination and Application Requirements
12VAC30-141-100. Eligibility requirements General
conditions of eligibility.
A. This section shall be used to determine eligibility of
children for FAMIS. An LDSS, DMAS, or the CPU determines eligibility for
Title XXI services.
B. FAMIS shall be in effect statewide.
C. Eligible children must: FAMIS serves targeted
low-income children consistent with requirements at 42 CFR 457.310, 42 CFR
457.315, and 42 CFR 457.320.
1. Be determined ineligible for Medicaid by a local
department of social services or be screened by the FAMIS central processing
unit and determined not Medicaid likely;
2. Be under 19 years of age;
3. Be residents of the Commonwealth;
4. Be either United States citizens, United States
nationals or qualified noncitizens;
5. Be uninsured, that is, not have comprehensive health
insurance coverage; and
6. Not be an inpatient in an institution for mental
diseases (IMD), or an inmate in a public institution that is not a medical
facility.
D. Income.
1. Screening. All child health insurance applications
received at the FAMIS central processing unit must be screened to identify
applicants who are potentially eligible for Medicaid. Children screened and
found potentially eligible for Medicaid cannot be enrolled in FAMIS until there
has been a finding of ineligibility for Medicaid. Children who do not appear to
be eligible for Medicaid shall have their eligibility for FAMIS determined.
Children determined to be eligible for FAMIS will be enrolled in the FAMIS
program. Child health insurance applications received at a local department of
social services shall have a full Medicaid eligibility determination completed.
Children determined to be ineligible for Medicaid due to excess income will
have their eligibility for FAMIS determined. If a child is found to be eligible
for FAMIS, the local department of social services will enroll the child in the
FAMIS program.
2. Standards. Income standards for FAMIS are based on a
comparison of countable income to 200% of the federal poverty level for the
family size, as defined in the State Plan for Title XXI as approved by the
Centers for Medicare and Medicaid Services. Children who have income at or
below 200% of the federal poverty level, but are ineligible for Medicaid due to
excess income, will be income eligible to participate in FAMIS.
3. Grandfathered CMSIP children. Children who were enrolled
in the Children's Medical Security Insurance Plan at the time of conversion
from CMSIP to FAMIS and whose eligibility determination was based on the
requirements of CMSIP shall continue to have their income eligibility determined
using the CMSIP income methodology. If their income exceeds the FAMIS standard,
income eligibility will be based on countable income using the same income
methodologies applied under the Virginia State Plan for Medical Assistance for
children as set forth in 12VAC30-40-90. Income that would be excluded when
determining Medicaid eligibility will be excluded when determining countable
income for the former CMSIP children. Use of the Medicaid income methodologies
shall only be applied in determining the financial eligibility of former CMSIP
children for FAMIS and for only as long as the children meet the income
eligibility requirements for CMSIP. When a former CMSIP child is determined to
be ineligible for FAMIS, these former CMSIP income methodologies shall no
longer apply and income eligibility will be based on the FAMIS income
standards.
4. Spenddown. Deduction of incurred medical expenses from
countable income (spenddown) shall not apply in FAMIS. If the family income
exceeds the income limits described in this section, the individual shall be
ineligible for FAMIS regardless of the amount of any incurred medical expenses.
E. Residency. The requirements for residency, as set forth
in 42 CFR 435.403, will be used when determining whether a child is a resident
of Virginia for purposes of eligibility for FAMIS. A child who is not
emancipated and is temporarily living away from home is considered living with
his parents, adult relative caretaker, legal guardian, or person having legal
custody if the absence is temporary and the child intends to return to the home
when the purpose of the absence (such as education, medical care,
rehabilitation, vacation, visit) is completed.
F. United States citizen or nationality. Upon signing the
declaration of citizenship or nationality required by § 1137(d) of the Social
Security Act, the applicant or recipient is required under § 2105(c)(9) to
furnish satisfactory documentary evidence of United States citizenship or
nationality and documentation of personal identity unless citizenship or
nationality has been verified by the Commissioner of Social Security or unless
otherwise exempt.
G. Qualified noncitizen. The requirements for qualified
aliens set out in Public Law 104-193, as amended, and the requirements for
noncitizens set out in subdivisions 3 b, c, and e of 12VAC30-40-10 will be used
when determining whether a child is a qualified noncitizen for purposes of
FAMIS eligibility.
H. Coverage under other health plans.
1. Any child covered under a group health plan or under health
insurance coverage, as defined in § 2791 of the Public Health Services Act (42
USC § 300gg-91(a) and (b)(1)), shall not be eligible for FAMIS.
2. No substitution for private insurance.
a. Only uninsured children shall be eligible for FAMIS. A
child is not considered to be insured if the health insurance plan covering the
child does not have a network of providers in the area where the child resides.
Each application for child health insurance shall include an inquiry about
health insurance. Each redetermination of eligibility shall also document
inquiry about current health insurance.
b. Health insurance does not include Medicare, Medicaid,
FAMIS, or insurance for which DMAS paid premiums under Title XIX through the
Health Insurance Premium Payment (HIPP) Program or under Title XXI through the
SCHIP premium assistance program
D. Each individual covered under the plan shall be:
1. Financially eligible to receive services as established
using the methods and standards described in subsection F of this section; and
2. Meet the applicable nonfinancial eligibility conditions.
E. Nonfinancial eligibility conditions.
1. Eligible individuals shall be younger than 19 years of
age.
2. Eligible individuals shall be residents of the
Commonwealth. A child is considered to be a resident of the Commonwealth under
the following conditions:
a. A noninstitutionalized child if capable of indicating
intent and who is emancipated or married if the child is living in the state
and intends to reside in the state, including without a fixed address;
b. A noninstitutionalized child not described in
subdivision E 2 a of this section and who is not in the custody of the state:
(1) Residing in the state, with or without a fixed address;
or
(2) The state of residency of the parent or caretaker, in
accordance with 42 CFR.435.403(h)(1), with whom the individual resides;
c. An institutionalized child who is not a ward of the
state if the state is the state of residence of the child's custodial parent or
caretaker at the time of placement;
d. A child who is in the custody of the state regardless of
where the child lives; or
e. A child physically located in the state when there is a
dispute with one or more states as to the child's actual state of residence.
3. FAMIS eligibility is open to:
a. United States citizens;
b. United States nationals;
c. Qualified noncitizens as defined in § 431 of the
Personal Responsibility and Work Opportunity Reconciliation Act (PRWORA) (8 USC
§ 1641) or whose eligibility is required by § 402(b) of PRWORA (8 USC
§ 1612(b)) and is not prohibited by § 403 of PRWORA (8 USC § 1613);
d. Individuals who have declared themselves to be citizens
or nationals of the United States or an individual having satisfactory
immigration status, during a reasonable opportunity period pending verification
of their citizenship, nationality, or satisfactory immigration status
consistent with requirements of §§ 1903(x), 1137(d), and 1902(ee) of the
Social Security Act and 42 CFR 435.407, 42 CFR 407, [ 42
CFR 956 42 CFR 435.956 ], and 42 CFR 457.380.
(1) The reasonable opportunity period begins on and extends
90 calendar days from the date the notice of reasonable opportunity is received
by the individual. [ "Notice of reasonable opportunity"
means the written notice that is sent to the applicant to inform the applicant
that the applicant must provide verification of citizenship and identity within
90 calendar days. ]
(2) An extension of the reasonable opportunity period is
allowed if the individual is making a good faith effort to resolve any
inconsistencies or obtain any necessary documentation, or the agency
determining eligibility needs more time to complete the verification process.
(3) The agency will provide benefits to otherwise eligible
individuals during the reasonable opportunity period;
e. Lawfully residing in the United States, as provided in § 2107(e)(1)(J)
of the Social Security Act (§ 214 of CHIPRA 2009, P.L. 111-3). An
individual is considered to be lawfully residing in the United States if the
person is:
(1) A qualified noncitizen as defined in 8 USC § 1641(b)
and (c);
(2) A noncitizen in a valid nonimmigrant status as defined
in 8 USC § 1101(a)(15) or otherwise under the immigration laws (as defined in 8
USC § 1101 (a)(17));
(3) A noncitizen who has been paroled into the United
States in accordance with 8 USC § 1182(d)(5) for less than one year,
except for an individual paroled for prosecution, for deferred inspection, or
pending removal proceedings;
(4) A noncitizen who belongs to one of the following
classes:
(a) Granted temporary resident status in accordance with 8
USC § 1160 or 1255a, respectively;
(b) Granted temporary protected status (TPS) in accordance
with 8 USC § 1254a and individuals with pending applications for TPS who have
been granted employment authorization;
(c) Granted employment authorization under 8 CFR § 274a.12(c);
(d) Family unity beneficiaries in accordance with § 301
of P.L. 101-649, as amended;
(e) Under deferred enforced departure in accordance with a
decision made by the President;
(f) Granted deferred action status;
(g) Granted an administrative stay of removal under 8 CFR
241; or
(h) Beneficiary of approved visa petition who has a pending
application for adjustment of status;
(5) Is an individual with a pending application for asylum
under 8 USC § 1158, for withholding of removal under 8 USC § 1231, or
under the Convention Against Torture who:
(a) Has been granted employment authorization; or
(b) Is younger than 14 years of age and has had an
application pending for at least 180 calendar days;
(6) Has been granted withholding of removal under the
Convention Against Torture;
(7) Is a child who has a pending application for Special
Immigrant Juvenile Status as described in 8 USC § 1101(a)(27)(J);
(8) Is lawfully present in American Samoa under the
immigration laws of American Samoa; or
(9) Is a victim of severe trafficking in persons, in
accordance with the Victims of Trafficking and Violence Protection Act of 2000,
P.L. 106-386, as amended (22 USC § 7105(b)).
f. An individual with deferred action under the Department
of Homeland Security's deferred action for the childhood arrivals process, as
described in the Secretary of Homeland Security's June 15, 2012, memorandum,
shall not be considered to be lawfully present with respect to any of the
categories in subdivision E 3 e of this section.
4. Eligible individuals shall be uninsured, that is, not
have creditable health insurance coverage. [ "Creditable
health insurance coverage" means coverage that meets the definition of 42
CFR 457.10. ]
a. Individuals eligible for FAMIS shall not be found
eligible or potentially eligible for Medicaid under policies of the State Plan
determined through the screening process described at 42 CFR 457.350.
b. Any child covered under a group health plan or under
health insurance coverage, as defined in § 2791 of the Public Health Services
Act (42 USC § 300gg-91(a) and (b)(1)), shall not be eligible for FAMIS.
(1) FAMIS shall not be a substitution for private
insurance.
(2) Only uninsured children shall be eligible for FAMIS. A
child is not considered to be insured if the health insurance plan covering the
child does not have a network of providers in the area where the child resides.
Each application for child health insurance shall include an inquiry about
health insurance. Each redetermination of eligibility shall also document
inquiry about current health insurance.
(3) Health insurance does not include Medicare, Medicaid,
FAMIS, or insurance for which DMAS paid premiums under Title XIX through the
Health Insurance Premium Payment Program or under Title XXI through the state
children's health insurance program premium assistance program known as FAMIS
Select.
5. Residents of an institution. Eligible individuals may
not be an inpatient in an institution for mental diseases or an inmate in a
public institution that is not a medical facility at the time of the initial
eligibility determination or redetermination.
6. Social Security Number.
a. All eligible individuals shall furnish their Social
Security Numbers (SSNs), with the following exceptions: (i) individuals
refusing to obtain a SSN because of well-established religious objections
[ ;, ] (ii) individuals who are not eligible
for a SSN [ ;, ] or (iii) individuals who
are issued a SSN only for a valid nonwork purpose.
b. DMAS or its designee shall:
(1) Assist individuals who are required to provide their
SSN to apply for or obtain an SSN from the Social Security Administration if
the individuals do not have or forgot their SSNs;
(2) Inform individuals required to provide their SSNs (i)
by what statutory authority the number is required to be provided; and (ii) how
the Commonwealth will use the SSN;
(3) Verify each SSN furnished by applicants or beneficiaries
with the Social Security Administration; and
(4) Not deny or delay services to an otherwise eligible
applicant pending issuance or verification of the individual's SSN by the
Social Security Administration.
c. The utilization of the SSN is consistent with §§ 205
and 1137 of the Social Security Act and the Privacy Act of 1974.
d. DMAS requests nonapplicant household members to
voluntarily provide their SSNs. When requesting an SSN for nonapplicant
household members, DMAS (i) informs the nonapplicant that this information is
voluntary and provides information regarding how the SSN will be used and (ii)
uses the SSN for determination of eligibility for Children's Health Insurance
Program (CHIP) or other insurance affordability programs or for a purpose
directly connected with the administration of the state plan.
F. Financial eligibility.
1. Screening. All applications shall have a Medicaid income
eligibility screen completed. Children determined to be ineligible for Medicaid
due to excess income will have their eligibility for FAMIS determined.
2. Standards.
a. The Commonwealth shall apply modified adjusted gross
income (MAGI) methodologies for all separate CHIP covered groups, consistent
with 42 CFR 457.315 and 435.603(b) through (i). FAMIS shall be available for
targeted low-income children. Income standards shall be applied statewide.
Children from birth to age 19 years who have income above the Medicaid-eligible
limit at or below 200% of the federal poverty level, with a 5% income disregard,
shall be income eligible to participate in FAMIS.
b. In determining family size for the eligibility
determination of other individuals in the household that includes a pregnant
woman, the pregnant woman is counted just as herself.
c. Financial eligibility is determined consistent with the
following provisions:
(1) For new applicants, financial eligibility is based on
the monthly income and family size.
(2) When determining eligibility for current beneficiaries,
financial eligibility is based on current monthly household income and family
size.
(3) In determining current household income, the agency
will use reasonable methods to account for current income and reasonable
prediction of changes in future income or family size.
d. Unless an exception exists, as provided at 42 CFR
457.315 and 42 CFR 435.603(d)(2) through (d)(4), household income is the sum of
the MAGI-based income for every person counted in the individual's MAGI
household.
3. Spenddown. The Commonwealth shall not apply a spenddown
process for FAMIS where household income exceeds the income eligibility limit
for FAMIS.
I. G. Eligibility of newborns.
1. If a child otherwise eligible for FAMIS is born
within the three months prior to the month in which a signed application is
received, the eligibility for coverage is effective retroactive to the child's
date of birth if the child would have met all eligibility criteria during that
time.
A child born to a mother who is enrolled in FAMIS, under
either the XXI Plan or a related waiver (such as FAMIS MOMS), on the date of
the child's birth shall be deemed eligible for FAMIS for one year from birth
unless the child is otherwise eligible for Medicaid.
2. A child born to a targeted low-income pregnant woman is
deemed to have applied for and be eligible for FAMIS or Medicaid until the
child turns age one year in accordance with § 2112 of the Social Security Act.
[ "Targeted low-income pregnant woman" means an uninsured
pregnant woman whose household income is within the Medicaid or FAMIS MOMS
eligibility standards established by the Commonwealth. ]
a. The child is deemed to have applied for and been found
eligible for FAMIS or Medicaid, as appropriate, as of the date of the child's
birth and remains eligible without regard to changes in circumstances until the
child's first birthday.
b. DMAS shall cover as a deemed newborn a child born to a
mother who is covered under Medicaid or CHIP through the authority of the
state's § 1115 demonstration on the date of the newborn's birth.
12VAC30-141-110. Duration of eligibility and renewal.
A. The effective date of FAMIS eligibility shall be the date
of birth for a newborn deemed eligible under 12VAC30-141-100 I G.
Otherwise For all other children, the effective date of FAMIS
eligibility shall be the first day of the month in which a signed completed
application was received by either the FAMIS central processing unit or a
local department of social services LDSS or CPU if the applicant met
all eligibility requirements in that month. In no case shall a child's
eligibility be effective earlier than the date of the child's birth.
B. Eligibility for FAMIS will continue for 12 months so long
as the child remains a resident of Virginia and the child's countable income
does not exceed 200% of the federal poverty level. A child born to a mother who
was enrolled in FAMIS, under either the Title XXI Plan or a related
waiver (such as FAMIS MOMS), on the date of the child's birth shall remain
eligible for one year regardless of income unless otherwise found to be
eligible for Medicaid. A change in eligibility will be effective the first of
the month following expiration of a 10-day 10-calendar-day
advance notice. Eligibility based on all eligibility criteria listed in
12VAC30-141-100 C D will be redetermined no less often than
annually.
C. Renewal of coverage.
1. Renewal of coverage for individuals whose financial
eligibility is based on the applicable modified adjusted gross income (MAGI)
standard are performed as follows, consistent with 42 CFR 457.343:
a. Renewal of coverage is completed once every 12 months,
and
b. Without requiring information from the individual if
able to do so based on an ex parte review of reliable information contained in
the individual's account or other more current information available to the
agency.
2. If the agency cannot determine eligibility solely on the
basis of the ex parte review or otherwise needs additional information to
complete the redetermination, the individual is provided with a renewal form
that is prepopulated with information contained in the individual's case. The
individual shall be allowed 30 calendar days to return the renewal form and the
necessary verifications.
If the individual's coverage is canceled because the
renewal was not completed (either electronically, by phone, or on paper) or
because verifications needed to complete the renewal were not returned, the
individual has 90 calendar days after the coverage is canceled to provide the
information necessary to complete the renewal without having to file a new
application. This 90-calendar-day period is called the reconsideration period.
If all necessary information is provided during the reconsideration period and
the individual found eligible, enrollment will be restored without any lapse in
coverage.
12VAC30-141-120. Children ineligible for FAMIS. (Repealed.)
A. If a child is:
1. Eligible for Medicaid, or would be eligible if he
applied for Medicaid, he shall be ineligible for coverage under FAMIS. A child
found through the screening process to be potentially eligible for Medicaid but
who fails to complete the Medicaid application process for any reason, cannot
be enrolled in FAMIS;
2. An inmate of a public institution as defined in 42 CFR §435.1009,
he shall be ineligible for FAMIS; or
3. An inpatient in an institution for mental disease (IMD)
as defined in 42 CFR §435.1010, he shall be ineligible for FAMIS.
B. If a child's parent or other authorized representative
does not meet the requirements of assignment of rights to benefits or
requirements of cooperation with the agency in identifying and providing
information to assist the Commonwealth in pursuing any liable third party, the
child shall be ineligible for FAMIS.
C. If a child, if age 18, or if under age 18, a parent,
adult relative caretaker, guardian, or legal custodian obtained benefits for a
child or children who would otherwise be ineligible by willfully
misrepresenting material facts on the application or failing to report changes,
the child or children for whom the application is made shall be ineligible for
FAMIS. The child, if age 18, or if under age 18, the parent, adult relative
caretaker, guardian, or legal custodian who signed the application shall be
liable for repayment of the cost of all benefits issued as the result of the
misrepresentation.
12VAC30-141-150. Application requirements.
A. Availability of program information. DMAS or its designee
shall furnish the following information in written form and orally as
appropriate to all applicants and to other individuals who request it:
1. The eligibility requirements;
2. Summary of covered benefits;
3. Copayment amounts required; and
4. The rights and responsibilities of applicants and
enrollees.
B. Opportunity to apply. DMAS or its designee must afford an
individual, wishing to do so, the opportunity to apply for child health
insurance. Applications for health insurance will be accepted at a
central site designated by DMAS and at local departments of social services
throughout the Commonwealth. Applicants may file an application for
child health insurance by mail, by fax, by phone, via the internet,
or in person at local departments of social services. Applications filed at
the FAMIS CPU can be submitted by mail, by fax, via the Internet, or by phone.
Face-to-face interviews for the program are not required. Eligibility
determinations for FAMIS shall occur at either local departments of social
services or at the, DMAS designated central site, or
the CPU.
C. Application. DMAS or its designee shall require an
application from the applicant if the applicant is at least 18 years of age or
older, or from a parent, adult relative caretaker, guardian, legal custodian,
or authorized representative if the applicant is younger than 18 years of age
or the applicant is incapacitated. [ "Incapacitated” means a
person who, pursuant to an order of a court of competent jurisdiction, has been
found to be incapable of receiving and evaluating information effectively or
responding to people, events, or environments to such an extent that the
individual lacks the capacity to (i) meet the essential requirements of his
health, care, safety, or therapeutic needs without the assistance or protection
of a guardian, or (ii) manage property or financial affairs or provide for his
support or for the support of his legal dependents without the assistance or
protection of a conservator. ]
1. DMAS employs a single, streamlined application developed
by the state and approved by the Secretary of the Department of Health and
Human Services in accordance with § 1413(b)(I)(B) of the Affordable Care Act.
2. DMAS may employ an alternative application used to apply
for multiple human service programs approved by the Secretary of the Department
of Health and Human Services, provided that the agency makes readily available
the single or alternative application used only for insurance affordability programs
to individuals seeking assistance only through such programs.
C. D. Right to apply. An individual who is 18
years of age shall not be refused the right to complete an application for health
insurance for himself and shall not be discouraged from asking for
assistance for himself under any circumstances.
D. E. Applicant's signature. The applicant must
sign state-approved application forms submitted, even if another person fills
out the form, unless the application is filed and signed by the applicant's
parent, adult relative caretaker, legal guardian or conservator,
attorney-in-fact or authorized representative.
E. F. The authorized representative for an
individual 18 years of age or older shall be those individuals as set forth in
12VAC30-110-1380.
F. G. The authorized representative for
children younger than 18 years of age shall be those individuals as set forth
in 12VAC30-110-1390.
G. H. Persons prohibited from signing an
application. An employee of, or an entity hired by, a medical service provider
who stands to obtain FAMIS payments shall not sign an application for health
insurance on behalf of an individual who cannot designate an authorized
representative.
H. Written application. DMAS or its designee shall require
a written application from the applicant if he is at least 18 years of age or
older, or from a parent, adult relative caretaker, guardian, legal custodian,
or authorized representative if the applicant is less than 18 years of age or
the applicant is incapacitated. The application must be on a form prescribed by
DMAS, and must be signed under a penalty of perjury. The application form shall
contain information sufficient to determine Medicaid and FAMIS eligibility.
I. Assistance with application. DMAS or its designee shall
allow an individual or individuals of the applicant's choice to assist
and represent the applicant in the application process, or a redetermination
renewal process for eligibility, or both.
J. Timely determination of eligibility. The time processing
standards for determining eligibility for child health insurance begin
with the date a signed an application is submitted online, by
telephone, by fax, or received in hard copy either at a local
department of social services LDSS or the FAMIS CPU. An
application for health insurance received at local departments of social
services must shall have a full Medicaid eligibility
determination and, when a child is determined to be ineligible for Medicaid due
to excess income, a FAMIS eligibility determination an eligibility determination
performed, within the same Medicaid established federal
case processing time standards.
Except in cases of unusual circumstances as described
below, an application for health insurance received at the FAMIS CPU and
screened as ineligible for Medicaid, shall have a FAMIS eligibility
determination completed within 10 business days of the date the complete
application was received at the CPU. Applications that are screened as Medicaid
likely will be processed within Medicaid case processing time standards.
1. Unusual circumstances include: administrative or other
emergency beyond the agency's control. In such case, DMAS, or its designee, or
the LDSS must document, in the applicant's case record, the reasons for delay.
DMAS or its designee or the local department of social services must not use
the time standards as a waiting period before determining eligibility or as a
reason for denying eligibility because it has not determined eligibility within
the time standards.
2. Incomplete applications shall be held open for a period
of 30 calendar days to enable applicants to provide outstanding information
needed for an eligibility determination. Any applicant who fails to provide,
within 30 calendar days of the receipt of the initial application, information
or verifications necessary to determine eligibility, shall have his application
for FAMIS eligibility denied.
K. Notice of DMAS', its designee's or the local
department of social services' decision concerning eligibility. DMAS,
its designee or the local department of social services must The
determining agency shall send each applicant a written notice of the agency's/designee's
agency's or designee's decision on his the applicant's
application, and, if approved, his the applicant's
obligations under the program. If eligibility for both FAMIS and
Medicaid is denied, notice must be given concerning the reasons for the
action and an explanation of the applicant's right to request a review of the
adverse actions, as described in 12VAC30-141-50.
L. Case documentation. DMAS, its designee, or the local
department of social services must The determining agency shall
include in each applicant's record all necessary facts to support the decision
on his the applicant's application, and must dispose of
each application by a finding of eligibility or ineligibility, unless (i) there
is an entry in the case record that the applicant voluntarily withdrew the
application and that the agency or its designee sent a notice confirming his
the applicant's decision; or (ii) there is a supporting entry in the
case record that the applicant cannot be located.
M. Case maintenance. All cases approved for FAMIS shall be
maintained at the FAMIS CPU local departments of social services or
another entity designated by DMAS. Children determined by local
departments of social services to be eligible for FAMIS shall have their cases
transferred to the FAMIS CPU for ongoing case maintenance. The FAMIS CPU The
determining agency will be responsible for providing newly enrolled
recipients with program information, benefits available, how to secure services
under the program, a FAMIS handbook, and for processing changes in eligibility
and annual renewals within established time frames timeframes. DMAS
outreach resources may also provide information or assistance to the enrollee.
N. Redetermination Renewal of eligibility. DMAS,
LDSS, or the FAMIS CPU must shall redetermine the
eligibility of enrollees with respect to circumstances that may change at least
every 12 months. During the 12-month period of coverage, enrollees must make
timely and accurate reports if an enrollee no longer resides in the
Commonwealth of Virginia or when changes in income exceed 200% of the federal
poverty level plus a 5.0% income disregard. DMAS or the FAMIS CPU must
The agency responsible for managing the case shall promptly redetermine
eligibility when it receives information about changes in a FAMIS enrollee's
circumstances that may affect eligibility. DMAS or its designee may assist
with documenting changes reported by the enrollee.
O. Notice of decision concerning eligibility. DMAS or the
FAMIS CPU must The agency responsible for managing the case shall
give enrollees timely notice of proposed action to terminate their eligibility
under FAMIS. The notice must meet the requirements of 42 CFR 457.1180.
Part IV
Cost Sharing
12VAC30-141-160. Copayments for families not participating in
FAMIS Select.
A. Copayments shall apply to all enrollees in an MCHIP.
B. These cost-sharing provisions shall be implemented with
the following restrictions:
1. Total cost sharing for each 12-month eligibility period
shall be limited to (i) for families with incomes equal to or less than 150% of
FPL federal poverty level (FPL), the lesser of (a) $180 and (b)
2.5% of the family's income for the year (or 12-month eligibility period); and
(ii) for families with incomes greater than 150% of FPL, the lesser of $350 and
5.0% of the family's income for the year (or 12-month eligibility period).
2. DMAS or its designee shall ensure that the annual aggregate
cost sharing for all FAMIS enrollees in a family does not exceed the
aforementioned caps.
3. Families will be required to submit documentation to DMAS
or its designee showing that their maximum copayment amounts are met for the
year.
4. Once the cap is met, DMAS or its designee will issue a new
eligibility card excluding such families from paying additional copays for
the 12-month enrollment period.
C. Exceptions to the above cost-sharing provisions:
1. Copayments shall not be required for [ well-child
well child ], well baby, and pregnancy-related services. This shall
include:
a. All healthy newborn inpatient physician visits, including
routine screening (inpatient or outpatient);
b. Routine physical examinations, laboratory tests,
immunizations, and related office visits;
c. Routine preventive and diagnostic dental services (i.e.,
oral examinations, prophylaxis and topical fluoride applications, sealants, and
x-rays);
d. Services to pregnant females related to the pregnancy; and
e. Other preventive services as defined by the department.
2. Enrollees are not held liable for any additional costs,
beyond the standard copayment amount, for emergency services furnished outside
of the individual's managed care network. Only one copayment charge will be
imposed for a single office visit.
3. No cost sharing will be charged to American Indians and
Alaska Natives.
12VAC30-141-175. FAMIS Select.
A. Enrollees in FAMIS may, but shall not be required to,
enroll in a private or employer-sponsored health plan if DMAS or its designee
determines that such enrollment is cost effective, as defined in this section.
B. Eligibility determination. FAMIS children may elect to
receive coverage under a health plan purchased privately or through an employer
and DMAS may elect to provide coverage by paying all or a portion of the
premium if all of the following conditions are met:
1. The children are determined to be eligible for FAMIS;
2. The cost of coverage for the child [ or children ]
under FAMIS Select is equal to or less than the Commonwealth's cost of
obtaining coverage under FAMIS only for the eligible targeted low-income
children involved. The cost-effectiveness determination methodology is
described in subsection E of this section;
3. The policyholder agrees to assign rights to benefits under
the private or [ employer's employer-sponsored health ]
plan to DMAS to assist the Commonwealth in pursuing these third-party payments
for childhood immunizations. When a child is provided coverage under a private
or [ employer's employer-sponsored health ] plan, that
plan becomes the payer for all other services covered under that plan; and
4. The policyholder is not under a court order to provide
medical support for the applicant child.
C. DMAS will continually verify the child's or [ or
children's ] coverage under the private or [ employer's employer-sponsored
health ] plan and will redetermine the eligibility of the child
[ or children ] for the FAMIS Select component when it
receives information concerning an applicant's or enrollee's circumstances that
may affect eligibility.
D. Application requirements.
1. DMAS shall furnish the following information in written form
and orally, as appropriate, to the families of FAMIS children who have
indicated an interest in FAMIS Select:
a. The eligibility requirements for FAMIS Select;
b. A description of how the program operates, the amount of
premium assistance available, and how children can move from FAMIS Select into
FAMIS if requested;
c. A summary of the covered benefits and cost-sharing
requirements available through FAMIS;
d. A guide to help families make an informed choice by
comparing the FAMIS plan to their private or employer-sponsored health plan.
Such guide shall include a notice to the effect that children covered by FAMIS
Select will not receive FAMIS-covered services, but only those health services
covered by their private or employer-sponsored health plan, and that the FAMIS
Select enrollee shall be responsible for any and all costs associated with
their chosen health plan;
e. Information on coverage for childhood immunizations through
FAMIS; and
f. The rights and responsibilities of applicants and enrollees.
2. DMAS will provide interested families with applications for
FAMIS Select.
3. A An electronic or written application for
the FAMIS Select component shall be required from interested families.
4. DMAS shall determine eligibility for the FAMIS Select
component promptly, within 45 calendar days from the date of receiving an
application that contains all information and verifications necessary to
determine eligibility, except in unusual circumstances beyond the agency's
control. Actual enrollment into the FAMIS Select component may not occur for
extended periods of time, depending on the ability of the family to enroll in
the employer's plan.
5. Incomplete FAMIS Select applications shall be held for a
period of 30 calendar days to enable applicants to provide outstanding
information needed for a FAMIS Select eligibility determination. Any applicant
who, within 30 calendar days of the receipt of the initial application, fails
to provide information or verifications necessary to determine FAMIS Select
eligibility shall have his application denied.
6. DMAS must send each applicant a written notice of the
agency's decision on his application for FAMIS Select and, if approved, his
obligations under the program. If eligibility is denied, notice will be given
concerning the reasons for the denial.
E. Cost effectiveness. DMAS may elect to provide coverage to
FAMIS children by paying all or a portion of the family's private or
employer-sponsored health insurance premium if the cost of such premium
assistance under FAMIS Select is equal to or less than the Commonwealth's cost
of obtaining coverage under FAMIS only for the eligible, targeted, low-income
child [ or children ] involved. Providing premium assistance
for the FAMIS-eligible children may result in the coverage of an adult or other
relative/dependent relative or dependent; however, this coverage
shall be solely incidental to covering the FAMIS child.
1. To ensure that the FAMIS Select program remains cost
effective, DMAS will establish a fixed premium assistance amount per child that
will be paid to a family choosing to enroll their FAMIS-eligible child in FAMIS
Select. The fixed premium assistance amount will be determined annually by:
a. Determining the cost of covering a child under FAMIS. The
cost will be determined by using the capitated payment rate paid to MCHIPs, or
an average cost amount developed by DMAS;
b. Determining the administrative costs associated with the
FAMIS Select program; and
c. Establishing a fixed premium assistance amount that
includes administrative costs and is less than or equal to the cost of covering
the FAMIS child [ or children ] under FAMIS.
DMAS will ensure that the total of the fixed premium
assistance amounts for all the FAMIS-eligible children per family do not exceed
the total cost of the family's health insurance premium payment for the private
or employer-sponsored [ coverage health plan ]. If the
total fixed premium assistance amounts do exceed the family's premium payment,
then the family premium assistance will be reduced by an amount necessary to
ensure the premium assistance payment is less than or equal to the family's
premium payment.
F. Enrollment and disenrollment.
1. FAMIS children applying for FAMIS Select will receive
coverage under FAMIS until their eligibility for coverage under the FAMIS
Select component is established and until they are able to enroll in the
private or employer-sponsored health plan.
2. The timing and procedures employed to transfer FAMIS
children's coverage to the FAMIS Select component will be coordinated between
DMAS and the CPU agency managing the case to ensure continuation
of health plan coverage.
3. Participation by families in the FAMIS Select component
shall be voluntary. Families may disenroll their child [ or children ]
from the FAMIS Select component as long as the proper timing and procedures
established by DMAS are followed to ensure continued health coverage.
G. Premium assistance. When a child is determined eligible
for coverage under the FAMIS Select component, premium assistance payments
shall become effective the month in which the FAMIS child [ or children
are is ] enrolled in the employer's plan. Payment of premium
assistance shall end:
1. On the last day of the month in which FAMIS eligibility
ends;
2. The last day of the month in which the child [ or
children lose loses ] eligibility for coverage under the
private or [ employer's employer-sponsored health ]
plan;
3. The last day of the month in which the family notifies DMAS
that it wishes to disenroll its child [ or children ] from the
FAMIS Select component; or
4. On the next business day following a request by the family
to immediately transfer the child from FAMIS Select into the FAMIS program. The
request must include notification that the child's private or
employer-sponsored [ coverage health plan ] has been
terminated as of the date of transfer and an agreement by the family to return
to DMAS the premium assistance payment prorated for that portion of the month
in which the child was not enrolled in the private or employer-sponsored
[ health ] plan.
H. Supplemental health benefits coverage will be provided to
ensure that FAMIS children enrolled in the FAMIS Select component receive all
childhood immunizations available under the FAMIS benefits. FAMIS children can
obtain these supplemental benefits through Medicaid providers.
I. Cost sharing. FAMIS Select families will be responsible
for all copayments, deductibles, coinsurance, fees, or other cost-sharing
requirements of the private or employer-sponsored health plan in which they
enroll their children. There is no Title XXI family cost-sharing cap applied to
families with children enrolled in FAMIS Select.
There is no copayment required for the supplemental
immunization benefits provided through FAMIS.
12VAC30-141-500. Benefits reimbursement.
A. Reimbursement for the services covered under FAMIS
fee-for-service and MCHIPs shall be as specified in this section.
B. Reimbursement for physician services, surgical services,
clinic services, prescription drugs, laboratory and radiological services,
outpatient mental health services, early intervention services, emergency
services, home health services, immunizations, mammograms, medical transportation,
organ transplants, skilled nursing services, well baby and well child care,
vision services, durable medical equipment, disposable medical supplies, dental
services, case management services, physical therapy/occupational
therapy/speech-language therapy, occupational therapy, or
speech-language therapy services, hospice services, school-based health
services, behavioral therapy services including but not limited to
applied behavior analysis, and certain community-based mental health services
shall be based on the Title XIX rates.
C. Reimbursement to MCHIPs shall be determined on the basis
of the estimated cost of providing the MCHIP benefit package and services to an
actuarially equivalent population. MCHIP rates will be determined annually and
published 30 days prior to the effective date.
D. Exceptions.
1. Prior authorization is required after five visits in a
fiscal year for physical therapy, occupational therapy, and speech
speech-language therapy provided by home health providers and outpatient
rehabilitation facilities and for home health skilled nursing visits. Prior
authorization is required after 26 visits for outpatient mental health
visits in the first year of service and prior authorization is required for
the following nonemergency outpatient procedures: Magnetic Resonance Imaging,
including Magnetic Resonance Angiography (MRA), Computerized Axial Tomography
(CAT) scans, including Computed Tomography Angiography (CTA), or Positron Emission
Tomography (PET) scans performed for the purpose of diagnosing a disease
process or physical injury. Prior authorization for dental services will be
based on the Title XIX prior authorization requirements for dental services.
2. Reimbursement for inpatient hospital services will be based
on the Title XIX rates in effect for each hospital. Reimbursement shall not
include payments for disproportionate share or graduate medical education
payments made to hospitals. Payments made shall be final and there shall be no
retrospective cost settlements.
3. Reimbursement for outpatient hospital services shall be
based on the Title XIX rates in effect for each hospital. Payments made will be
final and there will be no retrospective cost settlements.
4. Reimbursement for inpatient mental health services other
than by free standing psychiatric hospitals will be based on the Title XIX
rates in effect for each hospital. Reimbursement will not include payments for
disproportionate share or graduate medical education payments made to
hospitals. Payments made will be final and there will be no retrospective cost
settlements.
5. Reimbursement for outpatient rehabilitation services will
be based on the Title XIX rates in effect for each rehabilitation agency.
Payments made will be final and there will be no retrospective cost
settlements.
6. Reimbursement for outpatient substance abuse treatment
services will be based on rates determined by DMAS for children ages six
through 18 years. Payments made will be final and there will be no
retrospective cost settlements.
7. Reimbursement for prescription drugs will be based on the
Title XIX rates in effect. Reimbursements for Title XXI do not receive drug
rebates as under Title XIX.
8. Reimbursement for covered prescription drugs for
noninstitutionalized FAMIS recipients receiving the fee-for-service benefits
will be subject to review and prior authorization when their current number of
prescriptions exceeds nine unique prescriptions within 180 calendar
days, and as may be further defined by the agency's guidance documents for
pharmacy utilization review and the prior authorization program. The prior
authorization process shall be applied consistent with the process set forth in
12VAC30-50-210 A 7.
12VAC30-141-660. Assignment to managed care.
A. Except for children enrolled in the Virginia Birth-Related
Neurological Injury Compensation Program established pursuant to Chapter 50
(§ 38.2-5000 et seq.) of Title 38.2 of the Code of Virginia, all eligible
enrollees shall be assigned in managed care through the department or the
central processing unit (CPU) under contract to DMAS CPU. FAMIS
individuals, during the preassignment period to an MCHIP, shall receive Title
XXI benefits via fee-for-service utilizing a FAMIS card issued by DMAS. After
assignment to an MCHIP, benefits and the delivery of benefits shall be
administered specific to the managed care program in which the individual is
enrolled. DMAS shall contract with MCHIPs to deliver health care services for
infants born to mothers enrolled in FAMIS for the month of birth plus two
additional months regardless of the status of the newborn's application for
FAMIS. If federal funds are not available for those months of coverage, DMAS
shall use state funding only.
1. MCHIPs shall be offered to enrollees in all areas.
2. All enrollees shall be assigned to the contracted MCHIPs.
3. Enrollees Applicants for FAMIS may choose an
MCHIP at the time of application. If a choice is not made at application,
enrollees shall be assigned through a random system algorithm; provided
however, all children within the same family shall be assigned to the same
MCHIP.
4. All children enrolled in the Virginia Birth-Related
Neurological Injury Compensation Program shall be assigned to the
fee-for-service component.
5. Enrolled individuals will receive a letter indicating that
they may select one of the contracted MCHIPs that serve such area. Enrollees
who do not select an MCHIP as described above, shall be assigned to an MCHIP as
described in subdivision 3 of this subsection.
6. Individuals assigned to an MCHIP who lose and then regain
eligibility for FAMIS within 60 days will be reassigned to their previous
MCHIP.
B. Following their initial assignment to an MCHIP, those
enrollees shall be restricted to that MCHIP until their next annual eligibility
redetermination, unless appropriately disenrolled by the department.
1. During the first 90 calendar days of managed care
assignment, an enrollee may request reassignment for any reason. Such
reassignment shall be effective no later than the first day of the second month
after the month in which the enrollee requests reassignment.
2. Enrollees may only request reassignment to another MCHIP
serving that geographic area.
3. After the first 90 calendar days of the assignment period,
the enrollee may only be reassigned from one MCHIP to another MCHIP upon
determination by DMAS that good cause exists pursuant to subsection C of this
section or for any reason at annual renewal.
C. Disenrollment for good cause, defined in
12VAC30-120-370, may be requested at any time.
1. After the first 90 calendar days of assignment in
managed care, enrollees may request disenrollment from DMAS based on good
cause. The request must be made in writing to DMAS and cite the reasons
why the enrollee wishes to be reassigned. The department shall establish
procedures for good cause reassignment through written policy directives.
2. DMAS shall determine whether good cause exists for
reassignment.
Part VII
FAMIS MOMS
12VAC30-141-670. Definitions.
The following words and terms when used in this chapter shall
have the following meanings unless the context clearly indicates otherwise:
"Act" means the Social Security Act.
"Adult caretaker relative" or "caretaker
relative" means an individual who is 18 years of age or older, who is not
the parent of but who is related to the child applicant by blood or marriage,
and who lives with and assumes responsibility for day-to-day care of the child
applicant in a place of residence maintained as his or their own home.
"Adverse action," consistent with 42 CFR
457.1130, means the denial of eligibility; failure to make a timely
determination of eligibility; suspension or termination of enrollment,
including disenrollment for failure to pay cost sharing; or delay, denial,
reduction, suspension, or termination of health services, in whole or in part,
including a determination about the type or level of services; and failure to
approve, furnish, or provide payment for health services in a timely manner;
provided, however, that determination of eligibility to participate in and
termination of participation in the FAMIS Select program shall not constitute
an adverse action.
"Adverse benefit determination," consistent with
42 CFR 438.400, means the denial or limited authorization of a requested
service; the failure to take action or timely take action on a request for
service; the reduction, suspension, or termination of a previously authorized
service; denial in whole or in part of a payment for a service; failure to
provide services within the timeframes required by the state; for a resident of
a rural exception area with only one MCO, the denial of a enrollee's request to
exercise the enrollee's right under 42 CFR 438.52(b)(2)(ii) to obtain services
outside of the network; the denial of a enrollee's request to dispute a
financial liability as provided in 42 CFR [ 438(b)(7)
438.400(b)(7) ]; or the failure of an MCO to act within the
timeframes provided in 42 CFR 438.408(b).
"Agency" means a local department of social
services, the central processing unit, or other entity designated by DMAS to
make eligibility determinations for FAMIS MOMS. the same as defined in
12VAC30-141-10.
"Agency error" means a person or persons
received benefits to which they were not entitled as a result of an error on
the part of an eligibility worker at a local department of social services or
the central processing unit.
"Agent" means an individual designated in writing
to act on behalf of a FAMIS MOMS Plan applicant or enrollee during the
administrative review process.
"Appeal" means an enrollee's request for review
of an adverse benefit determination by an MCO or an adverse action by the LDSS,
CPU, or DMAS.
"Applicant" means a pregnant woman who has filed an
application (or who has an application filed on her behalf) for health
insurance and is awaiting a determination of eligibility. A pregnant woman is
an applicant until her eligibility has been determined.
"Application for health insurance" means the form
or forms developed and approved by the Department of Medical Assistance
Services that are used for determining eligibility for Medicaid for poverty
level children, for the Family Access to Medical Insurance Security Plan
(FAMIS) for children, for Medicaid for pregnant women, and for FAMIS MOMS
coverage for pregnant women single streamlined application for
determining eligibility in public health insurance programs operated by the
Commonwealth.
"Authorized representative" means a person who is
authorized to conduct the personal or financial affairs for an individual who
is 18 years of age or older.
"Board" or "BMAS" means that policy
board created by § 32.1-324 of the Code of Virginia to administer the
plans established by the Social Security Act.
"Central processing unit" or "CPU" means Cover
Virginia, which is the private contractor that will determine
eligibility for and administer part of the FAMIS MOMS Plan same as
defined in 12VAC30-141-10.
"Child" means an individual under the age of
younger than 19 years of age.
"Competent individual" means a person who has
not been judged by a court to be legally incapacitated.
"Comprehensive health insurance coverage" means
health benefits coverage, which includes the following categories of services
at a minimum: inpatient and outpatient hospital services, physician's surgical
and medical services, and laboratory and radiological services.
"Conservator" means a person appointed by a court
of competent jurisdiction to manage the estate and financial affairs of an
incapacitated individual.
"Continuation of enrollment coverage"
means ensuring an enrollee's benefits are continued until completion of the
review process, with the condition that should the enrollee not prevail in the
review process, the enrollee shall be liable for the repayment of all benefits
received during the review process.
"Director" means the individual, or his designee,
specified in § 32.1-324 of the Code of Virginia with all of the attendant
duties and responsibilities to administer the State Plan for Medical Assistance
and the State Plan for Title XXI.
"DMAS" or "department" means the
Department of Medical Assistance Services.
"Enrollee" means a pregnant woman who has been
determined eligible to participate in FAMIS MOMS and is enrolled in the FAMIS
MOMS program.
"External quality review organization" means the
independent contractor assigned by DMAS to handle quality reviews and to
conduct final review of MCHIP adverse actions for FAMIS MOMS.
"Family" for a pregnant woman under the age of
21, means parents, including adoptive parents, if they are all residing
together and the spouse of the pregnant woman if the woman is married and
living with her spouse, as well as any children under the age of 21 the woman
may have.
For a pregnant woman over the age of 21,
"family" means her spouse, if married and living together, as well as
any children under the age of 21 the pregnant woman may have.
"Family income" means the total income of all
family members in a household. Income includes, but is not necessarily limited
to, before-tax earnings from a job, including cash, wages, salary, commissions,
tips, self-employment net profits, Social Security, Retirement Survivor
Disability Insurance (RSDI), veterans benefits, Railroad Retirement, disability
workers' compensation, unemployment benefits, child support, alimony, spousal
support, pensions, retirement benefits, settlement benefits, rental income, and
lottery/bingo winnings. Income excludes public assistance program benefits such
as SSI and TANF payments, foster care payments, general relief, loans, grants,
or scholarships for educational expenses or earned income of a child who is a
student.
"FAMIS" means the Family Access to Medical
Insurance Security Plan.
"FAMIS MOMS" means the Title XXI program available
to eligible pregnant women.
"Federal poverty level" or "FPL" means
that income standard as published annually by the U.S. Department of Health and
Human Services in the Federal Register.
"Fee-for-service" means the traditional Medicaid
health care delivery and payment system in which physicians and other providers
receive a payment for each unit of service they provide.
"Fraud" means an intentional deception or
misrepresentation made by a person with the knowledge that the deception could
result in some unauthorized benefit to herself or some other person. It
includes any act that constitutes fraud under applicable federal or state laws.
"Group health plan" or "health insurance
coverage" means that health care coverage as defined in § 2791 of the
Public Health Services Act (42 USC § 300gg-91(a) and (b)(1)).
"Guardian" means a person appointed by a court of
competent jurisdiction to be responsible for the affairs of an incapacitated
individual, including responsibility for making decisions regarding the
person's support, care, health, safety, habilitation, education, and
therapeutic treatment, and, if not inconsistent with an order of commitment,
residence.
"Incapacitated individual" means a person
who, pursuant to an order of a court of competent jurisdiction, has been found
to be incapable of receiving and evaluating information effectively or
responding to people, events, or environments to such an extent that the
individual lacks the capacity to (i) meet the essential requirements of her
health, care, safety, or therapeutic needs without the assistance or protection
of a guardian, or (ii) manage property or financial affairs or provide for her
support or for the support of her legal dependents without the assistance or
protection of a conservator.
"Legally emancipated" means that the parents and
child have gone through the court and a judge has declared that the parents
have surrendered the right to care, custody, and earnings of the child and have
renounced parental duties. A married minor is not emancipated unless a court
has declared the married minor emancipated from her parents.
[ "Lawfully residing" means the
individual is lawfully present in the United States and meets state residency
requirements. ]
"LDSS" or "local department" means the
local department of social services.
"Managed care health insurance plan" or
"MCHIP," as defined in § 32.1-137.1 of the Code of Virginia,
means an arrangement for the delivery of health care in which a health carrier
under contract with DMAS for Title XXI delivery systems undertakes to provide,
arrange and pay for, or reimburse any of the costs of health care services for
a covered person on a prepaid or insured basis, which contains one or more
incentive arrangements, including any credential requirements intended to
influence the cost of the health care services between the health carrier and
one or more providers and requires or creates benefit payment differential
incentives for covered persons to use providers that are directly or indirectly
managed, owned, under contract with, or employed by the health carrier.
"Member of a family," for purposes of
determining whether the applicant is eligible for coverage under a state
employee health insurance plan, means a spouse, parent or parents, including
stepparents with whom the child is living if the stepparent claims the child as
a dependent on the employee's federal tax return.
"Managed care organization" or "MCO"
means an organization that offers managed care health insurance plans (MCHIPs)
as defined in [ this section § 32.1-137.1 of the Code
of Virginia ].
"Pregnant woman" means a woman of any age who is
medically determined to be pregnant. The pregnant woman definition is met from
the first day of the earliest month that the medical practitioner certifies as
being a month in which the woman was pregnant, through the last day of the
month in which the 60th day occurs, following the last day of the month in
which her pregnancy ended, regardless of the reason the pregnancy ended.
"Provider" means the individual, facility, or other
entity registered, licensed, or certified, as appropriate, and enrolled by an
MCHIP or in fee-for-service to render services to FAMIS MOMS enrollees eligible
for services.
"State fair hearing" means, consistent with 42
CFR 438.400, the process set forth in 42 CFR 431 Subpart E.
"Title XXI" means the federal State Children's
Health Insurance Program as established by Subtitle J of the Balanced Budget
Act of 1997.
"Virginia State Employee Health Insurance Plan"
means a health insurance plan offered by the Commonwealth of Virginia to its
employees.
12VAC30-141-680. Administration and general background.
A. The state shall use funds provided under Title XXI for
obtaining coverage that meets the requirements of Title XXI of the Social
Security Act and any waiver of federal regulations approved by the Centers for
Medicare and Medicaid Services.
B. The DMAS director will have the authority to contract with
entities for the purpose purposes of establishing a centralized
processing site, determining eligibility, enrolling eligible pregnant women into
health plans, performing outreach, data collection, reporting, and other
services necessary for the administration of the FAMIS MOMS program; and for
employing state staff to perform Medicaid eligibility determinations on
pregnant women referred by the contractor's staff.
C. Health care services under FAMIS MOMS shall be provided
through MCHIPs and fee-for-service or through any other health care delivery
system deemed appropriate by the Department of Medical Assistance Services.
12VAC30-141-690. Outreach and public participation.
A. DMAS will work cooperatively with other state agencies and
contractors to ensure that state and federal law and any applicable state and
federal regulations are met.
B. DMAS shall develop a comprehensive marketing and outreach
effort. The marketing and outreach efforts will be aimed at promoting FAMIS
MOMS and Medicaid for pregnant women and increasing enrollment, and may
include contracting with a public relations firm, nonprofit agencies, and
foundations, and coordination with other state agencies, coordination with
the business community, and coordination with health care associations and
providers.
12VAC30-141-700. Review Appeal of adverse actions
or adverse benefit determinations.
A. Upon written request, all FAMIS MOMS program
applicants and enrollees shall have the right to a review state fair
hearing of an adverse action made by the MCHIP, local department of
social services, CPU, or DMAS, or an internal appeal of an adverse
benefit determination made by the MCO.
B. During review the appeal of a suspension or
termination of enrollment or a reduction, suspension, or termination of
services, the enrollee shall have the right to continuation of coverage if the
enrollee requests review an internal appeal with the MCO or an appeal
to DMAS prior to the effective date of the suspension or termination of
enrollment or suspension, reduction, or termination of services.
C. Review An appeal of an adverse action made
by the local department of social services, CPU, or DMAS shall be heard
and decided by an agent of DMAS who has not been directly involved in the
adverse action under review appeal.
D. Review An internal appeal of an adverse action
benefit determination made by the MCHIP MCO must be
conducted by a person or agent of the MCHIP MCO who has not been
directly involved in the adverse action benefit determination
under review appeal.
E. After final review by Pursuant to 42 CFR
438.402(c)(1)(B), after exhausting the MCHIP MCO's internal
appeals process, there shall also be opportunity for final
independent the enrollee to request an external medical
review by the an independent external quality review
organization. [ "External quality review organization" means
the independent contractor assigned by DMAS to handle quality reviews and to
conduct final review of MCHIP adverse actions for FAMIS MOMS. ] The
review is optional and shall not be required before proceeding to a state fair
hearing. The review shall not extend any of the timeframes for issuing a
decision and shall not disrupt any continuation of coverage granted to the
enrollee.
F. There will be no opportunity for review appeal
of an adverse action to the extent that such adverse action is based on a
determination by the director that funding for FAMIS MOMS has been terminated
or exhausted. There will be no opportunity for review based on which type of
delivery system (i.e., fee-for-service, MCHIP) is assigned. There will be
no opportunity for review appeal if the sole basis for the adverse
action decision is a provision in the State Plan or in a
state or federal law or regulation requiring an automatic change in
eligibility or enrollment or a change in coverage under the health benefits
package that affects all applicants or enrollees or a group of applicants
or enrollees without regard to their individual circumstances.
G. The burden of proof shall be upon the applicant or
enrollee to show that an adverse action or adverse benefit determination
is incorrect.
H. At no time shall the MCHIP's, local department's of social
services, the CPU's MCO, LDSS, CPU, or DMAS' DMAS
failure to meet the time frames timeframes set in this chapter or
set in the MCHIP's MCO or DMAS' DMAS written review
procedures appeal procedure constitute a basis for granting the
applicant or enrollee the relief sought.
12VAC30-141-710. Notice of adverse action or adverse benefit
determination.
A. The CPU or LDSS, CPU, DMAS, or DMAS
contractor shall send written notification to enrollees at least 10
calendar days prior to suspension or termination of enrollment.
B. DMAS or the MCHIP MCO shall send written
notification to enrollees at least 10 calendar days prior to reduction,
suspension, or termination of a previously authorized health service.
C. The local department of social services, the CPU,
DMAS, or the MCHIP MCO shall send written notification to
applicants and enrollees of all other adverse actions within 10 calendar days
of the adverse action.
D. Notice shall include the reasons for determination, an
explanation of applicable rights to a review of that determination, the
standard and expedited time frames for review, the manner in which a review can
be requested, and the circumstances under which enrollment or services may
continue pending review.:
1. The determination the LDSS, CPU, DMAS, or MCO has made
or intends to make;
2. The reasons for the determination, including the right
of the enrollee to be provided upon request and free of charge reasonable
access to and copies of all documents, records, and other information relevant
to the determination;
3. An explanation of applicable rights to request an appeal
of that determination. For adverse benefit determinations by an MCO, this shall
include information on the MCO's internal appeals process and, after the
internal appeals process is exhausted, a state fair hearing pursuant to 42 CFR
402(b) and 42 CFR 402(c);
4. The procedures for exercising these appeal rights;
5. The circumstances under which an appeal process can be
expedited and how to request it; and
6. The circumstances under which enrollment or services may
continue pending appeal, how to request benefits be continued, and the
circumstances, consistent with state policy, under which the enrollee may be
required to pay the costs of these services.
12VAC30-141-720. Request for review appeal.
A. Requests for review internal appeal of MCHIP
MCO adverse actions benefit determinations shall be
submitted orally or in writing to the MCHIP MCO. Unless
the enrollee requests an expedited appeal, an oral appeal request must be
followed by a written appeal request. The enrollee must exhaust the MCO's
internal appeals process before appealing to DMAS.
B. If the MCO fails to adhere to the notice or timing
requirements set forth in this part, the enrollee is deemed to have exhausted
the MCO's internal appeals process and may initiate a state fair hearing.
[ B. ] C. Requests for review appeal
of adverse actions made by the local department of social services, LDSS,
the CPU, or DMAS, or of internal appeal decisions by the MCO
shall be submitted in writing to DMAS.
C. D. Any written communication clearly
expressing a desire to have an adverse action benefit determination
by an MCO reviewed shall be treated as a request for review an
internal appeal. Any communication expressing a desire to have an
adverse action by the LDSS, CPU, or DMAS reviewed shall be treated as a request
for a state fair hearing. Any communication expressing a desire to have an MCO
internal appeal decision reviewed shall be treated as a request for a state
fair hearing.
D. E. To be timely, requests for review an
internal appeal of a MCHIP an MCO's adverse benefit
determination shall be received by the MCHIP MCO no later than 30
60 calendar days from the date of the MCHIP's MCO's notice
of adverse action benefit determination.
E. F. To be timely, requests for an appeal of an
adverse benefit determination upheld in whole or in part by the MCO's internal
appeal decision shall be received by DMAS within 120 calendar days from the
date of the internal appeal decision.
G. To be timely, requests for review appeal
of a local department of social services, DMAS, or CPU determination adverse
action shall be filed with DMAS no later than 30 calendar days from the
date of the CPU's, LDSS' or DMAS' notice of adverse action. Requests for
review appeal of a local department of social services, DMAS,
or CPU an agency determination shall be considered filed with DMAS
on the date the request is postmarked, if mailed, or on the date the
request is received, if delivered other than by mail, by DMAS.
12VAC30-141-730. Review Appeal procedures.
A. At a minimum, the MCHIP review MCO internal
appeal shall be conducted pursuant to written procedures as defined in §
32.1-137.6 of the Code of Virginia and as may be further defined by DMAS
42 CFR 438.400 et seq. Such procedures shall be subject to review and
approval by DMAS.
B. Any adverse benefit determination upheld in whole or in
part by the internal appeal decision issued by the MCO may be appealed by the
enrollee to DMAS in accordance with the DMAS client appeals regulations at
12VAC30-110-10 through 12VAC30-110-370. DMAS shall conduct an evidentiary
hearing in accordance with 12VAC30-110-10 through 12VAC30-110-370 and shall not
base any appealed decision on the record established by any internal appeal
decision of the MCO. The MCO shall comply with the DMAS appeal decision. The
DMAS decision in these matters shall be final and shall not be subject to
appeal by the MCO.
The DMAS review C. Appeals of adverse actions by
the LDSS, CPU, or DMAS shall be conducted pursuant to written procedures
developed by DMAS 12VAC30-110.
C. The procedures in effect on the date a particular
request for review is received by the MCHIP or DMAS shall apply throughout the
review.
D. Copies of the procedures shall be promptly mailed provided
by the MCHIP MCO or DMAS to applicants and enrollees upon receipt
of timely requests for review internal appeals or state fair hearings.
Such written procedures shall include but not be limited to the
following:
1. The right to representation by an attorney or other agent
of the applicant's or enrollee's choice, but at no time shall the MCHIP,
local department of social services, MCO, LDSS, DSS, or DMAS be
required to obtain or compensate attorneys or other agents acting on behalf of
applicants or enrollees;
2. The right to timely review of their files and other
applicable information relevant to the review internal appeal or
state fair hearing of the decision;
3. The right to fully participate in the review internal
appeal or state fair hearing process, whether the review internal
appeal or state fair hearing is conducted in person or in writing,
including the presentation of supplemental information during the review
internal appeal or state fair hearing process;
4. The right to have personal and medical information and
records maintained as confidential; and
5. The right to a written final decision within 90 calendar
days of receipt of the request for review, unless the applicant or enrollee
requests or causes a delay.:
a. For internal appeals to the MCO, within 30 calendar days
of receipt of the request for an internal appeal; or
b. For state fair hearings, within the time limitations for
appeals imposed by federal regulations and as permitted in 12VAC30-110-30;
E. 6. For eligibility and enrollment matters, if
the applicant's or enrollee's physician or health plan determines that the
90-calendar-day timeframe could seriously jeopardize the applicant's or
enrollee's life or health or ability to attain, maintain, or regain maximum
function, an applicant or enrollee will have the opportunity to request an
expedited review appeal. Under these conditions, a request for review
an expedited appeal shall result in a written final decision within three
business days 72 hours after DMAS receives, the expedited
appeal request from the physician or health plan, with the
case record and information indicating that taking the time for a standard
resolution of the review appeal request could seriously
jeopardize the applicant's or enrollee's life or health or ability to attain,
maintain, or regain maximum function, unless the applicant or enrollee or
her authorized representative causes a delay. requests an extension;
F. 7. For health services matters for FAMIS MOMS
enrollees receiving services through MCHIPs, if an MCO:
a. If the enrollee's physician or health plan
determines that the 90-calendar-day 30-calendar-day timeframe for
a standard internal appeal could seriously jeopardize the enrollee's life or,
health, or ability to attain, maintain, or regain maximum function, an
enrollee will have the opportunity to request an expedited review
internal appeal. Under these conditions, a request for review an
internal appeal shall result in a written decision by the external
quality review organization MCO within 72 hours from the time
an enrollee requests the expedited review internal
appeal is requested, unless the applicant, enrollee, or authorized
representative requests or causes a delay. If a delay is requested or
caused by the applicant, enrollee, or authorized representative, then
expedited review internal appeal may be extended up to 14
calendar days.
b. If the adverse benefit determination is upheld in whole
or in part by the expedited internal appeal decision issued by the MCO, and if
the enrollee's physician or health plan determines that the timeframe for a
standard appeal to DMAS could seriously jeopardize the enrollee's life or
health or ability to attain, maintain, or regain maximum function, an enrollee
will have the opportunity to request an expedited appeal to DMAS. Under these
conditions, a request for a state fair hearing shall result in a written
decision within 72 hours from the time an enrollee requests the expedited
appeal, unless the applicant, enrollee, or authorized representative requests
or causes a delay. If a delay is requested by the applicant, enrollee, or
authorized representative, then the expedited appeal may be extended up to 14
calendar days; and
G. 8. For health services matters for FAMIS MOMS
enrollees receiving services through fee-for-service, if the enrollee's
physician or health plan determines that the 90-calendar-day timeframe for a
standard appeal could seriously jeopardize the enrollee's life, health,
or ability to attain, maintain, or regain maximum function, an enrollee will
have the opportunity to request an expedited review. Under these
conditions, a request for review an expedited appeal shall result
in a written decision within 72 hours from the time an enrollee requests
the expedited review appeal is requested, unless the
applicant, enrollee, or authorized representative requests or causes a delay.
If a delay is requested or caused by the applicant, enrollee, or authorized
representative, then expedited review appeal may be extended up
to 14 calendar days.
12VAC30-141-740. Eligibility requirements General
conditions of eligibility.
A. This section shall be used to determine eligibility of
pregnant women for FAMIS MOMS.
B. FAMIS MOMS shall be in effect statewide.
C. Eligible pregnant women must:
1. Be determined ineligible for Medicaid due to excess income
by a local department of social services or LDSS, by DMAS eligibility
staff co-located at the FAMIS, or by the CPU;
2. Be a pregnant woman at the time of application;
3. Be a resident of the Commonwealth as described in
12VAC30-141-100 E;
4. Be either a U.S. United States citizen, U.S.
United States national, lawfully residing, or a qualified
noncitizen as described in 12VAC30-141-100 E;
5. Be uninsured, that is, not have comprehensive creditable
health insurance coverage; and
6. Not be an inpatient in an institution for mental diseases (IMD),
or an inmate in a public institution that is not a medical facility.
[ "Lawfully residing" means the individual
is lawfully present in the United States and meets state residency
requirements. "Creditable health insurance coverage" means coverage
that meets the definition at 42 CFR 457.10. ]
D. Income Financial eligibility.
1. Screening. All applications for FAMIS MOMS coverage received
at the FAMIS central processing unit must be screened to identify
applicants who are potentially eligible for Medicaid shall have a
Medicaid income eligibility screen completed. Pregnant women screened
and found potentially eligible for Medicaid cannot be enrolled in FAMIS MOMS
until there has been a finding of ineligibility for Medicaid. Pregnant women
who do not appear to be eligible for Medicaid due to excess income determined
to be ineligible for Medicaid due to excess income shall have their
eligibility for FAMIS MOMS determined and, if eligible, will be enrolled in
the FAMIS MOMS program. Applications for FAMIS MOMS received at a local
department of social services shall have a full Medicaid eligibility
determination completed. Pregnant women determined to be ineligible for Medicaid
due to excess income will have their eligibility for FAMIS MOMS determined and,
if eligible, the local department of social services will enroll the pregnant
woman in the FAMIS MOMS program.
2. Standards. Income standards for FAMIS MOMS are based on
a comparison of countable income to 200% of the federal poverty level for the
family size. Countable income and family size are based on the methodology
utilized by the Medicaid program as defined in 12VAC30-40-100 B 1 b. Pregnant
women who have income at or below 200% of the federal poverty level, but are
ineligible for Medicaid due to excess income, will be income eligible to
participate in FAMIS MOMS the same as those described at 12VAC30-141-100
F 2, applied to pregnant women. For purposes of income determination, the
family size of the pregnant woman will count the unborn child.
3. Spenddown. Deduction of incurred medical expenses from
countable income (spenddown) shall not apply in FAMIS MOMS. If the family
income exceeds the income limits described in this section, the individual
shall be ineligible for FAMIS MOMS regardless of the amount of any incurred
medical expenses DMAS does not apply a spenddown process for FAMIS MOMS
where household income exceeds the income eligibility limit for FAMIS MOMS.
E. Residency. The requirements for residency, as set forth
in 42 CFR 435.403, will be used when determining whether a pregnant woman is a
resident of Virginia for purposes of eligibility for FAMIS MOMS. A child who is
not emancipated and is temporarily living away from home is considered living
with her parents, adult relative caretaker, legal guardian, or person having
legal custody if the absence is temporary and the child intends to return to
the home when the purpose of the absence (such as education, medical care,
rehabilitation, vacation, visit) is completed.
F. U.S. citizenship or nationality. Upon signing the
declaration of citizenship or nationality required by § 1137(d) of the Social
Security Act, the applicant or recipient is required under § 2105(c)(9) to
furnish satisfactory documentary evidence of U.S. citizenship or nationality
and documentation of personal identity unless citizenship or nationality has
been verified by the Commissioner of Social Security or unless otherwise
exempt.
G. Qualified noncitizen. The requirements for qualified
aliens set out in Public Law 104-193, as amended, and the requirements for
noncitizens set out in subdivisions 3 b, c, and e of 12VAC30-40-10 will be used
when determining whether a pregnant woman is a qualified noncitizen for
purposes of FAMIS MOMS eligibility.
H. E. Coverage under other health plans.
1. Any pregnant woman covered under a group health plan or
under health insurance coverage, as defined in § 2791 of the Public Health
Services Act (42 USC § 300gg-91(a) and (b)(1)), shall not be eligible for FAMIS
MOMS.
2. No FAMIS MOMS
shall not be a substitution for private insurance.
a. Only uninsured pregnant
women shall be eligible for FAMIS MOMS. A pregnant woman is not considered to
be insured if the health insurance plan covering the pregnant woman does not
have a network of providers in the area where the pregnant woman resides. Each
application for FAMIS MOMS coverage shall include an inquiry about health
insurance the pregnant woman has at the time of application.
b. Health insurance does not include Medicare, Medicaid, FAMIS
or insurance for which DMAS paid premiums under Title XIX through the Health
Insurance Premium Payment (HIPP) Program or under Title XXI through the SCHIP
premium assistance program.
12VAC30-141-750. Duration of eligibility.
A. The effective date of FAMIS MOMS eligibility shall be the
first day of the month in which a signed an application was
received by either the FAMIS central processing unit or a local department
of social services LDSS, DMAS, or the CPU if the applicant met all
eligibility requirements in that month.
B. Eligibility for FAMIS MOMS will continue through the last
day of the month in which the 60th day occurs, following the last day the woman
was pregnant, regardless of the reason the pregnancy ended. Eligibility will
continue until the end of the coverage period, regardless of changes in
circumstances such as income or family size.
12VAC30-141-760. Pregnant women ineligible for FAMIS MOMS.
A. If a pregnant woman is:
1. Eligible for Medicaid, or would be eligible if she
applied for Medicaid, she shall be ineligible for coverage under FAMIS MOMS.
A pregnant woman found through the screening process to be potentially eligible
for Medicaid but who fails to complete the Medicaid application process for any
reason, cannot be enrolled in FAMIS MOMS;
2. An inmate of a public institution as defined provided
in 42 CFR 435.1009 435.1009(a)(1), she shall be ineligible for
FAMIS MOMS at the initial determination of eligibility; or
3. An inpatient in an institution for mental disease (IMD)
as [ defined provided ] in [ 42 CFR 435.1010 42 CFR
435.1010(a)(2) ], she shall be ineligible for FAMIS MOMS at the
initial determination of eligibility.
B. If a pregnant woman age 18 years or older or, if younger
than age 18 years, a parent or other authorized representative does not meet
the requirements of assignment of rights to benefits or requirements of
cooperation with the agency in identifying and providing information to assist the
Commonwealth in pursuing any liable third party, the pregnant woman shall be
ineligible for FAMIS MOMS.
C. If a pregnant woman age 18 years or older, or if younger
than age 18 years, a parent, adult relative caretaker, guardian, or legal
custodian obtained benefits for a pregnant woman who would otherwise be
ineligible by willfully misrepresenting material facts on the application or
failing to report changes, the pregnant woman for whom the application is made
shall be ineligible for FAMIS MOMS. The pregnant woman age 18 years or older,
or if younger than age 18 years, the parent, adult relative caretaker,
guardian, or legal custodian who signed the application shall be liable for
repayment of the cost of all benefits issued as the result of the misrepresentation.
12VAC30-141-790. Application requirements.
A. Availability of program information. DMAS or its designee
shall furnish the following information in written form and orally as
appropriate to all applicants and to other individuals who request it:
1. The eligibility requirements;
2. Summary of covered benefits;
3. Copayment amounts required; and
4. The rights and responsibilities of applicants and
enrollees.
B. Opportunity to apply. DMAS or its designee must afford a
pregnant woman, wishing to do so, the opportunity to apply for the FAMIS MOMS
program. Applications from pregnant women will be accepted at a central site
designated by DMAS and at local departments of social services throughout the
Commonwealth. Applicants may file an application for health insurance
by mail, by fax, by phone, via the internet, or in person at local
departments of social services. Applications filed at the FAMIS CPU can be
submitted by mail, by fax, by the Internet, or by phone. Face-to-face
interviews for the program are not required. Eligibility determinations for
FAMIS MOMS shall occur at either local departments of social services or at
the DMAS-designated central site LDSS, DMAS, or the CPU.
C. Application. DMAS or its designee shall require an
application from the applicant if the applicant is at least 18 years of age or
older, or from a parent, adult relative caretaker, guardian, legal custodian,
or authorized representative if the applicant is younger than 18 years of age
or the applicant is incapacitated.
1. DMAS employs a single, streamlined application developed
by the state and approved by the Secretary of the Department of Health and
Human Services in accordance with § 1413(b)(1)(B) of the Affordable Care
Act.
2. DMAS may employ an alternative application used to apply
for multiple human service programs approved by the Secretary of the Department
of Health and Human Services, provided that the agency makes readily available
the single or alternative application used only for insurance affordability
programs to individuals seeking assistance only through such programs.
D. Right to apply. An individual who is 18 years of
age or older shall not be refused the right to complete an application for
health insurance for herself and shall not be discouraged from asking for
assistance for herself under any circumstances.
D. E. Applicant's signature. The applicant must
sign state-approved application forms submitted, even if another person fills
out the form, unless the application is filed and signed by the applicant's
parent, spouse, adult relative caretaker, legal guardian or conservator,
attorney-in-fact or authorized representative.
E. F. The authorized representative for an
individual 18 years of age or older shall be those individuals as set forth in
12VAC30-110-1380.
F. G. The authorized representative for
children younger than 18 years of age shall be those individuals as set forth
in 12VAC30-110-1390.
G. H. Persons prohibited from signing an
application. An employee of, or an entity hired by, a medical service provider
who stands to obtain FAMIS MOMS payments shall not sign an application for
health insurance on behalf of an individual who cannot designate an authorized
representative.
H. Written application. DMAS or its designee shall require
a written application from the applicant if she is at least 18 years of age or
older, or from a parent, adult relative caretaker, guardian, legal custodian,
or authorized representative if the applicant is less than 18 years of age or
the applicant is incapacitated. The application must be on a form prescribed by
DMAS and must be signed under a penalty of perjury. The application form shall
contain information sufficient to determine Medicaid and FAMIS MOMS
eligibility.
I. Assistance with application. DMAS or its designee shall
allow an individual or individuals of the applicant's choice to assist
and represent the applicant in the application process, or a redetermination
renewal process for eligibility.
J. Timely determination of eligibility. The time processing
standards for determining eligibility for FAMIS MOMS coverage begin with the
date a signed an application is submitted online, by
telephone, by fax, or received either in hard copy at a local
department of social services or the FAMIS CPU. All Applications
received at local departments of social services must applications
shall have a full Medicaid an eligibility determination and,
when a pregnant woman is determined to be ineligible for Medicaid due to
excess income, a for pregnant women and FAMIS MOMS eligibility
determination performed, within the same Medicaid case
processing time standards (10 business days) if all information necessary to
make the determination has been received.
Except in cases of unusual circumstances as described
below, health insurance applications for pregnant women received at the local
department of social services shall have a Medicaid eligibility determination
completed and, if denied Medicaid for excess income, a FAMIS MOMS eligibility
determination completed within 10 business days of the date the signed
application was received at the local department. An application from a
pregnant woman received at the FAMIS CPU and screened as ineligible for
Medicaid, shall have a FAMIS MOMS eligibility determination completed within 10
business days of the date the complete application was received at the CPU.
Complete applications that are screened as Medicaid likely will be processed
within the 10 business day time standard. If the application cannot be
processed within this standard, a notice will be sent to the applicant
explaining why a decision has not yet been made.
1. Unusual circumstances include administrative or other
emergency beyond the agency's control. In such case, DMAS or its designee or
the LDSS must document, in the applicant's case record, the reasons for delay.
DMAS or its designee or the local department of social services must not use
the time standards as a waiting period before determining eligibility or as a
reason for denying eligibility because it has not determined eligibility within
the time standards.
2. Applications filed at the CPU that are incomplete shall
be held open for a period of 30 calendar days to enable applicants to provide
outstanding information needed for an eligibility determination. Incomplete
applications determined complete by the receipt of additional information
required to determine FAMIS MOMS eligibility will be processed in an expedited
manner upon receipt of the additional information. Any applicant who fails to
provide, within 30 calendar days of the receipt of the initial application,
information or verifications necessary to determine eligibility, shall have her
application for FAMIS MOMS eligibility denied.
K. Notice of DMAS', its designee's or the local
department of social services' decision concerning eligibility. DMAS, its
designee or the local department of social services must an LDSS, or the
CPU shall send each applicant a written notice of the agency's/designee's
agency's or designee's decision on her the applicant's
application, and, if approved, her the applicant's
obligations under the program. If eligibility for FAMIS MOMS is denied, notice must
shall be given concerning the reasons for the action and an explanation
of the applicant's right to request a review of the adverse actions, as
described in 12VAC30-141-50.
L. Case documentation. DMAS, its designee, or the
local department of social services must, or the CPU shall include
in each applicant's record all necessary facts to support the decision on her
the applicant's application, and must shall dispose
of each application by a finding of eligibility or ineligibility, unless (i)
there is an entry in the case record that the applicant voluntarily withdrew
the application and that the agency or its designee sent a notice confirming her
the applicant's decision; or (ii) there is a supporting entry in
the case record that the applicant cannot be located.
M. Case maintenance. All cases approved for FAMIS MOMS shall
be maintained at the FAMIS CPU departments of social services or the
CPU. Pregnant women determined by local departments of social services
to be eligible for FAMIS MOMS shall have their cases transferred to the FAMIS
CPU for ongoing case maintenance. The FAMIS CPU The LDSS or the
agency determining eligibility will be responsible for providing newly
enrolled recipients with program information, benefits available, how to secure
services under the program, a FAMIS MOMS handbook, and for processing changes
in eligibility within established time frames timeframes. DMAS
outreach resources may also provide information or assistance to the enrollee.
N. Notice of decision concerning eligibility. DMAS or the
FAMIS CPU LDSS, DMAS, or the CPU must give enrollees timely notice
of proposed action to terminate their eligibility under FAMIS MOMS. The notice
must meet the requirements of 42 CFR 457.1180.
12VAC30-141-800. Copayments.
A. Pregnant women enrolled in FAMIS MOMS will be subject to
copayments for medical services in the same manner and amount as pregnant women
covered by the Medicaid program as defined in 12VAC30-10-570 B and C.
B. These cost-sharing provisions shall be implemented with
the following restrictions:
1. Total cost sharing for a pregnant woman shall be limited to
the lesser of (i) $180 and (ii) 2.5% of the family's income (i) for
families with incomes equal to or less than 150% of federal poverty level
(FPL), the lesser of (a) $180 and (b) 2.5% of the family's income for the year;
and (ii) for families with incomes greater than 150% of FPL, the lesser of $350
and 5.0% of the family's income for the year for the duration of her
the pregnant woman's enrollment in FAMIS MOMS.
2. If a family includes a pregnant woman enrolled in FAMIS
MOMS and a child or children enrolled in FAMIS, DMAS or its designee
shall ensure that the annual aggregate cost sharing for all Title XXI enrollees
in a family does not exceed the cost sharing caps as defined in 12VAC30-141-160
B.
3. Families will be required to submit documentation to DMAS
or its designee showing that their maximum copayment amounts are met for the
year.
4. Once the cap is met, DMAS or its designee will issue a new
eligibility card or written documentation excluding such families from paying
additional copays.
C. Exceptions to the above cost-sharing provisions. No cost
sharing will be charged to American Indians and Alaska Natives.
12VAC30-141-880. Assignment to managed care.
A. All eligible enrollees shall be assigned in managed care
through the department or the central processing unit (CPU) under contract to
DMAS. FAMIS MOMS individuals, during the preassignment period to an MCHIP,
shall receive Medicaid-like benefits via fee-for-service utilizing a FAMIS MOMS
card issued by DMAS. After assignment to an MCHIP, benefits and the delivery of
benefits shall be administered specific to the managed care program in which
the individual is enrolled.
1. MCHIPs shall be offered to enrollees in all areas.
2. All enrollees shall be assigned to that contracted MCHIP.
3. Enrollees shall be assigned through a random system
algorithm.
4. Enrolled individuals will receive a letter indicating that
they may select one of the contracted MCHIPs that serve such area. Enrollees
who do not select an MCHIP as described above, shall be assigned to an MCHIP as
described in subdivision 3 of this subsection.
5. Individuals assigned to an MCHIP who lose and then regain
eligibility for FAMIS MOMS within 60 calendar days will be reassigned to
their previous MCHIP.
B. Following their initial assignment to an MCHIP, those
enrollees shall be restricted to that MCHIP until their next annual eligibility
redetermination, unless appropriately disenrolled by the department.
1. During the first 90 calendar days of managed care
assignment, an enrollee may request reassignment for any reason from that MCHIP
to another MCHIP serving that geographic area. Such reassignment shall be
effective no later than the first day of the second month after the month in
which the enrollee requests reassignment.
2. After the first 90 calendar days of the assignment period,
the enrollee may only be reassigned from one MCHIP to another MCHIP upon
determination by DMAS that good cause exists pursuant to subsection C of this
section.
C. Disenrollment for good cause may be requested at any time.
1. After the first 90 calendar days of assignment in
managed care, enrollees may request disenrollment from DMAS based on good
cause. The request must be made in writing to DMAS and cite the reasons
why the enrollee wishes to be reassigned. The department shall establish
procedures for good cause reassignment through written policy directives.
2. DMAS shall determine whether good cause exists for
reassignment.
D. Exclusion for assignment to a MCHIP. The following
individuals shall be excluded from assignment to a MCHIP. Newly eligible individuals
who are in the third trimester of pregnancy and who request exclusion within a
department-specified time frame timeframe of the effective date
of their MCHIP enrollment. Exclusion may be granted only if the member's
obstetrical provider (physician or hospital) does not participate with the
enrollee's assigned MCHIP. Exclusion requests made during the third trimester
may be made by the enrollee, MCHIP, or provider. DMAS shall determine if the
request meets the criteria for exclusion.
VA.R. Doc. No. R17-4662; Filed April 30, 2019, 4:22 p.m.
TITLE 13. HOUSING
BOARD OF HOUSING AND COMMUNITY DEVELOPMENT
Emergency Regulation
Title of Regulation: 13VAC5-63. Virginia Uniform
Statewide Building Code (amending 13VAC5-63-540).
Statutory Authority: § 36-98 of the Code of Virginia.
Effective Dates: May 14, 2019, through November 12,
2020.
Agency Contact: Kyle Flanders, Senior Policy Analyst,
Department of Housing and Community Development, Main Street Centre, 600 East
Main Street, Suite 300, Richmond, VA 23219, telephone (804) 786-6761, FAX (804)
371-7090, TTY (804) 371-7089, or email kyle.flanders@dhcd.virginia.gov.
Preamble:
Section 2.2-4011 A of the Code of Virginia states that
regulations that an agency finds are necessitated by an emergency situation may
be adopted upon consultation with the Attorney General, which approval shall be
granted only after the agency has submitted a request stating in writing the
nature of the emergency, and the necessity for such action shall be at the sole
discretion of the Governor.
Currently, the Virginia Maintenance Code (VMC), a part of
the Uniform Statewide Building Code (USBC), requires that when cooling is
provided to tenants of certain multifamily buildings, it must be provided to a
temperature of at least 80° Fahrenheit. The current threshold has been
identified as a public health concern in multiple localities that adopt the
VMC. The amendment lowers the required cooling temperature as provided in the
USBC to to 77° Fahrenheit.
13VAC5-63-540. Chapter 6 Mechanical and electrical
requirements.
A. Delete the following sections from Chapter 6 of the IPMC:
1. Section 601.2 Responsibility.
2. Section 603.6 Energy conservation devices.
3. Section 604.2 Service.
4. Section 604.3.2 Abatement of electrical hazards associated
with fire exposure.
B. Change the following sections in Chapter 6 of the IPMC to
read:
1. Section 601.1 General. The provisions of this chapter shall
govern the maintenance of mechanical and electrical facilities and equipment.
2. Section 602 Heating and cooling facilities.
3. Section 602.2 Heat supply. Every owner and operator of a
Group R-2 apartment building or other residential building who rents, leases,
or lets one or more dwelling unit, rooming unit, dormitory, or guestroom on
terms, either expressed or implied, to furnish heat to the occupants thereof
shall supply heat during the period from October 15 to May 1 to maintain a
temperature of not less than 68°F (20°C) in all habitable rooms, bathrooms, and
toilet rooms. The code official may also consider modifications as provided in
Section 104.5.2 when requested for unusual circumstances or may issue notice
approving building owners to convert shared heating and cooling piping HVAC
systems 14 calendar days before or after the established dates when extended
periods of unusual temperatures merit modifying these dates.
Exception: When the outdoor temperature is below the winter
outdoor design temperature for the locality, maintenance of the minimum room
temperature shall not be required provided that the heating system is operating
at its full design capacity. The winter outdoor design temperature for the
locality shall be as indicated in Appendix D of the IPC.
4. Section 602.3 Occupiable work spaces. Indoor occupiable
work spaces shall be supplied with heat during the period from October 1 to May
15 to maintain a minimum temperature of 65°F (18°C) during the period the
spaces are occupied.
Exceptions:
1. Processing, storage, and operation areas that require
cooling or special temperature conditions.
2. Areas in which persons are primarily engaged in vigorous
physical activities.
5. Section 602.4 Cooling supply. Every owner and operator of a
Group R-2 apartment building who rents, leases, or lets one or more dwelling
units, rooming units, or guestrooms on terms, either expressed or implied, to
furnish cooling to the occupants thereof shall supply cooling during the period
from May 15 to October 1 to maintain a temperature of not more than 80°F
(27°C) 77°F (25°C) in all habitable rooms. The code official may
also consider modifications as provided in Section 104.5.2 when requested for
unusual circumstances or may issue notice approving building owners to convert
shared heating and cooling piping HVAC systems 14 calendar days before or after
the established dates when extended periods of unusual temperatures merit
modifying these dates.
Exception: When the outdoor temperature is higher than the
summer design temperature for the locality, maintenance of the room temperature
shall not be required provided that the cooling system is operating at its full
design capacity. The summer outdoor design temperature for the locality shall
be as indicated in the IECC.
6. Section 603.1 Mechanical equipment and appliances. Required
or provided mechanical equipment, appliances, fireplaces, solid fuel-burning
appliances, cooking appliances, chimneys, vents, and water heating appliances
shall be maintained in compliance with the code under which the appliances,
system, or equipment was installed, kept in safe working condition, and capable
of performing the intended function.
7. Section 603.2 Removal of combustion products. Where
required by the code under which installed, fuel-burning equipment and
appliances shall be connected to an approved chimney or vent.
8. Section 603.5 Combustion air. Where required by the code
under which installed, a supply of air for complete combustion of the fuel
shall be provided for the fuel-burning equipment.
9. Section 604.1 Electrical system. Required or provided
electrical systems and facilities shall be maintained in accordance with the
applicable building code.
10. Section 604.3 Electrical system hazards. Where it is found
that the electrical system in a structure constitutes a hazard to the occupants
or the structure by reason of deterioration or damage or for similar reasons,
the code official shall require the defects to be corrected to eliminate the
hazard.
11. Section 604.3.1.1 Electrical equipment. Electrical
distribution equipment, motor circuits, power equipment, transformers, wire,
cable, flexible cords, wiring devices, ground fault circuit interrupters, surge
protectors, molded case circuit breakers, low-voltage fuses, luminaires,
ballasts, motors, and electronic control, signaling, and communication
equipment that have been exposed to water shall be replaced in accordance with
the provisions of the VCC.
Exception: The following equipment shall be allowed to be
repaired or reused where an inspection report from the equipment manufacturer,
an approved representative of the equipment manufacturer, a third party
licensed or certified electrician, or an electrical engineer indicates that the
exposed equipment has not sustained damage that requires replacement:
1. Enclosed switches, rated 600 volts or less;
2. Busway, rated 600 volts or less;
3. Panelboards, rated 600 volts or less;
4. Switchboards, rated 600 volts or less;
5. Fire pump controllers, rated 600 volts or less;
6. Manual and magnetic motor controllers;
7. Motor control centers;
8. Alternating current high-voltage circuit breakers;
9. Low-voltage power circuit breakers;
10. Protective relays, meters, and current transformers;
11. Low-voltage and medium-voltage switchgear;
12. Liquid-filled transformers;
13. Cast-resin transformers;
14. Wire or cable that is suitable for wet locations and whose
ends have not been exposed to water;
15. Wire or cable, not containing fillers, that is suitable
for wet locations and whose ends have not been exposed to water;
16. Luminaires that are listed as submersible;
17. Motors; or
18. Electronic control, signaling, and communication
equipment.
12. 604.3.2.1 Electrical equipment. Electrical switches,
receptacles and fixtures, including furnace, water heating, security system and
power distribution circuits, that have been exposed to fire shall be replaced
in accordance with the provisions of the Virginia Construction Code.
Exception: Electrical switches, receptacles and fixtures that
shall be allowed to be repaired or reused where an inspection report from the
equipment manufacturer or an approved representative of the equipment
manufacturer, a third party licensed or certified electrician, or an electrical
engineer indicates that the equipment has not sustained damage that requires
replacement.
13. Section 605.1 Electrical components. Electrical equipment,
wiring, and appliances shall be maintained in accordance with the applicable
building code.
14. Section 605.2 Power distribution and receptacles. Required
or provided power circuits and receptacles shall be maintained in accordance
with the applicable building code, and ground fault and arc-fault circuit
interrupter protection shall be provided where required by the applicable
building code. All receptacle outlets shall have the appropriate faceplate
cover for the location when required by the applicable building code.
15. Section 605.3 Lighting distribution and luminaires. Required
or provided lighting circuits and luminaires shall be maintained in accordance
with the applicable building code.
16. Section 605.4 Flexible cords. Flexible cords shall not be
run through doors, windows, or cabinets or concealed within walls, floors, or
ceilings.
17. Section 606.1 General. Elevators, dumbwaiters, and
escalators shall be maintained in compliance with ASME A17.1. The most current
certificate of inspection shall be on display at all times within the elevator
or attached to the escalator or dumbwaiter, be available for public inspection
in the office of the building operator, or be posted in a publicly conspicuous
location approved by the code official. Where not displayed in the elevator or
attached on the escalator or dumbwaiter, there shall be a notice of where the
certificate of inspection is available for inspection. An annual periodic
inspection and test is required of elevators and escalators. A locality shall
be permitted to require a six-month periodic inspection and test. All periodic
inspections shall be performed in accordance with Section 8.11 of ASME A17.1.
The code official may also provide for such inspection by an approved agency or
through agreement with other local certified elevator inspectors. An approved
agency includes any individual, partnership, or corporation who has met the
certification requirements established by the VCS.
C. Add the following sections to Chapter 6 of the IPMC:
1. Section 602.2.1 Prohibited use. In dwelling units subject
to Section 602.2, one or more unvented room heaters shall not be used as the
sole source of comfort heat in a dwelling unit.
2. Section 607.2 Clothes dryer exhaust duct. Required or
provided clothes dryer exhaust systems shall be maintained in accordance with
the applicable building code.
VA.R. Doc. No. R19-5869; Filed May 14, 2019, 4:47 p.m.
TITLE 13. HOUSING
VIRGINIA MANUFACTURED HOUSING BOARD
Final Regulation
Title of Regulation: 13VAC6-20. Manufactured Housing
Licensing and Transaction Recovery Fund Regulations (amending 13VAC6-20-10, 13VAC6-20-30,
13VAC6-20-50, 13VAC6-20-60, 13VAC6-20-80, 13VAC6-20-90, 13VAC6-20-100,
13VAC6-20-170, 13VAC6-20-320).
Statutory Authority: § 36-85.18 of the Code of Virginia.
Effective Date: July 1, 2019.
Agency Contact: Kyle Flanders, Senior Policy Analyst,
Department of Housing and Community Development, 600 East Main Street, Suite
300, Richmond, VA 23219, telephone (804) 786-6761, FAX (804) 371-7090, TTY
(804) 371-7089, or email kyle.flanders@dhcd.virginia.gov.
Summary:
The amendments include (i) clarifying the parameters for
warranties on manufactured homes, (ii) eliminating unnecessary individual
biographical information of license applicants, (iii) expanding the list of
specific items that must be included on a sales contract, and (iv) providing
when and what disclosures must be given to buyers.
Summary of Public Comments and Agency's Response: No
public comments were received by the promulgating agency.
Part I
General
13VAC6-20-10. Definitions.
The following words and terms when used in this chapter shall
have the following meanings unless the context clearly indicates otherwise.
"Board" means the Virginia Manufactured Housing
Board.
"Buyer" means the person who purchases at retail
from a dealer or manufacturer a manufactured home for personal use as a
residence or other related use.
"Claimant" means any person who has filed a
verified claim under Chapter 4.2 (§ 36-85.16 et seq.) of Title 36 of the
Code of Virginia.
"Code" means the appropriate standards of the
Virginia Uniform Statewide Building Code (13VAC5-63) and the
Manufactured Home Safety Regulations (13VAC5-95) adopted by the Board of
Housing and Community Development and administered by the Department of Housing
and Community Development pursuant to the National Manufactured Housing
Construction and Safety Standards Act of 1974 (42 USC § 5401 et seq.)
for manufactured homes.
"Controlling financial interest" means the direct
or indirect ownership or control of a firm.
"Date of delivery" means the date on which all
terms or conditions of the sales contract agreed to or required of the regulant
have been completed.
"Dealer/manufacturer sales agreement" means a
written contract or agreement between a manufactured housing manufacturer and a
manufactured housing dealer whereby the dealer is granted the right to engage
in the business of offering, selling, and servicing new manufactured homes of a
particular line or make of the stated manufacturer of such line or make. The
term shall include any severable part [ or parts ] of such
sales agreement which separately provides for selling or servicing different
lines or makes of the manufacturer.
"Defect" means any deficiency in or damage to materials
or workmanship occurring in a manufactured home which has been reasonably
maintained and cared for in normal use. The term also means any failure of any
structural element, utility system or the inclusion of a component part of the
manufactured home which fails to comply with the Code.
"Department" means the Department of Housing and
Community Development.
"Director" means the Director of the Department of
Housing and Community Development, or his the director's
designee.
"Fund" or "recovery fund" means the
Virginia Manufactured Housing Transaction Recovery Fund.
"HUD" means the United States U.S.
Department of Housing and Urban Development.
"Imminent safety hazard" means a hazard that
presents an imminent and unreasonable risk of death or severe personal injury
that may or may not be related to failure to comply with an applicable federal
manufactured home construction or safety standard.
"Licensed" means the regulant has met all
applicable requirements of this chapter, paid all required fees, and been
authorized by the board to manufacture or offer for sale or sell manufactured
homes in accordance with this chapter.
"Manufactured home" means a structure constructed
to federal standards, transportable in one or more sections, which, in the
traveling mode is eight feet or more in width and is 40 feet or more in length,
or when erected on site, is 320 or more square feet, and which is built on a
permanent chassis and designed to be used as a dwelling with or without a
permanent foundation when connected to the required utilities, and includes the
plumbing, heating, air conditioning, and electrical systems contained therein.
"Manufactured home broker" or "broker"
means any person, partnership, association or corporation, resident or
nonresident, who, for compensation or valuable consideration, sells or offers
for sale, buys or offers to buy, negotiates the purchase or sale or exchange,
or leases or offers to lease used manufactured homes that are owned by a party
other than the broker.
"Manufactured home dealer" or "dealer"
means any person engaged in the business of buying, selling, or dealing
in manufactured homes or offering or displaying manufactured homes for sale in
Virginia. Any person who buys, sells, or deals in three or more manufactured
homes in any 12-month period shall be presumed to be a manufactured home
dealer. The terms "selling" and "sale" include lease-purchase
transactions. The term "manufactured home dealer" does not include
banks and finance companies that acquire manufactured homes as an incident to
their regular business.
"Manufactured home manufacturer" or
"manufacturer" means any persons, resident or nonresident, who manufacture
or assemble manufactured homes for sale in Virginia.
"Manufactured home salesperson" or
"salesperson" means any person who for compensation or valuable
consideration is employed either directly or indirectly by, or affiliated as an
independent contractor with, a manufactured home dealer to sell or offer to
sell; or to buy or offer to buy; or to negotiate the purchase, sale or
exchange; or to lease or offer to lease new or used manufactured homes.
"New manufactured home" means any manufactured home
that (i) has not been previously sold except in good faith for the purpose of
resale, (ii) has not been previously occupied as a place of habitation, (iii)
has not been previously used for commercial purposes such as offices or
storage, and (iv) has not been titled by the Virginia Department of Motor
Vehicles and is still in the possession of the original dealer. If the home is
later sold to another dealer and then sold to a consumer within two years of
the date of manufacture, the home is still considered new and must continue to
meet all state warranty requirements. However, if a home is sold from the
original dealer to another dealer and it is more than two years after the date
of manufacture, and it is then sold to a consumer, the home must be sold as
"used" for warranty purposes. Notice of the "used" status
of the manufactured home and how this status affects state warranty
requirements must be provided, in writing, to the consumer prior to the closing
of the sale.
"Person" means any individual, natural person,
firm, partnership, association, corporation, legal representative, or other
recognized legal entity.
"Regulant" means any person, firm, corporation,
association, partnership, joint venture, or any other legal entity required by
Chapter 4.2 (§ 36-85.16 et seq.) of Title 36 of the Code of Virginia to be
licensed by the board.
"Regulations" or "these regulations"
means this chapter, the Virginia Manufactured Housing Licensing and
Transaction Recovery Fund Regulations.
"Reinstatement" means having a license restored to
effectiveness after the expiration date has passed or license has been revoked
or not renewed by the board.
"Relevant market area" means the geographical area
established in the dealer/manufacturer sales agreement and agreed to by both
the dealer and the manufacturer in the agreement.
"Renewal" means continuing the effectiveness of a
license for another period of time.
"Responsible management" means the following
individuals:
1. The sole proprietor of a sole proprietorship;
2. The partners of a general partnership;
3. The managing partners of a limited partnership;
4. The officers of a corporation;
5. The managers of a limited liability company;
6. The officers or directors of an association or both; and
7. Individuals in other business entities recognized under the
laws of the Commonwealth as having a fiduciary responsibility to the firm.
"Responsible party" means a manufacturer, dealer,
or supplier of manufactured homes.
"Set-up" means the operations performed at the
occupancy site which render a manufactured home fit for habitation. Such
operations include, but are not limited to, transportation, positioning,
blocking, leveling, supporting, anchoring, connecting utility systems, making
minor adjustments, or assembling multiple or expandable units. Such operations
do not include lawful transportation services performed by public utilities
operating under certificates or permits issued by the State Corporation
Commission.
"Standards" means the Federal Manufactured Home
Construction and Safety Standards adopted by the U.S. Department of Housing and
Urban Development.
"Statement of Compliance" means the statement found
on the initial license application and on the renewal application, that
the regulant licensed by the board will comply with the Manufactured Housing
Licensing and Transaction Recovery Fund Law, this chapter, and the
orders of the board.
"Substantial identity of interest" means (i) a
controlling financial interest by the individual or corporate principals of the
manufactured home broker, dealer, or manufacturer whose license has been
revoked or not renewed for cause by the board or (ii) substantially identical
principals or officers as the manufactured home broker, dealer, or manufacturer
whose license has been revoked or not renewed for cause by the board.
"Supplier" means the original producers of
completed components, including refrigerators, stoves, water heaters,
dishwashers, cabinets, air conditioners, heating units, and similar components,
and materials such as floor coverings, paneling, siding, trusses, and similar
materials, which are furnished to a manufacturer or a dealer for installation
in the manufactured home prior to sale to a buyer.
"Used manufactured home" means any manufactured
home other than a new home as defined in this section.
"Warranty" means any written assurance of the
manufacturer, dealer, or supplier or any promise made by a regulant in
connection with the sale of a manufactured home that becomes part of the basis
of the sale. The term "warranty" pertains to the obligations of the
regulant in relation to materials, workmanship, and fitness of a manufactured
home for ordinary and reasonable use of the home for the term of the promise or
assurance.
13VAC6-20-30. Application for licensing; renewal.
A. Application for license or renewal shall be on forms
supplied by the department and may be submitted as designated in hard copy or
by electronic means. All information required on the form shall be furnished by
the applicant for the board's review.
B. Each application for original licensure shall be
accompanied by the following:
1. Deposit in the Transaction Recovery Fund required by
13VAC6-20-420 A 1.
2. Licensing fee required by 13VAC6-20-200 A 1.
3. Copy of the manufacturer's homeowner and installation manual
or manuals.
4. Statement of Compliance compliance.
5. List of salespeople licensed in Virginia with the
following biographical information for each:.
Date of birth
Sex
Weight
Height
Eye/hair color
C. The Department of Housing and Community Development will
mail a notice of renewal to the licensee at the last known address of record.
Licensees may submit renewals by mail or electronically. Failure to
receive this notice shall not relieve the licensee of the obligation to
renew. If the licensee does not receive the notice of renewal, a copy of
the license may be substituted with the required fee. Each application for
renewal shall be accompanied by the following:
1. Licensing fee required by 13VAC6-20-200 A 2.
2. If revised, a copy of the revised homeowner and
installation manual or manuals.
3. Statement of Compliance compliance.
4. Updated list of salespeople employed.
Article 2
Dealers
13VAC6-20-50. License required; annual renewal.
A. Any person located in or outside of the Commonwealth
buying or selling or offering or displaying manufactured homes for sale in
Virginia and meeting the definition of a dealer in 13VAC6-20-10 shall apply to
the board for a license. The license shall be displayed in a conspicuous place
accessible to the public in the office of the business location. The license
shall be issued for a term of one year from the date of issuance.
B. Each licensed dealer shall apply for license renewal
annually, by application and accompanied by the required fee. Applicants
for license renewal shall meet all the criteria for original licensing. Upon
failure to renew, the license shall automatically expire.
C. Should the department fail to receive a licensed dealer's
renewal form and appropriate fee within 30 days of the license expiration date,
the dealer shall be required to reinstate the license according to the terms
and conditions of Article 8 (13VAC6-20-201 et seq.) of this part.
D. For licensing purposes, a dealer operating more than one
retail location shall have each location treated as a separate entity and shall
adhere to all requirements for dealer licensing including posting a license at
each location.
E. Each dealer licensed under this chapter shall also obtain
a certificate of dealer registration from the Virginia Department of
Motor Vehicles Vehicle Dealer Board (MVDB). The certificate of
registration shall be renewed annually and shall be maintained in effect with
the Department of Motor Vehicles MVDB as long as the dealer is
licensed under this chapter.
13VAC6-20-60. Application for licensing; renewal.
A. Application for license or renewal shall be on forms
supplied by the department and may be submitted as designated in hard copy or
by electronic means. All information required on the form shall be furnished by
the applicant for the board's review.
B. Each application for original licensure shall be
accompanied by the following:
1. Deposit in the Transaction Recovery Fund required by
13VAC6-20-420 A 2.
2. Licensing fee required by 13VAC6-20-200 A 3.
3. Statement of Compliance compliance.
4. Verification of a business office with all utilities,
including a business telephone, and where the required business records are
maintained.
5. Verification of a permanent business sign, in view of
public traffic, bearing the name of the firm.
6. List of salespeople employed with the following
biographical information for each:.
Date of Birth
Sex
Weight
Height
Eye/hair color
7. Name of the owner, principal, manager, agent, or
other person designated as the holder of the dealer's license for the specific
location and the names of other partners or principals in the dealership.
Photographs of the front of the business office and required
sign may be considered as verification required by this subsection.
C. The Department of Housing and Community Development will
mail a notice of renewal to the licensee at the last known address of record.
Licensees may submit renewals by mail or electronically. Failure to receive
this notice shall not relieve the licensee of the obligation to renew. If the
licensee does not receive the notice of renewal, a copy of the license may be
substituted with the required fee. Each application for renewal shall be
accompanied by the following:
1. Licensing fee required by 13VAC6-20-200 A 4.
2. Statement of Compliance compliance.
3. Notification of any significant changes to the office or
the business sign.
4. Updated list of salespeople employed.
5. Any changes of officers or directors of the company or
corporation.
6. A copy of the dealer's current certificate of registration
from the Department of Motor Vehicles Virginia Motor Vehicle Dealer
Board.
D. Any change in the form of ownership of the dealer or any
changes (deletions or additions) in the partners or principals of the dealer
shall be submitted to the board with an application and fee for a new license.
If the new owner or owners assume the liabilities of the previous owner or
owners, then a new recovery fund assessment is not required. New recovery
fund assessments shall be required when the new owner or owners do does
not assume the liabilities of the previous owner or owners. The board
shall be notified immediately by the dealer of any change in the operating name
of the dealer. The director shall endorse the change on the license without
requiring an additional fee. The board shall be notified immediately by the
dealer of any change in the location of the dealer. The dealer shall pay a fee
of $50 for the change of location on the license, but shall not be
required to pay an additional assessment to the recovery fund for the change of
location only.
13VAC6-20-80. Dealer responsibility for inspections; other
items.
A. The dealer shall inspect every new manufactured home unit
upon delivery from a manufacturer. If a dealer becomes aware of a noncompliance
or an imminent safety hazard in a manufactured home, the dealer shall contact
the manufacturer, provide full information concerning the problem, and request
appropriate action by the manufacturer. No dealer shall sell a new manufactured
home if he becomes aware that it contains a noncompliance defect
or an imminent safety hazard.
B. The dealer shall inspect every new manufactured home unit
prior to selling to determine that all items of furniture, appliances,
fixtures, and devices are not damaged and are in place and operable.
C. A dealer shall not alter or cause to be altered any
manufactured home to which a HUD label has been affixed if such alteration or
conversion causes the manufactured home to be in violation of the standards.
D. If the dealer provides for the installation of any
manufactured home he the dealer sells, the dealer shall be
responsible for making sure the installation of the home meets the
manufacturer's installation requirements and the Code.
E. On each home sold by the dealer, the dealer shall collect
the applicable title fees and title tax for the manufactured home, to include
an additional $30 inspection/administrative fee, and forward such fees and
taxes to the Virginia Department of Motor Vehicles.
The above fees shall be submitted to the Virginia Department
of Motor Vehicles within 30 days from the completion date of the sale.
F. On each home sold by the dealer, the dealer shall provide
the owner with information to file a claim supplied by the department.
Article 3
Brokers
13VAC6-20-90. License required; annual renewal.
A. Any person located in or outside of the Commonwealth (i)
buying or selling, negotiating the purchase or sale or exchange of, or leasing
used manufactured homes and (ii) meeting the definition of broker in
13VAC6-20-10 shall apply to the board for a license. The license shall be
displayed in a conspicuous place accessible to the public in the office of the
business location. The license shall be issued for a term of one year from the
date of issuance.
B. Each licensed broker shall apply for license renewal
annually, by application and accompanied by the required fee. Applicants
for license renewal shall meet all the criteria for original licensing. Upon
failure to renew, the license shall automatically expire.
C. Should the department fail to receive a licensed broker's
renewal form and appropriate fee within 30 days of the license expiration date,
the broker shall be required to reinstate the license according to the terms
and conditions of Article 8 (13VAC6-20-201 et seq.) of this part.
D. For licensing purposes, a broker operating more than one
business location shall have each location treated as a separate entity and
shall adhere to all requirements for broker licensing, including posting a
license, at each location.
E. Each broker licensed under this chapter shall also obtain
a certificate of dealer registration from the Virginia Department of
Motor Vehicles Vehicle Dealer Board (MVDB). The certificate of
registration shall be renewed annually and shall be maintained in effect with
the Department of Motor Vehicles MVDB as long as the broker is
licensed under this chapter.
13VAC6-20-100. Application for licensing; renewal.
A. Application for license or renewal shall be on forms
supplied by the department and may be submitted as designated in hard copy or
by electronic means. All information required on the form shall be furnished by
the applicant for the board's review.
B. Each application for original licensure shall be
accompanied by the following:
1. Deposit in the Transaction Recovery Fund required by
13VAC6-20-420 A 3.
2. Licensing fee required by 13VAC6-20-200 A 5.
3. Statement of Compliance compliance.
4. Verification of a business office with all utilities,
including a business telephone, and where the required business records are
maintained.
5. Verification of a permanent business sign, in view of
public traffic, bearing the name of the firm.
6. Name of the owner, principal, manager, agent or other person
designated as the holder of the broker's license for the specific location and
the names of the partners or principals in the broker's firm.
7. List of salespeople employed with the following
biographical information for each:.
Date of birth
Sex
Weight
Height
Eye/hair color
Photographs of the front of the business office and required
sign may be considered as verification required by this subsection.
C. The Department of Housing and Community Development will
mail a notice of renewal to the licensee at the last known address of
record. Licensees may submit renewals by mail or electronically.
Failure to receive this notice shall not relieve the licensee of the obligation
to renew. If the licensee does not receive the notice of renewal, a copy
of the license may be substituted with the required fee. Each application for
renewal shall be accompanied by the following:
1. Licensing fee required by 13VAC6-20-200 A 6.
2. Statement of Compliance compliance.
3. Notification of any significant changes to the office or
the business sign.
4. Any changes of officers or directors of the company or
corporation.
5. A copy of the broker's current certificate of registration
from the Department of Motor Vehicles Virginia Motor Vehicle Dealer
Board.
6. Updated list of salespeople employed.
D. Any change in the form of ownership of the broker or any
changes (deletions or additions) in the partners or principals of the broker
shall be submitted to the board with an application and fee for a new license.
If the new owner(s) owner assume the liabilities of the previous owner(s)
owner, then a new recovery fund assessment is not required. New recovery
fund assessments shall be required when the new owner(s) do owner
does not assume the liabilities of the previous owner(s) owner.
The board shall be notified immediately by the broker of any
change in the operating name of the broker. The director shall endorse the
change on the license without requiring an additional fee. The board shall be
notified immediately by the broker of any change in location of the broker. The
broker shall pay a fee of $50 for the change of location on the license,
but shall not be required to pay an additional assessment to the recovery fund
for the change of location only.
Article 6
Violations and Hearings
13VAC6-20-170. Prohibited conduct; grounds for denying,
suspending or revoking license.
A. The following acts by regulants are prohibited and may be
considered by the board as grounds for action against the regulant:
1. Engaging in business as a manufactured home manufacturer,
dealer, or broker without first obtaining a license from the board.
2. Engaging in business as a manufactured home salesperson
without first applying to the board for a license.
3. Making a material misstatement in an application for
license.
4. Failing to pay a required assessment to the Transaction
Recovery Fund.
5. Failing to comply with the warranty service obligations and
claims procedures required by this chapter.
6. Failing to comply with the set-up and tie-down requirements
of the Code.
7. Knowingly failing or refusing to account for or pay over
money or other valuables belonging to others which have come into the
regulant's possession due to the sale of a manufactured home.
8. Using unfair methods of competition or unfair or deceptive
commercial acts or practices.
9. Failing to comply with the advertising provisions in Part
IV of this chapter (13VAC6-20-270 et seq.) of this chapter.
10. Defrauding any buyer to the buyer's damage, and any other
person in the conduct of the regulant's business.
11. Employing an unlicensed salesperson.
12. Knowingly offering for sale a manufactured home produced
by a manufacturer which that is not licensed as a manufacturer
under this chapter.
13. Knowingly selling a manufactured home to a dealer who is
not licensed as a dealer under this chapter.
14. Failing to appear before the board upon due notice.
15. Failing to comply with orders issued by the board pursuant
to this chapter.
16. Failing to renew a license and continuing to engage in
business as a manufacturer, dealer, broker, or salesperson after the
expiration of any license.
17. A salesperson selling, exchanging, or offering to
sell or exchange a manufactured home for any dealer or broker other than the
licensed dealer or broker employing the salesperson.
18. A salesperson offering, transferring, or assigning
any negotiated sale or exchange of a manufactured home to another dealer,
broker, manufacturer, or salesperson.
19. Failing to comply with the Statement statement
of Compliance compliance.
20. Failing to notify the board of a change of location or
address of the business office.
21. Failing to comply with any provisions of this chapter.
a. The board may revoke or deny renewal of an existing license
or refuse to issue a license to any manufactured home broker, dealer,
manufacturer, or salesperson who is shown to have a substantial identity of
interest with a manufactured home broker, dealer, or manufacturer whose license
has been revoked or not renewed by the board.
b. Any person whose license is revoked or not renewed for
cause by the board shall not be eligible for a license under any circumstances
or under any name, except as provided by regulations of the board pursuant to § 36-85.18
of the Code of Virginia.
22. Failing to comply with the regulations of state or federal
agencies regarding the financing, titling, taxation, or transporting of
manufactured homes.
23. Failing to perform a written contract between the
regulant and seller or buyer that contains the following minimum requirements:
a. A statement of the total cost of the contract and the
amounts, including specific statement on the cost of the home, any additional
costs for work to be performed, and the amount of the down payment, taxes, and
titling fees.
b. A listing of specified materials and work to be
performed and who is to supply the materials and perform that work.
c. Contract to identify the business name as shown on the
license issued per this chapter and to include the address and the phone number
of the business.
d. Specify the make and model of the home.
e. Specify if the home is new or used.
f. Specify the length and width of the home as defined by
the HUD Standards.
g. Specify the date of manufacture and the serial number,
except when the home is specially ordered from the manufacturer for the buyer
and this information is not known.
24. Failing to provide a statement notifying consumers of
the limitations on damages retained by dealer disclosure to the buyer.
25. Failing to provide a statement notifying consumers of
the dispute resolution program available to resolve disputes concerning defects
in manufactured homes.
B. The board may deny, suspend, revoke, or refuse to
renew or reinstate the license of a regulant because of, but not limited to,
one or more of the following grounds:
1. Having had a license previously denied, revoked, or
suspended under this chapter.
2. Having a license denied, suspended, or revoked by a
similar licensing entity in another state.
3. Engaging in conduct in another state which that
would have been a violation of this chapter if the actions were committed in
Virginia.
4. Failing to obtain a required certification of registration
from the Department of Motor Vehicles Vehicle Dealer Board
(MVDB), failing to renew the annual certificate of registration from the
MVDB, or having the certificate of registration suspended or revoked by the
Department of Motor Vehicles MVDB.
5. Having been convicted or found guilty in any jurisdiction
of a felony.
13VAC6-20-320. Duration of warranties.
All warranties provided by regulants as required by
13VAC6-20-310 shall be for a period of not less than 12 months, measured
from the date of delivery of the home to the buyer. The date of delivery
shall be the date on which all terms or conditions of the sales contract agreed
to or required of the regulant have been completed.
NOTICE: The forms used in administering the regulation were
filed by the agency. The forms are not being published; however, online users
of this issue of the Virginia Register of Regulations may click on the
accompanying web address to access the online forms. Contact the State Building
Codes office, (804) 371-7060 or sbco@dhcd.virginia.gov, with questions regarding the online application.
FORMS (13VAC6-20)
Complete license registration
application forms for broker, dealer, manufacturer, salesperson, and special licensing online at
https://dmz1.dhcd.virginia.gov/BFR/Main/LogOn.aspx.
VA.R. Doc. No. R17-5104; Filed May 1, 2019, 3:25 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
VIRGINIA BOARD FOR ASBESTOS, LEAD, AND HOME INSPECTORS
Final Regulation
Title of Regulation: 18VAC15-20. Virginia Asbestos
Licensing Regulations (amending 18VAC15-20-10, 18VAC15-20-20,
18VAC15-20-33, 18VAC15-20-52, 18VAC15-20-53, 18VAC15-20-454, 18VAC15-20-456,
18VAC15-20-459.4; adding 18VAC15-20-33.1, 18VAC15-20-33.2, 18VAC15-20-456.1).
Statutory Authority: §§ 54.1-201 and 54.1-501 of
the Code of Virginia.
Effective Date: September 1, 2019.
Agency Contact: Trisha Henshaw, Executive Director,
Virginia Board for Asbestos, Lead, and Home Inspectors, 9960 Mayland Drive,
Suite 400, Richmond, VA 23233, telephone (804) 367-8595, FAX (866) 350-5354, or
email alhi@dpor.virginia.gov.
Summary:
The amendments (i) clarify requirements for entities
required to obtain a license for asbestos-related work by amending the
definition of "person," the licensure requirements for asbestos
analytical laboratories with multiple locations, the asbestos firm entry
requirements for consistency with other similar regulations applicable to
firms, and the information applicants need to be licensed; (ii) specify that
firm licenses may not be transferred and are valid only so long as the business
entity holding the license is in existence and when asbestos analytical
laboratories must notify the board of changes to responsible personnel and
types of analysis performed at laboratory locations; (iii) expand the responsibilities
of asbestos project monitors to include changes to air sample reporting
requirements; and (iv) add language (a) detailing specific entry requirements
for asbestos contractors and asbestos analytical laboratories, respectively and
(b) pertaining to conduct during onsite analysis.
Amendments since publication of the proposed regulation
clarify that to qualify for onsite phase contrast microscopy analysis a
laboratory must maintain a training and quality control document demonstrating
the competency of each onsite analyst who performs onsite analysis.
Summary of Public Comments and Agency's Response: No
public comments were received by the promulgating agency.
Part I
Scope
18VAC15-20-10. Scope.
The purpose of this section is to identify individuals and
firms persons, as defined in 18VAC15-20-20, who need to be licensed.
Asbestos Contractor's License: Required for firms that
contract with another person, for compensation, to carry out an asbestos
abatement project that exceeds 10 linear or 10 square feet.
Asbestos Worker's License: Required for individuals who remove
or otherwise engage in an asbestos project.*
Asbestos Supervisor's License: Required for individuals who
supervise an asbestos abatement project. The Commonwealth of Virginia National
Emission Standards for Hazardous Air Pollutants (NESHAP) Program recognizes the
"competent person" as an individual licensed under this
classification.*
Asbestos Inspector's License: Required for individuals who
inspect buildings to identify asbestos-containing material.*
Asbestos Management Planner's License: Required for
individuals who prepare or update an asbestos management plan.*
Asbestos Project Monitor's License: Required for individuals
who act as a project monitor on asbestos abatement sites. Project monitors
who analyze Phase Contrast Microscopy (PCM) asbestos air samples on an asbestos
abatement project shall be employed by a firm that holds a valid Virginia
Asbestos Analytical Laboratory license, and shall have National Institute of
Occupational Safety and Health (NIOSH) 582 training, or equivalent.
Asbestos Analytical Laboratory License: Required for firms
serving as laboratories that analyze air or bulk samples for the presence
of asbestos by Polarized Light Microscopy polarized light microscopy
(PLM), phase contrast microscopy (PCM), or Transmission
Electron Microscopy transmission electron microscopy (TEM). A
laboratory that has multiple locations shall obtain an asbestos analytical
laboratory license for the main office, and submit the remaining offices as
branch offices in accordance with this chapter.
Asbestos Project Designer's License: Required for individuals
who prepare or update an asbestos abatement project design, specifications for
asbestos abatement projects, and addenda to the specifications.*
Accredited Asbestos Training Program: Required Approval
from the board is required for those who offer asbestos training programs
to individuals seeking licensure as an asbestos worker, supervisor, inspector,
management planner, project monitor or project designer.
*Employees who conduct asbestos response actions, inspections,
prepare management plans or project designs for their employer, on property
owned or leased by the employer, are exempt from Virginia asbestos licensure;
however, they are required to meet all OSHA and EPA training requirements.
Part II
Definitions and General
18VAC15-20-20. Definitions.
The following words and terms when used in this chapter shall
have the following meanings unless the context clearly indicates otherwise:
"AAR" means the Asbestos Analyst Analysts
Registry program offered by the AIHA Registry Programs.
"AAT" means Asbestos Analyst Testing.
[ "ACM" means asbestos-containing material. ]
"Accredited asbestos training program" means a training
program that has been approved by the board to provide training for individuals
to engage in asbestos abatement, conduct asbestos inspections, prepare
management plans, prepare project designs or act as a project monitor.
"Accredited asbestos training provider" means a
firm or individual who has been approved by the board to offer an accredited
asbestos training program.
"AHERA" means Asbestos Hazard Emergency Response
Act, 40 CFR Part 763, Subpart E.
"AIHA" means American Industrial Hygiene Association.
"Approval letter" means a written notice confirming
the firm or individual applicant's licensure or accreditation by the board.
"Asbestos" means the asbestiform varieties of
actinolite, amosite, anthophyllite, chrysotile, crocidolite, and tremolite.
"Asbestos Analytical Laboratory License" means an
authorization issued by the board to perform phase contrast, polarized light,
or transmission electron microscopy on material known or suspected to contain
asbestos.
"Asbestos-containing material" or "ACM"
means any material or product which contains more than 1.0% asbestos or such
percentage as established by EPA final rule.
"Asbestos contractor" means any person who has met
the board's requirements and has been issued an asbestos contractor's license
by the board to enter into contracts to perform asbestos projects.
"Asbestos Contractor's License" means an
authorization issued by the board permitting a person to enter into contracts
to perform an asbestos abatement project.
"Asbestos inspector" means any person who performs
an inspection as defined in this chapter.
"Asbestos Inspector's License" means an
authorization issued by the board permitting a person to perform on-site
onsite investigations to identify, classify, record, sample, test and
prioritize by exposure potential asbestos-containing materials.
"Asbestos Management Plan" means a program designed
to control or abate any potential risk to human health from asbestos.
"Asbestos management planner" means any person
preparing or updating a management plan.
"Asbestos Management Planner's License" means an
authorization issued by the board permitting a person to prepare or update an
asbestos management plan.
"Asbestos project" or "asbestos abatement
project" means an activity involving job set-up for containment, removal,
encapsulation, enclosure, encasement, renovation, repair, construction or
alteration of asbestos-containing materials. An asbestos project or asbestos
abatement project shall not include nonfriable asbestos-containing roofing,
flooring and siding material which when installed, encapsulated or removed does
not become friable.
"Asbestos project design" means any descriptive
form written as instructions or drafted as a plan describing the construction
of an asbestos abatement area or site, response action or work practices to be
utilized on the asbestos abatement project.
"Asbestos project designer" means any person
providing an asbestos project design or specifications for an asbestos abatement
project.
"Asbestos Project Designer's License" means an
authorization issued by the board permitting a person to design an asbestos
abatement project.
"Asbestos project monitor" means any person hired
by a building owner, lessee or his agent to monitor, inspect, provide visual
clearance or clearance monitoring of an asbestos abatement project.
"Asbestos Project Monitor's License" means an
authorization issued by the board permitting a person to monitor an asbestos
project, subject to board regulations.
"Asbestos supervisor" means any person so
designated by an asbestos contractor who provides on-site onsite
supervision and direction to the workers engaged in asbestos projects.
"Asbestos Supervisor's License" means an
authorization issued by the board permitting an individual to supervise and
work on an asbestos project.
"Asbestos worker" means any person who engages in
an asbestos abatement project.
"Asbestos Worker's License" means an authorization
issued by the board permitting an individual to work on an asbestos project.
"ASHARA" means Asbestos School Hazard Abatement
Reauthorization Act, 40 CFR Part 763, Subpart E.
"BAPAT" means the Bulk Asbestos Proficiency
Analytical Testing Program of the AIHA Proficiency Analytical Testing Programs.
"Board" means the Virginia Board for Asbestos,
Lead, and Home Inspectors.
"Department" means the Department of Professional
and Occupational Regulation.
"Direct supervision" means a licensed or accredited
inspector, management planner, project monitor or project designer, who
undertakes to supervise the activities of an unlicensed inspector, management
planner, project monitor or project designer, shall be physically present on
the premises at all times while any unlicensed inspector, management planner,
project monitor or project designer under his supervision is engaged in the
activities of an inspector, management planner, project monitor or project
designer.
"Director" means the Director of the Department of
Professional and Occupational Regulation.
"Employee" means all persons in the service of
another under any contract of hire, express or implied, oral or written.
"Encapsulation" means the treatment of
asbestos-containing material (ACM) with a material that surrounds or embeds
asbestos fibers in an adhesive matrix to prevent the release of fibers, as the
encapsulant creates a membrane over the surface (bridging encapsulant) or
penetrates the material and binds its components together (penetrating
encapsulant).
"Encasement" means any process by which an asbestos-containing
material (ACM) is sprayed with an insulating sealer which is then mechanically
fastened to the asbestos covered substrate. The insulating sealer is then
covered with a sealer to give structural strength and durability.
"Enclosure" means the construction or installation
over or around the asbestos-containing material (ACM) of any leak tight solid
or flexible coverings, which will not deteriorate or decompose for an extended
period of time, so as to conceal the ACM, contain ACM fibers, and render the
ACM inaccessible.
"Environmental remediation activity" means any
activity planned or carried out for the purpose of reducing or eliminating any
environmental hazard, including activities necessary to train individuals in
the proper or lawful conduct of such activities, which are regulated by federal
or state law or regulation.
"EPA" means United States U.S.
Environmental Protection Agency.
"Financial interest" means financial benefit
accruing to an individual or to a member of his immediate family. Such interest
shall exist by reason of (i) ownership in a business if the ownership exceeds
3.0% of the total equity of the business; (ii) annual gross income that
exceeds, or may be reasonably anticipated to exceed $1,000 from ownership in
real or personal property or a business; (iii) salary, other compensation,
fringe benefits, or benefits from the use of property, or any combination of
it, paid or provided by a business that exceeds or may be reasonably expected
to exceed $1,000 annually; (iv) ownership of real or personal property if the
interest exceeds $1,000 in value and excluding ownership in business, income,
salary, other compensation, fringe benefits or benefits from the use of
property.
"Firm" means any company, partnership, corporation,
sole proprietorship, association, or other business entity.
"Friable" means that the material when dry, may be
crumbled, pulverized or reduced to powder by hand pressure and includes
previously nonfriable material after such previously nonfriable material
becomes damaged to the extent that when dry it may be crumbled, pulverized, or
reduced to powder by hand pressure.
"Guest instructor" means an instructor who is
invited to instruct a specific topic or topics in an accredited asbestos
training program and whose instruction is limited to two hours per day.
"Hands-on experience" means the physical
participation of students in an asbestos training program. The physical
participation includes mock sampling and inspection techniques, report
preparation, writing project specifications, glovebag demonstrations and
containment construction.
"IHLAP" means the Industrial Hygiene Laboratory
Accreditation Program of the AIHA Laboratory Accreditation Programs, LLC.
"IHPAT" means the Industrial Hygiene Proficiency
Analytical Testing Program of the AIHA Proficiency Analytical Testing Programs
[ , LLC ].
"Immediate family" means (i) a spouse, (ii) a
sibling or step sibling, (iii) a parent or step parent, (iv) children or step
children, or (v) any other person residing in the same household as the
individual.
"Inspection" means an activity undertaken to
determine the presence or location, or to access the condition of, friable or
nonfriable asbestos-containing material (ACM) or suspected ACM, whether by
visual or physical examination, or by collecting samples of such material. This
term includes reinspections of friable and nonfriable known or assumed ACM that
has been previously identified. The term does not include the following:
1. Periodic surveillance of the type described in 40 CFR
763.92(b) solely for the purpose of recording or reporting a change in the
condition of known or assumed ACM;
2. Inspections performed by employees or agents of federal,
state, or local governments solely for the purpose of determining compliance
with applicable statutes or regulations; or
3. Visual inspections solely for the purpose of determining
completion of response actions.
"Instructor" means a person who instructs one or
more accredited asbestos training programs, to include the principal
instructor, but excluding guest instructors.
"Licensee" means any person, as [ "person"
is ] defined by § 54.1-500 of the Code of Virginia, who has been
issued and holds a currently valid license as an asbestos worker, asbestos
supervisor, asbestos inspector, asbestos management planner, asbestos project
designer, asbestos project monitor or asbestos contractor under this chapter.
"NIOSH" means National Institute of Occupational
Safety and Health.
"NIST" means National Institute of Standards and
Technology.
"NVLAP" means the Asbestos Fiber Analysis
Program of the National Institute of Standards and Technology National
Voluntary Laboratory Accreditation Program.
"Occupied" means any area of any building designed
or intended for human occupancy for any purpose.
"OSHA" means the U.S. Department of Labor
Occupational Safety and Health Administration.
"OSHA Class III Work" means repair and maintenance
operations where asbestos-containing material (ACM), including thermal system
insulation and surfacing material, is likely to be disturbed.
"PAT" means Proficiency Analytical Testing proficiency
analytical testing.
"PCM" means phase contrast microscopy.
"Person" means a corporation, partnership, sole
proprietorship, firm, enterprise, franchise, association or any other firm,
individual, or any other entity.
"PLM" means polarized light microscopy.
"Preliminary review" means a review conducted by
the department following the submission of training materials to ascertain if
the proposed asbestos training program meets the standards established by this
chapter.
"Principal instructor" means an instructor whose
main responsibility is to instruct accredited asbestos training programs,
supervise other instructors, and manage the overall asbestos training
program curriculum.
"Removal" means the physical removal of
asbestos-containing material (ACM) in accordance with all applicable
regulations.
"Renovation" means altering in any way, one or more
facility components.
"Repair" means returning damaged
asbestos-containing material (ACM) to an undamaged condition or to an intact
state so as to prevent fiber release.
"Residential buildings" means site-built homes,
modular homes, condominium units, mobile homes, manufactured housing, and
duplexes, or other multi-unit dwellings consisting of four units or fewer that
are currently in use or intended for use only for residential purposes.
"Response action" means any method, including
removal, encapsulation, enclosure, encasement, or operation and maintenance,
that protects human health and the environment from friable asbestos-containing
material.
"Responsible individual" means the employee,
officer, manager, owner, or principal of the firm who shall be designated by
each firm to ensure compliance with Chapter 5 (§ 54.1-500 et seq.) of
Title 54.1 of the Code of Virginia and all regulations of the board and to
receive communications and notices from the board that may affect the
firm. In the case of a sole proprietorship, the sole proprietor shall be
the responsible individual.
"Substantial change" means a change in overall
asbestos training program, materials, principal instructors, training managers,
directors, ownership, facilities, equipment, examinations, and certificates of
completion. The addition of updated regulations, exam questions or news
articles shall not be considered a substantial change.
"TEM" means transmission electron microscopy.
"Training manager" means the individual responsible
for administering a training program and monitoring the performance of the
instructors.
"Visual inspection" means a process of looking for
conditions [ , which that ] if not corrected during the
asbestos abatement project, will lead to residual asbestos-containing dust or
debris. Visual inspection includes examination of an asbestos abatement project
area prior to clearance air monitoring for evidence that the project has been successfully
completed as indicated by the absence of residue, dust and debris.
18VAC15-20-33. Qualifications General qualifications
for licensure—business entities licensure: firms.
A. General. Every business entity shall secure a license
before transacting business. Each firm applying for a license shall meet
the requirements of this section.
B. Name. The business name shall be disclosed on the
application. The name under which the entity conducts business and holds itself
out to the public (i.e., the trade or fictitious name) shall also be disclosed
on the application. Business entities The applicant shall
disclose the name under which the business entity conducts business and holds
itself out to the public. The firm shall register their trade or
fictitious names, when applicable, with the State Corporation Commission
or the clerk of the circuit court in the county or jurisdiction locality
where the business is to be conducted in accordance with §§ 59.1-69 through
59.1-76 Chapter 5 (§ 59.1-69 et seq.) of Title 59.1 of the Code
of Virginia before submitting their an application to the board.
C. Address. The applicant shall disclose the firm's
mailing address, and the firm's physical address. A post office box is
only acceptable as a mailing address when a physical address is also provided.
D. Form of organization. Applicants shall meet the
additional requirements listed below in this subsection for their
business type the firm's form of organization:
1. Corporations. All applicants Applicants shall
have been incorporated in the Commonwealth of Virginia or, if a foreign
corporation, shall have obtained a certificate of authority to conduct business
in Virginia from the State Corporation Commission in accordance with §
13.1-544.2 requirements governing corporations pursuant to Title 13.1
of the Code of Virginia. The corporation Corporations shall be in
good standing with the State Corporation Commission at the time of application
to the board and at all times when the license is in effect.
2. Limited liability companies. All applicants Applicants
shall have obtained a certificate of organization in the Commonwealth of
Virginia or, if a foreign limited liability company, shall have obtained a
certificate of registration to do business in Virginia from the State
Corporation Commission in accordance with § 13.1-1105 requirements
governing limited liability companies pursuant to Title 13.1 of the Code of
Virginia. The company Companies shall be in good standing with
the State Corporation Commission at the time of application to the board and at
all times when the license is in effect.
3. Partnerships. All applicants Applicants shall
have a written partnership agreement. The partnership agreement shall state
that all professional asbestos abatement services of the
partnership shall be under the direction and control of a licensed or
certified professional the appropriate asbestos abatement licensee.
4. Sole proprietorships. Sole proprietorships desiring to
use an assumed or fictitious name, that is, a name other than the individual's
full name, shall have their assumed or fictitious name recorded by the clerk of
the court of the county or jurisdiction wherein the business is to be
conducted.
E. Qualifications.
1. Asbestos contractor. Each applicant shall hold a valid
Virginia contractor license issued by the Virginia Board for Contractors with
an asbestos specialty and shall be in compliance with all other requirements
found in Chapter 11 (§ 54.1-1100 et seq.) of Title 54.1 of the Code of Virginia
governing the regulation of contractors.
2. Asbestos analytical laboratory. Each applicant shall
submit evidence of meeting the standards to perform one or more of the
following analysis:
a. For PLM analysis, a current NVLAP accreditation for bulk
asbestos fiber analysis or a current AIHA accreditation and proficiency in the
AIHA bulk asbestos program. A copy of the NVLAP Certificate of Accreditation,
Scope of Accreditation and documentation of NVLAP proficiency or a copy of an
AIHA accreditation certificate and proof of proficiency in the AIHA bulk
program shall be submitted with the application.
b. For PCM analysis:
(1) At fixed laboratory sites, a current accreditation by
AIHA or evidence that each facility has been rated "proficient" in
the PAT Program's most recent round of asbestos evaluations, or evidence that
each analyst is listed or has applied for listing in the Asbestos Analyst
Registry (AAR) and has a performance rating of "acceptable" for the
most recent Asbestos Analyst Testing (AAT) round. Each analyst shall have
completed the NIOSH 582 training program or equivalent.
(2) For on-site analysis, each on-site analyst shall be
listed or shall have applied for listing in the AAR and have a performance
rating of "acceptable" for the most recent AAT round, or is
accredited by AIHA or has been rated "proficient" in the PAT
Program's most recent round of asbestos evaluations. Each analyst shall have
completed the NIOSH 582 training program or equivalent.
c. For TEM analysis, a current accreditation by NVLAP to
analyze asbestos airborne fibers using TEM. A copy of the NVLAP Certificate of
Accreditation, Scope of Accreditation and documentation of NVLAP proficiency
shall be submitted with the application.
F. Conviction or guilt. Neither E. In accordance
with § 54.1-204 of the Code of Virginia, the applicant shall disclose the
following information about the firm nor the and its owners,
officers or, managers, members, and directors shall have been
convicted or found guilty, regardless of adjudication, in any jurisdiction of
any felony or of any misdemeanor involving lying, cheating or stealing or of
any violation while engaged in environmental remediation activity that resulted
in the significant harm or the imminent and substantial threat of significant
harm to human health or the environment, there being no appeal pending
therefrom or the time of appeal having lapsed. Any plea of nolo contendre shall
be considered a conviction for the purposes of this section. A certified copy
of the final order, decree or case decision by a court or regulatory agency
with lawful authority to issue such order, decree or case decision shall be
admissible as prima facie evidence of such conviction or discipline. The board,
at its discretion, may deny licensure to any applicant in accordance with §
54.1-204 of the Code of Virginia, as applicable:
1. All felony convictions;
2. All misdemeanor convictions involving lying, cheating,
or stealing; and
3. Any conviction resulting from engaging in environmental
remediation activity that resulted in the significant harm or the imminent and
substantial threat of significant harm to human health or the environment.
Any plea of nolo contendre or finding of guilt, regardless
of adjudication or deferred adjudication, shall be considered a conviction for
the purposes of this section. The board, at its discretion, may deny licensure
to any applicant in accordance with § 54.1-204 of the Code of Virginia.
The applicant has the right to request further review of any such action by the
board under the Administrative Process Act (§ 2.2-4000 et seq. of the Code
of Virginia).
G. Standards of practice and conduct. Applicants shall be
in compliance with the standards of practice and conduct set forth
18VAC15-20-400 through 18VAC15-20-454 and 18VAC15-20-459.2 through
18VAC15-20-459.5 at the time of application to the board, while the application
is under review by the board, and at all times when the license is in effect.
H. Standing. Both the firm and the owners, officers and
directors shall be in good standing in every jurisdiction where licensed and
the applicant shall not have had a license that was suspended, revoked or
surrendered in connection with any disciplinary action in any jurisdiction
prior to applying for licensure in Virginia. F. The applicant shall
report (i) the suspension, revocation, or surrender of a license,
certification, or registration in connection with a disciplinary action by any
jurisdiction and (ii) whether the firm, owners, officers, managers, members, or
directors have been the subject of discipline in any jurisdiction prior to
applying for licensure and while the application is under review by the board.
The board, at its discretion, may deny licensure to any an
applicant based on disciplinary action by any jurisdiction.
I. Denial of license. The board may refuse to issue a
license to any asbestos contractor or asbestos analytical laboratory applicant
if the applicant or its owners, officers or directors have a financial interest
in an asbestos contractor whose asbestos license has been revoked, suspended,
or denied renewal in any jurisdiction.
G. The board may deny the application of an applicant who
is shown to have a substantial identity of interest with a person whose license
or certificate has been revoked or not renewed by the board. A substantial
identity of interest includes (i) a controlling financial interest by the
individual or corporate principals of the person whose license or certificate
has been revoked or has not been renewed or (ii) substantially identical
owners, officers, managers, members, or directors, as applicable.
H. An applicant shall not knowingly make a materially
false statement, submit falsified documents, or fail to disclose a material
fact requested in connection with an application submitted to the board.
18VAC15-20-33.1. Qualifications for asbestos contractor
license.
In addition to the requirements of 18VAC15-20-33, each
applicant for an asbestos contractor license shall hold a valid Virginia
contractor license issued by the Virginia Board for Contractors with an
asbestos contracting specialty and shall be in compliance with all other
requirements found in Chapter 11 (§ 54.1-1100 et seq.) of Title 54.1 of the
Code of Virginia governing the regulation of contractors.
18VAC15-20-33.2. Qualifications for asbestos analytical
laboratory license.
A. In addition to the requirements of 18VAC15-20-33, each
applicant for an asbestos analytical laboratory license shall submit evidence
of meeting the standards to perform one or more of PLM, PCM, or TEM analysis.
1. For PLM analysis, one of the following:
a. Current NVLAP accreditation demonstrated by submittal of
a copy of the Certificate of Accreditation, Scope of Accreditation, and
documentation of proficiency with the application;
b. The asbestos analytical laboratory is rated
"proficient" in the BAPAT Program and maintains the training and
quality control document such as is necessary to demonstrate competency in
performing analysis; or
c. The asbestos analytical laboratory is accredited under
the IHLAP and maintains the training and quality control documentation such as
is necessary to demonstrate competency.
2. For PCM analysis, each analyst shall have completed the
NIOSH 582 or NIOSH 582 Equivalency course. In addition, at least one of the following
must be satisfied:
a. At fixed laboratory sites, one of the following
qualifications must be met:
(1) The asbestos analytical laboratory is accredited under
the IHLAP and maintains the training and quality control documentation such as
is necessary to demonstrate competency;
(2) The asbestos analytical laboratory is rated
"proficient" in the IHPAT Program and maintains the training and
quality control document such as is necessary to demonstrate competency in
performing analysis; or
(3) Each analyst is listed in the AAR and has a performance
rating of "acceptable" for the most recent AAT round.
b. For onsite analysis, one of the following qualifications
must be met:
(1) The asbestos analytical laboratory is rated
"proficient" in the IHPAT Program and maintains the training and
quality control document such as is necessary to demonstrate competency in
performing onsite analysis [ for each onsite analyst ];
(2) The asbestos analytical laboratory is accredited under
the IHLAP and maintains compliance with the requirements of its accreditation,
as well as the training and quality control document such as is necessary to
demonstrate competency in performing [ onsite ] analysis
[ for each onsite analyst ]; or
(3) Each analyst is listed in the AAR and has a performance
rating of "acceptable" for the most recent AAT round.
3. For TEM analysis, a current accreditation by NVLAP to
analyze asbestos airborne fibers using TEM. A copy of the NVLAP Certificate of
Accreditation, Scope of Accreditation, and documentation of NVLAP proficiency
shall be submitted with the application.
B. The applicant shall name a responsible individual for
the asbestos analytical laboratory.
C. Any branch office of an asbestos analytical laboratory
shall complete a branch office application from the board. Each branch office
shall name a resident responsible individual at each branch office.
D. The branch office application shall provide the
information contained in subsection A of this section for the applicable branch
office.
E. Any of the training and quality control documentation
required to be maintained pursuant to this section shall be provided to the
board upon request.
18VAC15-20-52. Application fees.
Application fees are set out in this section.
Fee Type
|
Fee Amount
|
When Due
|
Application for worker,
supervisor, inspector, management planner, project designer or project
monitor license
|
$80
|
With application
|
Application for asbestos
analytical laboratory license
|
$120
|
With application
|
Application for asbestos analytical laboratory branch office
|
$100
|
With application
|
Application for an asbestos
contractor license
|
$110
|
With application
|
Application for accredited
asbestos training program approval
|
$500 per day of training
|
With application
|
18VAC15-20-53. Renewal and late renewal fees.
A. Renewal and late renewal fees are set out in this section.
Fee Type
|
Fee Amount
|
When Due
|
Renewal for worker,
supervisor, inspector, management planner, project designer or project
monitor license
|
$45
|
With renewal application
|
Renewal for asbestos
analytical laboratory license
|
$75
|
With renewal application
|
Renewal for asbestos
analytical laboratory branch office
|
$55
|
With renewal application
|
Renewal for asbestos
contractor's license
|
$70
|
With renewal application
|
Renewal for accredited
asbestos training program approval
|
$125
|
With renewal application
|
Late renewal for worker,
supervisor, inspector, management planner, project designer or project
monitor license (includes a $35 late renewal fee in addition to the regular
$45 renewal fee)
|
$80
|
With renewal application
|
Late
renewal for asbestos analytical laboratory license (includes a $35 late
renewal fee in addition to the regular $75 renewal fee)
|
$110
|
With
renewal application
|
Late renewal for asbestos
analytical laboratory branch office (includes $35 late renewal fee in
addition to the regular $55 renewal fee)
|
$90
|
With renewal application
|
Late renewal for asbestos
contractor's license (includes a $35 late renewal fee in addition to the
regular $70 renewal fee)
|
$105
|
With renewal application
|
Late renewal for accredited
asbestos training program approval (includes a $35 late renewal fee in
addition to the regular $125 renewal fee)
|
$160
|
With renewal application
|
B. For licenses expiring after February 1, 2018, and before
February 1, 2020, the renewal fees shall be as follows:
Renewal for worker, supervisor, inspector, management
planner, project designer, or project monitor license
|
$25
|
Renewal for asbestos analytical laboratory license
|
$40
|
Renewal for asbestos contractor's license
|
$30
|
Renewal for accredited asbestos training program approval
|
$40
|
For late renewals received after March 1, 2018, and on or
before February 28, 2020, the late renewal fees shall be as follows:
Late renewal for worker, supervisor, inspector, management
planner, project designer, or project monitor license
|
$60
|
Late renewal for asbestos analytical laboratory license
|
$75
|
Late renewal for asbestos contractor's license
|
$65
|
Late renewal for accredited asbestos training program
approval
|
$75
|
18VAC15-20-454. Transfer of asbestos contractor license.
The transfer of an asbestos contractor license is
prohibited.
Asbestos contractor licenses are issued to firms as
defined in this chapter and are not transferable. Whenever the legal firm
holding the license is dissolved or altered to form a new firm, the original
license becomes void and shall be returned to the board within 30 days of the
change. Additionally, the new firm shall apply for a new license, on a form
provided by the board, within 30 days of the change in the firm. Such changes
include:
1. Death of a sole proprietor;
2. Death or withdrawal of a general partner in a general
partnership or the managing partner in a limited partnership;
3. Termination or cancellation of a corporation or limited
liability company; and
4. Conversion, formation, or dissolution of a corporation,
a limited liability company, or an association or any other firm recognized
under the laws of the Commonwealth of Virginia.
18VAC15-20-456. Responsibilities.
A. Asbestos project monitors shall conduct inspections of the
contractor's work practices and inspections of the containment.
B. Asbestos project monitors shall be present on the job site
each day response actions are being conducted or in accordance with the
owner-approved contractual agreement with the project monitor, shall perform
the duties and functions established in 18VAC15-20-455, and shall maintain a
daily log of all work performed. The daily log shall include, but not be
limited to, inspection reports, air sampling data, type of work performed
by the contractor, problems encountered and corrective action taken.
C. Asbestos project monitors shall take final air samples on
all abatement projects, except for abatement projects in residential buildings.
D. Project monitors who analyze PCM air samples on site
shall be employed by a licensed analytical laboratory and shall be listed or
have applied for listing in the AAR and rated "acceptable" or is
accredited by AIHA or has been rated "proficient" in the PAT
Program's most recent round of asbestos evaluations. The asbestos
project monitor shall include, prior to reoccupancy, the air sample report on
the employing asbestos analytical laboratory's letterhead in the final
clearance report. Such report shall include the licensed asbestos project
monitor's signature.
18VAC15-20-456.1. Onsite analysis by project monitors.
Project monitors who analyze PCM air samples on site shall
(i) be employed by a licensed asbestos analytical laboratory, (ii) have
completed the NIOSH 582 or NIOSH 582 Equivalency Course, and (iii) satisfy one
of the following:
1. The project monitor is listed in the AAR and rated
"acceptable" for the most recent AAT round;
2. The licensed asbestos analytical laboratory employing
the project monitor is rated as "proficient" in the IHPAT Program and
maintains training and quality control documentation necessary to demonstrate
competency in performing onsite analysis; or
3. The licensed asbestos analytical laboratory employing the
project monitor is accredited under the IHLAP, remains in compliance with
accreditation requirements, and maintains training and quality control
documentation necessary to demonstrate competency in performing onsite
analysis.
18VAC15-20-459.4. Change of status.
A. The licensee shall notify the department immediately
within 10 days of any addition or deletion regarding employment of
trained and experienced supervisors, and any changes regarding the signing
officer's relationship with the company changes to the resident
responsible individual for each laboratory location.
B. The licensee shall notify the board within 10 business
days upon the loss of accreditation or proficiency rating by NVLAP or AIHA,
IHLAP, or IHPAT by any laboratory location. The asbestos analytical
laboratory shall notify the board if an employed analyst or project monitor
performing asbestos laboratory analysis is removed from the AAR.
C. The licensee shall notify the board, in writing, if the type
of analysis to be performed it will undertake is different
from the type of analysis in for which the initial license was
issued. The licensee shall submit a new application or branch office
application, as applicable, reflecting the changes and submit evidence
of meeting the qualifications required by this chapter to perform the
analysis. The above information shall be submitted to the board prior to
performing the analysis. The licensee must receive approval from the
board prior to performing the analysis. No additional fees are required to upgrade
amend the type of analysis performed by the analytical laboratory
license licensee.
D. The licensee shall notify the department within 10 days
of any changes in the laboratory location.
E. Asbestos analytical laboratory licenses are issued to
firms as defined in this chapter and are not transferable. Whenever the legal
firm holding the license is dissolved or altered to form a new firm, the
original license becomes void and shall be returned to the board within 30 days
of the change. Additionally, the new firm shall apply for a new license, on a
form provided by the board, within 30 days of the change in the firm. Such
changes include:
1. Death of a sole proprietor;
2. Death or withdrawal of a general partner in a general
partnership or the managing partner in a limited partnership;
3. Termination or cancellation of a corporation or limited
liability company; and
4. Conversion, formation, or dissolution of a corporation,
a limited liability company, or an association or any other firm recognized
under the laws of the Commonwealth of Virginia.
NOTICE: Forms used in
administering the regulation have been filed by the agency. The forms are not
being published; however, online users of this issue of the Virginia Register
of Regulations may click on the name of a form with a hyperlink to access it.
The forms are also available from the agency contact or may be viewed at the
Office of the Registrar of Regulations, 900 East Main Street, 11th Floor,
Richmond, Virginia 23219.
[ FORMS (18VAC15-20)
Asbestos Worker License Application,
A506-3301LIC-v4 (rev. 8/2015)
Asbestos Supervisor License Application,
A506-3302LIC-v4 (rev. 8/2015)
Asbestos Inspector License Application,
A506-3303LIC-v5 (rev. 8/2015)
Asbestos Management Planner License Application,
A506-3304LIC-v4 (rev. 8/2015)
Asbestos Project Designer License Application,
A506-3305LIC-v4 (rev. 8/2015)
Asbestos Project Monitor License Application,
A506-3309LIC-v5 (rev. 8/2015)
Individual - Asbestos License Renewal Form,
A506-33AREN-v4 (rev. 2/2018)
Asbestos Analytical Laboratory License Renewal Form,
A506-3333REN-v4 (rev. 2/2018)
Contractor - Asbestos & Lead License Renewal Form,
A506-33CONREN-v4 (rev. 2/2018)
Asbestos
Analytical Laboratory License Renewal/Branch Office Renewal Form,
A506-3333REN-v4 (rev. 9/2019)
Contractor
- Asbestos & Lead License Renewal Form, A506-33CONREN-v5 (rev. 9/2019)
Asbestos - Experience Verification Application,
A506-33AEXP-v4 (rev. 8/2015)
Asbestos - Education Verification Application,
A506-33AED-v3 (rev. 8/2015)
Virginia Asbestos Licensing Consumer Information Sheet,
A506-33ACIS-v2 (rev. 8/2013)
Inspector/Project Designer/Contractor Disclosure
Form, A506-33DIS-v2 (rev. 8/2013)
Asbestos Contractor License Application, A506-3306LIC-v4
(rev. 8/2015)
Asbestos Analytical Laboratory License Application,
A506-3333LIC-v6 (rev. 8/2015)
Asbestos
Contractor License Application, A506-3306LIC-v5 (rev. 9/2019)
Asbestos
Analytical Laboratory License Application, A506-3333LIC-v7 (rev. 9/2019)
Asbestos
Analytical Laboratory - Branch Office Application, A506-3333BR-v1 (rev. 9/2019)
Change
of Laboratory Analysis Type Form, A506-3333COA-v1 (rev. 9/2019)
Asbestos Training Program Review and Audit
Application, A506-3331ACRS-v4 (rev. 8/2015)
Asbestos Project Monitor - Work Experience Log,
A506-3309EXP-v3 (rev. 8/2015) ]
VA.R. Doc. No. R17-4855; Filed May 6, 2019, 3:55 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF NURSING
Fast-Track Regulation
Title of Regulation: 18VAC90-25. Regulations
Governing Certified Nurse Aides (amending 18VAC90-25-10, 18VAC90-25-15,
18VAC90-25-70, 18VAC90-25-71, 18VAC90-25-80 through 18VAC90-25-120; adding
18VAC90-25-16; repealing 18VAC90-25-130, 18VAC90-25-140).
Statutory Authority: §§ 54.1-2400 and 54.1-3005 of the
Code of Virginia.
Public Hearing Information: No public hearings are
scheduled.
Public Comment Deadline: June 26, 2019.
Effective Date: July 15, 2019.
Agency Contact: Jay P. Douglas, R.N., Executive
Director, Board of Nursing, 9960 Mayland Drive, Suite 300, Richmond, VA
23233-1463, telephone (804) 367-4520, FAX (804) 527-4455, or email
jay.douglas@dhp.virginia.gov.
Basis: Regulations are promulgated under the general
authority of § 54.1-2400 of the Code of Virginia. The specific statutory
authority for registration of medication aides and approval of training
programs is found in § 54.1-3005 of the Code of Virginia.
Purpose: It is necessary to retain the current chapter
because its provisions protect the health and safety of a vulnerable population
of patients or clients who receive services from a nurse aide. The regulatory
changes are consistent with the principle that regulations should be clearly
written and easily understandable.
Rationale for Using Fast-Track Rulemaking Process: As
required by Executive Order 14 (2018), the Board of Nursing conducted a
periodic review of this chapter. The amendments are either less restrictive and
clarifying or intended for consistency with similar regulations for medication
aides or nursing. There are no substantive changes, so the amendments are not
expected to be controversial.
Substance: Pursuant to its periodic review of 18VAC90-25,
the Board of Nursing has amended regulations to clarify certain provisions,
make some rules less burdensome, and add requirements that are necessary for
protection of the public or clients of nurse aides. Additional requirements
include (i) a requirement for an applicant who does not take the state
examination within two years of approval or who fails it three times to take
another training program; (ii) a new subsection on reinstatement after
revocation or suspension; and (iii) repeal of 18VAC90-25-130 and 18VAC90-25-140
and move of the requirements for an approved nurse aide advanced certification
education program to 18VAC90-26.
Issues: There are no substantive changes to the
regulation, so there are no real advantages or disadvantages to the public. The
consolidation of fees into one section and the nametag changes are advantageous
to a certified nursing aide (CNA) or a person seeking registration as a CNA.
Most of the amendments are technical and clarifying.
There are no advantages or disadvantages to the agency or the
Commonwealth, except clearer regulations may result in fewer inquiries to
staff.
Small Business Impact Review Report of Findings: This
fast-track regulatory action serves as the report of the findings of the
regulatory review pursuant to § 2.2-4007.1 of the Code of Virginia.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. Pursuant to a
periodic review,1 the Board of Nursing (Board) proposes to 1)
require certified nurse aides (aides), who do not take the certification exam
within two years of completing training or who fail it three times, repeat the
training program before reapplying for certification, 2) incorporate in the
regulations the option to send license renewal notices electronically, 3) allow
facilities to establish their own policy for the name identification (nametags)
of aides subject to certain requirements, and 4) clarify existing processes and
requirements and change the location of some of the requirements.
Result of Analysis. The benefits likely exceed the costs for
all proposed changes.
Estimated Economic Impact. The Board proposes to require that
an aide who does not take the certification exam within two years of completing
training or who fails the exam three times to repeat the training program
before applying for certification. According to Department of Health
Professions (DHP), it is highly unlikely that an applicant who has not taken
the examination within two years of completion or who has failed three times
would be able to pass the skills and written portions of the exam. Nurse aide
training programs are usually offered by the community colleges. The training
consists of seven credit hours and can be completed over a semester or an
eight-week period. The costs include tuition ($1,085 -$1,140), trainee's time
(approximately 180 hours of class time), and other costs such as background
check, drug screen, immunizations, textbooks, uniform, stethoscope, etc. ($200
-$300). DHP does not have an estimate on the number of individuals who may have
to repeat training. However, the proposed change would encourage the applicants
to achieve certification and help ensure that they are competent to perform
their tasks.
The Board also proposes to
incorporate in the regulations the option of sending license renewal notices
electronically as has been the current practice. Currently, licensees are
providing an email address for the purpose of receiving notices and
communications from the Board. As with other boards under DHP, the Board's
renewal notices are currently being sent to the email address on record. If a
licensee fails to renew before the renewal deadline, a paper renewal notice is
also sent as a courtesy to the licensee.
According to DHP, each paper
renewal notice costs $0.45 ($0.38 for postage and $0.07 for tri-fold generic
stock). Currently, there are 53,055 certified nurse aides who would likely
renew their licenses every two years with a cost of about $11,937 per year
which has been avoided by the electronic notifications. However, the cost
savings from electronic notices would likely be less than this amount because
the Board may not have an email address for some of the licensees, and a paper
copy would still be sent if renewal does not occur 30 days prior to the
expiration of the license. In addition to the savings, electronic notices are
likely beneficial because they expedite the renewal process with an almost
instantaneous delivery process and also mitigate potential issues that could
result from the delivery of paper notices. Since the Board already sends
electronic notices, the main impact of this change is providing consistency
between the current practice and the regulatory text.
Another amendment would replace
the current requirement that the nametag include the aide's first and last name
with a requirement that the facility employing the aide set the policy for
identifying the aide on nametags. The requirement that the nametag must include
the title under which the person is practicing would be retained. It should be
noted that a similar change was made in the nursing regulations in response to
a petition for rulemaking.2
In a survey of 320 nurses in the
Commonwealth conducted by the Virginia Nurses Association, 81% preferred that
that the nametag not include their full name.3 Those supporting the
change cited concerns for safety and stalking as reasons to establish a more
confidential method of identification. The proposal to allow flexibility to
employers concerning name identification on the badge would potentially be
beneficial due to the chance that some or many employers may elect to not list
the full name, which may reduce the occurrences of stalking and harassment of
aides.
The proposed regulations maintain
the requirement that the nametag have the person's appropriate title, but does
not establish a minimum criteria for name identification. An employer could
potentially choose to not have the name on the badge at all. It seems likely
though, that most employers would prefer to have a form of name (first name and
last initial for example) on the badge so that patients or family members could
correctly identify an aide.
The remaining amendments would
provide clarification to existing board processes and regulatory requirements
and change the location of existing requirements. These amendments would not
reflect a change in current practice and would not create any significant
economic impact beyond adding clarity to existing processes and expectations.
Businesses and Entities Affected.
There are 53,055 certified nurse aides in the Commonwealth.
Localities Particularly Affected.
The proposed amendments would not disproportionately affect particular
localities.
Projected Impact on Employment.
The proposed retraining requirement would likely add to the demand for nurse
aide educators by a small amount. Switching from paper to electronic renewal
notices may have reduced the demand for U.S. Postal Service workers by a
negligible amount. However, the proposed amendments are unlikely to
significantly affect total employment.
Effects on the Use and Value of
Private Property. The proposed amendments would not significantly affect the
use and value of private property.
Real Estate Development Costs.
The proposed amendments would not affect real estate development costs.
Small Businesses:
Definition. Pursuant to §
2.2-4007.04 of the Code of Virginia, small business is defined as "a
business entity, including its affiliates, that (i) is independently owned and
operated and (ii) employs fewer than 500 full-time employees or has gross
annual sales of less than $6 million."
Costs and Other Effects. Most
training programs are offered by community colleges and large health care
entities. Thus, proposed amendments would not significantly affect small
businesses.
Alternative Method that Minimizes
Adverse Impact. The proposed amendments would not impose adverse impact on
small businesses.
Adverse Impacts:
Businesses. The proposed
amendments would not impose adverse impact on businesses.
Localities. The proposed amendments
would not adversely affect localities.
Other Entities. Switching from
paper to electronic renewal notices may have reduced the demand for U.S. Postal
Service workers by a negligible amount. In addition, the demand for training
offered by community colleges and large health care institutions may increase
by a small amount.
_____________________________
1http://townhall.virginia.gov/l/ViewPReview.cfm?PRid=1635
2http://townhall.virginia.gov/L/ViewStage.cfm?stageid=8139
3http://townhall.virginia.gov/L/viewcomments.cfm?commentid=55675
Agency's Response to Economic Impact Analysis: The Board
of Nursing concurs with the analysis of the Department of Planning and Budget.
Summary:
Pursuant to a periodic review of 18VAC90-25, the amendments
(i) require certified nurse aides who do not take the certification exam within
two years of completing training or who fail it three times to repeat the
training program before reapplying for certification, (ii) incorporate into the
regulations an option to send license renewal notices electronically, (iii)
allow a facility to establish its own policy for the name identification of
aides subject to certain requirements, (iv) add a new subsection on
reinstatement after revocation or suspension, and (v) remove the requirements
for an approved nurse aide advanced certification education program from this
chapter because they are being added to 18VAC90-26.
Part I
General Provisions
18VAC90-25-10. Definitions.
The following words and terms when used in this chapter shall
have the following meanings unless the context clearly indicates otherwise:
"Board" means the Virginia Board of Nursing.
"Client" means a person receiving the services of a
certified nurse aide, to include a patient in a health care facility or at home
or a resident of a long-term care facility.
"Nurse aide education program" means a program
designed to prepare nurse aides for certification that is approved by the
board.
18VAC90-25-15. Identification; accuracy of records.
A. Any person regulated by this chapter who provides direct
patient care shall, while on duty, wear identification that is clearly visible
and indicates the person's first and last name and the appropriate title
issued to such person by the board under which he is practicing in that
setting. Any person practicing in hospital emergency departments,
psychiatric and mental health units and programs, or in health care facilities
units offering treatment for patients in custody of state or local
law-enforcement agencies may use identification badges of first name and first
letter only of last name and appropriate title. Name identification on a
badge shall follow the policy of the facility in which the nurse aide is
employed.
B. A certificate holder who has changed his name shall submit
as legal proof to the board a copy of the marriage certificate, a certificate
of naturalization, or court order evidencing the change. A duplicate
certificate shall be issued by the board upon receipt of such evidence.
C. Each certificate holder shall maintain an address of
record with the board. Any change in the address of record or in the public
address, if different from the address of record, shall be submitted in writing
or electronically to the board within 30 days of such change. All notices
required by law and by this chapter to be mailed sent by the
board to any certificate holder shall be validly given when mailed sent
to the latest address of record on file with the board.
18VAC90-25-16. Fees.
A. The following fees shall apply:
1. Annual renewal for certified nurse aide
|
$30
|
2. Returned check
|
$35
|
3. Application for certification as an advanced certified
nurse aide
4. Renewal of advanced certified nurse aide certification
5. Reinstatement of advanced certified nurse aide
certification
|
$25
$20
$30
|
B. Fees shall not be refunded once submitted.
Part II
Certification of Nurse Aides
18VAC90-25-70. Initial certification for the nurse aide
registry.
A. The executive director of the board shall issue a
certificate as a certified nurse aide to each applicant who qualifies for such
a certificate under §§ 54.1-3024, 54.1-3025, 54.1-3026, and 54.1-3028 of
the Code of Virginia and provisions of this chapter.
B. Nurse aide competency evaluation.
1. The board may contract with a test service for the
development and administration of a competency evaluation, which shall be a
state examination.
2. All individuals completing a nurse aide education program
in Virginia shall successfully complete the competency evaluation state
examination required by the board prior to being certified and to using the
title Certified Nurse Aide.
3. The board shall determine the minimum passing standard on
the competency evaluation state examination.
C. Initial certification shall be for two years.
18VAC90-25-71. Certification by examination.
A. To be placed on the registry and certified by
examination, the nurse aide must:
1. Have satisfactorily completed:
a. A nurse aide education program approved by the board;
b. At least one clinical nursing course that includes at least
40 hours of clinical experience involving direct client care within the past 12
months while enrolled in a nursing education program preparing for registered
nurse or practical nurse licensure; or
c. A nursing education program preparing for registered nurse
licensure or practical nurse licensure;
2. Pass the competency evaluation state examination
required by the board; and
3. Submit the required application and testing fee as
prescribed by the board.
B. An applicant who fails to take the board-approved
skills and written portions of the state examination within two years of
completion of the training or who has failed the examination in three attempts
shall reenroll and successfully complete another approved nurse aide training
program before reapplying.
18VAC90-25-80. Renewal or reinstatement of certification.
A. Renewal of certification.
1. No less than 30 days prior to the expiration date of the
current certification, a notice for renewal shall be mailed sent
by the board to the address of record of each currently registered
certified nurse aide.
2. The certified nurse aide shall annually submit a completed
renewal application with the required fee of $30 and verification
attestation of performance of nursing-related activities for
compensation within the two years immediately preceding the expiration date.
3. Failure to receive the application for renewal shall not
relieve the certificate holder of the responsibility for renewing the certification
by the expiration date.
4. A certified nurse aide who has not performed
nursing-related activities for compensation during the two years preceding the
expiration date of the certification shall repeat and pass the nurse aide competency
evaluation state examination prior to applying for recertification
renewal of certification.
5. The board shall also charge a fee of $35 for a returned
check.
B. Reinstatement of certification.
1. An individual whose certification has lapsed for more than
90 days shall submit the required application and renewal fee and provide:
a. Verification of performance of nursing-related activities
for compensation in the two years prior to the expiration date of the
certificate and within the preceding two years; or
b. Evidence of having repeated and passed the nurse aide competency
evaluation state examination.
2. An individual who has previously had a finding of abuse,
neglect, or misappropriation of property is not eligible for
reinstatement of his certification, except as provided in 18VAC90-25-81,
which provides a process for removal of the finding of neglect based on a
single occurance.
C. A certified nurse aide whose certification has been
suspended or revoked by the board and who is eligible for reinstatement may
apply for reinstatement by filing a reinstatement application and fulfilling
requirements of subsection B of this section.
18VAC90-25-81. Removal of a finding of neglect.
A. If a finding of neglect was made against a certificate
holder based on a single occurrence, an individual may petition for removal of
the finding of neglect provided:
1. A period of at least one year has passed since the finding
was made; and
2. The individual seeking reinstatement demonstrates
sufficient evidence that employment and personal history do not reflect a
pattern of abusive behavior or neglect.
B. A certificate holder can petition the board only once for
removal of a finding of neglect.
18VAC90-25-100. Disciplinary provisions for nurse aides.
The board has the authority to deny, revoke, or
suspend a certificate issued, or to otherwise discipline a certificate holder
upon proof that he the certificate holder has violated any of the
provisions of § 54.1-3007 of the Code of Virginia. For the purpose of
establishing allegations to be included in the notice of hearing, the board has
adopted the following definitions:
1. Fraud or deceit in order to procure or maintain a
certificate shall mean, but shall not be limited to:
a. Filing false credentials;
b. Falsely representing facts on an application for initial
certification, reinstatement or renewal of a certificate; or
c. Giving or receiving assistance in taking the competency
evaluation state examination.
2. Unprofessional conduct shall mean, but shall not be
limited to:
a. Performing acts beyond those authorized for practice as a
nurse aide or an advanced certified nurse aide as defined in Chapter 30 (§
54.1-3000 et seq.) of Title 54.1 of the Code of Virginia, and beyond those
authorized by the Drug Control Act (§ 54.1-3400 et seq. of the Code of
Virginia) or by provisions for delegation of nursing tasks in Part X
(18VAC90-20-420 VI (18VAC90-19-240 et seq.) of 18VAC90-20 18VAC90-19.
b. Assuming duties and responsibilities within the practice of
a nurse aide or an advanced certified nurse aide without adequate training or
when competency has not been maintained;
c. Obtaining supplies, equipment or drugs for personal or
other unauthorized use;
d. Falsifying or otherwise altering client or employer
records, including falsely representing facts on a job application or other
employment-related documents;
e. Abusing, neglecting, or abandoning clients;
f. Having been denied a license or certificate or having had a
license or certificate issued by the board revoked or suspended;
g. Giving to or accepting from a client property or money for
any reason other than fee for service or a nominal token of appreciation;
h. Obtaining money or property of a client by fraud,
misrepresentation, or duress;
i. Entering into a relationship with a client or the
client's family that constitutes a professional boundary violation in which
the nurse aide uses his professional position to take advantage of the
vulnerability of a client or his family, to include but not limited to
actions that result in personal gain at the expense of the client, an
inappropriate personal involvement or sexual conduct with a client;
j. Violating state laws relating to the privacy of client
information, including but not limited to § 32.1-127.1:03 of the
Code of Virginia; or
k. Providing false information to staff or board members
during the course of an investigation or proceeding.
3. For the purposes of interpreting provisions of subdivision
7 of § 54.1-3007 (7) of the Code of Virginia, a restriction on nurse
aide certification shall be interpreted as having a finding of abuse, neglect,
or misappropriation of patient property made in another state or being placed
on the abuse registry in another state.
Part III
Advanced Certification
18VAC90-25-110. Requirements for initial certification as an
advanced certified nurse aide.
A. In order to be certified as and use the title of
"Advanced Certified Nurse Aide," an applicant shall meet the
following qualifications:
1. Hold current certification as a certified nurse aide in
Virginia;
2. Have been certified for at least three years as a certified
nurse aide;
3. Have never had a finding of abuse, neglect, or
misappropriation of patient property entered on a nurse aide registry in any
jurisdiction and have not had any disciplinary actions taken by the board
within the five years preceding application for advanced certification;
4. Have a recommendation for advanced certification from a
licensed nurse who has supervised the applicant in providing direct patient
care for at least six months within the past year; and
5. Have successfully completed a minimum of 120 hours of
advanced training in an approved program that includes a competency evaluation
acceptable to the board.
B. An application for certification shall be accompanied by
an application fee of $25 as specified in 18VAC90-25-16.
18VAC90-25-120. Renewal and reinstatement of certification as
an advanced certified nurse aide.
A. Current certification as a nurse aide in Virginia must be
maintained in order to hold certification as an advanced certified nurse aide.
B. Renewal. If an individual is not eligible to renew as a
certified nurse aide, certification as an advanced certified nurse aide may not
be renewed. An advanced certification shall be renewed concurrently with the
renewal of the basic certification as a nurse aide in Virginia by:
1. Submitting a completed renewal form and renewal fee of
$20 as specified in 18VAC90-25-16; and
2. Attesting to completion of at least three contact hours per
year of continuing education and training in any of the competency areas
identified in the advanced certification training program. The board may grant
an extension or waiver of the continuing education requirement based on good
cause shown by the certified nurse aide.
C. Late renewal. An advanced certified nurse aide may renew
certification for 90 days following the expiration date by meeting the
requirements of subsection A of this section.
D. Reinstatement. If an advanced certification has not been
renewed for 90 days following the expiration date, it shall only be reinstated
if the applicant for reinstatement:
1. Holds current certification as a nurse aide in Virginia;
2. Submits a completed reinstatement application on a form
provided by the board;
3. Pays the reinstatement fee of $30 as specified in
18VAC90-25-16; and
4. Provides evidence that he the applicant has
completed all required hours of continuing education and training.
18VAC90-25-130. Requirements for an approved advanced
certification education program. (Repealed.)
A. The advanced certification education program shall be
approved by the Virginia Board of Nursing. An approved advanced certification
education program shall also be an approved nurse aide education program as set
forth in 18VAC90-25-20.
B. An advanced certification education program shall
consist of a minimum of 120 hours including a minimum of 40 hours of clinical
skills instruction in direct client care with on-site supervision by
instructional personnel. When nurse aides are engaged in direct client care in
the course of advanced certification training, the ratio shall not exceed 10
students to one instructor.
C. The instructional personnel in an approved advanced
certification education program shall meet the requirements as set forth in
18VAC90-25-30.
D. The curricula of an approved advanced certification
education program shall, at a minimum, meet the requirements of 18VAC90-25-140.
E. Each advanced certification program shall develop an
individual record of major skills taught and the date of performance by the
student. At the completion of the program, the program shall provide each nurse
aide with a copy of this record and a certificate of completion.
F. An advanced certification education program shall
develop and submit to the board a competency evaluation based on the curriculum
content required in 18VAC90-25-140. Such an evaluation shall include both a
written test on the curriculum and an assessment of manual skills. A record of
the reports of graduates' performance on the approved competency evaluation
program shall be maintained for a minimum of three years.
G. Program review shall be in accordance with requirements
of 18VAC90-25-60 and shall be conducted concurrently with the on-site review of
the basic nurse aide education program. Loss of board approval for the basic
nurse aide education program shall automatically result in the loss of approval
for the advanced certification education program.
H. When an advanced certification education program
closes, the provider shall notify the board of the date of closing and submit a
list of all graduates with their date of graduation.
18VAC90-25-140. Required curriculum content for an advanced
certification education program. (Repealed.)
A. An advanced certification education program shall
include classroom and clinical instruction in the following curriculum:
1. Leadership and mentoring skills.
a. Principles of adult learning;
b. Learning styles;
c. Evaluation methods to assess learner knowledge;
d. Communication techniques and communication barriers;
emphasizing cultural diversity of coworkers and clients;
e. Conflict management;
f. Precepting and mentoring new certified nurse aides;
g. Teamwork;
h. Contributing to care plan development and
implementation;
i. Organizational responsibilities; and
j. Principles of documentation.
2. Care of the cognitively impaired client.
a. Signs and symptoms of dementia;
b. Concepts and techniques for addressing the unique needs
and behaviors of individuals with dementia, including but not limited to
agitation, combativeness, sundown syndrome, wandering, forgetfulness;
c. Basic concepts of communication with cognitively
impaired clients, including techniques to reduce the effects of cognitive
impairment;
d. Basic concepts of behavior management with cognitively
impaired clients; and
e. Recognizing changes in the client's condition and
reporting and documenting such changes.
3. Restorative care.
a. Anatomy and physiology with emphasis on the effects of
aging;
b. Pathophysiology of common disorders of the elderly;
c. Measures to assist clients with common medical problems;
d. Recognizing changes in the client's condition and
reporting and documenting such changes;
e. Concepts to maintain or improve client mobility and
ability to perform activities of daily living; and
f. Rehabilitation procedures.
4. Wound care.
a. Prevention, identification and treatment of Stage I and
Stage II pressure ulcers;
b. Positioning;
c. Sterile and clean technique;
d. Dressing changes;
e. Concepts of hydration;
f. Nutrition and weight loss; and
g. Recognizing changes in the client's condition and
reporting and documenting such changes.
B. Written objectives for each unit of instruction shall
be stated in behavioral terms that are measurable and shall be reviewed with
the students at the beginning of each unit.
VA.R. Doc. No. R19-5681; Filed April 30, 2019, 1:09 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF NURSING
Fast-Track Regulation
Title of Regulation: 18VAC90-60. Regulations
Governing the Registration of Medication Aides (amending 18VAC90-60-20, 18VAC90-60-30,
18VAC90-60-40, 18VAC90-60-60, 18VAC90-60-70, 18VAC90-60-90, 18VAC90-60-91,
18VAC90-60-92, 18VAC90-60-100, 18VAC90-60-120; adding 18VAC90-60-75).
Statutory Authority: §§ 54.1-2400 and 54.1-3005 of the
Code of Virginia.
Public Hearing Information: No public hearings are
scheduled.
Public Comment Deadline: June 26, 2019.
Effective Date: July 15, 2019.
Agency Contact: Jay P. Douglas, R.N., Executive
Director, Board of Nursing, 9960 Mayland Drive, Suite 300, Richmond, VA
23233-1463, telephone (804) 367-4520, FAX (804) 527-4455, or email
jay.douglas@dhp.virginia.gov.
Basis: Regulations are promulgated under the general authority
of § 54.1-2400 of the Code of Virginia. The specific statutory authority for
registration of medication aides and approval of training programs is found in
§ 54.1-3005 of the Code of Virginia.
Purpose: It is necessary to retain the current chapter
because its provisions protect the health and safety of a vulnerable population
of residents in assisted living to whom medications are administered. The
regulatory changes are consistent with the principle that regulations should be
clearly written and easily understandable.
Rationale for Using Fast-Track Rulemaking Process: As
required by Executive Order 14 (2018), the Board of Nursing conducted a
periodic review of this chapter. The amendments are either less restrictive and
clarifying or intended for consistency with similar regulations for nurse aide
or nursing education programs. There are no substantive changes, so the
amendments are not expected to be controversial.
Substance: Pursuant to its periodic review of
18VAC90-60, the Board of Nursing has amended regulations to clarify certain
provisions, make some rules less burdensome, and add requirements that are
necessary for protection of the public or the medication aide. Additional
requirements include (i) more information on the certificate of completion;
(ii) a process for conditional approval or withdrawal of approval of a
medication aide training program; (iii) a new section on reinstatement after
revocation or suspension; and (iv) language clarifying that the board may take
disciplinary action for any violation of the chapter, including the standards
of practice.
Issues: There are no substantive changes to the
regulation, so there are no real advantages or disadvantages to the public. The
additional information on a certificate of completion and the additional year
in which the applicant has to take the examination are advantageous to a person
seeking registration as a medication aide. Most of the amendments are technical
and clarifying.
There are no advantages or disadvantages to the agency or the
Commonwealth, except that clearer regulations may result in fewer inquiries to
staff.
Small Business Impact Review Report of Findings: This
fast-track regulatory action serves as the report of the findings of the
regulatory review pursuant to § 2.2-4007.1 of the Code of Virginia.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. Pursuant to a
periodic review,1 the Board of Nursing (Board) proposes to 1) allow
an additional year for medication aides (aides) to take the certification exam,
2) add a fourth option for aides to meet the clinical training requirement, 3)
allow assisted living facilities to establish their own policy for the name
identification (nametags) of aides subject to certain requirements, and 4)
clarify several existing processes and requirements.
Result of Analysis. The benefits likely exceed the costs for
all proposed changes.
Estimated Economic Impact. Currently, an aide has one year to
pass the board-approved exam for registration after completing a training
program. Those who cannot pass the exam in one year are required to repeat
their training. The Board proposes to allow an additional year to pass the
exam. The additional time afforded to the applicants would likely help them
pass the exam (in terms of providing more time to study and/or flexibility to
find the time to prepare) and avoid the costs of repeating training for some of
them.
The Board also proposes to provide an additional option for an
aide to document training requirements in client/patient care that would
include a clinical nursing course with at least 40 hours of clinical experience
in direct client care within the past 12 months. There are currently three
pathways to provide documentation of training in client/patient care in the
regulation; this fourth option would allow an applicant who has completed such
a course to meet the criteria for documentation of training without incurring
additional costs or repeating additional training in client care.
Another amendment would replace the current requirement that
the nametag include the aide's first and last name with a requirement that the
assisted living facility employing the aide set the policy for identifying the
aide on nametags. The requirement that the nametag must include the title under
which the person is practicing would be retained. It should be noted that a
similar change was made in the nursing regulations in response to a petition
for rulemaking.2
In a survey of 320 nurses in the Commonwealth conducted by the
Virginia Nurses Association, 81% preferred that that the nametag not include
their full name.3 Those supporting the change cited concerns for
safety and stalking as reasons to establish a more confidential method of
identification. The proposal to allow flexibility to employers concerning name
identification on the badge would potentially be beneficial due to the chance
that some or many employers may elect to not list the full name, which may
reduce the occurrences of stalking and harassment of aides.
The proposed regulation maintains the requirement that the
nametag have the person's appropriate title, but does not establish a minimum
criteria for name identification. An employer could potentially choose to not
have the name on the badge at all. It seems likely though, that most employers
would prefer to have a form of name (first name and last initial for example)
on the badge so that patients or family members could correctly identify an
aide.
The remaining amendments would provide clarification to
existing board processes and regulatory requirements. The Board proposes to add
language to describe the existing process for conditional approval and
withdrawal of approval of an aide training program. Language would also be
added to include the instructions for reinstatement of an aide after revocation
or suspension of a registration. The proposal would add language to specify
that the certificate of completion issued by training providers include the
name of the program, the board approval number, and the signature of the
instructor. An additional amendment would clarify that disciplinary action
would result if an aide violated any provision of this chapter, rather than
only including the standards of practice. Although all of these processes and
requirements are currently reflected in practice, the Board is proposing to
clarify them in regulation due to inquiries received from training programs or
applicants. These amendments would not reflect a change in current practice and
would not create any significant economic impact beyond adding clarity to
existing processes and expectations.
Businesses and Entities Affected. There are 284 medication aide
training programs and 6,595 registered medication aides in the Commonwealth.
Localities Particularly Affected. The proposed amendments would
not disproportionately affect particular localities.
Projected Impact on Employment. The proposed amendments are
unlikely to significantly affect total employment.
Effects on the Use and Value of Private Property. The proposed
amendments would not affect the use and value of private property.
Real Estate Development Costs. The proposed amendments would
not affect real estate development costs.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. While some training programs are
offered by large health care entities that include assisted living facilities,
most are operated by small businesses. The proposed amendments would not affect
costs for them.
Alternative Method that Minimizes Adverse Impact. The proposed
amendments would not impose adverse impact on small businesses.
Adverse Impacts:
Businesses. The proposed amendments would not impose adverse
impact on businesses.
Localities. The proposed amendments would not adversely affect
localities.
Other Entities. The proposed amendments would not adversely
affect other entities.
________________________________
1http://townhall.virginia.gov/l/ViewPReview.cfm?PRid=1637
2http://townhall.virginia.gov/L/ViewStage.cfm?stageid=8139
3http://townhall.virginia.gov/L/viewcomments.cfm?commentid=55675
Agency's Response to Economic Impact Analysis: The Board
of Nursing concurs with the analysis of the Department of Planning and Budget.
Summary:
Pursuant to a periodic review of 18VAC90-60, amendments
include (i) allowing an additional year for medication aides to take the
certification exam; (ii) adding a fourth option for aides to meet the clinical
training requirement; (iii) allowing assisted living facilities to establish
their own policy for the name identification of aides, subject to certain
requirements; (iv) requiring more information on the certificate of completion
and a process for withdrawal of approval of a medication aide training program;
(v) adding a new section on reinstatement after revocation or suspension; and
(vi) clarifying that the board may take disciplinary action for any violation
of the chapter, including the standards of practice.
18VAC90-60-20. Identification; accuracy of records.
A. Any person regulated by this chapter shall, while on duty,
wear identification that is clearly visible to the client and that indicates
the person's first and last name and the appropriate title issued to
such person by the board under which he the person is practicing
in that setting. Name identification on a badge shall follow the policy of
the assisted living facility in which the medication aide is employed.
B. A medication aide who has changed his name shall submit as
legal proof to the board a copy of the marriage certificate, a certificate of
naturalization, or a court order evidencing the change. A duplicate certificate
shall be issued by the board upon receipt of such evidence.
C. A medication aide shall maintain an address of record with
the board. Any change in the address of record or in the public address, if
different from the address of record, shall be submitted electronically or in
writing to the board within 30 days of such change. All notices required by law
and by this chapter to be mailed sent by the board to any
registrant shall be validly given when mailed sent to the latest
address of record on file with the board.
18VAC90-60-30. Fees.
A. The following fees shall
apply:
1. Application for program approval
|
$500
|
2. Application for registration as a medication aide
|
$50
|
3. Annual renewal for medication aide
|
$30
|
4. Late renewal
|
$15
|
5. Reinstatement of registration
|
$90
|
6. Returned check
|
$35
|
7. Duplicate registration
|
$15
|
8. Reinstatement following suspension, mandatory suspension,
or revocation
|
$120
|
B. Fees shall not be refunded once submitted.
C. The fee for the competency evaluation state
examination shall be paid directly to the examination service contracted by
the board for its administration.
D. For renewal of registration from July 1, 2017, through
June 30, 2018, the following fee shall be in effect:
Annual renewal for medication aide
|
$22
|
Part II
Medication Aide Training Programs
18VAC90-60-40. Establishing and maintaining a medication aide
training program.
A. Establishing a medication aide training program.
1. A program provider wishing to establish a medication aide
training program shall submit a completed application and pay the prescribed
fee to the board at least 90 days in advance of the first expected offering of
the program.
2. Initial approval may be granted when all documentation of
the program's compliance with requirements as set forth in this part has been
submitted and deemed satisfactory to the board.
3. If approval is denied, the applicant may request, within 30
days of the mailing of the decision, an informal conference committee to be
convened in accordance with § 2.2-4019 of the Code of Virginia.
4. If the committee's recommendation is to deny approval, no
further action will be required of the board unless the program requests a
hearing before the board or a panel thereof in accordance with § 2.2-4020
and subdivision 11 of § 54.1-2400 of the Code of Virginia.
B. Maintaining an approved medication aide training program.
To maintain approval, the program shall:
1. Continue to comply with requirements as set forth in this
part.
2. Document that the cumulative passing rate for the program's
first-time test takers taking the competency evaluation required for
registration over the past two years is not less than 80%.
3. Report all substantive changes within 10 days of the change
to the board to include, but not be limited to, a change in the program
instructors, curriculum or program location.
4. Cooperate with any unannounced visits to the program
conducted by board representatives for the purpose of ensuring compliance with
requirements for approval or in response to complaints about the program.
5. Provide documentation that each student enrolled in such
program has been given a copy of applicable Virginia law and regulation for the
registration and practice of medication aides.
6. Provide each student with a certificate of completion,
which shall include the name of the program, the approval number provided by
the board, and the signature of the instructor.
18VAC90-60-60. Requirements for the program curriculum.
A. Prerequisite for the program. A student seeking enrollment
in a medication aide training program shall have successfully completed the
direct care staff training required by the Department of Social Services for
employment in an assisted living facility or an approved nurse aide education
program.
B. Hours of instruction. An approved program shall consist of
a minimum of 68 hours of student instruction and training to include:
1. At least 40 hours of classroom or didactic instruction over
and above any facility orientation program or training in direct client care
provided by the facility;
2. At least 20 hours of supervised skills practice in
medication administration to residents of an assisted living facility, after
which the training program shall evaluate the student's minimal competency in
the clinical skills of administering medications on a form provided by the
board. Up to 20% of the supervised skills practice may be completed by a
simulation experience in a simulation laboratory. The clinical evaluation shall
be conducted one-on-one with a qualified instructor with experience in
medications in long-term care; and
3. An eight-hour module in facilitating client
self-administration or assisting with the administration of insulin to include
instruction and skills practice in the administration of insulin as specified
in the board-approved curriculum.
C. Content of the curriculum. An approved program shall use
the curriculum developed and provided by the board, which shall, at a minimum,
include the following topics:
1. Preparing for safe administration of medications to clients
in assisted living facilities;
2. Maintaining aseptic conditions;
3. Understanding of basic pharmacology;
4. Facilitating client self-administration or assisting with
medication administration;
5. Following proper procedure for preparing, administering,
and maintaining medications; and
6. Following appropriate procedures for documentation and
reporting to the licensed health care professional on duty at the facility or
to the client's prescriber.
D. In addition to the training curriculum, the program shall
may provide one or more four-hour modules that can be used by facilities
as refresher courses or by medication aides to satisfy requirements for
continuing education.
18VAC90-60-70. Other program requirements.
A. Ratio. An approved training program shall maintain a ratio
of no more than 10 students for one instructor for the 20 hours of supervised
skills practice as required by 18VAC90-60-60 B.
B. Records.
1. Each medication aide training education program shall
develop and maintain an individual record of major skills taught and the date
of performance by the student. At the completion of the program, the medication
aide must receive a copy of this record and a certificate of completion from
the program, as specified in 18VAC90-60-40.
2. A record of the reports of graduates' performance on the
approved competency evaluation program shall be maintained.
3. A record that documents the disposition of complaints
against the program shall be maintained.
4. All records required by this section shall be maintained
for at least five years.
C. Student identification. The medication aide students shall
wear identification that clearly distinguishes them as a "medication aide
student" while engaged in practical skills training under direct
supervision by an instructor. Name identification shall follow the policy of
the assisted living facility in which the medication aide is engaged in practical
training.
18VAC90-60-75. Conditional or withdrawal of approval of a
medication aide training program.
A. If the board determines that a medication aide training
program is not maintaining the requirements of Part II (18VAC90-60-40 et seq.)
of this chapter, the board may:
1. Place the program on conditional approval with terms and
conditions to be met within the timeframe specified by the board; or
2. Withdraw program approval.
B. If the board either places a program on conditional
approval with terms and conditions to be met within a timeframe specified by
the board or withdraws approval, the following shall apply:
1. No further action will be required of the board unless
the program requests an informal conference pursuant to §§ 2.2-4019 and
54.1-109 of the Code of Virginia.
2. If withdrawal or continued program approval with terms
and conditions is recommended following the informal conference, the
recommendation shall be presented to the board or a panel of the board for
review and action.
3. If the recommendation of the informal conference
committee is accepted by the board or a panel of the board, the decision shall
be reflected in a board order, and no further action by the board is required
unless the program requests a formal hearing within 30 days from entry of the
order in accordance with § 2.2-4020 of the Code of Virginia.
4. If the decision of the board or a panel of the board
following a formal hearing is to withdraw approval or continue on conditional
approval with terms or conditions, the program shall be advised of the right to
appeal the decision to the appropriate circuit court in accordance with
§ 2.2-4026 of the Code of Virginia and Part 2A of the Rules of the Supreme
Court of Virginia.
Part III
Registration of Medication Aides
18VAC90-60-90. Requirements for initial registration.
A. To be registered as a medication aide, an applicant shall:
1. Provide documentation of successful completion of a:
a. A staff training program in direct client care
approved by the Department of Social Services, a;
b. A nursing education program, or;
c. An approved nurse aide education program, an;
or
d. A clinical nursing course that includes at least 40
hours of clinical experience involving direct client care within the past 12
months;
2. Provide documentation of successful completion of one of
the following:
a. A medication aide training program approved by the board in
accordance with this chapter; or
b. A nursing education program preparing for registered nurse
licensure or practical nurse licensure;
3. Submit the required application and fee as prescribed by
the board;
4. Disclose whether there are grounds for denial of
registration as specified in § 54.1-3007 of the Code of Virginia; and
5. Provide documentation of successful completion of competency
evaluations consisting of:
a. A clinical evaluation of minimal competency in the skills
of administering medications as specified in 18VAC90-60-60 B 2; and
b. A written examination as specified by the board with a
passing score determined by the board.
B. An applicant who fails to take the board-approved
examination within one year two years of completion of the
training or who has failed the examination in three attempts shall reenroll and
successfully complete another approved medication aide training program before
reapplying for registration.
18VAC90-60-91. Requirements for provisional practice.
A. An applicant for registration who wants to practice as a
medication aide on a provisional basis shall:
1. Submit the required application for registration and fee as
prescribed by the board; and
2. Provide evidence to the board of successful completion of
the medication aide training course or a nursing education program.
B. An applicant shall practice for no more than 120 days from
the date of a letter from the board acknowledging receipt of the documentation
required in subsection A of this section and granting provisional
authorization.
C. An applicant acting as a medication aide under provisional
authorization shall be identified as a "provisional medication aide"
on a nametag worn in the facility.
D. An applicant with provisional authorization shall
immediately cease acting as a medication aide at the conclusion of the 120-day
period or upon notification of failure after three attempts to pass the written
examination required for registration, whichever comes first.
18VAC90-60-92. Requirements for registration by endorsement.
An applicant applying for registration by endorsement who has
met the requirements for registration or certification as a medication aide in
another state or the District of Columbia may be deemed eligible to sit for the
competency evaluation state examination if there are no grounds
for denial of registration as specified in § 54.1-3007 of the Code of Virginia
and upon submission of:
1. A completed application and fee; and
2. Verification of registration or certification as a
medication aide in another state or the District of Columbia that is current or
eligible for reinstatement.
18VAC90-60-100. Renewal or reinstatement of registration.
A. Renewal of registration.
1. Registered medication aides shall renew by the last day of
their birth month each year.
2. The medication aide shall complete the application renewal
notice and submit it with the required fee and an attestation that he has
completed continuing education as required by subsection B of this section.
3. Failure to receive the application notice for
renewal shall not relieve the medication aide of the responsibility for
renewing his registration by the expiration date.
4. The registration shall automatically lapse if the
medication aide fails to renew by the expiration date.
5. Any person administering medications in an assisted living
facility during the time a registration has lapsed shall be considered an
illegal practitioner and shall be subject to prosecution under the provisions
of § 54.1-3008 of the Code of Virginia.
B. Continuing education required for renewal.
1. In addition to hours of continuing education in direct
client care required for employment in an assisted living facility, a
medication aide shall have the following:
a. Four hours each year of population-specific training in
medication administration in the assisted living facility in which the aide is
employed; or
b. A refresher course in medication administration offered by
an approved program.
2. A medication aide shall maintain documentation of
continuing education for a period of four years following the renewal period
for which the records apply.
3. The board shall periodically conduct a random audit of its
registrants to determine compliance. A medication aide selected for audit shall
provide documentation as evidence of compliance within 30 days of receiving
notification of the audit.
4. The board may grant an extension for compliance with continuing
education requirements for up to one year, for good cause shown, upon a written
request from the registrant prior to the renewal deadline.
C. Reinstatement of registration.
1. An individual whose registration has lapsed for less than
one renewal cycle may renew by payment of the renewal fee and late fee and
attestation that he the individual has completed all required
continuing education for the period since his last renewal.
2. An individual whose registration has lapsed for more than
one year shall:
a. Apply for reinstatement of registration by submission of a
completed application and fee;
b. Provide evidence of completion of all required continuing
education for the period since his last renewal, not to exceed eight hours of
training in medication administration;
c. Retake the written and practical competency evaluation as
required by the board; and
d. Attest that there are no grounds for denial of registration
as specified in § 54.1-3007 of the Code of Virginia.
D. A medication aide whose registration has been suspended
or revoked by the board may apply for reinstatement by filing a reinstatement
application, fulfilling requirements of subsection C of this section, and
paying the fee for reinstatement after suspension or revocation. A medication
aide whose registration has been revoked may not apply for reinstatement sooner
than three years from entry of the order of revocation.
18VAC90-60-120. Disciplinary provisions for medication aides.
The board has the authority to deny, revoke, or
suspend a registration issued, or to otherwise discipline a registrant upon
proof that he the registrant has violated any of the provisions
of § 54.1-3007 of the Code of Virginia. For the purpose of establishing
allegations to be included in the notice of hearing, the board has adopted the
following definitions:
1. Fraud or deceit in order to procure or maintain a
registration shall mean, but shall not be limited to:
a. Filing false credentials;
b. Falsely representing facts on an application for initial
registration, reinstatement or renewal of a registration; or
c. Giving or receiving assistance in taking the competency
evaluation.
2. Unprofessional conduct shall mean, but shall not be limited
to:
a. Performing acts beyond those authorized by the Code of
Virginia and this chapter for practice as a medication aide;
b. Assuming duties and responsibilities within the practice of
a medication aide without adequate training or when competency has not been
maintained;
c. Obtaining supplies, equipment or drugs for personal or
other unauthorized use;
d. Falsifying or otherwise altering client or drug records
relating to administration of medication;
e. Falsifying or otherwise altering employer records,
including falsely representing facts on a job application or other
employment-related documents;
f. Abusing, neglecting or abandoning clients;
g. Having been denied a license, certificate, or registration
or having had a license, certificate, or registration issued by the board
revoked or suspended;
h. Giving to or accepting from a client property or money for
any reason other than fee for service or a nominal token of appreciation;
i. Obtaining money or property of a client by fraud,
misrepresentation or duress;
j. Entering into a relationship with a client that constitutes
a professional boundary violation in which the medication aide uses his
professional position to take advantage of a client's vulnerability, to include
but not limited to actions that result in personal gain at the expense
of the client, an inappropriate personal involvement or sexual conduct with a
client;
k. Violating state laws relating to the privacy of client
information, including but not limited to § 32.1-127.1:03 of the
Code of Virginia;
l. Failing to follow provisions of the Medication Management
Plan for the assisted living facility in which the aide is employed; or
m. Violating any provision of this chapter, including the
standards of practice as set forth in 18VAC90-60-110.
3. For the purposes of interpreting provisions of subdivision 5
of § 54.1-3007 of the Code of Virginia, a pattern of medication errors may
constitute practice that presents a danger to the health and welfare of clients
or to the public.
VA.R. Doc. No. R19-5680; Filed April 30, 2019, 1:10 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHARMACY
Final Regulation
Title of Regulation: 18VAC110-20. Regulations
Governing the Practice of Pharmacy (amending 18VAC110-20-80, 18VAC110-20-105;
adding 18VAC110-20-22).
Statutory Authority: § 54.1-2400 of the Code of
Virginia.
Effective Date: June 26, 2019.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Summary:
The amendments require a pharmacist, pharmacy intern, or
pharmacy technician applicant to provide an e-profile identification number
from the National Association of Boards of Pharmacy in an application for a
license, registration, or renewal or reinstatement of license or registration.
Summary of Public Comments and Agency's Response: No
public comments were received by the promulgating agency.
18VAC110-20-22. Application to include e-profile number.
An application for licensure as a pharmacist by
examination or endorsement or for registration as a pharmacy intern or pharmacy
technician shall include an e-profile number issued by NABP.
18VAC110-20-80. Renewal and reinstatement of license.
A. Pharmacist licenses expire on December 31 and shall be
renewed annually prior to that date by the submission of a renewal fee, renewal
form, an e-profile number issued by NABP, and statement of compliance
with continuing education requirements.
B. A pharmacist newly licensed on or after October 1 shall
not be required to renew that license until December 31 of the following year.
C. A pharmacist who fails to renew his license by the
expiration date may renew his license at any time within one year of its expiration
by submission of the renewal fee and late fee, renewal form, and statement of
compliance with continuing education requirements.
D. A pharmacist who fails to renew his license for more than
one year following expiration and who wishes to reinstate such license shall
submit an application for reinstatement, pay the current renewal fee and a
reinstatement fee, and submit documentation showing compliance with continuing
education requirements. Reinstatement is at the discretion of the board and may
be granted by the executive director of the board provided no grounds exist to
deny said reinstatement.
E. A pharmacist who has been registered as inactive for more
than one year must apply for reinstatement, submit documentation showing
compliance with continuing education requirements, and pay the current year
active renewal fee in order to resume active licensure.
F. In order to reactivate or reinstate a license to active
status, a pharmacist who holds an inactive license, who has allowed his license
to lapse, or who has had his license suspended or revoked must submit evidence
of completion of CEU's or hours equal to the requirements for the number of
years in which his license has not been active, not to exceed a total of 60
hours of CE.
G. A pharmacist whose license has been lapsed, in inactive
status, or suspended or revoked for more than five years shall, as a condition
of reinstatement in addition to 60 hours CE, take and receive a passing score
on the board-approved law examination and furnish acceptable documentation of
one of the following:
1. Active pharmacy practice within the past five years as a
properly licensed pharmacist in another state; or
2. Practical experience as a pharmacy intern registered with
the board of at least 160 hours within six months immediately prior to being
reinstated.
H. The practice of pharmacy without a current, active
pharmacist license is unlawful and shall constitute grounds for disciplinary
action by the board.
I. It shall be the duty and responsibility of each licensee
to inform the board of his current address. A licensee shall notify the board
within 14 days in writing or electronically of any change of an address of
record. Properly updating address of record directly through the board's
web-based application or other approved means shall constitute lawful
notification. All notices required by law or by these rules and regulations are
deemed to be legally given when mailed to the address of record and shall not
relieve the licensee of the obligation to comply.
18VAC110-20-105. Renewal and reinstatement of registration.
A. Pharmacy technician registrations expire on December 31
and shall be renewed annually prior to that date by the submission of a renewal
fee, and renewal form, and an e-profile number issued by NABP. A
pharmacy technician newly registered on or after July 1 shall not be required
to renew that registration until December 31 of the following year. Failure to
receive the application for renewal shall not relieve the pharmacy technician
of the responsibility for renewing the registration by the expiration date.
B. A pharmacy technician who fails to renew his registration
by the expiration date may renew his registration at any time within one year
of its expiration by submission of the renewal fee and late fee, renewal form,
and attestation of having obtained required continuing education.
C. A pharmacy technician who fails to renew his registration
for more than one year following expiration and who wishes to reinstate such
registration shall submit an application for reinstatement, pay the current
renewal fee and a reinstatement fee, and submit documentation showing
compliance with continuing education requirements. Reinstatement is at the
discretion of the board and may be granted by the executive director of the
board provided no grounds exist to deny said reinstatement. Conducting tasks
associated with a pharmacy technician with a lapsed registration shall be
illegal and may subject the registrant to disciplinary action by the board.
D. A person who fails to reinstate a pharmacy technician
registration within five years of expiration, shall not be eligible for
reinstatement and shall repeat an approved training program and repeat and pass
the examination, or hold current PTCB certification, before applying to be
reregistered.
VA.R. Doc. No. R18-5278; Filed April 30, 2019, 12:18 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHARMACY
Final Regulation
REGISTRAR'S NOTICE: The
Board of Pharmacy is claiming an exemption from Article 2 of the Administrative
Process Act in accordance with § 2.2-4006 A 13 of the Code of Virginia,
which exempts amendments to regulations of the board to schedule a substance in
Schedule I or II pursuant to subsection D of § 54.1-3443 of the Code of
Virginia. The board will receive, consider, and respond to petitions by any
interested person at any time with respect to reconsideration or revision.
Title of Regulation: 18VAC110-20. Regulations Governing
the Practice of Pharmacy (amending 18VAC110-20-322).
Statutory Authority: §§ 54.1-2400 and 54.1-3443 of the
Code of Virginia.
Effective Date: June 26, 2019.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Summary:
The amendments add three compounds into Schedule I of the
Drug Control Act as recommended by the Virginia Department of Forensic Science
pursuant to § 54.1-3443 of the Code of Virginia. The compounds
added by this regulatory action will remain in effect for 18 months or until
the compounds are placed in Schedule I by legislative action of the General
Assembly.
18VAC110-20-322. Placement of chemicals in Schedule I.
A. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. 2-(methylamino)-2-phenyl-cyclohexanone (other name:
Deschloroketamine), its optical, position, and geometric isomers, salts, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
2. 2-methyl-1-(4-(methylthio)phenyl)-2-morpholinopropiophenone
(other name: MMMP), its optical, position, and geometric isomers, salts, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
3. Alpha-ethylaminohexanophenone (other name:
N-ethylhexedrone), its optical, position, and geometric isomers, salts, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
4. N-ethyl-1-(3-methoxyphenyl)cyclohexylamine (other name:
3-methoxy-PCE), its optical, position, and geometric isomers, salts, and salts
of isomers whenever the existence of such salts, isomers, and salts of isomers
is possible within the specific chemical designation.
5. 4-fluoro-alpha-pyrrolidinohexiophenone (other name:
4-fluoro-alpha-PHP), its optical, position, and geometric isomers, salts, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
6. N-ethyl-1,2-diphenylethylamine (other name: Ephenidine),
its optical, position, and geometric isomers, salts, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation.
7. Synthetic opioids:
a.
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-1,3-benzodioxole-5-carboxamide
(other name: Benzodioxole fentanyl), its isomers, esters, ethers, salts, and
salts of isomers, esters, and ethers, unless specifically excepted, whenever
the existence of these isomers, esters, ethers, and salts is possible within
the specific chemical designation.
b. 3,4-dichloro-N-[2-(diethylamino)cyclohexyl]-N-methylbenzamide
(other name: U-49900), its isomers, esters, ethers, salts, and salts of
isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
c. 2-(2,4-dichlorophenyl)-N-[2-(dimethylamino)
cyclohexyl]-N-methylacetamide (other name: U-48800), its isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers, and salts is
possible within the specific chemical designation.
8. Central nervous system stimulants:
a. Methyl 2-(4-fluorophenyl)-2-(2-piperidinyl)acetate (other
name: 4-fluoromethylphenidate), including its salts, isomers, and salts of
isomers.
b. Isopropyl-2-phenyl-2-(2-piperidinyl)acetate (other name:
Isopropylphenidate), including its salts, isomers, and salts of isomers.
The placement of drugs listed in this subsection shall remain
in effect until August 21, 2019, unless enacted into law in the Drug Control
Act.
B. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. Research chemicals:
a. 2-(ethylamino)-2-phenyl-cyclohexanone (other name:
deschloro-N-ethyl-ketamine), its optical, position, and geometric isomers,
salts, and salts of isomers, whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation.
b. 3,4-methylenedioxy-N-tert-butylcathinone, its optical,
position, and geometric isomers, salts, and salts of isomers, whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation.
c. 4-fluoro-N-ethylamphetamine, its optical, position, and
geometric isomers, salts, and salts of isomers, whenever the existence of such
salts, isomers, and salts of isomers is possible within the specific chemical
designation.
d. Beta-keto-4-bromo-2,5-dimethoxyphenethylamine (other name:
bk-2C-B), its optical, position, and geometric isomers, salts, and salts of
isomers, whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation.
2. Synthetic opioids:
a. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2butenamide
(other name: Crotonyl fentanyl), its isomers, esters, ethers, salts, and salts
of isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
b. 2-(3,4-dichlorophenyl)-N-[2-(dimethylamino)
cyclohexyl]-N-methylacetamide (other name: U-51754), its isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers, and salts is
possible within the specific chemical designation.
c.
N-phenyl-N-[4-phenyl-1-(2-phenylethyl)-4piperidinyl]-propanamide (other name:
4phenylfentanyl), its isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, unless specifically excepted, whenever the existence of
these isomers, esters, ethers, and salts is possible within the specific
chemical designation.
The placement of drugs listed in this subsection shall remain
in effect until December 12, 2019, unless enacted into law in the Drug Control
Act.
C. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. 2,5-dimethoxy-4-chloroamphetamine (other name: DOC), its
optical, position, and geometric isomers, salts, and salts of isomers whenever
the existence of such salts, isomers, and salts of isomers is possible within
the specific chemical designation.
2. Synthetic opioids:
a.
N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide
(other name: Ocfentanil), its isomers, esters, ethers, salts, and salts of
isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
b.
N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide (other name:
4-methoxybutyrylfentanyl), its isomers, esters, ethers, salts, and salts of
isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
c.
N-phenyl-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide (other name:
Isobutyryl fentanyl), its isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, unless specifically excepted, whenever the existence of
these isomers, esters, ethers, and salts is possible within the specific
chemical designation.
d. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-cyclopentanecarboxamide
(other name: Cyclopentyl fentanyl), its isomers, esters, ethers, salts, and
salts of isomers, esters, and ethers, unless specifically excepted, whenever
the existence of these isomers, esters, ethers, and salts is possible within
the specific chemical designation.
e. N-phenyl-N-(1-methyl-4-piperidinyl)-propanamide (other
name: N-methyl norfentanyl), its isomers, esters, ethers, salts, and salts of
isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
3. Cannabimimetic agent:
1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide (other
name: 4-cyano CUMYL-BUTINACA), its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation.
4. Benzodiazepine: Flualprazolam, its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
The placement of drugs listed in this subsection shall remain
in effect until March 4, 2020, unless enacted into law in the Drug Control Act.
D. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. Synthetic opioid:
N-[2-(dimethylamino)cyclohexyl]-N-methyl-1,3-benzodioxole-5-carboxamide (other
names: 3,4-methylenedioxy U-47700 or 3,4-MDO-U-47700), its isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers, and salts is
possible within the specific chemical designation.
2. Cannabimimetic agent: N-(adamantanyl)-1-(5-chloropentyl)
indazole-3-carboxamide (other name: 5-chloro-AKB48), its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation.
The placement of drugs listed in this subsection shall remain
in effect until May 27, 2020, unless enacted into law in the Drug Control Act.
E. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. Synthetic opioid:
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-benzamide (other names: Phenyl
fentanyl, Benzoyl fentanyl), its isomers, esters, ethers, salts, and salts of
isomers, esters, and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation.
2. Research chemicals:
a. 4-acetyloxy-N,N-diallyltryptamine (other name: 4-AcO-DALT),
its optical, position, and geometric isomers, salts, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation.
b. 4-chloro-N,N-dimethylcathinone, its optical, position, and geometric
isomers, salts, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation.
c. 4-hydroxy-N,N-methylisopropyltryptamine (other name:
4-hydroxy-MiPT), its optical, position, and geometric isomers, salts, and salts
of isomers whenever the existence of such salts, isomers, and salts of isomers
is possible within the specific chemical designation.
d. 3,4-Methylenedioxy-alpha-pyrrolidinohexanophenone (other
name: MDPHP), its optical, position, and geometric isomers, salts, and salts of
isomers whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation.
3. Cannabimimetic agent: Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate
(other name: 5-Fluoro-MDMB-PICA), its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation.
The placement of drugs listed in this subsection shall remain
in effect until October 2, 2020, unless enacted into law in the Drug Control
Act.
F. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1.
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-isopropyl-benzamide (other name:
Isopropyl U-47700), its isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, unless specifically excepted, whenever the existence of
these isomers, esters, ethers, and salts is possible within the specific
chemical designation.
2. Alpha-pyrrolidinoisohexiophenone (other name:
alpha-PiHP), its optical, position, and geometric isomers, salts, and salts of
isomers whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation.
3. 1-[1-(3-hydroxyphenyl)cyclohexyl]piperidine (other name:
3-hydroxy PCP), its optical, position, and geometric isomers, salts, and salts
of isomers whenever the existence of such salts, isomers, and salts of isomers
is possible within the specific chemical designation.
The placement of drugs listed in this subsection shall
remain in effect until December 25, 2020, unless enacted into law in the Drug
Control Act.
VA.R. Doc. No. R19-5898; Filed May 2, 2019, 8:20 a.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHARMACY
Proposed Regulation
Titles of Regulations: 18VAC110-20. Regulations
Governing the Practice of Pharmacy (amending 18VAC110-20-20, 18VAC110-20-121).
18VAC110-30. Regulations for Practitioners of the Healing
Arts to Sell Controlled Substances (amending 18VAC110-30-15).
18VAC110-50. Regulations Governing Wholesale Distributors,
Manufacturers, and Warehousers (amending 18VAC110-50-20).
Statutory Authority: §§ 54.1-2400 and 54.1-3307 of the
Code of Virginia.
Public Hearing Information:
June 5, 2019 - 9:05 a.m. - Department of Health
Professions, Perimeter Center, 9960 Mayland Drive, Suite 201, Board Room 2,
Richmond, VA 23233
Public Comment Deadline: July 26, 2019.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Basis: Regulations of the Board of Pharmacy are promulgated
under the general authority of § 54.1-2400 of the Code of Virginia. The
proposed regulation is mandated by § 54.1-113 of the Code of Virginia.
Purpose: Fees charged to applicants and licensees of the
Board of Pharmacy have not been increased since 2002. During that time period,
there have been three reductions in renewal fees, in 2005, 2006 and 2009. The
number of regulated entities has substantially increased in recent years from
12,861 in 2002 to 37,608 in 2018, so the need for additional staff, six in 2002
to 12 in 2018, has increased costs to the board. Additionally, the cost of
inspections has increased, as have expenditures for investigation and
adjudication of disciplinary cases. Enforcement inspection and investigative
hours have increased from 7,179.30 in fiscal year (FY) 2002 to 13,220.30 in
FY17. The number of cases adjudicated have increased from 269 in 2002 to 651 in
2017. Additionally, the board's share of allocated expenditures has grown as
costs to the department have increased. For example, in FY02, information
technology costs were approximately $300,000; in FY17, they were $1.84 million.
Expenditures are now projected to exceed revenues in the
2018-2020 biennium. While the board has maintained a positive cash balance due
to carry-over revenue, expenditures in FY18 of $3,745,630 are projected to
exceed revenue of $3,131,895 by June 30, 2018. The imbalance will continue to
grow in the next biennium and beyond. Therefore, the board will have a
projected shortfall in its budget by 2021 of $648,614, which is projected to
grow to $2,657,527 by June 30, 2022. The Board of Pharmacy must amend
regulations as soon as possible to avoid the additional fee assessments that
other boards had to adopt or being forced to curtail vital functions of inspection
and investigation.
Without adequate revenue to support inspections of pharmacy
facilities, licensing, and discipline functions, applicants for licensure or
pharmacy permits cannot be approved in a timely manner, thus depriving the
citizens of the Commonwealth with the pharmacy services needed. Additionally,
if there is a substantial backlog of disciplinary cases, public health and
safety may be at risk by allowing practitioners guilty of drug diversion or
unprofessional conduct to continue in practice for several months while
awaiting a review and adjudication of an investigative report.
Substance: The board has proposed a 30% increase in all
fees with the exception of those functions that require an inspection,
including an initial pharmacy permit and changes in location or remodeling.
Those fees are set at an amount to offset the actual charge to the board by the
enforcement division of the department.
Issues: The primary advantage to the public is avoidance
of a reduction in investigations or inspections. There are no disadvantages to
the public. The advantage to the agency is adequate revenue to offset
expenditures so that a growing shortfall can be avoided, which would
necessitate a one-time assessment for all regulated entities or an additional
fee increase.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. The Board of
Pharmacy (Board) proposes to raise fees.
Result of Analysis. The benefits likely1 outweigh
the costs for the proposed amendments.
Estimated Economic Impact.
Background:
Fees charged to applicants and licensees of the Board of
Pharmacy have not increased since December 2002.2 During that
period, there have been three reductions in renewal fees (2005, 2006 and 2009),
while the rate of price inflation has been 33 percent.3 The number
of regulated entities has substantially increased in recent years (12,861 in
2002 to 37,608 in 2018); so the need for additional staff (six in 2002 to 12 in
2018) has increased costs to the Board. Additionally, the cost of inspections
has increased, as have expenditures for investigation and adjudication of
disciplinary cases. Enforcement inspection and investigative hours have
increased from 7,179.30 in Fiscal Year (FY) 2002 to 13,220.30 in FY 2017. The
number of cases adjudicated have increased from 269 in 2002 to 651 in 2017.
Additionally, the Board's share of allocated expenditures has grown as costs to
the Department of Health Professions (DHP) have increased. For example, in FY
2002, information technology (IT) costs were approximately $300,000; in FY
2017, IT costs were $1.84 million.4
Code of Virginia § 54.1-113.A (commonly called the
Callahan Act)5 states that:
Following the close of any biennium, when the account for any
regulatory board within the Department of Professional and Occupational
Regulation or the Department of Health Professions maintained under
§ 54.1-308 or 54.1-2505 shows expenses allocated to it for
the past biennium to be more than 10 percent greater or less than moneys
collected on behalf of the board, it shall revise the fees levied by it for
certification, licensure, registration, or permit and renewal thereof so that
the fees are sufficient but not excessive to cover expenses.
In FY2017, the Board's expenditures were $3,272,687, while its
revenues were $3,293,583. DHP projects that expenditures for FY2018 will be
$3,745,630 and revenues will be $3,131,895. Thus, total expenditures for the
biennium are projected to be $7,018,317, with revenues projected at $6,425,478.
The projected expenditures are 9.2 percent higher than the projected revenues.
This being less than 10 percent, the mandate to raise fees via the Callahan Act
is not yet triggered. Nevertheless, DHP does anticipate that expenditures will
continue to rise faster than revenues, necessitating higher fees to cover
costs.
Proposal:
The Board proposes to increase 110 different fees in this
regulatory action, primarily those paid by pharmacists, pharmacies, pharmacist
interns, and pharmacy technicians. In addition, the Board is also proposing fee
increases for practitioners of the healing arts and wholesale manufacturers,
distributors, and warehousers. The minimum dollar value of the proposed fee
increases is $5,6 while the maximum dollar value of the proposed fee
increases is $230.7
The majority of the fees would increase by approximately thirty
percent.8 For the fees that result from an inspection, the Board
plans to increase the current fees to an amount to offset the actual costs of
enforcement. There are 91 separate fees that would be subject to the roughly
thirty percent fee increase.9 For pharmacists, these cover such
areas as initial application fees, annual renewal fees, late fees,
reinstatement fees, facility change and inspection fees, and the innovative
program approval fee. For practitioners of the healing arts, these cover
initial application fees, annual renewal fees, late fees, and reinstatement
fees. For manufacturers and distributors, these cover application fees, renewal
fees, late fees, and reinstatement fees.
The Board also proposes to increase the fee for facility
permits where practitioners of the healing arts sell controlled substances,
from $40 to $50. In addition, the Board proposes to repeal several fees related
to humane society permits; these fees are no longer assessed since these
facilities now pay a controlled substance registration fee. With the proposed
fee increases, the DHP projects that the Board will have sufficient revenue to
offset expenditures by June 30, 2021.
Analysis:
DHP points out that without adequate revenue to support
inspections of pharmacy facilities, licensing and discipline functions,
applicants for licensure or pharmacy permits cannot be approved in a timely
manner. This may slow the growth of pharmacy services for the citizens of the
Commonwealth. In addition, sufficient funding is needed to carry out the
investigative and disciplinary activities of the board without creating significant
delays in both activities. If there is a substantial backlog of
disciplinary cases, public health and safety may be at risk by allowing
practitioners guilty of drug diversion, unprofessional conduct, or careless
security to continue in practice for several months awaiting a review and
adjudication of an investigative report. Thus, there are both clear benefits
and clear costs introduced by the fee increases.
It is not 100 percent certain whether or not the benefits
exceed the costs. Since regulation of professions is not a market good, there
is not an obvious market price at which speedier license processing and
disciplinary investigations are valued. Nevertheless, since the proposed fee
increases bring fees to approximately the same level as 15 years ago once
inflation is taken into consideration, the benefits likely outweigh the costs.
Businesses and Entities Affected. The proposed amendments
affect all entities that and individuals who are regulated by the Board,
including: 1,857 pharmacies, 14,714 pharmacists, 1,848 pharmacy interns, 14,552
pharmacy technicians, 140 pharmacy technician-training programs, 727 physicians
selling controlled substances, 175 physician selling drugs locations, 10 pilot
programs, 2 repackaging training programs, 66 restricted manufacturers, 47
warehousers, 116 wholesale distributors, 1,196 business controlled substance
registrants, 9 continuing education course providers, 19 limited use pharmacy
technicians, 258 medical equipment suppliers, 335 nonresident medical equipment
suppliers, 26 nonresident outsourcing facilities, 732 nonresident pharmacies,
749 nonresident wholesale distributors, 29 non-restricted manufacturers, and 1
permitted physician.10
Localities Particularly Affected. The proposed amendments do
not disproportionately affect particular localities.
Projected Impact on Employment. The proposed fee increases are
not likely to significantly affect employment but may at the margin discourage
the creation of a limited number of positions at affected firms.
Effects on the Use and Value of Private Property. The proposed
fee increases moderately increase costs for affected businesses and would have
a commensurate moderate effect on their value.
Real Estate Development Costs. The proposed amendments do not
affect real estate development costs.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. The proposed fee increases raise costs
for small pharmacies and other small businesses.
Alternative Method that Minimizes Adverse Impact. If decision makers
were to decide that not all current functions of the Board were necessary, or
necessary to perform at the frequency or speed supported by the revenue that
would be raised by the proposed fee increases, then smaller fee increases could
potentially be set.
Adverse Impacts:
Businesses. The proposed fee increases raise costs for
pharmacies, pharmacy technician-training programs, repackaging training
programs, manufacturers, warehousers, wholesale distributors, continuing
education course providers, medical equipment suppliers, outsourcing
facilities, and physician practices that sell drugs.
Localities. The proposed fee increases would not likely
significantly adversely affect localities.
Other Entities. The proposed fee increases would not likely
significantly adversely affect other entities.
__________________________
1This is not 100 percent certain. See Analysis
subsection for discussion.
2This applies to fees that existed in 2002. There have
been new fees introduced since then. Verification fees for the pharmacy
professions were added in 2015 (http://townhall.virginia.gov/L/ViewAction.cfm
?actionid=3444), and permit fees for
practitioners selling controlled substances were added in 2017 (http://townhall.virginia.gov/L/ViewAction.cfm?actionid=4451).
3This rate of inflation is calculated using the Gross
Domestic Product: Implicit Price Deflator. See https://fred.stlouisfed.org/series/GDPDEF
4All data (other than inflation rate) provided by
Department of Health Professions.
5See https://law.lis.virginia.gov/vacode/title54.1/chapter1/section54.1-113/
6Several fees are proposed to increase from $15 to $20
(the pharmacy intern registration fee, the late fee for an inactive pharmacist
license, and the late fee for approval of a pharmacy technician training
program), or from $10 to $15 (the late fee for approval of a repackaging
training program, and the duplicate license or registration fee).
7Some fees would increase from $270 to $500; these
include the pharmacy permit application fee and the permit for a physician who
is licensed to dispense drugs. This latter fee was just introduced in 2017. See
http://townhall.virginia.gov/l/ViewAction.cfm?actionid=4451.
8The actual percentages range from 28.57 percent to
33.33 percent for those fees that are increasing by approximately 30 percent.
9For a more complete list of the proposed fee increases,
see http://townhall.virginia.gov/L/ViewXML.cfm?textid=12504.
10Data source: Department of Health Professions
Agency's Response to Economic Impact Analysis: The Board
of Pharmacy concurs with the Analysis of the Department of Planning and Budget.
Summary:
The proposed amendments increase Board of Pharmacy fees to
cover expenses for essential functions of reviewing applications, licensing,
inspecting, investigating complaints against licensees, and adjudicating and
monitoring disciplinary cases. The board proposes a 30% increase in all fees,
with the exception of those functions that require an inspection, including an
initial pharmacy permit and changes in location or remodeling, which are set at
the actual charge to the board by the enforcement division of the Department of
Health Professions.
18VAC110-20-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Unless otherwise provided, any fees for taking required
examinations shall be paid directly to the examination service as specified by
the board.
C. Initial application fees.
1. Pharmacist license
|
$180 $235
|
2. Pharmacy intern registration
|
$15 $20
|
3. Pharmacy technician registration
|
$25 $35
|
4. Pharmacy permit
|
$270 $500
|
5. Permitted physician licensed to dispense drugs
|
$270 $500
|
6. Medical equipment supplier permit
|
$180 $235
|
7. Humane society permit
|
$20
|
8. 7. Outsourcing facility permit
|
$270 $350
|
9. 8. Nonresident pharmacy registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration
|
$270 $350
|
11. 10. Controlled substances registrations
|
$90 $120
|
12. 11. Innovative program approval.
If the board determines that a technical consultant is
required in order to make a decision on approval, any consultant fee, not to
exceed the actual cost, shall also be paid by the applicant in addition to
the application fee.
|
$250 $325
|
13. 12. Approval of a pharmacy technician
training program
|
$150 $200
|
14. 13. Approval of a continuing education
program
|
$100 $130
|
15. 14. Approval of a repackaging training
program
|
$50 $65
|
D. Annual renewal fees.
1. Pharmacist active license – due no later than December 31
|
$90 $120
|
2. Pharmacist inactive license – due no later than December 31
|
$45 $60
|
3. Pharmacy technician registration – due no later than
December 31
|
$25 $35
|
4. Pharmacy permit – due no later than April 30
|
$270 $350
|
5. Physician permit to practice pharmacy – due no later than
February 28
|
$270 $350
|
6. Medical equipment supplier permit – due no later than
February 28
|
$180 $235
|
7. Humane society permit – due no later than February 28
|
$20
|
8. 7. Outsourcing facility permit – due no later
than April 30
|
$270 $350
|
9. 8. Nonresident pharmacy registration – due no
later than the date of initial registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration – due no later than the date of initial registration
|
$270 $350
|
11. 10. Controlled substances registrations –
due no later than February 28
|
$90 $120
|
12. 11. Innovative program continued approval
based on board order not to exceed $200 $260 per approval
period.
|
|
13. 12. Approval of a pharmacy technician
training program
|
$75 $100 every two years
|
14. 13. Approval of a repackaging training
program
|
$30 $40 every two years
|
E. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date or within two years in the case of a pharmacy technician
training program. In addition, engaging in activities requiring a license,
permit, or registration after the expiration date of such license, permit, or
registration shall be grounds for disciplinary action by the board.
1. Pharmacist license
|
$30 $40
|
2. Pharmacist inactive license
|
$15 $20
|
3. Pharmacy technician registration
|
$10 $15
|
4. Pharmacy permit
|
$90 $120
|
5. Physician permit to practice pharmacy
|
$90 $120
|
6. Medical equipment supplier permit
|
$60 $80
|
7. Humane society permit
|
$5
|
8. 7. Outsourcing facility permit
|
$90 $120
|
9. 8. Nonresident pharmacy registration
|
$90 $120
|
10. 9. Nonresident outsourcing facility
registration
|
$90 $120
|
11. 10. Controlled substances registrations
|
$30 $40
|
12. 11. Approval of a pharmacy technician
training program
|
$15 $20
|
13. 12. Approval of a repackaging training
program
|
$10 $15
|
F. Reinstatement fees. Any person or entity attempting to
renew a license, permit, or registration more than one year after the
expiration date, or more than two years after the expiration date in the case
of a pharmacy technician training program, shall submit an application for
reinstatement with any required fees. Reinstatement is at the discretion of the
board and, except for reinstatement following license revocation or suspension,
may be granted by the executive director of the board upon completion of an
application and payment of any required fees.
1. Pharmacist license
|
$210 $275
|
2. Pharmacist license after revocation or suspension
|
$500 $650
|
3. Pharmacy technician registration
|
$35 $45
|
4. Pharmacy technician registration after revocation or
suspension
|
$125 $165
|
5. Facilities or entities that cease operation and wish to
resume shall not be eligible for reinstatement but shall apply for a new
permit or registration. Facilities or entities that failed to renew and
continued to operate for more than one renewal cycle shall pay the current
and all back renewal fees for the years in which they were operating plus the
following reinstatement fees:
|
|
a. Pharmacy permit
|
$240 $315
|
b. Physician permit to practice pharmacy
|
$240 $315
|
c. Medical equipment supplier permit
|
$210 $275
|
d. Humane society permit
|
$30
|
e. d. Outsourcing facility permit
|
$240 $315
|
f. e. Nonresident pharmacy registration
|
$115 $150
|
g. f. Nonresident outsourcing facility
registration
|
$240 $315
|
h. g. Controlled substances registration
|
$180 $235
|
i. h. Approval of a pharmacy technician
training program
|
$75 $100
|
j. i. Approval of a repackaging training
program
|
$50 $65
|
G. Application for change or inspection fees for facilities
or other entities.
1. Change of pharmacist-in-charge
|
$50 $65
|
2. Change of ownership for any facility
|
$50 $65
|
3. Inspection for remodeling or
change of location for any facility
|
$150 $300
|
4. Reinspection of any facility
|
$150 $300
|
5. Board-required inspection
for a robotic pharmacy system
|
$150 $300
|
6. Board-required inspection of an innovative program location
|
$150 $300
|
7. Change of pharmacist responsible for an approved innovative
program
|
$25 $35
|
H. Miscellaneous fees.
1. Duplicate wall certificate
|
$25 $50
|
2. Returned check
|
$35
|
3. Duplicate license or registration
|
$10 $15
|
4. Verification of licensure or registration
|
$25 $35
|
18VAC110-20-121. Innovative program approval.
A. An informal conference committee of the board may approve
an innovative or pilot program in accordance with § 54.1-3307.2 of the Code of
Virginia upon receipt of an application and fee specified in 18VAC110-20-20.
B. If the informal conference committee determines that an
inspection is necessary to adequately consider an application, it may require
that the applicant pay a fee specified in 18VAC110-20-20 to cover the cost of
the inspection.
C. If the informal conference committee determines that a
technical consultant is necessary in order for the board to make an informed
decision on approval of a program, the applicant shall pay a consultant fee,
not to exceed the actual cost of the consultation.
D. In the initial order granting approval of a program, the
informal conference committee shall set the approval period with a schedule for
submission of required reports and outcome data. The frequency of required
reports shall not exceed four times a year.
E. The informal conference committee shall determine the
appropriate fee for continued approval of the program based on the requirements
for review and monitoring. Such renewal fee shall not exceed $200 $260
per approval period.
18VAC110-30-15. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. License for practitioner of the healing arts to sell
controlled substances: $180 $235.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
C. Annual renewal fees.
1. License for practitioner of the healing arts to sell
controlled substances: $90 $120.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date.
1. License for practitioner of the healing arts to sell
controlled substances: $30 $40.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $40 $50.
E. Reinstatement fees. Any person or entity attempting to
renew a license or permit more than one year after the expiration date shall
submit an application for reinstatement with any required fees.
1. License for practitioner of the healing arts to sell
controlled substances: $150 $195.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
3. Application fee for reinstatement of a license or permit
that has been revoked or suspended indefinitely: $500 $650.
F. Facilities in which only one practitioner of the healing
arts is licensed by the board to sell controlled substances shall be exempt
from fees associated with obtaining and renewing a facility permit. Facilities
that change from only one practitioner to more than one shall notify the board
within 30 days of such change.
G. The fee for reinspection of any facility shall be $150
300.
H. The fee for a returned check shall be $35.
18VAC110-50-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. Nonrestricted manufacturer
permit
|
$270 $350
|
2. Restricted manufacturer
permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale
distributor registration
|
$270 $350
|
6. Controlled substances
registration
|
$90 $120
|
7. Third-party logistics
provider permit
|
$270 $350
|
8. Nonresident manufacturer
registration
|
$270 $350
|
9. Nonresident warehouser
registration
|
$270 $350
|
10. Nonresident third-party
logistics provider registration
|
$270 $350
|
C. Annual renewal fees shall be due on February 28 of each
year.
1. Nonrestricted manufacturer permit
|
$270 $350
|
2. Restricted manufacturer permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale distributor registration
|
$270 $350
|
6. Controlled substances registration
|
$90 $120
|
7. Third-party logistics provider permit
|
$270 $350
|
8. Nonresident manufacturer registration
|
$270 $350
|
9. Nonresident warehouser registration
|
$270 $350
|
10. Nonresident third-party logistics provider registration
|
$270 $350
|
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date. In addition, engaging in activities requiring a
license, permit, or registration after the expiration date of such license,
permit, or registration shall be grounds for disciplinary action by the board.
1. Nonrestricted manufacturer permit
|
$90 $120
|
2. Restricted manufacturer permit
|
$60 $80
|
3. Wholesale distributor license
|
$90 $120
|
4. Warehouser permit
|
$90 $120
|
5. Nonresident wholesale distributor registration
|
$90 $120
|
6. Controlled substances registration
|
$30 $40
|
7. Third-party logistics provider permit
|
$90 $120
|
8. Nonresident manufacturer registration
|
$90 $120
|
9. Nonresident warehouser registration
|
$90 $120
|
10. Nonresident third-party logistics provider registration
|
$90 $120
|
E. Reinstatement fees.
1. Any entity attempting to renew a license, permit, or
registration more than one year after the expiration date shall submit an
application for reinstatement with any required fees. Reinstatement is at the
discretion of the board and, except for reinstatement following license
revocation or suspension, may be granted by the executive director of the board
upon completion of an application and payment of any required fees.
2. Engaging in activities requiring a license, permit, or
registration after the expiration date of such license, permit, or registration
shall be grounds for disciplinary action by the board. Facilities or entities
that cease operation and wish to resume shall not be eligible for reinstatement,
but shall apply for a new permit or registration.
3. Facilities or entities that failed to renew and continued
to operate for more than one renewal cycle shall pay the current and all back
renewal fees for the years in which they were operating plus the following
reinstatement fees:
a. Nonrestricted manufacturer permit
|
$240 $315
|
b. Restricted manufacturer permit
|
$210 $275
|
c. Wholesale distributor license
|
$240 $315
|
d. Warehouser permit
|
$240 $315
|
e. Nonresident wholesale distributor registration
|
$240 $315
|
f. Controlled substances registration
|
$180 $235
|
g. Third-party logistics provider permit
|
$240 $315
|
h. Nonresident manufacturer registration
|
$240 $315
|
i. Nonresident warehouser registration
|
$240 $315
|
j. Nonresident third-party logistics provider registration
|
$240 $315
|
F. Application for change or inspection fees.
1. Reinspection fee
|
$150 $300
|
2. Inspection fee for change of location, structural changes,
or security system changes
|
$150 $300
|
3. Change of ownership fee
|
$50 $65
|
4. Change of responsible party
|
$50 $65
|
G. The fee for a returned check shall be $35.
H. The fee for verification of license, permit, or
registration shall be $25 $35.
VA.R. Doc. No. R18-5322; Filed May 8, 2019, 2:58 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHARMACY
Proposed Regulation
Titles of Regulations: 18VAC110-20. Regulations
Governing the Practice of Pharmacy (amending 18VAC110-20-20, 18VAC110-20-121).
18VAC110-30. Regulations for Practitioners of the Healing
Arts to Sell Controlled Substances (amending 18VAC110-30-15).
18VAC110-50. Regulations Governing Wholesale Distributors,
Manufacturers, and Warehousers (amending 18VAC110-50-20).
Statutory Authority: §§ 54.1-2400 and 54.1-3307 of the
Code of Virginia.
Public Hearing Information:
June 5, 2019 - 9:05 a.m. - Department of Health
Professions, Perimeter Center, 9960 Mayland Drive, Suite 201, Board Room 2,
Richmond, VA 23233
Public Comment Deadline: July 26, 2019.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Basis: Regulations of the Board of Pharmacy are promulgated
under the general authority of § 54.1-2400 of the Code of Virginia. The
proposed regulation is mandated by § 54.1-113 of the Code of Virginia.
Purpose: Fees charged to applicants and licensees of the
Board of Pharmacy have not been increased since 2002. During that time period,
there have been three reductions in renewal fees, in 2005, 2006 and 2009. The
number of regulated entities has substantially increased in recent years from
12,861 in 2002 to 37,608 in 2018, so the need for additional staff, six in 2002
to 12 in 2018, has increased costs to the board. Additionally, the cost of
inspections has increased, as have expenditures for investigation and
adjudication of disciplinary cases. Enforcement inspection and investigative
hours have increased from 7,179.30 in fiscal year (FY) 2002 to 13,220.30 in
FY17. The number of cases adjudicated have increased from 269 in 2002 to 651 in
2017. Additionally, the board's share of allocated expenditures has grown as
costs to the department have increased. For example, in FY02, information
technology costs were approximately $300,000; in FY17, they were $1.84 million.
Expenditures are now projected to exceed revenues in the
2018-2020 biennium. While the board has maintained a positive cash balance due
to carry-over revenue, expenditures in FY18 of $3,745,630 are projected to
exceed revenue of $3,131,895 by June 30, 2018. The imbalance will continue to
grow in the next biennium and beyond. Therefore, the board will have a
projected shortfall in its budget by 2021 of $648,614, which is projected to
grow to $2,657,527 by June 30, 2022. The Board of Pharmacy must amend
regulations as soon as possible to avoid the additional fee assessments that
other boards had to adopt or being forced to curtail vital functions of inspection
and investigation.
Without adequate revenue to support inspections of pharmacy
facilities, licensing, and discipline functions, applicants for licensure or
pharmacy permits cannot be approved in a timely manner, thus depriving the
citizens of the Commonwealth with the pharmacy services needed. Additionally,
if there is a substantial backlog of disciplinary cases, public health and
safety may be at risk by allowing practitioners guilty of drug diversion or
unprofessional conduct to continue in practice for several months while
awaiting a review and adjudication of an investigative report.
Substance: The board has proposed a 30% increase in all
fees with the exception of those functions that require an inspection,
including an initial pharmacy permit and changes in location or remodeling.
Those fees are set at an amount to offset the actual charge to the board by the
enforcement division of the department.
Issues: The primary advantage to the public is avoidance
of a reduction in investigations or inspections. There are no disadvantages to
the public. The advantage to the agency is adequate revenue to offset
expenditures so that a growing shortfall can be avoided, which would
necessitate a one-time assessment for all regulated entities or an additional
fee increase.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. The Board of
Pharmacy (Board) proposes to raise fees.
Result of Analysis. The benefits likely1 outweigh
the costs for the proposed amendments.
Estimated Economic Impact.
Background:
Fees charged to applicants and licensees of the Board of
Pharmacy have not increased since December 2002.2 During that
period, there have been three reductions in renewal fees (2005, 2006 and 2009),
while the rate of price inflation has been 33 percent.3 The number
of regulated entities has substantially increased in recent years (12,861 in
2002 to 37,608 in 2018); so the need for additional staff (six in 2002 to 12 in
2018) has increased costs to the Board. Additionally, the cost of inspections
has increased, as have expenditures for investigation and adjudication of
disciplinary cases. Enforcement inspection and investigative hours have
increased from 7,179.30 in Fiscal Year (FY) 2002 to 13,220.30 in FY 2017. The
number of cases adjudicated have increased from 269 in 2002 to 651 in 2017.
Additionally, the Board's share of allocated expenditures has grown as costs to
the Department of Health Professions (DHP) have increased. For example, in FY
2002, information technology (IT) costs were approximately $300,000; in FY
2017, IT costs were $1.84 million.4
Code of Virginia § 54.1-113.A (commonly called the
Callahan Act)5 states that:
Following the close of any biennium, when the account for any
regulatory board within the Department of Professional and Occupational
Regulation or the Department of Health Professions maintained under
§ 54.1-308 or 54.1-2505 shows expenses allocated to it for
the past biennium to be more than 10 percent greater or less than moneys
collected on behalf of the board, it shall revise the fees levied by it for
certification, licensure, registration, or permit and renewal thereof so that
the fees are sufficient but not excessive to cover expenses.
In FY2017, the Board's expenditures were $3,272,687, while its
revenues were $3,293,583. DHP projects that expenditures for FY2018 will be
$3,745,630 and revenues will be $3,131,895. Thus, total expenditures for the
biennium are projected to be $7,018,317, with revenues projected at $6,425,478.
The projected expenditures are 9.2 percent higher than the projected revenues.
This being less than 10 percent, the mandate to raise fees via the Callahan Act
is not yet triggered. Nevertheless, DHP does anticipate that expenditures will
continue to rise faster than revenues, necessitating higher fees to cover
costs.
Proposal:
The Board proposes to increase 110 different fees in this
regulatory action, primarily those paid by pharmacists, pharmacies, pharmacist
interns, and pharmacy technicians. In addition, the Board is also proposing fee
increases for practitioners of the healing arts and wholesale manufacturers,
distributors, and warehousers. The minimum dollar value of the proposed fee
increases is $5,6 while the maximum dollar value of the proposed fee
increases is $230.7
The majority of the fees would increase by approximately thirty
percent.8 For the fees that result from an inspection, the Board
plans to increase the current fees to an amount to offset the actual costs of
enforcement. There are 91 separate fees that would be subject to the roughly
thirty percent fee increase.9 For pharmacists, these cover such
areas as initial application fees, annual renewal fees, late fees,
reinstatement fees, facility change and inspection fees, and the innovative
program approval fee. For practitioners of the healing arts, these cover
initial application fees, annual renewal fees, late fees, and reinstatement
fees. For manufacturers and distributors, these cover application fees, renewal
fees, late fees, and reinstatement fees.
The Board also proposes to increase the fee for facility
permits where practitioners of the healing arts sell controlled substances,
from $40 to $50. In addition, the Board proposes to repeal several fees related
to humane society permits; these fees are no longer assessed since these
facilities now pay a controlled substance registration fee. With the proposed
fee increases, the DHP projects that the Board will have sufficient revenue to
offset expenditures by June 30, 2021.
Analysis:
DHP points out that without adequate revenue to support
inspections of pharmacy facilities, licensing and discipline functions,
applicants for licensure or pharmacy permits cannot be approved in a timely
manner. This may slow the growth of pharmacy services for the citizens of the
Commonwealth. In addition, sufficient funding is needed to carry out the
investigative and disciplinary activities of the board without creating significant
delays in both activities. If there is a substantial backlog of
disciplinary cases, public health and safety may be at risk by allowing
practitioners guilty of drug diversion, unprofessional conduct, or careless
security to continue in practice for several months awaiting a review and
adjudication of an investigative report. Thus, there are both clear benefits
and clear costs introduced by the fee increases.
It is not 100 percent certain whether or not the benefits
exceed the costs. Since regulation of professions is not a market good, there
is not an obvious market price at which speedier license processing and
disciplinary investigations are valued. Nevertheless, since the proposed fee
increases bring fees to approximately the same level as 15 years ago once
inflation is taken into consideration, the benefits likely outweigh the costs.
Businesses and Entities Affected. The proposed amendments
affect all entities that and individuals who are regulated by the Board,
including: 1,857 pharmacies, 14,714 pharmacists, 1,848 pharmacy interns, 14,552
pharmacy technicians, 140 pharmacy technician-training programs, 727 physicians
selling controlled substances, 175 physician selling drugs locations, 10 pilot
programs, 2 repackaging training programs, 66 restricted manufacturers, 47
warehousers, 116 wholesale distributors, 1,196 business controlled substance
registrants, 9 continuing education course providers, 19 limited use pharmacy
technicians, 258 medical equipment suppliers, 335 nonresident medical equipment
suppliers, 26 nonresident outsourcing facilities, 732 nonresident pharmacies,
749 nonresident wholesale distributors, 29 non-restricted manufacturers, and 1
permitted physician.10
Localities Particularly Affected. The proposed amendments do
not disproportionately affect particular localities.
Projected Impact on Employment. The proposed fee increases are
not likely to significantly affect employment but may at the margin discourage
the creation of a limited number of positions at affected firms.
Effects on the Use and Value of Private Property. The proposed
fee increases moderately increase costs for affected businesses and would have
a commensurate moderate effect on their value.
Real Estate Development Costs. The proposed amendments do not
affect real estate development costs.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. The proposed fee increases raise costs
for small pharmacies and other small businesses.
Alternative Method that Minimizes Adverse Impact. If decision makers
were to decide that not all current functions of the Board were necessary, or
necessary to perform at the frequency or speed supported by the revenue that
would be raised by the proposed fee increases, then smaller fee increases could
potentially be set.
Adverse Impacts:
Businesses. The proposed fee increases raise costs for
pharmacies, pharmacy technician-training programs, repackaging training
programs, manufacturers, warehousers, wholesale distributors, continuing
education course providers, medical equipment suppliers, outsourcing
facilities, and physician practices that sell drugs.
Localities. The proposed fee increases would not likely
significantly adversely affect localities.
Other Entities. The proposed fee increases would not likely
significantly adversely affect other entities.
__________________________
1This is not 100 percent certain. See Analysis
subsection for discussion.
2This applies to fees that existed in 2002. There have
been new fees introduced since then. Verification fees for the pharmacy
professions were added in 2015 (http://townhall.virginia.gov/L/ViewAction.cfm
?actionid=3444), and permit fees for
practitioners selling controlled substances were added in 2017 (http://townhall.virginia.gov/L/ViewAction.cfm?actionid=4451).
3This rate of inflation is calculated using the Gross
Domestic Product: Implicit Price Deflator. See https://fred.stlouisfed.org/series/GDPDEF
4All data (other than inflation rate) provided by
Department of Health Professions.
5See https://law.lis.virginia.gov/vacode/title54.1/chapter1/section54.1-113/
6Several fees are proposed to increase from $15 to $20
(the pharmacy intern registration fee, the late fee for an inactive pharmacist
license, and the late fee for approval of a pharmacy technician training
program), or from $10 to $15 (the late fee for approval of a repackaging
training program, and the duplicate license or registration fee).
7Some fees would increase from $270 to $500; these
include the pharmacy permit application fee and the permit for a physician who
is licensed to dispense drugs. This latter fee was just introduced in 2017. See
http://townhall.virginia.gov/l/ViewAction.cfm?actionid=4451.
8The actual percentages range from 28.57 percent to
33.33 percent for those fees that are increasing by approximately 30 percent.
9For a more complete list of the proposed fee increases,
see http://townhall.virginia.gov/L/ViewXML.cfm?textid=12504.
10Data source: Department of Health Professions
Agency's Response to Economic Impact Analysis: The Board
of Pharmacy concurs with the Analysis of the Department of Planning and Budget.
Summary:
The proposed amendments increase Board of Pharmacy fees to
cover expenses for essential functions of reviewing applications, licensing,
inspecting, investigating complaints against licensees, and adjudicating and
monitoring disciplinary cases. The board proposes a 30% increase in all fees,
with the exception of those functions that require an inspection, including an
initial pharmacy permit and changes in location or remodeling, which are set at
the actual charge to the board by the enforcement division of the Department of
Health Professions.
18VAC110-20-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Unless otherwise provided, any fees for taking required
examinations shall be paid directly to the examination service as specified by
the board.
C. Initial application fees.
1. Pharmacist license
|
$180 $235
|
2. Pharmacy intern registration
|
$15 $20
|
3. Pharmacy technician registration
|
$25 $35
|
4. Pharmacy permit
|
$270 $500
|
5. Permitted physician licensed to dispense drugs
|
$270 $500
|
6. Medical equipment supplier permit
|
$180 $235
|
7. Humane society permit
|
$20
|
8. 7. Outsourcing facility permit
|
$270 $350
|
9. 8. Nonresident pharmacy registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration
|
$270 $350
|
11. 10. Controlled substances registrations
|
$90 $120
|
12. 11. Innovative program approval.
If the board determines that a technical consultant is
required in order to make a decision on approval, any consultant fee, not to
exceed the actual cost, shall also be paid by the applicant in addition to
the application fee.
|
$250 $325
|
13. 12. Approval of a pharmacy technician
training program
|
$150 $200
|
14. 13. Approval of a continuing education
program
|
$100 $130
|
15. 14. Approval of a repackaging training
program
|
$50 $65
|
D. Annual renewal fees.
1. Pharmacist active license – due no later than December 31
|
$90 $120
|
2. Pharmacist inactive license – due no later than December 31
|
$45 $60
|
3. Pharmacy technician registration – due no later than
December 31
|
$25 $35
|
4. Pharmacy permit – due no later than April 30
|
$270 $350
|
5. Physician permit to practice pharmacy – due no later than
February 28
|
$270 $350
|
6. Medical equipment supplier permit – due no later than
February 28
|
$180 $235
|
7. Humane society permit – due no later than February 28
|
$20
|
8. 7. Outsourcing facility permit – due no later
than April 30
|
$270 $350
|
9. 8. Nonresident pharmacy registration – due no
later than the date of initial registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration – due no later than the date of initial registration
|
$270 $350
|
11. 10. Controlled substances registrations –
due no later than February 28
|
$90 $120
|
12. 11. Innovative program continued approval
based on board order not to exceed $200 $260 per approval
period.
|
|
13. 12. Approval of a pharmacy technician
training program
|
$75 $100 every two years
|
14. 13. Approval of a repackaging training
program
|
$30 $40 every two years
|
E. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date or within two years in the case of a pharmacy technician
training program. In addition, engaging in activities requiring a license,
permit, or registration after the expiration date of such license, permit, or
registration shall be grounds for disciplinary action by the board.
1. Pharmacist license
|
$30 $40
|
2. Pharmacist inactive license
|
$15 $20
|
3. Pharmacy technician registration
|
$10 $15
|
4. Pharmacy permit
|
$90 $120
|
5. Physician permit to practice pharmacy
|
$90 $120
|
6. Medical equipment supplier permit
|
$60 $80
|
7. Humane society permit
|
$5
|
8. 7. Outsourcing facility permit
|
$90 $120
|
9. 8. Nonresident pharmacy registration
|
$90 $120
|
10. 9. Nonresident outsourcing facility
registration
|
$90 $120
|
11. 10. Controlled substances registrations
|
$30 $40
|
12. 11. Approval of a pharmacy technician
training program
|
$15 $20
|
13. 12. Approval of a repackaging training
program
|
$10 $15
|
F. Reinstatement fees. Any person or entity attempting to
renew a license, permit, or registration more than one year after the
expiration date, or more than two years after the expiration date in the case
of a pharmacy technician training program, shall submit an application for
reinstatement with any required fees. Reinstatement is at the discretion of the
board and, except for reinstatement following license revocation or suspension,
may be granted by the executive director of the board upon completion of an
application and payment of any required fees.
1. Pharmacist license
|
$210 $275
|
2. Pharmacist license after revocation or suspension
|
$500 $650
|
3. Pharmacy technician registration
|
$35 $45
|
4. Pharmacy technician registration after revocation or
suspension
|
$125 $165
|
5. Facilities or entities that cease operation and wish to
resume shall not be eligible for reinstatement but shall apply for a new
permit or registration. Facilities or entities that failed to renew and
continued to operate for more than one renewal cycle shall pay the current
and all back renewal fees for the years in which they were operating plus the
following reinstatement fees:
|
|
a. Pharmacy permit
|
$240 $315
|
b. Physician permit to practice pharmacy
|
$240 $315
|
c. Medical equipment supplier permit
|
$210 $275
|
d. Humane society permit
|
$30
|
e. d. Outsourcing facility permit
|
$240 $315
|
f. e. Nonresident pharmacy registration
|
$115 $150
|
g. f. Nonresident outsourcing facility
registration
|
$240 $315
|
h. g. Controlled substances registration
|
$180 $235
|
i. h. Approval of a pharmacy technician
training program
|
$75 $100
|
j. i. Approval of a repackaging training
program
|
$50 $65
|
G. Application for change or inspection fees for facilities
or other entities.
1. Change of pharmacist-in-charge
|
$50 $65
|
2. Change of ownership for any facility
|
$50 $65
|
3. Inspection for remodeling or
change of location for any facility
|
$150 $300
|
4. Reinspection of any facility
|
$150 $300
|
5. Board-required inspection
for a robotic pharmacy system
|
$150 $300
|
6. Board-required inspection of an innovative program location
|
$150 $300
|
7. Change of pharmacist responsible for an approved innovative
program
|
$25 $35
|
H. Miscellaneous fees.
1. Duplicate wall certificate
|
$25 $50
|
2. Returned check
|
$35
|
3. Duplicate license or registration
|
$10 $15
|
4. Verification of licensure or registration
|
$25 $35
|
18VAC110-20-121. Innovative program approval.
A. An informal conference committee of the board may approve
an innovative or pilot program in accordance with § 54.1-3307.2 of the Code of
Virginia upon receipt of an application and fee specified in 18VAC110-20-20.
B. If the informal conference committee determines that an
inspection is necessary to adequately consider an application, it may require
that the applicant pay a fee specified in 18VAC110-20-20 to cover the cost of
the inspection.
C. If the informal conference committee determines that a
technical consultant is necessary in order for the board to make an informed
decision on approval of a program, the applicant shall pay a consultant fee,
not to exceed the actual cost of the consultation.
D. In the initial order granting approval of a program, the
informal conference committee shall set the approval period with a schedule for
submission of required reports and outcome data. The frequency of required
reports shall not exceed four times a year.
E. The informal conference committee shall determine the
appropriate fee for continued approval of the program based on the requirements
for review and monitoring. Such renewal fee shall not exceed $200 $260
per approval period.
18VAC110-30-15. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. License for practitioner of the healing arts to sell
controlled substances: $180 $235.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
C. Annual renewal fees.
1. License for practitioner of the healing arts to sell
controlled substances: $90 $120.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date.
1. License for practitioner of the healing arts to sell
controlled substances: $30 $40.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $40 $50.
E. Reinstatement fees. Any person or entity attempting to
renew a license or permit more than one year after the expiration date shall
submit an application for reinstatement with any required fees.
1. License for practitioner of the healing arts to sell
controlled substances: $150 $195.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
3. Application fee for reinstatement of a license or permit
that has been revoked or suspended indefinitely: $500 $650.
F. Facilities in which only one practitioner of the healing
arts is licensed by the board to sell controlled substances shall be exempt
from fees associated with obtaining and renewing a facility permit. Facilities
that change from only one practitioner to more than one shall notify the board
within 30 days of such change.
G. The fee for reinspection of any facility shall be $150
300.
H. The fee for a returned check shall be $35.
18VAC110-50-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. Nonrestricted manufacturer
permit
|
$270 $350
|
2. Restricted manufacturer
permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale
distributor registration
|
$270 $350
|
6. Controlled substances
registration
|
$90 $120
|
7. Third-party logistics
provider permit
|
$270 $350
|
8. Nonresident manufacturer
registration
|
$270 $350
|
9. Nonresident warehouser
registration
|
$270 $350
|
10. Nonresident third-party
logistics provider registration
|
$270 $350
|
C. Annual renewal fees shall be due on February 28 of each
year.
1. Nonrestricted manufacturer permit
|
$270 $350
|
2. Restricted manufacturer permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale distributor registration
|
$270 $350
|
6. Controlled substances registration
|
$90 $120
|
7. Third-party logistics provider permit
|
$270 $350
|
8. Nonresident manufacturer registration
|
$270 $350
|
9. Nonresident warehouser registration
|
$270 $350
|
10. Nonresident third-party logistics provider registration
|
$270 $350
|
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date. In addition, engaging in activities requiring a
license, permit, or registration after the expiration date of such license,
permit, or registration shall be grounds for disciplinary action by the board.
1. Nonrestricted manufacturer permit
|
$90 $120
|
2. Restricted manufacturer permit
|
$60 $80
|
3. Wholesale distributor license
|
$90 $120
|
4. Warehouser permit
|
$90 $120
|
5. Nonresident wholesale distributor registration
|
$90 $120
|
6. Controlled substances registration
|
$30 $40
|
7. Third-party logistics provider permit
|
$90 $120
|
8. Nonresident manufacturer registration
|
$90 $120
|
9. Nonresident warehouser registration
|
$90 $120
|
10. Nonresident third-party logistics provider registration
|
$90 $120
|
E. Reinstatement fees.
1. Any entity attempting to renew a license, permit, or
registration more than one year after the expiration date shall submit an
application for reinstatement with any required fees. Reinstatement is at the
discretion of the board and, except for reinstatement following license
revocation or suspension, may be granted by the executive director of the board
upon completion of an application and payment of any required fees.
2. Engaging in activities requiring a license, permit, or
registration after the expiration date of such license, permit, or registration
shall be grounds for disciplinary action by the board. Facilities or entities
that cease operation and wish to resume shall not be eligible for reinstatement,
but shall apply for a new permit or registration.
3. Facilities or entities that failed to renew and continued
to operate for more than one renewal cycle shall pay the current and all back
renewal fees for the years in which they were operating plus the following
reinstatement fees:
a. Nonrestricted manufacturer permit
|
$240 $315
|
b. Restricted manufacturer permit
|
$210 $275
|
c. Wholesale distributor license
|
$240 $315
|
d. Warehouser permit
|
$240 $315
|
e. Nonresident wholesale distributor registration
|
$240 $315
|
f. Controlled substances registration
|
$180 $235
|
g. Third-party logistics provider permit
|
$240 $315
|
h. Nonresident manufacturer registration
|
$240 $315
|
i. Nonresident warehouser registration
|
$240 $315
|
j. Nonresident third-party logistics provider registration
|
$240 $315
|
F. Application for change or inspection fees.
1. Reinspection fee
|
$150 $300
|
2. Inspection fee for change of location, structural changes,
or security system changes
|
$150 $300
|
3. Change of ownership fee
|
$50 $65
|
4. Change of responsible party
|
$50 $65
|
G. The fee for a returned check shall be $35.
H. The fee for verification of license, permit, or
registration shall be $25 $35.
VA.R. Doc. No. R18-5322; Filed May 8, 2019, 2:58 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHARMACY
Proposed Regulation
Titles of Regulations: 18VAC110-20. Regulations
Governing the Practice of Pharmacy (amending 18VAC110-20-20, 18VAC110-20-121).
18VAC110-30. Regulations for Practitioners of the Healing
Arts to Sell Controlled Substances (amending 18VAC110-30-15).
18VAC110-50. Regulations Governing Wholesale Distributors,
Manufacturers, and Warehousers (amending 18VAC110-50-20).
Statutory Authority: §§ 54.1-2400 and 54.1-3307 of the
Code of Virginia.
Public Hearing Information:
June 5, 2019 - 9:05 a.m. - Department of Health
Professions, Perimeter Center, 9960 Mayland Drive, Suite 201, Board Room 2,
Richmond, VA 23233
Public Comment Deadline: July 26, 2019.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Basis: Regulations of the Board of Pharmacy are promulgated
under the general authority of § 54.1-2400 of the Code of Virginia. The
proposed regulation is mandated by § 54.1-113 of the Code of Virginia.
Purpose: Fees charged to applicants and licensees of the
Board of Pharmacy have not been increased since 2002. During that time period,
there have been three reductions in renewal fees, in 2005, 2006 and 2009. The
number of regulated entities has substantially increased in recent years from
12,861 in 2002 to 37,608 in 2018, so the need for additional staff, six in 2002
to 12 in 2018, has increased costs to the board. Additionally, the cost of
inspections has increased, as have expenditures for investigation and
adjudication of disciplinary cases. Enforcement inspection and investigative
hours have increased from 7,179.30 in fiscal year (FY) 2002 to 13,220.30 in
FY17. The number of cases adjudicated have increased from 269 in 2002 to 651 in
2017. Additionally, the board's share of allocated expenditures has grown as
costs to the department have increased. For example, in FY02, information
technology costs were approximately $300,000; in FY17, they were $1.84 million.
Expenditures are now projected to exceed revenues in the
2018-2020 biennium. While the board has maintained a positive cash balance due
to carry-over revenue, expenditures in FY18 of $3,745,630 are projected to
exceed revenue of $3,131,895 by June 30, 2018. The imbalance will continue to
grow in the next biennium and beyond. Therefore, the board will have a
projected shortfall in its budget by 2021 of $648,614, which is projected to
grow to $2,657,527 by June 30, 2022. The Board of Pharmacy must amend
regulations as soon as possible to avoid the additional fee assessments that
other boards had to adopt or being forced to curtail vital functions of inspection
and investigation.
Without adequate revenue to support inspections of pharmacy
facilities, licensing, and discipline functions, applicants for licensure or
pharmacy permits cannot be approved in a timely manner, thus depriving the
citizens of the Commonwealth with the pharmacy services needed. Additionally,
if there is a substantial backlog of disciplinary cases, public health and
safety may be at risk by allowing practitioners guilty of drug diversion or
unprofessional conduct to continue in practice for several months while
awaiting a review and adjudication of an investigative report.
Substance: The board has proposed a 30% increase in all
fees with the exception of those functions that require an inspection,
including an initial pharmacy permit and changes in location or remodeling.
Those fees are set at an amount to offset the actual charge to the board by the
enforcement division of the department.
Issues: The primary advantage to the public is avoidance
of a reduction in investigations or inspections. There are no disadvantages to
the public. The advantage to the agency is adequate revenue to offset
expenditures so that a growing shortfall can be avoided, which would
necessitate a one-time assessment for all regulated entities or an additional
fee increase.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. The Board of
Pharmacy (Board) proposes to raise fees.
Result of Analysis. The benefits likely1 outweigh
the costs for the proposed amendments.
Estimated Economic Impact.
Background:
Fees charged to applicants and licensees of the Board of
Pharmacy have not increased since December 2002.2 During that
period, there have been three reductions in renewal fees (2005, 2006 and 2009),
while the rate of price inflation has been 33 percent.3 The number
of regulated entities has substantially increased in recent years (12,861 in
2002 to 37,608 in 2018); so the need for additional staff (six in 2002 to 12 in
2018) has increased costs to the Board. Additionally, the cost of inspections
has increased, as have expenditures for investigation and adjudication of
disciplinary cases. Enforcement inspection and investigative hours have
increased from 7,179.30 in Fiscal Year (FY) 2002 to 13,220.30 in FY 2017. The
number of cases adjudicated have increased from 269 in 2002 to 651 in 2017.
Additionally, the Board's share of allocated expenditures has grown as costs to
the Department of Health Professions (DHP) have increased. For example, in FY
2002, information technology (IT) costs were approximately $300,000; in FY
2017, IT costs were $1.84 million.4
Code of Virginia § 54.1-113.A (commonly called the
Callahan Act)5 states that:
Following the close of any biennium, when the account for any
regulatory board within the Department of Professional and Occupational
Regulation or the Department of Health Professions maintained under
§ 54.1-308 or 54.1-2505 shows expenses allocated to it for
the past biennium to be more than 10 percent greater or less than moneys
collected on behalf of the board, it shall revise the fees levied by it for
certification, licensure, registration, or permit and renewal thereof so that
the fees are sufficient but not excessive to cover expenses.
In FY2017, the Board's expenditures were $3,272,687, while its
revenues were $3,293,583. DHP projects that expenditures for FY2018 will be
$3,745,630 and revenues will be $3,131,895. Thus, total expenditures for the
biennium are projected to be $7,018,317, with revenues projected at $6,425,478.
The projected expenditures are 9.2 percent higher than the projected revenues.
This being less than 10 percent, the mandate to raise fees via the Callahan Act
is not yet triggered. Nevertheless, DHP does anticipate that expenditures will
continue to rise faster than revenues, necessitating higher fees to cover
costs.
Proposal:
The Board proposes to increase 110 different fees in this
regulatory action, primarily those paid by pharmacists, pharmacies, pharmacist
interns, and pharmacy technicians. In addition, the Board is also proposing fee
increases for practitioners of the healing arts and wholesale manufacturers,
distributors, and warehousers. The minimum dollar value of the proposed fee
increases is $5,6 while the maximum dollar value of the proposed fee
increases is $230.7
The majority of the fees would increase by approximately thirty
percent.8 For the fees that result from an inspection, the Board
plans to increase the current fees to an amount to offset the actual costs of
enforcement. There are 91 separate fees that would be subject to the roughly
thirty percent fee increase.9 For pharmacists, these cover such
areas as initial application fees, annual renewal fees, late fees,
reinstatement fees, facility change and inspection fees, and the innovative
program approval fee. For practitioners of the healing arts, these cover
initial application fees, annual renewal fees, late fees, and reinstatement
fees. For manufacturers and distributors, these cover application fees, renewal
fees, late fees, and reinstatement fees.
The Board also proposes to increase the fee for facility
permits where practitioners of the healing arts sell controlled substances,
from $40 to $50. In addition, the Board proposes to repeal several fees related
to humane society permits; these fees are no longer assessed since these
facilities now pay a controlled substance registration fee. With the proposed
fee increases, the DHP projects that the Board will have sufficient revenue to
offset expenditures by June 30, 2021.
Analysis:
DHP points out that without adequate revenue to support
inspections of pharmacy facilities, licensing and discipline functions,
applicants for licensure or pharmacy permits cannot be approved in a timely
manner. This may slow the growth of pharmacy services for the citizens of the
Commonwealth. In addition, sufficient funding is needed to carry out the
investigative and disciplinary activities of the board without creating significant
delays in both activities. If there is a substantial backlog of
disciplinary cases, public health and safety may be at risk by allowing
practitioners guilty of drug diversion, unprofessional conduct, or careless
security to continue in practice for several months awaiting a review and
adjudication of an investigative report. Thus, there are both clear benefits
and clear costs introduced by the fee increases.
It is not 100 percent certain whether or not the benefits
exceed the costs. Since regulation of professions is not a market good, there
is not an obvious market price at which speedier license processing and
disciplinary investigations are valued. Nevertheless, since the proposed fee
increases bring fees to approximately the same level as 15 years ago once
inflation is taken into consideration, the benefits likely outweigh the costs.
Businesses and Entities Affected. The proposed amendments
affect all entities that and individuals who are regulated by the Board,
including: 1,857 pharmacies, 14,714 pharmacists, 1,848 pharmacy interns, 14,552
pharmacy technicians, 140 pharmacy technician-training programs, 727 physicians
selling controlled substances, 175 physician selling drugs locations, 10 pilot
programs, 2 repackaging training programs, 66 restricted manufacturers, 47
warehousers, 116 wholesale distributors, 1,196 business controlled substance
registrants, 9 continuing education course providers, 19 limited use pharmacy
technicians, 258 medical equipment suppliers, 335 nonresident medical equipment
suppliers, 26 nonresident outsourcing facilities, 732 nonresident pharmacies,
749 nonresident wholesale distributors, 29 non-restricted manufacturers, and 1
permitted physician.10
Localities Particularly Affected. The proposed amendments do
not disproportionately affect particular localities.
Projected Impact on Employment. The proposed fee increases are
not likely to significantly affect employment but may at the margin discourage
the creation of a limited number of positions at affected firms.
Effects on the Use and Value of Private Property. The proposed
fee increases moderately increase costs for affected businesses and would have
a commensurate moderate effect on their value.
Real Estate Development Costs. The proposed amendments do not
affect real estate development costs.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. The proposed fee increases raise costs
for small pharmacies and other small businesses.
Alternative Method that Minimizes Adverse Impact. If decision makers
were to decide that not all current functions of the Board were necessary, or
necessary to perform at the frequency or speed supported by the revenue that
would be raised by the proposed fee increases, then smaller fee increases could
potentially be set.
Adverse Impacts:
Businesses. The proposed fee increases raise costs for
pharmacies, pharmacy technician-training programs, repackaging training
programs, manufacturers, warehousers, wholesale distributors, continuing
education course providers, medical equipment suppliers, outsourcing
facilities, and physician practices that sell drugs.
Localities. The proposed fee increases would not likely
significantly adversely affect localities.
Other Entities. The proposed fee increases would not likely
significantly adversely affect other entities.
__________________________
1This is not 100 percent certain. See Analysis
subsection for discussion.
2This applies to fees that existed in 2002. There have
been new fees introduced since then. Verification fees for the pharmacy
professions were added in 2015 (http://townhall.virginia.gov/L/ViewAction.cfm
?actionid=3444), and permit fees for
practitioners selling controlled substances were added in 2017 (http://townhall.virginia.gov/L/ViewAction.cfm?actionid=4451).
3This rate of inflation is calculated using the Gross
Domestic Product: Implicit Price Deflator. See https://fred.stlouisfed.org/series/GDPDEF
4All data (other than inflation rate) provided by
Department of Health Professions.
5See https://law.lis.virginia.gov/vacode/title54.1/chapter1/section54.1-113/
6Several fees are proposed to increase from $15 to $20
(the pharmacy intern registration fee, the late fee for an inactive pharmacist
license, and the late fee for approval of a pharmacy technician training
program), or from $10 to $15 (the late fee for approval of a repackaging
training program, and the duplicate license or registration fee).
7Some fees would increase from $270 to $500; these
include the pharmacy permit application fee and the permit for a physician who
is licensed to dispense drugs. This latter fee was just introduced in 2017. See
http://townhall.virginia.gov/l/ViewAction.cfm?actionid=4451.
8The actual percentages range from 28.57 percent to
33.33 percent for those fees that are increasing by approximately 30 percent.
9For a more complete list of the proposed fee increases,
see http://townhall.virginia.gov/L/ViewXML.cfm?textid=12504.
10Data source: Department of Health Professions
Agency's Response to Economic Impact Analysis: The Board
of Pharmacy concurs with the Analysis of the Department of Planning and Budget.
Summary:
The proposed amendments increase Board of Pharmacy fees to
cover expenses for essential functions of reviewing applications, licensing,
inspecting, investigating complaints against licensees, and adjudicating and
monitoring disciplinary cases. The board proposes a 30% increase in all fees,
with the exception of those functions that require an inspection, including an
initial pharmacy permit and changes in location or remodeling, which are set at
the actual charge to the board by the enforcement division of the Department of
Health Professions.
18VAC110-20-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Unless otherwise provided, any fees for taking required
examinations shall be paid directly to the examination service as specified by
the board.
C. Initial application fees.
1. Pharmacist license
|
$180 $235
|
2. Pharmacy intern registration
|
$15 $20
|
3. Pharmacy technician registration
|
$25 $35
|
4. Pharmacy permit
|
$270 $500
|
5. Permitted physician licensed to dispense drugs
|
$270 $500
|
6. Medical equipment supplier permit
|
$180 $235
|
7. Humane society permit
|
$20
|
8. 7. Outsourcing facility permit
|
$270 $350
|
9. 8. Nonresident pharmacy registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration
|
$270 $350
|
11. 10. Controlled substances registrations
|
$90 $120
|
12. 11. Innovative program approval.
If the board determines that a technical consultant is
required in order to make a decision on approval, any consultant fee, not to
exceed the actual cost, shall also be paid by the applicant in addition to
the application fee.
|
$250 $325
|
13. 12. Approval of a pharmacy technician
training program
|
$150 $200
|
14. 13. Approval of a continuing education
program
|
$100 $130
|
15. 14. Approval of a repackaging training
program
|
$50 $65
|
D. Annual renewal fees.
1. Pharmacist active license – due no later than December 31
|
$90 $120
|
2. Pharmacist inactive license – due no later than December 31
|
$45 $60
|
3. Pharmacy technician registration – due no later than
December 31
|
$25 $35
|
4. Pharmacy permit – due no later than April 30
|
$270 $350
|
5. Physician permit to practice pharmacy – due no later than
February 28
|
$270 $350
|
6. Medical equipment supplier permit – due no later than
February 28
|
$180 $235
|
7. Humane society permit – due no later than February 28
|
$20
|
8. 7. Outsourcing facility permit – due no later
than April 30
|
$270 $350
|
9. 8. Nonresident pharmacy registration – due no
later than the date of initial registration
|
$270 $350
|
10. 9. Nonresident outsourcing facility
registration – due no later than the date of initial registration
|
$270 $350
|
11. 10. Controlled substances registrations –
due no later than February 28
|
$90 $120
|
12. 11. Innovative program continued approval
based on board order not to exceed $200 $260 per approval
period.
|
|
13. 12. Approval of a pharmacy technician
training program
|
$75 $100 every two years
|
14. 13. Approval of a repackaging training
program
|
$30 $40 every two years
|
E. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date or within two years in the case of a pharmacy technician
training program. In addition, engaging in activities requiring a license,
permit, or registration after the expiration date of such license, permit, or
registration shall be grounds for disciplinary action by the board.
1. Pharmacist license
|
$30 $40
|
2. Pharmacist inactive license
|
$15 $20
|
3. Pharmacy technician registration
|
$10 $15
|
4. Pharmacy permit
|
$90 $120
|
5. Physician permit to practice pharmacy
|
$90 $120
|
6. Medical equipment supplier permit
|
$60 $80
|
7. Humane society permit
|
$5
|
8. 7. Outsourcing facility permit
|
$90 $120
|
9. 8. Nonresident pharmacy registration
|
$90 $120
|
10. 9. Nonresident outsourcing facility
registration
|
$90 $120
|
11. 10. Controlled substances registrations
|
$30 $40
|
12. 11. Approval of a pharmacy technician
training program
|
$15 $20
|
13. 12. Approval of a repackaging training
program
|
$10 $15
|
F. Reinstatement fees. Any person or entity attempting to
renew a license, permit, or registration more than one year after the
expiration date, or more than two years after the expiration date in the case
of a pharmacy technician training program, shall submit an application for
reinstatement with any required fees. Reinstatement is at the discretion of the
board and, except for reinstatement following license revocation or suspension,
may be granted by the executive director of the board upon completion of an
application and payment of any required fees.
1. Pharmacist license
|
$210 $275
|
2. Pharmacist license after revocation or suspension
|
$500 $650
|
3. Pharmacy technician registration
|
$35 $45
|
4. Pharmacy technician registration after revocation or
suspension
|
$125 $165
|
5. Facilities or entities that cease operation and wish to
resume shall not be eligible for reinstatement but shall apply for a new
permit or registration. Facilities or entities that failed to renew and
continued to operate for more than one renewal cycle shall pay the current
and all back renewal fees for the years in which they were operating plus the
following reinstatement fees:
|
|
a. Pharmacy permit
|
$240 $315
|
b. Physician permit to practice pharmacy
|
$240 $315
|
c. Medical equipment supplier permit
|
$210 $275
|
d. Humane society permit
|
$30
|
e. d. Outsourcing facility permit
|
$240 $315
|
f. e. Nonresident pharmacy registration
|
$115 $150
|
g. f. Nonresident outsourcing facility
registration
|
$240 $315
|
h. g. Controlled substances registration
|
$180 $235
|
i. h. Approval of a pharmacy technician
training program
|
$75 $100
|
j. i. Approval of a repackaging training
program
|
$50 $65
|
G. Application for change or inspection fees for facilities
or other entities.
1. Change of pharmacist-in-charge
|
$50 $65
|
2. Change of ownership for any facility
|
$50 $65
|
3. Inspection for remodeling or
change of location for any facility
|
$150 $300
|
4. Reinspection of any facility
|
$150 $300
|
5. Board-required inspection
for a robotic pharmacy system
|
$150 $300
|
6. Board-required inspection of an innovative program location
|
$150 $300
|
7. Change of pharmacist responsible for an approved innovative
program
|
$25 $35
|
H. Miscellaneous fees.
1. Duplicate wall certificate
|
$25 $50
|
2. Returned check
|
$35
|
3. Duplicate license or registration
|
$10 $15
|
4. Verification of licensure or registration
|
$25 $35
|
18VAC110-20-121. Innovative program approval.
A. An informal conference committee of the board may approve
an innovative or pilot program in accordance with § 54.1-3307.2 of the Code of
Virginia upon receipt of an application and fee specified in 18VAC110-20-20.
B. If the informal conference committee determines that an
inspection is necessary to adequately consider an application, it may require
that the applicant pay a fee specified in 18VAC110-20-20 to cover the cost of
the inspection.
C. If the informal conference committee determines that a
technical consultant is necessary in order for the board to make an informed
decision on approval of a program, the applicant shall pay a consultant fee,
not to exceed the actual cost of the consultation.
D. In the initial order granting approval of a program, the
informal conference committee shall set the approval period with a schedule for
submission of required reports and outcome data. The frequency of required
reports shall not exceed four times a year.
E. The informal conference committee shall determine the
appropriate fee for continued approval of the program based on the requirements
for review and monitoring. Such renewal fee shall not exceed $200 $260
per approval period.
18VAC110-30-15. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. License for practitioner of the healing arts to sell
controlled substances: $180 $235.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
C. Annual renewal fees.
1. License for practitioner of the healing arts to sell
controlled substances: $90 $120.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date.
1. License for practitioner of the healing arts to sell
controlled substances: $30 $40.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $40 $50.
E. Reinstatement fees. Any person or entity attempting to
renew a license or permit more than one year after the expiration date shall
submit an application for reinstatement with any required fees.
1. License for practitioner of the healing arts to sell
controlled substances: $150 $195.
2. Permit for facility in which practitioners of the healing
arts sell controlled substances: $240 $315.
3. Application fee for reinstatement of a license or permit
that has been revoked or suspended indefinitely: $500 $650.
F. Facilities in which only one practitioner of the healing
arts is licensed by the board to sell controlled substances shall be exempt
from fees associated with obtaining and renewing a facility permit. Facilities
that change from only one practitioner to more than one shall notify the board
within 30 days of such change.
G. The fee for reinspection of any facility shall be $150
300.
H. The fee for a returned check shall be $35.
18VAC110-50-20. Fees.
A. Unless otherwise provided, fees listed in this section
shall not be refundable.
B. Initial application fees.
1. Nonrestricted manufacturer
permit
|
$270 $350
|
2. Restricted manufacturer
permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale
distributor registration
|
$270 $350
|
6. Controlled substances
registration
|
$90 $120
|
7. Third-party logistics
provider permit
|
$270 $350
|
8. Nonresident manufacturer
registration
|
$270 $350
|
9. Nonresident warehouser
registration
|
$270 $350
|
10. Nonresident third-party
logistics provider registration
|
$270 $350
|
C. Annual renewal fees shall be due on February 28 of each
year.
1. Nonrestricted manufacturer permit
|
$270 $350
|
2. Restricted manufacturer permit
|
$180 $235
|
3. Wholesale distributor license
|
$270 $350
|
4. Warehouser permit
|
$270 $350
|
5. Nonresident wholesale distributor registration
|
$270 $350
|
6. Controlled substances registration
|
$90 $120
|
7. Third-party logistics provider permit
|
$270 $350
|
8. Nonresident manufacturer registration
|
$270 $350
|
9. Nonresident warehouser registration
|
$270 $350
|
10. Nonresident third-party logistics provider registration
|
$270 $350
|
D. Late fees. The following late fees shall be paid in
addition to the current renewal fee to renew an expired license within one year
of the expiration date. In addition, engaging in activities requiring a
license, permit, or registration after the expiration date of such license,
permit, or registration shall be grounds for disciplinary action by the board.
1. Nonrestricted manufacturer permit
|
$90 $120
|
2. Restricted manufacturer permit
|
$60 $80
|
3. Wholesale distributor license
|
$90 $120
|
4. Warehouser permit
|
$90 $120
|
5. Nonresident wholesale distributor registration
|
$90 $120
|
6. Controlled substances registration
|
$30 $40
|
7. Third-party logistics provider permit
|
$90 $120
|
8. Nonresident manufacturer registration
|
$90 $120
|
9. Nonresident warehouser registration
|
$90 $120
|
10. Nonresident third-party logistics provider registration
|
$90 $120
|
E. Reinstatement fees.
1. Any entity attempting to renew a license, permit, or
registration more than one year after the expiration date shall submit an
application for reinstatement with any required fees. Reinstatement is at the
discretion of the board and, except for reinstatement following license
revocation or suspension, may be granted by the executive director of the board
upon completion of an application and payment of any required fees.
2. Engaging in activities requiring a license, permit, or
registration after the expiration date of such license, permit, or registration
shall be grounds for disciplinary action by the board. Facilities or entities
that cease operation and wish to resume shall not be eligible for reinstatement,
but shall apply for a new permit or registration.
3. Facilities or entities that failed to renew and continued
to operate for more than one renewal cycle shall pay the current and all back
renewal fees for the years in which they were operating plus the following
reinstatement fees:
a. Nonrestricted manufacturer permit
|
$240 $315
|
b. Restricted manufacturer permit
|
$210 $275
|
c. Wholesale distributor license
|
$240 $315
|
d. Warehouser permit
|
$240 $315
|
e. Nonresident wholesale distributor registration
|
$240 $315
|
f. Controlled substances registration
|
$180 $235
|
g. Third-party logistics provider permit
|
$240 $315
|
h. Nonresident manufacturer registration
|
$240 $315
|
i. Nonresident warehouser registration
|
$240 $315
|
j. Nonresident third-party logistics provider registration
|
$240 $315
|
F. Application for change or inspection fees.
1. Reinspection fee
|
$150 $300
|
2. Inspection fee for change of location, structural changes,
or security system changes
|
$150 $300
|
3. Change of ownership fee
|
$50 $65
|
4. Change of responsible party
|
$50 $65
|
G. The fee for a returned check shall be $35.
H. The fee for verification of license, permit, or
registration shall be $25 $35.
VA.R. Doc. No. R18-5322; Filed May 8, 2019, 2:58 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF PHYSICAL THERAPY
Reproposed Regulation
Title of Regulation: 18VAC112-20. Regulations
Governing the Practice of Physical Therapy (adding 18VAC112-20-121).
Statutory Authority: § 54.1-2400 of the Code of
Virginia.
Public Hearing Information:
June 27, 2019 - 9 a.m. - Department of Health
Professions, Perimeter Center, 9960 Mayland Drive, 2nd Floor Conference Center,
Hearing Room 3 Henrico, VA 23233
Public Comment Deadline: July 6, 2019.
Agency Contact: Corie Tillman Wolf, Executive Director,
Board of Physical Therapy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233,
telephone (804) 367-4674, FAX (804) 527-4413, or email
ptboard@dhp.virginia.gov.
Basis: Regulations Governing the Practice of Physical
Therapy (18VAC112-20) are promulgated under the general authority of § 54.1-2400
of the Code of Virginia, which provides the Board of Physical Therapy the
authority to promulgate regulations to administer the regulatory system.
Purpose: The purpose of the action is to specify the
qualifications for and limitations of the practice of dry needling as performed
by physical therapists. For physical therapists, dry needling is not an entry
level skill for which competency has been assured through an accredited
educational program and national examination. It is an advanced procedure that
requires additional training, referral and direction, and informed consent.
Without a regulatory standard, the board cannot hold a physical therapist
accountable for requirements specific to dry needling. Therefore, the board has
determined that regulations are necessary to protect the health and safety of
patients who may receive dry needling in the course of a physical therapy
treatment.
Substance: Upon recommendation of a regulatory advisory
panel, which was convened to consider comment on proposed regulations and to
identify any additional safeguards that should be included in regulation, the following
clarifications and changes have been proposed:
18VAC112-20-121 B states that dry needling is not an entry
level skill but an advanced procedure that requires additional training. The
term "post-graduate" is added to clarify that the additional training
must occur subsequent to a physical therapist's graduate education in physical
therapy.
18VAC112-20-121 B 2 specifies that the training must consist of
didactic and hands-on laboratory education and must include passage of a
theoretical and practical examination. The hands-on laboratory education shall
be face-to-face.
18VAC112-20-121 B 3 specifies that the training must be in a
course certified by the Federation of State Boards of Physical Therapy or
approved or provided by a sponsor listed in regulations on continuing
education.
18VAC112-20-121 B 4 specifies that the practitioner shall not
practice beyond the scope of the highest level of the practitioner's training.
18VAC112-20-121 C is amended to delete a requirement that the
informed consent must clearly state that the patient is not receiving an
acupuncture treatment.
18VAC112-20-121 D is added to provide that dry needling can
only be performed by a physical therapist trained pursuant to 18VAC112-20-121 B
and cannot be delegated to a physical therapist assistant or other support
personnel.
Issues: The board believes the proposed regulation
offers the advantage of protection for patients who receive a dry needling
procedure during the course of physical therapy treatment. Regulatory
requirements for referral, training, and informed consent provide greater
assurance of competency and accountability than the guidance document that
currently exists. The board does not believe there are disadvantages to the
public as the procedure is limited in scope and relatively safe to perform.
There are no advantages or disadvantages to the agency or the
Commonwealth.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. The Board of
Physical Therapy (the board) proposes to add to its main regulation provisions
regarding the practice of dry needling including referral, training, informed
consent, and disclosure requirements.
Result of Analysis. The benefits likely exceed the costs for
all proposed changes.
Estimated Economic Impact. Dry
needling is a technique used in the practice of physical therapy to treat
muscle tension and pain by inserting a special type of needle into areas of the
muscle known as trigger points. According to the board, dry needling has been
performed by physical therapists in Virginia for more than a decade. Currently,
physical therapists performing the procedure are subject to the board's
guidance document 112-9, which sets out referral, training, informed consent,
and disclosure requirements for practice of dry needling.1 The board
proposes to add to this regulation provisions that are substantially similar to
those in the guidance document. Adding these provisions to the regulation
should not create any significant economic effects as there will be no change
in practice. One notable exception is that 54 hours of post-professional
training is required under the guidance while the proposed regulation does not
state a specific number of training hours. This provision is not being added
because the scope and content of each training may be different. However, a
practitioner is not permitted to perform dry needling beyond the scope of the
highest level of his training.
According to the board, if a physical therapist who has not
received education and training in dry needling chooses to add it as a modality
for his/her patients, there are a variety of courses offered. Most involve
multi-day seminars with hands-on training and cost approximately $1,000. Thus,
under the regulations, some physical therapists may be able to obtain
sufficient training at less than the current cost while some others may have to
incur a larger cost. In any event, practice of dry needling is voluntary, and
by choosing to offer it as a modality, a therapist reveals that expected
benefits to him or her are greater than the expected costs.
The board also notes that without a regulatory standard, a
physical therapist cannot be held accountable for requirements specific to dry
needling. Thus, having the requirements in regulations could improve
enforcement, should there be a violation.2
Businesses and Entities Affected. Currently, there are 7,786
physical therapists licensed in Virginia. Not all of the physical therapists
perform dry needling.
Localities Particularly Affected. The proposed changes apply
statewide.
Projected Impact on Employment. No impact on employment is
expected.
Effects on the Use and Value of Private Property. No impact on
the use and value of private property is expected.
Real Estate Development Costs. No impact on real estate
development costs is expected.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. Most if not all of the physical
therapists work in offices that are small business.
Alternative Method that Minimizes Adverse Impact
No adverse impact on small businesses is expected.
Adverse Impacts:
Businesses. The proposed amendments do not have an adverse
impact on businesses.
Localities. The proposed amendments will not adversely affect
localities.
Other Entities. The proposed amendments will not adversely
affect other entities.
________________________
1This guidance document posted on the Regulatory Town
Hall on August 2010 can be found at: http://townhall.virginia.gov/L/GetFile.cfm?File=C:\TownHall\docroot\GuidanceDocs\223\GDoc_DHP_3650_v2.pdf
2DHP is unaware of any complaints regarding the practice
of dry needling by physical therapists at least since 2010 when the guidance
was adopted.
Agency's Response to Economic Impact Analysis: The Board
of Physical Therapy concurs with the analysis of the Department of Planning and
Budget.
Summary:
This action establishes the qualifications for and
limitations of the performance of dry needling by physical therapists,
including referral and direction from a medical practitioner, training,
requirements for additional post-graduate training, the content of the
post-graduate training, and informed consent.
18VAC112-20-121. Practice of dry needling.
A. Dry needling is an invasive procedure that requires
referral and direction in accordance with § 54.1-3482 of the Code of
Virginia. Referral should be in writing; if the initial referral is received
orally, it shall be followed up with a written referral.
B. Dry needling is not an entry level skill but an
advanced procedure that requires additional [ post-graduate ]
training.
[ 1. ] The training shall be specific to
dry needling and shall include emergency preparedness and response,
contraindications and precautions, secondary effects or complications,
palpation and needle techniques, and physiological responses.
[ 2. The training shall consist of didactic and
hands-on laboratory education and shall include passage of a theoretical and
practical examination. The hands-on laboratory education shall be face-to-face.
3. The training shall be in a course certified by FSBPT or
approved or provided by a sponsor listed in subsection B of 18VAC112-20-131.
4. The practitioner shall not perform dry needling beyond
the scope of the highest level of the practitioner's training. ]
C. Prior to the performance of dry needling, the physical
therapist shall obtain informed consent from the patient or his representative.
The informed consent shall include the risks and benefits of the technique
[ and shall clearly state that the patient is not receiving an
acupuncture treatment ]. The informed consent form shall be
maintained in the patient record.
[ D. Dry needling shall only be performed by a
physical therapist trained pursuant to subsection B of this section and shall
not be delegated to a physical therapist assistant or other support personnel. ]
VA.R. Doc. No. R16-4433; Filed April 30, 2019, 2:49 p.m.